<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Psychosocial interventions for people with both severe mental illness and substance misuse - Hunt, GE - 2019 | Cochrane Library</title> <meta content="Psychosocial interventions for people with both severe mental illness and substance misuse - Hunt, GE - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001088.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Psychosocial interventions for people with both severe mental illness and substance misuse - Hunt, GE - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001088.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD001088.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Psychosocial interventions for people with both severe mental illness and substance misuse" name="citation_title"/> <meta content="Glenn E Hunt" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="glenn.hunt@sydney.edu.au" name="citation_author_email"/> <meta content="Nandi Siegfried" name="citation_author"/> <meta content="South African Medical Research Council" name="citation_author_institution"/> <meta content="Kirsten Morley" name="citation_author"/> <meta content="The University of Sydney" name="citation_author_institution"/> <meta content="Carrie Brooke‐Sumner" name="citation_author"/> <meta content="South African Medical Research Council" name="citation_author_institution"/> <meta content="Michelle Cleary" name="citation_author"/> <meta content="University of Tasmania" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="12" name="citation_issue"/> <meta content="10.1002/14651858.CD001088.pub4" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/12/12" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001088.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001088.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD001088.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Cognitive Behavioral Therapy; Hospitalization [statistics &amp; numerical data]; Mental Disorders [*therapy]; Psychotherapy; Randomized Controlled Trials as Topic; Recurrence; Substance‐Related Disorders [*therapy]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD001088.pub4&amp;doi=10.1002/14651858.CD001088.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="Ko3zGe0H";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD001088\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD001088\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANT","ms","ja","de","hr","fa","pl","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD001088.pub4",title:"Psychosocial interventions for people with both severe mental illness and substance misuse",firstPublishedDate:"Dec 12, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Schizophrenia Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Ko3zGe0H&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001088.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001088.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD001088.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD001088.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001088.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD001088.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;Plain language summary&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD001088.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD001088.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD001088.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD001088.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>21814 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD001088.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-sec-0296"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-sec-0022"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-sec-0023"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-sec-0028"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-sec-0029"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-sec-0116"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-sec-0279"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/appendices#CD001088-sec-0308"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/table_n/CD001088StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/table_n/CD001088StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Psychosocial interventions for people with both severe mental illness and substance misuse </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/information#CD001088-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Glenn E Hunt</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/information#CD001088-cr-0003">Nandi Siegfried</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/information#CD001088-cr-0004">Kirsten Morley</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/information#CD001088-cr-0005">Carrie Brooke‐Sumner</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD001088.pub4/information#CD001088-cr-0006">Michelle Cleary</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/information/en#CD001088-sec-0376">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 12 December 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD001088.pub4">https://doi.org/10.1002/14651858.CD001088.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD001088-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001088-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD001088-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001088-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001088-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD001088-abs-0001" lang="en"> <section id="CD001088-sec-0001"> <h3 class="title" id="CD001088-sec-0001">Background</h3> <p>Even low levels of substance misuse by people with a severe mental illness can have detrimental effects. </p> </section> <section id="CD001088-sec-0002"> <h3 class="title" id="CD001088-sec-0002">Objectives</h3> <p>To assess the effects of psychosocial interventions for reduction in substance use in people with a serious mental illness compared with standard care. </p> </section> <section id="CD001088-sec-0003"> <h3 class="title" id="CD001088-sec-0003">Search methods</h3> <p>The Information Specialist of the Cochrane Schizophrenia Group (CSG) searched the CSG Trials Register (2 May 2018), which is based on regular searches of major medical and scientific databases. </p> </section> <section id="CD001088-sec-0004"> <h3 class="title" id="CD001088-sec-0004">Selection criteria</h3> <p>We included all randomised controlled trials (RCTs) comparing psychosocial interventions for substance misuse with standard care in people with serious mental illness. </p> </section> <section id="CD001088-sec-0005"> <h3 class="title" id="CD001088-sec-0005">Data collection and analysis</h3> <p>Review authors independently selected studies, extracted data and appraised study quality. For binary outcomes, we calculated standard estimates of risk ratio (RR) and their 95% confidence intervals (CIs) on an intention‐to‐treat basis. For continuous outcomes, we calculated the mean difference (MD) between groups. Where meta‐analyses were possible, we pooled data using a random‐effects model. Using the GRADE approach, we identified seven patient‐centred outcomes and assessed the quality of evidence for these within each comparison. </p> </section> <section id="CD001088-sec-0006"> <h3 class="title" id="CD001088-sec-0006">Main results</h3> <p>Our review now includes 41 trials with a total of 4024 participants. We have identified nine comparisons within the included trials and present a summary of our main findings for seven of these below. We were unable to summarise many findings due to skewed data or because trials did not measure the outcome of interest. In general, evidence was rated as low‐ or very‐low quality due to high or unclear risks of bias because of poor trial methods, or inadequately reported methods, and imprecision due to small sample sizes, low event rates and wide confidence intervals. </p> <p>1. Integrated models of care versus standard care (36 months)</p> <p>No clear differences were found between treatment groups for loss to treatment (RR 1.09, 95% CI 0.82 to 1.45; participants = 603; studies = 3; low‐quality evidence), death (RR 1.18, 95% CI 0.39 to 3.57; participants = 421; studies = 2; low‐quality evidence), alcohol use (RR 1.15, 95% CI 0.84 to 1.56; participants = 143; studies = 1; low‐quality evidence), substance use (drug) (RR 0.89, 95% CI 0.63 to 1.25; participants = 85; studies = 1; low‐quality evidence), global assessment of functioning (GAF) scores (MD 0.40, 95% CI ‐2.47 to 3.27; participants = 170; studies = 1; low‐quality evidence), or general life satisfaction (QOLI) scores (MD 0.10, 95% CI ‐0.18 to 0.38; participants = 373; studies = 2; moderate‐quality evidence). </p> <p>2. Non‐integrated models of care versus standard care</p> <p>There was no clear difference between treatment groups for numbers lost to treatment at 12 months (RR 1.21, 95% CI 0.73 to 1.99; participants = 134; studies = 3; very low‐quality evidence). </p> <p>3. Cognitive behavioural therapy (CBT) versus standard care</p> <p>There was no clear difference between treatment groups for numbers lost to treatment at three months (RR 1.12, 95% CI 0.44 to 2.86; participants = 152; studies = 2; low‐quality evidence), cannabis use at six months (RR 1.30, 95% CI 0.79 to 2.15; participants = 47; studies = 1; very low‐quality evidence) or mental state insight (IS) scores by three months (MD 0.52, 95% CI ‐0.78 to 1.82; participants = 105; studies = 1; low‐quality evidence). </p> <p>4. Contingency management versus standard care</p> <p>We found no clear differences between treatment groups for numbers lost to treatment at three months (RR 1.55, 95% CI 1.13 to 2.11; participants = 255; studies = 2; moderate‐quality evidence), number of stimulant positive urine tests at six months (RR 0.83, 95% CI 0.65 to 1.06; participants = 176; studies = 1) or hospitalisations (RR 0.21, 95% CI 0.05 to 0.93; participants = 176; studies = 1); both low‐quality evidence<i>.</i> </p> <p>5. Motivational interviewing (MI) versus standard care</p> <p>We found no clear differences between treatment groups for numbers lost to treatment at six months (RR 1.71, 95% CI 0.63 to 4.64; participants = 62; studies = 1). A clear difference, favouring MI, was observed for abstaining from alcohol (RR 0.36, 95% CI 0.17 to 0.75; participants = 28; studies = 1) but not other substances (MD ‐0.07, 95% CI ‐0.56 to 0.42; participants = 89; studies = 1), and no differences were observed in mental state general severity (SCL‐90‐R) scores (MD ‐0.19, 95% CI ‐0.59 to 0.21; participants = 30; studies = 1). All very low‐quality evidence. </p> <p>6. Skills training versus standard care</p> <p>At 12 months, there were no clear differences between treatment groups for numbers lost to treatment (RR 1.42, 95% CI 0.20 to 10.10; participants = 122; studies = 3) or death (RR 0.15, 95% CI 0.02 to 1.42; participants = 121; studies = 1)<i>.</i> Very low‐quality, and low‐quality evidence, respectively. </p> <p>7. CBT + MI versus standard care</p> <p>At 12 months, there was no clear difference between treatment groups for numbers lost to treatment (RR 0.99, 95% CI 0.62 to 1.59; participants = 327; studies = 1; low‐quality evidence), number of deaths (RR 0.60, 95% CI 0.20 to 1.76; participants = 603; studies = 4; low‐quality evidence), relapse (RR 0.50, 95% CI 0.24 to 1.04; participants = 36; studies = 1; very low‐quality evidence), or GAF scores (MD 1.24, 95% CI ‐1.86 to 4.34; participants = 445; studies = 4; very low‐quality evidence). There was also no clear difference in reduction of drug use by six months (MD 0.19, 95% CI ‐0.22 to 0.60; participants = 119; studies = 1; low‐quality evidence). </p> </section> <section id="CD001088-sec-0007"> <h3 class="title" id="CD001088-sec-0007">Authors' conclusions</h3> <p>We included 41 RCTs but were unable to use much data for analyses. There is currently no high‐quality evidence to support any one psychosocial treatment over standard care for important outcomes such as remaining in treatment, reduction in substance use or improving mental or global state in people with serious mental illnesses and substance misuse. Furthermore, methodological difficulties exist which hinder pooling and interpreting results. Further high‐quality trials are required which address these concerns and improve the evidence in this important area. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD001088-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD001088-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD001088-abs-0008">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD001088-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD001088-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD001088-abs-0009">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD001088-abs-0006">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD001088-abs-0005">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD001088-abs-0012">Polski</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD001088-abs-0014">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD001088-abs-0004">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD001088-abs-0003" lang="en"> <h3>Psychosocial interventions for people with both severe mental illness and substance misuse. </h3> <p><b>What is the aim of this review?</b> </p> <p>The aim of this Cochrane Review is to find out if psychosocial interventions aimed at reducing substance abuse in people with a serious mental illness improve patient outcomes compared to standard care. Researchers in the Cochrane collected and analysed all relevant studies that randomly allocated people with severe mental illness and substance misuse to a psychosocial treatment or standard care to answer this question and found 41 relevant studies. </p> <p><b>Key message</b> </p> <p>From these 41 studies we did not find any high‐quality evidence to support any one psychosocial intervention over standard care. However, the differences in study designs made comparisons between studies problematic. </p> <p><b>What was studied in the review?</b> </p> <p>“Dual” diagnosis is the term used to describe people who have a mental health problem and also have problems with drugs or alcohol. In some areas, over 50% of all those with a serious mental illness (these include schizophrenia, bipolar disorders and major depression) will have problems with drugs or alcohol that have negative and damaging effects on the illness symptoms and the way their medication works. People who have substance misuse problems can be treated via a variety of psychosocial interventions. These include motivational interviewing, or MI, that looks at people’s motivation for change; cognitive behavioural therapy, or CBT, which helps people adapt their behaviour by improving coping strategies; contingency management which rewards patients to abstain from taking substances, psycho‐education for patients and their carers or family, group and individual skills training. Other interventions include provider‐oriented long‐term interventions unifying services to provide integrated treatment so patients do not have to negotiate separate mental health and substance abuse treatment programmes. Integrated care is often linked to assertive community treatment (ACT) for patients with a dual diagnosis. There are a variety of psychosocial interventions that can be added to routine care and these can be provided individually or in various combinations. Currently, we do not know if any psychosocial treatment is better or worse than standard care or if they work better given in combination or individually. </p> <p><b>What are the main results of the review?</b> </p> <p>The review found 41 relevant studies with a total of 4024 people. These studies looked at a variety of different psychosocial interventions (including CBT, MI, skills training, integrated models of care and contingency management) and compared them to standard care (the care a participant in the trial would normally receive). Main results showed there was: </p> <p>1. no real difference in terms of numbers lost to treatment (low‐quality evidence);</p> <p>2. no real difference in terms of death (low‐quality evidence);</p> <p>3. no real difference in alcohol or substance used (low‐quality evidence);</p> <p>4. no real difference in global functioning or general life satisfaction (low‐ to moderate‐quality evidence). </p> <p>In addition, studies had high numbers of people leaving early, differences in outcomes measured, and differing ways in which psychosocial interventions were delivered. More large‐scale, high‐quality and better reported studies are required to address these shortcomings. This will better address whether psychosocial interventions are effective for people with serious mental illness and substance misuse problems. </p> <p><b>How up‐to‐date is this review?</b> </p> <p>The review authors searched for studies that had been published up to October 2018.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD001088-sec-0296" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD001088-sec-0296"></div> <h3 class="title" id="CD001088-sec-0297">Implications for practice</h3> <section id="CD001088-sec-0297"> <p>This review is larger than the previous or original review (41 as opposed to 32 and six studies, respectively), although all three have similar results. The findings reveal no compelling evidence to support any one psychosocial treatment to reduce substance use or to improve mental state for people with severe mental illnesses. Some support for substance use reduction came from one small study assessing motivational interviewing, where more participants receiving this treatment abstained from alcohol. Further, more participants receiving motivational interviewing attended their first aftercare appointment. In combination with cognitive behavioural therapy, motivational interviewing also improved mental state, life satisfaction and social functioning. Little support was found for integrated, non‐integrated, or skills‐training programmes being superior to standard care. A recent study (<a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>) reported reduced stimulant use in homeless people randomised to contingency management. This intervention was combined in another study (<a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>) with motivational interviewing and cognitive behavioural therapy, with some positive outcomes. </p> <p>However, methodological difficulties exist which hinder pooling and interpreting results and include high attrition rates; varying fidelity of interventions; varying outcome measures, settings and samples (sample size, participant level of substance use, motivation to change, diagnoses, age, gender, cultural, socioeconomic and contextual influences); and, in some cases, comparison groups may have received higher levels of treatment than usual standard care. Therefore, it is not yet possible to reach clear conclusions, although it is pleasing to see that the field is developing with an increase in high‐quality randomised controlled trials offering high‐fidelity programmes and reporting more usable data. However, the largest trial to date (<a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>) did not find that motivational interviewing combined with cognitive behavioural therapy significantly improved patient outcomes. </p> <section id="CD001088-sec-0298"> <h5 class="title">1. For people with severe mental illness and substance misuse problems, and their carers </h5> <p>People with both severe mental health and substance misuse problems should be aware that at present there is little evidence to support any particular psychosocial intervention over another or over standard care. This does not mean that particular treatments do not help, but that data are few and the little supportive evidence found in these studies need further studies to support their use. No‐one can suggest to people entering a service that one form of support should really take precedence over another. </p> </section> <section id="CD001088-sec-0299"> <h5 class="title">2. For clinicians</h5> <p>Clinicians need to keep up‐to‐date on the latest research findings in this area because as new trials are published, the evidence base should rapidly build to support particular interventions for this challenging group of patients. Interventions for substance reduction may need to be further developed and adapted for people with a serious mental illness. Clinicians who seek to offer existing interventions over and above standard care should take the opportunity to work with trial researchers to generate useful data. </p> </section> <section id="CD001088-sec-0300"> <h5 class="title">3. For policy makers and commissioners of care</h5> <p>Developments in specific treatments and in models of service delivery are still taking place. While there is no evidence that the innovative integrated services that have been developed in the USA are helpful, conversely there is also no convincing evidence that they lead to a worse outcome. The development of such services may be unlikely in other countries, such as the UK where the general policy is to build on the existing links and to use mainstream services as far as possible (<a href="./references#CD001088-bbs2-0207" title="HaddockG , EisnerE , BooneC , DaviesG , CooganC , BarrowcloughC . An investigation of the implementation of NICE‐recommended CBT interventions for people with schizophrenia. Journal of Mental Health2014;23(4):162‐5. ">Haddock 2014</a>; <a href="./references#CD001088-bbs2-0281" title="SeivewrightN , McMahonC , EglestonP . Stimulant use still going strong: revisiting ....misuse of amphetamines and related drugs. Advances in Psychiatric Treatment2005;11(July):262‐9. ">Seivewright 2005</a>). This may be a function of methodological problems within the studies or it may be that there is, in fact, no effect. Policies in this difficult area are needed. These policies should be either based on good evidence or in their implementation should generate the relevant evidence. </p> </section> </section> <h3 class="title" id="CD001088-sec-0301">Implications for research</h3> <section id="CD001088-sec-0301"> <section id="CD001088-sec-0302"> <h5 class="title">1. General</h5> <section id="CD001088-sec-0303"> <h6 class="title">1.1 Reporting of outcome measures</h6> <p>Only validated and non‐adapted scales should be used in future trials. Clear reporting of data during treatment and at various follow‐up periods with an indication that they meet the assumptions of the analyses undertaken would be helpful. Wherever possible, dichotomous data should be reported in addition to continuous data, as the use of outcomes such as retention in treatment, relapse, hospitalisation and abstinence rates are relevant to the topic and are preferable to reporting skewed data (<a href="./references#CD001088-bbs2-0223" title="JonesC , CormacI , Silveira da Mota NetoJI , CampbellC . Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD000524] ">Jones 2004</a>). </p> </section> <section id="CD001088-sec-0304"> <h6 class="title">1.2 Methodology</h6> <p>Clear and strict adherence to the CONSORT statement (<a href="./references#CD001088-bbs2-0144" title="AltmanDG , SchulzKF , MoherD , EggerM , DavidoffF , ElbourneD , et al. The revised CONSORT statement for reporting randomized trial: explanation and elaboration. Annals of Internal Medicine2001;134(8):663‐94. ">Altman 2001</a>; <a href="./references#CD001088-bbs2-0152" title="BeggC , ChoM , EastwoodS , HortonR , MoherD , OlkinI , et al. Improving the quality of randomized controlled trials. The CONSORT statement. JAMA1996;276(8):637‐9. ">Begg 1996</a>; <a href="./references#CD001088-bbs2-0256" title="MoherD , PhamB , JonesA , CookDJ , JadadAR , MoherM , et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet1998;352(9128):609‐13. ">Moher 1998</a>; <a href="./references#CD001088-bbs2-0293" title="TurpinDL . CONSORT and QUOROM guidelines for reporting randomized clinical trials and systematic reviews. American Journal of Orthodontics and Dentofacial Orthodapedics2005;128(6):681‐6. ">Turpin 2005</a>) for methodology and all outcomes should be the goal of future trials. A full description of the number of participants lost to treatment and evaluation after the randomisation process should be completed at each time point for both treatment arms. A clear description of the randomisation process and blinding is also not difficult and is now necessary. The use of intention‐to‐treat analysis can assist with minimising bias resulting from missing data. Double‐blind evaluation of outcomes of psychosocial interventions is not possible due to the nature of the intervention. However, researchers should take every precaution to minimise the effect of bias by at least using raters blind to group assignment. </p> </section> </section> <section id="CD001088-sec-0305"> <h5 class="title">2. Specific</h5> <p>Consistent with our suggestions for more high‐quality randomised controlled trials, other recently published reviews advocate a need for more consistent and methodologically rigorous trials on this topic to test both individual components and integrated programme (<a href="./references#CD001088-bbs2-0153" title="BennettME , BradshawKR , CatalanoLT . Treatment of substance use disorders in schizophrenia. American Journal of Drug &amp; Alcohol Abuse2017;43(4):377‐90. ">Bennett 2017</a>; <a href="./references#CD001088-bbs2-0162" title="BonifaceS , Malet‐LambertI , ColemanR , DelucaP , DonoghueK , DrummondC , et al. The effect of brief interventions for alcohol among people with comorbid mental health conditions: A systematic review of randomized trials and narrative synthesis. Alcohol &amp; Alcoholism2018;53(3):282‐93. ">Boniface 2018</a>; <a href="./references#CD001088-bbs2-0176" title="DeWitteNA , CrunelleCL , SabbeB , MoggiF , DomG . Treatment for outpatients with comorbid schizophrenia and substance use disorders: a review. European Addiction Research2014;20(3):105‐14. ">De Witte 2014</a>; <a href="./references#CD001088-bbs2-0187" title="DonaldM , DownerJ , KavanaghD . Integrated versus non‐integrated management and care for clients with co‐occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials. Social Science and Medicine2005;60(6):1371‐83. ">Donald 2005</a>; <a href="./references#CD001088-bbs2-0192" title="DrakeRE , MueserKT , BrunetteMF , McHugoGJ . A review of treatments for people with severe mental illnesses and co‐occurring substance use disorders. Psychiatric Rehabilitation Journal2004;27(4):360‐74. ">Drake 2004</a>; <a href="./references#CD001088-bbs2-0245" title="LubmanDI , KingJA , CastleDJ . Treating comorbid substance use disorders in schizophrenia. International Review of Psychiatry2010;22(2):191‐201. ">Lubman 2010</a>; <a href="./references#CD001088-bbs2-0262" title="MueserKT , DrakeRE , SigmonSC , BrunetteMF . Psychosocial interventions of adults with severe mental illnesses and co‐occurring substance use disorders: a review of specific interventions. Journal of Dual Diagnosis2005;1(2):57‐82. ">Mueser 2005</a>; <a href="./references#CD001088-bbs2-0264" title="MurthyP , ChandP . Treatment of dual diagnosis disorders. Current Opinion in Psychiatry2012;25(3):194‐200. ">Murthy 2012</a>; <a href="./references#CD001088-bbs2-0290" title="TietQQ , MausbachB . Treatment for patients with dual diagnosis: a review. Alcoholism: Clinical and Experimental Research2007;31(4):513‐36. ">Tiet 2007</a>). Also worth noting are recent treatment recommendations and guidelines on psychosocial interventions for substance reduction modified for people with a mental illness (<a href="./references#CD001088-bbs2-0148" title="BaandrupL , Østrup RasmussenJ , KlokkerL , AustinS , BjornshaveT , Fuglsang BlikstedV , et al. Treatment of adult patients with schizophrenia and complex mental health needs‐A national clinical guideline. Nordic Journal of Psychiatry2016;70(3):231‐40. ">Baandrup 2016</a>; <a href="./references#CD001088-bbs2-0149" title="BakerAL , HilesSA , ThorntonLK , HidesL , LubmanDI . A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders. Acta Psychiatrica Scandinavica2012;126(4):243‐55. ">Baker 2012</a>; <a href="./references#CD001088-bbs2-0172" title="CrockfordD , AddingtonD . Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders. Canadian Journal of Psychiatry2017;62(9):624‐34. ">Crockford 2017</a>; <a href="./references#CD001088-bbs2-0185" title="DixonLB , DickersonF , BellackAS , BennettM , DickinsonD , GoldbergRW , et al. The 2009 schizophrenia PORTpsychosocial treatment recommendations and summary statements. Schizophrenia Bulletin2010;36(1):48‐70. ">Dixon 2010</a>; <a href="./references#CD001088-bbs2-0201" title="GalletlyC , CastleD , DarkF , HumberstoneV , JablenskyA , KillackeyE , et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry2016;50(5):410‐72. ">Galletly 2016</a>; <a href="./references#CD001088-bbs2-0210" title="HasanA , FalkaiP , WobrockT , LiebermanJ , GlenthojB , GattazWF , et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation. World Journal of Biological Psychiatry2015;16(3):142‐70. ">Hasan 2015</a>; <a href="./references#CD001088-bbs2-0228" title="KellyTM , DaleyDC , DouaihyAB . Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors2012;37(1):11‐24. ">Kelly 2012</a>; <a href="./references#CD001088-bbs2-0265" title="NICE . Psychosis with coexisting substance misuse. Assessment and management in adults and young people. National Clinical Guideline 120. London: British Psychological Society and the Royal College of Psychiatrists, 2011:1‐322. [http://www.nice.org.uk/CG120] ">NICE 2011</a>; <a href="./references#CD001088-bbs2-0301" title="Work Group on Substance Use Disorders, KleberHD , WeissRD , AntonRF , RounsavilleBJ , GeorgeTP , StrainEC , et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Americal Journal of Psychiatry2007;164 Suppl:5‐123. ">Work Group 2007</a>; <a href="./references#CD001088-bbs2-0305" title="ZiedonisDM , SmelsonD , RosenthalRN , BatkiSL , GreenAI , HenryRJ , et al. Improving the care of individuals with schizophrenia and substance use disorders: consensus recommendations. Journal of Psychiatric Practice2005;11(5):315‐39. ">Ziedonis 2005</a>). </p> <p>Future high‐quality trials in this area will contribute to the growing body of data and will allow future reviews to tease out findings. Assessing brief interventions (such as motivational interviewing) over standard care will allow the identification of cost‐effective and easy‐to‐implement components that can be quickly integrated into standard care. New trials should aim to recruit sufficiently large sample sizes and collect data that can be reported and, if appropriate, synthesised in meta‐analyses. Informed consent of participants should include statements that all anonymous data will be publicly available. The use of measurement scales should be of clinical value, in common use, and have demonstrated reliability and validity. We suggest a design for a future trial with the key methodological points highlighted in <a href="#CD001088-tbl-0011">Table 2</a>. Future reviews may explore differences between subgroups (determined a priori), such as differences between levels of substance use (misuse versus dependence), differences between substances used, and differences between age groups (for example, first‐episode schizophrenia versus older patients). </p> <div class="table" id="CD001088-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Suggested design for trial</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: centralised sequence generation with table of random numbers or computer‐generated code, stratified by severity of substance use. Sequence concealed until interventions assigned.<br/> Blinding: those recruiting and assigning participants, those assessing outcomes will be blind to treatment allocation.<br/> Duration: minimum of 1 year. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis: severe mental illness based on a diagnosis of schizophrenia, schizoaffective disorder, and other psychotic disorders.<br/> N = 440* recruited to obtain a minimum sample of 280 at 12 months given the high drop‐out rate for some of the outcome measures.<br/> Age: adults 18‐55 years.<br/> Sex: men and women.<br/> Setting: hospital and community. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. Standard care plus 3‐5 sessions of motivational interviewing + 3 months of weekly CBT.<br/> 2. Standard care plus one motivational interview. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lost to treatment.<br/> Death.<br/> Substance use: number of patients using substances, OTI.<br/> Mental state: BPRS, PANSS.<br/> Relapse: number of patients readmitted to hospital over a specified follow‐up period.<br/> Quality of life: BQOL.<br/> Functioning: GAF.<br/> Arrests, number homeless. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* size of study to detect a 10% difference in improvement with 80% certainty.<br/> If scales are used to measure outcome then there should be binary cut‐off points, defined before study start, of clinically important improvement. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>BPRS: Brief Psychiatric Rating Scale<br/> BQOL: Brief Quality of Life Scale<br/> CBT: Cognitive behavioural therapy<br/> GAF: Global Assessment of Functioning<br/> OTI: Opiate Treatment Index<br/> PANSS: Positive &amp; Negative Syndrome Scale for schizophrenia </p> </div> </div> </section> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD001088-sec-0022" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD001088-sec-0022"></div> <div class="table" id="CD001088-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Integrated models of care compared to standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>INTEGRATED MODELS OF CARE compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> outpatient<br/> <b>Intervention:</b> INTEGRATED MODELS OF CARE<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>INTEGRATED MODELS OF CARE</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b><br/> Follow‐up: mean 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>212 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>231 per 1000</b><br/> (174 to 308) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.09</b> <br/> (0.82 to 1.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>603<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were available for 36 months only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b><br/> Follow‐up: mean 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>28 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b><br/> (11 to 101) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.18</b> <br/> (0.39 to 3.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>421<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were available for 36 months only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: any change ‐ Alcohol use (not in remission)</b> <br/> Follow‐up: mean 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>575 per 1000</b><br/> (420 to 780) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.15</b> <br/> (0.84 to 1.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>143<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were available for 36 months only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: any change ‐ Drug use (not in remission)</b> <br/> Follow‐up: mean 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>650 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>578 per 1000</b><br/> (409 to 812) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.89</b> <br/> (0.63 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were available for 36 months only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were available for this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: average score</b> <br/> <b>(</b>GAF scale of 1 ‐ 100)Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean global assessment</p> <p>of functioning in the intervention groups was <b>0.70 higher</b> (‐2.07 lower to 3.47 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>171<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NOTE: The GAF measures functioning on a scale of 1 to 100 and the difference detected in this single trial is not of clinical importance. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction: avearge score (General life satisfaction)</b><br/> Quality of Life Interview section, scale of 1 to 7<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean general life satisfaction in the intervention groups was<br/> <b>0.02 higher</b><br/> (‐0.28 lower to 0.32 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>372<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The scale is from 1 to 7 and the very small difference was not statistically significant and is not of clinical importance. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as SERIOUS: Blinding of participants and personnel in all three trials was not possible and performance bias was rated as unclear risk of bias. Similarly, all trials were at an unclear risk of detection bias.<br/> <sup>2</sup> Imprecision: Rated as SERIOUS: The number of events is less than 300 and the overall sample size is small.<br/> <sup>3</sup> Risk of bias: Rated as SERIOUS: Blinding of participants and personnel in both trials was not possible and performance bias was rated as unclear risk of bias. Similarly all trials were at an unclear risk of detection bias as outcomes ratings were not blinded.<br/> <sup>4</sup> Imprecision: Rated as SERIOUS: The event rate is very low and the 95% confidence interval is wide.<br/> <sup>5</sup> Risk of bias: Rated as SERIOUS: Blinding of participants and personnel was not possible and performance bias was rated as unclear risk of bias. Similarly there was an unclear risk of detection bias as outcomes ratings were not blinded.<br/> <sup>6</sup> Imprecision: Rated as SERIOUS: The confidence interval is very wide and the sample size small. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001088-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Non‐integrated models of care ‐ Assertive community treatment only/Intensive case management/Specialised case management services versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>ASSERTIVE COMMUNITY TREATMENT INTENSIVE CASE MANAGEMENT compared to STANDARD CARE for people with both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> outpatient<br/> <b>Intervention:</b> ASSERTIVE COMMUNITY TREATMENT<b>/</b> INTENSIVE CASE MANAGEMENT<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NON‐INTEGRATED MODELS OF CARE OR INTENSIVE CASE MANAGEMENT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b><br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>239 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>289 per 1000</b><br/> (174 to 475) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.21</b> <br/> (0.73 to 1.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>134<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death was not measured in any of the trials.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol ‐ average score</b> <br/> (C‐DIS‐R computer program for Diagnostic Interview Schedule: average score)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed from one trial and there was no analysis of the difference between randomised arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug ‐ average score</b> <br/> C‐DIS‐R computer program for Diagnostic Interview Schedule: average score<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed from one trial and there was no analysis of the difference between randomised arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: Average score</b><br/> Schizophrenia symptoms on C‐DIS‐R computer program for Diagnostic Interview Schedule: average score<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed from one trial and there was no analysis of the difference between randomised arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global State: Average score</b><br/> (Role Functioning Scale, high = better functioning)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean global assessment of functioning in the intervention groups was<br/> <b>0.70 higher</b><br/> (1.56 lower to 2.96 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NOTE: the scale is 1 to 7 and the difference observed is not of clinical importance and is not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction:</b> (Quality of Life Interview section, scale of 1 to 7)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed from one trial and there was no analysis of the difference between randomised arms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as VERY SERIOUS: Random generation and allocation concealment was not adequately reported and the risk of bias is unclear. Both performance and detection bias was unclear as blinding was not performed or was unclearly reported. Attrition was unclear or very high (57% in Bond‐Anderson 91) so overall the risk of bias was rated as very serious.<br/> <sup>2</sup> Imprecision: Rated as SERIOUS: The confidence interval is wide and the sample size is very small.<br/> <sup>3</sup> Risk of bias: Rated as SERIOUS: Blinding of participants and personnel was not possible and performance bias was rated as unclear risk of bias. Similarly there was an unclear risk of detection bias as outcomes ratings were participant/clinician mediated.<br/> <br/> <sup>4</sup>Imprecision: Rated as VERY SERIOUS: The sample size is small and the confidence interval is very wide. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001088-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Cognitive behavioural therapy versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>COGNITIVE BEHAVIOUR THERAPY compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> outpatient<br/> <b>Intervention:</b> COGNITIVE BEHAVIOUR THERAPY<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>COGNITIVE BEHAVIOUR THERAPY</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b><br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>97 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>108 per 1000</b><br/> (43 to 277) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.12</b> <br/> (0.44 to 2.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death was not measured in any of the trials.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a> measured alcohol together with drug use in the Health of the Nation Outcome (HoNOS) scale. Edwards did not report on alcohol. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (Cannabis)</b><br/> Percentage of participants who used cannabis in last 4 weeks<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>650 per 1000</b><br/> (395 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.30</b> <br/> (0.79 to 2.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data for other drugs were skewed and were not compared between intervention and control.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: average score</b> (Insight scale)<br/> Follow‐up: by 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean mental state in the intervention groups was<br/> <b>0.52 higher</b><br/> (0.78 lower to 1.82 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference noted is unlikely to be clinically important</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Social functioning: Average score*</b><br/> The Social and Occupational Functioning Scale (SOFAS): scale of 1 to 100<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean global assessment of functioning in the intervention groups was<br/> <b>4.70 lower</b><br/> (14.52 lower to 5.12 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Global state data were not reported by the trials</p> <p>The other trial in this comparison (<a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>) measured Functioning with the HoNOS scale. Data were skewed and meta‐analysis was not possible </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/ life satisfaction</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study measured Quality of life</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as SERIOUS: The participants and personnel were not blinded and performance bias may be present. Missing data were addressed by Last Observation Carried Forward in Edward 2006 but attrition bias may be present as loss to follow‐up was 30% at 9 months.<br/> <sup>2</sup> Imprecision: Rated as SERIOUS: The event rate is low and the confidence interval is wide.<br/> <sup>3</sup> Imprecision: Rated as VERY SERIOUS: The event rate is low, the sample size small and the confidence interval is wide.<br/> <sup>4</sup> Imprecision: Rated as VERY SERIOUS: The confidence interval is very wide and the sample size small. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001088-tbl-0004"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Contingency management versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CONTINGENCY MANAGEMENT compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> community<br/> <b>Intervention:</b> Contingency Management<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>CONTINGENCY MANAGEMENT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b><br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>315 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>487 per 1000</b><br/> (355 to 664) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.55</b> <br/> (1.13 to 2.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None of the trials measured death as an outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed and no between‐arm comparison were reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (non‐alcohol)</b> <br/> Number with stimulant‐positive urine test<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>647 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>537 per 1000</b><br/> (421 to 686) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b> <br/> (0.65 to 1.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>176<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service use*:</b><br/> Number hospitalised<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>106 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>22 per 1000</b><br/> (5 to 98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.21</b> <br/> (0.05 to 0.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>176<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Predefinded outcome of <b>Mental state</b> data were skewed and unuseable. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neither trial measured <b>Global state</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neither trial measured <b>Quality of life</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as SERIOUS: Blinding was not possible so performance bias was rated as an unclear risk of bias. Primary outcome in both trials was urinalysis so detection bias was unlikely, Attrition bias was an unclear risk and greater than 20% across groups in both trials.<br/> <sup>2</sup> Imprecision: We did not downgrade. The confidence interval is wide although it does not cross 1 indicating appreciable harm. </p> <p><sup>3</sup> Impresion: Rated as SERIOUS: The event rate is low (less than 300 according to GRADE) and the confidence interval includes 1 and appreciable benefit.<br/> <sup>4</sup> Imprecision: Rated as SERIOUS: The event rate is very low and the confidence interval is wide. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001088-tbl-0005"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Motivational interviewing versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>MOTIVATIONAL INTERVIEWING compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> hospital and community<br/> <b>Intervention:</b> MOTIVATIONAL INTERVIEWING<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MOTIVATIONAL INTERVIEWING</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lost to treatment</b><br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>156 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>266 per 1000</b><br/> (94 to 560) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.71</b> <br/> (0.63 to 4.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death</b><br/> Follow‐up: mean 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b><br/> (3 to 629) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.04</b> <br/> (0.07 to 15.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Alcohol use</b><br/> Not abstaining from alcohol<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>923 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>332 per 1000</b><br/> (157 to 692) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.36</b> <br/> (0.17 to 0.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Drug (non‐alcohol) use</b><br/> Polydrug consumption levels measured by Opiate Treatment Index (OT)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean drug (non‐alcohol) use in the intervention groups was<br/> <b>0.07 lower</b><br/> (0.56 lower to 0.42 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state</b><br/> Symptom Checklist 90‐revised ‐ General Severity Index: Scale 0 to 4: Average score<br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean mental state in the intervention groups was<br/> <b>0.19 lower</b><br/> (0.59 lower to 0.21 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This is unlikely to be of clinical significance.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global Assessment of Functioning</b> <br/> GAF scale of 1‐ 100<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean global assessment of functioning in the intervention groups was<br/> <b>2.30 higher</b><br/> (1.30 lower to 5.90 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference is unlikely to be of clinical significance given the scale is from 1 to 100. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None of the eight trials contributing data to this comparison measured general life satisfaction. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as SERIOUS: This single trial has unclear risk of allocation concealment and an unclear risk for performance bias.<br/> <sup>2</sup> Imprecision: Rated as VERY SERIOUS: The sample size is very small (N = 62), the event rate very low and the confidence interval very wide.<br/> <sup>3</sup> Risk of bias: Rated as SERIOUS: Allocation concealment was unclear and blinding was not possible so performance bias is unclear. Assessors were not blinded so there is a high risk of detection bias. Attrition was 29% at 18 months.<br/> <sup>4</sup> Imprecision: Rated as VERY SERIOUS: The event rate is very small and the confidence interval is very wide.<br/> <sup>5</sup> Risk of bias: Rated as SERIOUS: Random generation, allocation concealment and performance bias (lack of blinding) posed an unclear risk of bias. Detection bias was likely as assessors were not blinded. <br/> <sup>6</sup> Imprecision: Rated as VERY SERIOUS: The sample size was extremely small (N = 30), and the event rate very low. <br/> <sup>7</sup> Risk of bias: Rated as SERIOUS: Selection bias was unclear and performance bias may be present as personnel and participants were not blinded. Assessors were blinded. Attrition bias is a high risk as 44% were lost to follow‐up by 12 months. <br/> <sup>8</sup> Imprecision: Rated as VERY SERIOUS: The single trial has a very small sample size (N = 30) and imprecision is very likely.<br/> <sup>9</sup> Imprecision: Rated as VERY SERIOUS: The single trial sample size is very small (N = 54) and the confidence interval is very wide.<br/> <sup>10</sup> Risk of bias: Rated as VERY SERIOUS: Selection bias was a high risk as allocation concealment was modified to allow for participant refusal and to minimise disruption to the treatment programme. Performance and detection bias were unclear as blinding was not possible for personnel and participants and assessor blinding was not reported. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001088-tbl-0006"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Skills training versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SKILLS TRAINING compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> community and outpatient<br/> <b>Intervention:</b> SKILLS TRAINING<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SKILLS TRAINING</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b> <br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>138 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>196 per 1000</b><br/> (28 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.42</b> <br/> (0.20 to 10.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000</p> <p>(2 to 112)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.15</b> </p> <p>(0.02 to 1.42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>121</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol</b><br/> (C‐DIS‐R average score)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed and no estimate of effect was calculated between randomised arms.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (non‐alcohol)</b> <br/> (C‐DIS‐R average score)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed and no estimate of effect was calculated between randomised arms.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were available for analyses.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Social functioning*:</b><br/> Role Functioning Scale: scale 1 to 7<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean assessment of functioning in the intervention groups was<br/> <b>1.07 higher</b><br/> (1.15 lower to 3.29 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Global state data were not reported.</p> <p>NOTE: the scale is 1 to 7 and the difference observed is not of clinical importance and is not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neither trial measured general life satisfaction.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of Bias: Rated as VERY SERIOUS: Blinding was not possible and performance bias may be present. It was unclear whether assessors were blinded and detection bias may be present. Attrition bias was a high risk in <a href="./references#CD001088-bbs2-0022" title="HellersteinDJ , RosenthalRN , MinerCR . A prospective study of integrated outpatient treatment for substance‐abusing schizophrenic patients. American Journal on Addictions1995;4(1):33‐42. [CSzG: 5029] HellersteinDJ , RosenthalRN , MinerCR . Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly2001;72(4):291‐306. [CSzG: 8206] ">Hellerstein 1995</a> with 47% loss to follow‐up at 4 months and 64% at 8 months with no reasons for drop‐outs provided and not addressed in analysis.<br/> <sup>2</sup> Imprecision: Rated as SERIOUS: The event rate was low (zero events in one trial) with a wide confidence interval.<br/> <sup>3</sup> Risk of Bias: Rated as SERIOUS: The trial outcomes were self‐reported abstinence and there is no report of whether raters were blind to treatment allocation when assessing the participant's self‐report. </p> <p><sup>4</sup> Inconsistency: this is not possible to evaluate as there is only a single study. </p> <p><sup>5</sup> Imprecision: The single trial has a small sample size of 121 with very low event rates. The confidence interval crosses the line of no effect and appreciable harm.<br/> <sup>6</sup> Risk of Bias: Rated as SERIOUS: Blinding was not possible and performance bias may be present. It was unclear whether<br/> <sup>7</sup> Imprecision: Rated as VERY SERIOUS: The single trial has a very small sample size (N =47) and the confidence interval is wide. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001088-tbl-0007"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Cognitive behavioural therapy + motivational interviewing versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>COGNITIVE BEHAVIOURAL THERAPY + MOTIVATIONAL INTERVIEWING compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> outpatient<br/> <b>Intervention:</b> COGNITIVE BEHAVIOUR THERAPY + MOTIVATIONAL INTERVIEWING<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>COGNITIVE BEHAVIOUR THERAPY + MOTIVATIONAL INTERVIEWING</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b><br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>178 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>176 per 1000</b> </p> <p>(110 to 283)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.99</b> <br/> (0.62 to 1.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>327<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse event: Death</b> <br/> Follow‐up: mean 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>32 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>19 per 1000</b> </p> <p>(6 to 56)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.60</b> <br/> (0.20 to 1.76) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>603<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol</b> (<br/> Estimated daily consumption in previous month)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed from one trial and there was no analysis of the difference between randomised arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (non‐alcohol) use</b><br/> (Average number of different drugs used during the past month measured by the Opiate Treatment Index)<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>32 per 1000</b> </p> <p>The average number of different drugs used in past month in the intervention group was <b>0.19 higher</b> (0.22 lower to 0.60 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b><br/> (6 to 56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>119<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relapse:*</b><br/> Relapse at 3 months after 9 months of treatment<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>667 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1000</b><br/> (160 to 693) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.50</b> <br/> (0.24 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Clinically important change in mental state not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global State:</b><br/> GAF scale of 1‐ 100<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Global Assessment of Functioning in the intervention groups was <b>1.24 higher</b> (1.86 lower to 4.34 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>445<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>8,9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NOTE: The GAF measures functioning on a scale of 1 to 100 and the difference detected in this single trial is not of clinical importance. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life / life satisfaction:</b><br/> Brief Quality of Life Scale<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean general life satisfaction in the intervention groups was<br/> <b>0.58 higher</b><br/> (0.00 to 1.16 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>110<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>11,12</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as SERIOUS: The single trial which reported on 12 month loss to treatment had adequate random generation and allocation concealment. However, we down‐graded it for possible performance bias as participants and clinicians were not blinded. Detection bias was a low risk as outcome assessors were blinded.<br/> <sup>2</sup> Imprecision: Rated as SERIOUS: The event rate is low and the confidence interval is wide and includes the line of no effect and appreciable harm.<br/> <sup>3</sup> Risk of bias: Rated as SERIOUS: The four trials included in this meta‐analysis were well‐conducted. A lack of blinding is unlikely to affect measurement of death. However, attrition was &gt; 20% in all four trials and although missing data were balanced across groups, there is an unclear risk of bias due to attrition bias.<br/> <sup>4</sup> Risk of bias: Rated as SERIOUS: Random generation and allocation concealment were unclear and blinding was not possible for participants or clinicians. Attrition was high at 20% at 12 months, but missing outcome data were balanced between groups.<br/> <sup>5</sup> Imprecision: Rated as SERIOUS: The sample size is small and the confidence interval is wide.<br/> <sup>6</sup> Risk of bias: Rated as SERIOUS: The risk of attrition bias is unclear (22% across both groups at 18 months) despite missing outcome balanced between groups. A lack of blinding of participants and clinicians may result in performance bias.<br/> <sup>7</sup> Imprecision: Rated as VERY SERIOUS: The event rate is extremely low in this very small single trial (N = 36) and the confidence interval is wide.<br/> <sup>8</sup> Risk of bias: Rated as SERIOUS: Attrition was &gt; 20% in all four trials and although missing data were balanced across groups, there is an unclear risk of bias due to attrition bias.<br/> <sup>9</sup> Inconsistency: Rated as SERIOUS: Heterogeneity was present (ChiÂ² = 5.20, df = 3 (P = 0.16); IÂ² = 42%). One trial (Barrowclough) showed significant improvement in the treatment group compared with the others, but we were unable to explain the reason for this.<br/> <sup>10</sup> Imprecision: Rated as SERIOUS: Four trials provided data for this meta‐analysis. The confidence interval is wide.<br/> <sup>11</sup> Risk of bias: Rated as SERIOUS: Blinding of participants and clinicians was not possible and performance bias may be a risk. Attrition was 25% at 6 months and missing data were not balanced across interventions. Missing outcomes are enough to induce clinically relevant bias in observed effect size.<br/> <sup>12</sup> Imprecision: Rated as SERIOUS: The sample size of the single trial is small and the confidence interval is wide. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001088-tbl-0008"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Cognitive behavioural therapy + psychosocial rehabilitation versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>COGNITIVE BEHAVIOUR THERAPY and PSYCHOSOCIAL REHABILITATION compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> jail and community<br/> <b>Intervention:</b> COGNITIVE BEHAVIOUR THERAPY and PSYCHOSOCIAL REHABILITATION<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>COGNITIVE BEHAVIOUR THERAPY and PSYCHOSOCIAL REHABILITATION</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leavint the study early: Loss to Treatment</b><br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were only reported per trial and not per randomised arm.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial did not measure death as an outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (non‐alcohol)</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. The data were skewed and was not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. The data were skewed and was not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global State</b>‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. The data were skewed and was not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. The data were skewed and was not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as VERY SERIOUS: Although the random generation is reported as computer‐generated the numbers in the arms vary and no report is made as to whether randomisation was done in a ratio fashion. Blinding was not done and performance bias may be unclear and detection bias is high risk as the assessors were not blinded. There is a high risk of selective reporting bias as few outcomes are reported per arm and mainly by site.<br/> <sup>2</sup> Imprecision: Rated as VERY SERIOUS: The sample size is small and any estimate of effect (had it been reported per arm) is highly likely to be imprecise. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD001088-tbl-0009"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Cognitive behavioural therapy + intensive case management versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>COMBINED COGNITIVE BEHAVIOUR THERAPY and INTENSIVE CASE MANAGEMENT compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> jail and community<br/> <b>Intervention:</b> COMBINED COGNITIVE BEHAVIOUR THERAPY and INTENSIVE CASE MANAGEMENT<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>COMBINED COGNITIVE BEHAVIOUR THERAPY and INTENSIVE CASE MANAGEMENT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Loss to Treatment</b><br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to use data ‐ (no breakdown by treatment arms)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial did not measure death.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: alcohol</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (non‐alcohol)</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global State</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as VERY SERIOUS: Although the random generation is reported as computer‐generated the numbers in the arms vary and no report is made as to whether randomisation was done in a ratio fashion. Blinding was not done and performance bias may be unclear and detection bias is high risk as the assessors were not blinded. There is a high risk of selective reporting bias as few outcomes are reported per arm and mainly by site.<br/> <sup>2</sup> Risk of bias: Rated as VERY SERIOUS: Although the random generation is reported as computer‐generated the numbers in the arms vary and no report is made as to whether randomisation was done in a ratio fashion. Blinding was not done and performance bias may be unclear and detection bias is high risk as the assessors were not blinded. There is a high risk of selective reporting bias as few outcomes are reported per arm and mainly by site. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD001088-sec-0023" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD001088-sec-0023"></div> <section id="CD001088-sec-0024"> <h3 class="title" id="CD001088-sec-0024">Description of the condition</h3> <p>Substance misuse among people with a severe mental illness is a major concern, with prevalence rates over 50%. This figure varies across studies, depending on location, methodologies and by the way substance misuse problems and severe mental illness are defined (<a href="./references#CD001088-bbs2-0163" title="BrunetteMF , MueserKT , BabbinS , Meyer‐KalosP , RosenheckR , CorrellCU , et al. Demographic and clinical correlates of substance use disorders in first episode psychosis. Schizophrenia Research2018;194:4‐12. ">Brunette 2018</a>; <a href="./references#CD001088-bbs2-0167" title="CarraG , JohnsonS . Variations in rates of comorbid substance use in psychosis between mental health settings and geographical areas in the UK. A systematic review. Social Psychiatry &amp; Psychiatric Epidemiology2009;44(6):429‐47. ">Carra 2009</a>; <a href="./references#CD001088-bbs2-0204" title="GreenAI , DrakeRE , BrunetteMF , NoordsyDL . Schizophrenia and co‐occurring substance use disorder. Americal Journal of Psychiatry2007;164(3):402‐8. ">Green 2007</a>; <a href="./references#CD001088-bbs2-0205" title="GreggL , BarrowcloughC , HaddockG . Reasons for increased substance use in psychosis. Clinical Psychology Review2007;27(4):494‐510. ">Gregg 2007</a>; <a href="./references#CD001088-bbs2-0209" title="HartzSM , PatoCN , MedeirosH , Cavazos‐RehgP , SobellJL , KnowlesJA , et al. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry2014;71(3):248‐54. ">Hartz 2014</a>; <a href="./references#CD001088-bbs2-0231" title="LaiHM , SitharthanT , HuangQR . Exploration of the comorbidity of alcohol use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia. Substance Abuse2012;33(2):138‐45. ">Lai 2012a</a>; <a href="./references#CD001088-bbs2-0232" title="LaiHM , SitharthanT . Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia. American Journal of Drug &amp; Alcohol Abuse2012;38(6):567‐74. ">Lai 2012b</a>; <a href="./references#CD001088-bbs2-0244" title="LoweAL , Abou‐SalehMT . The British experience of dual diagnosis in the national health service. Acta Neuropsychiatrica2004;16(1):41‐6. ">Lowe 2004</a>; <a href="./references#CD001088-bbs2-0259" title="MorganVA , WaterreusA , CarrV , CastleD , CohenM , HarveyC , et al. Responding to challenges for people with psychotic illness: Updated evidence from the Survey of High Impact Psychosis. Australian &amp; New Zealand Journal of Psychiatry2017;51(2):124‐40. ">Morgan 2017</a>; <a href="./references#CD001088-bbs2-0272" title="RegierDA , FarmerME , RaeDS , LockeBZ , KeithSJ , JuddLL , et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA1990;264(19):2511‐8. ">Regier 1990</a>; <a href="./references#CD001088-bbs2-0291" title="ToddJ , GreenG , HarrisonM , IkuesanBA , SelfC , BaldacchinoA , et al. Defining dual diagnosis of mental illness and substance misuse: some methodological issues. Journal of Psychiatric and Mental Health Nursing2004;11(1):48‐54. ">Todd 2004</a>). Recent meta‐analyses have shown high rates of co‐morbidity between substance use disorders (SUD) and schizophrenia (<a href="./references#CD001088-bbs2-0220" title="HuntGE , LargeM , ClearyM , LaiHMX , SaundersJB . Prevalence of comorbid substance use in schizophrenia spectrum disorders in community and clinical settings, 1990‐2017: Systematic review and meta‐analysis. Drug and Alcohol Dependence2018;191:234‐58. ">Hunt 2018</a>), bipolar disorders (<a href="./references#CD001088-bbs2-0219" title="HuntGE , MalhiGS , ClearyM , LaiHMX , SitharthanT . Prevalence of comorbid bipolar and substance use disorders in clinical settings, 1990‐2015: Systematic review and meta‐analysis. Journal of Affective Disorders2016;206:331‐49. ">Hunt 2016</a>) and major depression (<a href="./references#CD001088-bbs2-0233" title="LaiHM , ClearyM , SitharthanT , HuntGE . Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990‐2014: A systematic review and meta‐analysis. Drug and Alcohol Dependence2015;154:1‐13. ">Lai 2015</a>). Improving services for people with a serious mental illness (often labelled as having a 'dual diagnosis') is a priority as using drugs or consuming alcohol, even at low levels, is associated with a range of adverse consequences, including higher rates of non‐adherence, relapse, suicide, HIV, hepatitis, homelessness, aggression, incarceration, and fewer social supports or financial resources (<a href="./references#CD001088-bbs2-0187" title="DonaldM , DownerJ , KavanaghD . Integrated versus non‐integrated management and care for clients with co‐occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials. Social Science and Medicine2005;60(6):1371‐83. ">Donald 2005</a>; <a href="./references#CD001088-bbs2-0204" title="GreenAI , DrakeRE , BrunetteMF , NoordsyDL . Schizophrenia and co‐occurring substance use disorder. Americal Journal of Psychiatry2007;164(3):402‐8. ">Green 2007</a>; <a href="./references#CD001088-bbs2-0218" title="HuntGE , BergenJ , BashirM . Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophrenia Research2002;54(3):253‐64. ">Hunt 2002</a>; <a href="./references#CD001088-bbs2-0229" title="KhokharJY , DwielLL , HenricksAM , DoucetteWT , GreenAI . The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophrenia Research2018;194:78‐85. ">Khokhar 2018</a>; <a href="./references#CD001088-bbs2-0268" title="PettersenH , RuudT , RavndalE , HavnesI , LandheimA . Engagement in assertive community treatment as experienced by recovering clients with severe mental illness and concurrent substance use. International Journal of Mental Health Systems2014;8(1):40. ">Pettersen 2014</a>; <a href="./references#CD001088-bbs2-0277" title="SchmidtLM , HesseM , LykkeJ . The impact of substance use disorders on the course of schizophrenia ‐ a 15‐year follow‐up study: dual diagnosis over 15 years. Schizophrenia Research2011;130(1‐3):228‐33. ">Schmidt 2011</a>; <a href="./references#CD001088-bbs2-0292" title="TsuangJ , FongTW , LesserI . Psychosocial treatment of patients with schizophrenia and substance abuse disorders. Addictive Disorders and Their Treatment2006;5(2):53‐66. ">Tsuang 2006</a>). Further, co‐morbidity places an additional burden on families, psychiatric and government resources and is particularly challenging to those providing services as these patients have lower rates of treatment completion and higher rates of relapse (<a href="./references#CD001088-bbs2-0229" title="KhokharJY , DwielLL , HenricksAM , DoucetteWT , GreenAI . The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophrenia Research2018;194:78‐85. ">Khokhar 2018</a>; <a href="./references#CD001088-bbs2-0263" title="MueserKT , DeaversF , PennDL , CassisiJE . Psychosocial treatments for schizophrenia. Annual Review of Clinical Psychology2013;9:465‐97. ">Mueser 2013</a>; <a href="./references#CD001088-bbs2-0283" title="SiegfriedN . A review of comorbidity: major mental illness and problematic substance use. Australian and New Zealand Journal of Psychiatry1998;32(5):707‐17. ">Siegfried 1998</a>; <a href="./references#CD001088-bbs2-0295" title="TyrerP , WeaverT . Desperately seeking solutions: the search for appropriate treatment for comorbid substance misuse and psychosis. Psychiatric Bulletin2004;28(1):1‐2. ">Tyrer 2004</a>; <a href="./references#CD001088-bbs2-0297" title="WarrenJI , SteinJA , GrellaCE . Role of social support and self‐efficacy in treatment outcomes among clients with co‐occurring disorders. Drug and Alcohol Dependence.2007;89(2‐3):267‐74. ">Warren 2007</a>). </p> </section> <section id="CD001088-sec-0025"> <h3 class="title" id="CD001088-sec-0025">Description of the intervention</h3> <p>It is important that co‐occurring substance use is detected as early as possible and that appropriate and effective treatment is provided (<a href="./references#CD001088-bbs2-0204" title="GreenAI , DrakeRE , BrunetteMF , NoordsyDL . Schizophrenia and co‐occurring substance use disorder. Americal Journal of Psychiatry2007;164(3):402‐8. ">Green 2007</a>; <a href="./references#CD001088-bbs2-0263" title="MueserKT , DeaversF , PennDL , CassisiJE . Psychosocial treatments for schizophrenia. Annual Review of Clinical Psychology2013;9:465‐97. ">Mueser 2013</a>). Treatment has traditionally been complicated by different approaches and philosophies among mental health and drug services as they may differ in their theoretical underpinnings, policies and protocols. Separate treatment programmes have been offered in parallel or sequentially by different clinicians, which may result in less than optimum patient care with the patient having to negotiate two separate treatment systems (<a href="./references#CD001088-bbs2-0176" title="DeWitteNA , CrunelleCL , SabbeB , MoggiF , DomG . Treatment for outpatients with comorbid schizophrenia and substance use disorders: a review. European Addiction Research2014;20(3):105‐14. ">De Witte 2014</a>; <a href="./references#CD001088-bbs2-0193" title="DrakeRE , O'NealEL , WallachMA . A systematic review of psychosocial research on psychosocial interventions for people with co‐occurring severe mental and substance use disorders. Journal of Substance Abuse and Treatment2008;34(1):123‐38. ">Drake 2008</a>; <a href="./references#CD001088-bbs2-0204" title="GreenAI , DrakeRE , BrunetteMF , NoordsyDL . Schizophrenia and co‐occurring substance use disorder. Americal Journal of Psychiatry2007;164(3):402‐8. ">Green 2007</a>). Another approach to care is the integrated treatment model where mental health and substance use treatments are brought together simultaneously by the same service, clinician or team of clinicians who are competent in both service areas and place similar importance on both (<a href="./references#CD001088-bbs2-0192" title="DrakeRE , MueserKT , BrunetteMF , McHugoGJ . A review of treatments for people with severe mental illnesses and co‐occurring substance use disorders. Psychiatric Rehabilitation Journal2004;27(4):360‐74. ">Drake 2004</a>). Basic elements include an assertive style of engagement, techniques of close monitoring, comprehensive services (including inpatient, day hospital, community team and outpatient care), supportive living environments, flexibility and specialisation of clinicians, step‐wise treatment, and a long‐term perspective and optimism (<a href="./references#CD001088-bbs2-0160" title="BondGR , DrakeRE . The critical ingredients of assertive community treatment. World Psychiatry2015;14(2):240‐2. ">Bond 2015</a>; <a href="./references#CD001088-bbs2-0189" title="DrakeRE , BartelsSJ , TeagueGB , NoordsyDL , ClarkRE . Treatment of substance abuse in severely mentally ill patients. Journal of Nervous and Mental Disease1993;181(10):606‐11. ">Drake 1993</a>; <a href="./references#CD001088-bbs2-0193" title="DrakeRE , O'NealEL , WallachMA . A systematic review of psychosocial research on psychosocial interventions for people with co‐occurring severe mental and substance use disorders. Journal of Substance Abuse and Treatment2008;34(1):123‐38. ">Drake 2008</a>). Assertive Community Treatment (ACT) and residential programmes are generally long term and can form a basis for integrated programmes (<a href="./references#CD001088-bbs2-0263" title="MueserKT , DeaversF , PennDL , CassisiJE . Psychosocial treatments for schizophrenia. Annual Review of Clinical Psychology2013;9:465‐97. ">Mueser 2013</a>). </p> </section> <section id="CD001088-sec-0026"> <h3 class="title" id="CD001088-sec-0026">How the intervention might work</h3> <p>As many substance users in the general population have benefited from a range of psychosocial interventions, it would follow that these same interventions should also benefit people with psychosis when their mental health problems are taken into account (<a href="./references#CD001088-bbs2-0150" title="BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: A descriptive review. Journal of Mental Health2006;15(6):619‐32. ">Barrowclough 2006a</a>). Most, if not all, substances of abuse increase dopaminergic activity in the brain (<a href="./references#CD001088-bbs2-0230" title="KoobGF , VolkowND . Neurocircuitry of addiction. Neuropsychopharmacology2010;35(1):217‐38. ">Koob 2010</a>). Given that schizophrenia and other forms of psychosis are characterised by heightened dopaminergic transmission and that neuroleptics decrease activity or block dopamine receptors (<a href="./references#CD001088-bbs2-0225" title="KapurS , MizrahiR , LiM . From dopamine to salience to psychosis ‐ linking biology, pharmacology and phenomenology of psychosis. Schizophrenia Research2005;79:59‐68. ">Kapur 2005</a>), it stands to reason that most substances of abuse increase symptoms, the risk of relapse and compromise the beneficial effects of neuroleptics (<a href="./references#CD001088-bbs2-0229" title="KhokharJY , DwielLL , HenricksAM , DoucetteWT , GreenAI . The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophrenia Research2018;194:78‐85. ">Khokhar 2018</a>; <a href="./references#CD001088-bbs2-0235" title="LargeM , MullinK , GuptaP , HarrisA , NielssenO . Systematic meta‐analysis of outcomes associated with psychosis and co‐morbid substance use. Australian &amp; New Zealand Journal of Psychiatry2014;48(5):418‐32. ">Large 2014</a>; <a href="./references#CD001088-bbs2-0237" title="LeDucPA , MittlemanG . Schizophrenia and psychostimulant abuse: a review and re‐analysis of clinical evidence. Psychopharmacology1995;121:407‐27. ">LeDuc 1995</a>; <a href="./references#CD001088-bbs2-0280" title="SeibylJP , SatelSL , DominicA , SouthwickSM , KrystalJH , CharneyDS . Effects of cocaine on hospital course in schizophrenia. Journal of Nervous and Mental Disease1993;181(1):30‐7. ">Seibyl 1993</a>). This is especially true for stimulant drugs like amphetamine, cocaine and concentrated forms such as crack cocaine and methamphetamine ('ice') that can exacerbate or mimic psychotic symptoms and elevate risk of readmission (<a href="./references#CD001088-bbs2-0165" title="CallaghanRC , CunninghamJK , AllebeckP , ArenovichT , SajeevG , RemingtonG , et al. Methamphetamine use and schizophrenia: a population‐based cohort study in California. American Journal of Psychiatry2012;169(4):389‐96. ">Callaghan 2012</a>; <a href="./references#CD001088-bbs2-0234" title="LappinJM , RoxburghA , KayeS , ChalmersJ , SaraG , DobbinsT , et al. Increased prevalence of self‐reported psychotic illness predicted by crystal methamphetamine use: Evidence from a high‐risk population. International Journal of Drug Policy2016;38:16‐20. ">Lappin 2016</a>; <a href="./references#CD001088-bbs2-0251" title="McKetinR , LubmanDI , BakerAL , DaweS , AliRL . Dose‐related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study. JAMA Psychiatry2013;70(3):319‐24. ">McKetin 2013</a>; <a href="./references#CD001088-bbs2-0269" title="PluddemannA , DadaS , ParryCD , KaderR , ParkerJS , TemminghH , et al. Monitoring the prevalence of methamphetamine‐related presentations at psychiatric hospitals in Cape Town, South Africa. African Journal of Psychiatry2013;16(1):45‐9. ">Pluddemann 2013</a>; <a href="./references#CD001088-bbs2-0274" title="Romer ThomsenK , ThylstrupB , PedersenMM , PedersenMU , SimonsenE , HesseM . Drug‐related predictors of readmission for schizophrenia among patients admitted to treatment for drug use disorders. Schizophrenia Research2018;195:495‐500. ">Romer Thomsen 2018</a>; <a href="./references#CD001088-bbs2-0275" title="SaraGE , LargeMM , MathesonSL , BurgessPM , MalhiGS , WhitefordHA , et al. Stimulant use disorders in people with psychosis: a meta‐analysis of rate and factors affecting variation. Australian &amp; New Zealand Journal of Psychiatry2015;49(2):106‐17. ">Sara 2015</a>). Substance use is also related to poor adherence with treatment, further increasing the risk of relapse (<a href="./references#CD001088-bbs2-0218" title="HuntGE , BergenJ , BashirM . Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophrenia Research2002;54(3):253‐64. ">Hunt 2002</a>). Interventions that reduce substance use are likely to improve symptoms, relapse rates, recovery and other outcomes (<a href="./references#CD001088-bbs2-0169" title="ClearyM , HuntGE , MathesonS , WalterG . Psychosocial treatments for people with co‐occurring severe mental illness and substance misuse: systematic review. Journal of Advanced Nursing2009;65(2):238‐58. ">Cleary 2009a</a>; <a href="./references#CD001088-bbs2-0193" title="DrakeRE , O'NealEL , WallachMA . A systematic review of psychosocial research on psychosocial interventions for people with co‐occurring severe mental and substance use disorders. Journal of Substance Abuse and Treatment2008;34(1):123‐38. ">Drake 2008</a>; <a href="./references#CD001088-bbs2-0217" title="HorsfallJ , ClearyM , HuntGE , WalterG . Psychosocial treatments for people with co‐occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence. Harvard Review of Psychiatry2009;17(1):24‐34. ">Horsfall 2009</a>). Common psychosocial interventions to reduce substance use and misuse include Twelve‐Step recovery, which adopts a supportive approach such as that used by Alcoholics Anonymous (AA); motivational interviewing, which aims to increase an individual's motivation for change; group and individual skills training; family psycho‐education regarding the signs and effects of substance use; and individual or group psychotherapy involving cognitive or behavioural principles, or both, which aim to increase coping strategies, awareness and self‐monitoring behaviour (<a href="./references#CD001088-bbs2-0263" title="MueserKT , DeaversF , PennDL , CassisiJE . Psychosocial treatments for schizophrenia. Annual Review of Clinical Psychology2013;9:465‐97. ">Mueser 2013</a>). All of these interventions can vary in intensity and duration, and can be offered in a variety of settings, either individually or as part of an integrated programme. Integrated treatment ensures mental health and substance misuse services are available in the same setting and delivered in a coherent fashion. </p> </section> <section id="CD001088-sec-0027"> <h3 class="title" id="CD001088-sec-0027">Why it is important to do this review</h3> <p>While encouraging, results of trials assessing the effectiveness of these psychosocial interventions for mental health consumers are equivocal (for reviews, see: <a href="./references#CD001088-bbs2-0153" title="BennettME , BradshawKR , CatalanoLT . Treatment of substance use disorders in schizophrenia. American Journal of Drug &amp; Alcohol Abuse2017;43(4):377‐90. ">Bennett 2017</a>; <a href="./references#CD001088-bbs2-0156" title="BogenschutzMP , GeppertCM , GeorgeJ . The role of twelve‐step approaches in dual diagnosis treatment and recovery. American Journal on Addictions2006;15(1):50‐60. ">Bogenschutz 2006</a>; <a href="./references#CD001088-bbs2-0169" title="ClearyM , HuntGE , MathesonS , WalterG . Psychosocial treatments for people with co‐occurring severe mental illness and substance misuse: systematic review. Journal of Advanced Nursing2009;65(2):238‐58. ">Cleary 2009a</a>; <a href="./references#CD001088-bbs2-0176" title="DeWitteNA , CrunelleCL , SabbeB , MoggiF , DomG . Treatment for outpatients with comorbid schizophrenia and substance use disorders: a review. European Addiction Research2014;20(3):105‐14. ">De Witte 2014</a>; <a href="./references#CD001088-bbs2-0185" title="DixonLB , DickersonF , BellackAS , BennettM , DickinsonD , GoldbergRW , et al. The 2009 schizophrenia PORTpsychosocial treatment recommendations and summary statements. Schizophrenia Bulletin2010;36(1):48‐70. ">Dixon 2010</a>; <a href="./references#CD001088-bbs2-0191" title="DrakeRE , Mercer‐McFaddenC , MueserKT , McHugoGJ , BondGR . A review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin1998;24(4):589‐608. ">Drake 1998b</a>; <a href="./references#CD001088-bbs2-0192" title="DrakeRE , MueserKT , BrunetteMF , McHugoGJ . A review of treatments for people with severe mental illnesses and co‐occurring substance use disorders. Psychiatric Rehabilitation Journal2004;27(4):360‐74. ">Drake 2004</a>; <a href="./references#CD001088-bbs2-0193" title="DrakeRE , O'NealEL , WallachMA . A systematic review of psychosocial research on psychosocial interventions for people with co‐occurring severe mental and substance use disorders. Journal of Substance Abuse and Treatment2008;34(1):123‐38. ">Drake 2008</a>; <a href="./references#CD001088-bbs2-0217" title="HorsfallJ , ClearyM , HuntGE , WalterG . Psychosocial treatments for people with co‐occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence. Harvard Review of Psychiatry2009;17(1):24‐34. ">Horsfall 2009</a>; <a href="./references#CD001088-bbs2-0309" title="LeyA , JefferyDP , McLarenS , SiegfriedN . Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2000, Issue 4. [DOI: 10.1002/14651858.CD001088] ">Ley 2000</a>; <a href="./references#CD001088-bbs2-0262" title="MueserKT , DrakeRE , SigmonSC , BrunetteMF . Psychosocial interventions of adults with severe mental illnesses and co‐occurring substance use disorders: a review of specific interventions. Journal of Dual Diagnosis2005;1(2):57‐82. ">Mueser 2005</a>; <a href="./references#CD001088-bbs2-0263" title="MueserKT , DeaversF , PennDL , CassisiJE . Psychosocial treatments for schizophrenia. Annual Review of Clinical Psychology2013;9:465‐97. ">Mueser 2013</a>; <a href="./references#CD001088-bbs2-0265" title="NICE . Psychosis with coexisting substance misuse. Assessment and management in adults and young people. National Clinical Guideline 120. London: British Psychological Society and the Royal College of Psychiatrists, 2011:1‐322. [http://www.nice.org.uk/CG120] ">NICE 2011</a>). Many studies have been hampered by small heterogeneous samples, poor experimental design (for example non‐random assignment), high attrition rates, short follow‐up periods, lack of accuracy of measuring substance use, skewed data, use of non‐standardised outcome measures and unclear descriptions of treatment components (<a href="./references#CD001088-bbs2-0150" title="BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: A descriptive review. Journal of Mental Health2006;15(6):619‐32. ">Barrowclough 2006a</a>; <a href="./references#CD001088-bbs2-0307" title="ClearyM , HuntGE , MathesonSL , SiegfriedN , WalterG . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD001088.pub2] ">Cleary 2008</a>; <a href="./references#CD001088-bbs2-0308" title="HuntGE , SiegfriedN , MorleyK , SitharthanT , ClearyM . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD001088.pub3] ">Hunt 2013</a>). When assessing integrated programmes, it can also be difficult to determine exactly which part of the programme is the most effective, and control groups (particularly in the USA) may involve a certain level of service integration, making interpretations difficult (<a href="./references#CD001088-bbs2-0190" title="DrakeRE , MueserKT , ClarkeRE , WallachMA . The course, treatment, and outcome of substance disorder in persons with severe mental illness. American Journal of Orthopsychiatry1996;66(1):42‐51. ">Drake 1996</a>). Moreover, study methodologies, interventions and outcome measures vary across studies, as do patterns of participants' readiness to change, severity and type of illness and substance use, all of which make combining results in a review problematic (<a href="./references#CD001088-bbs2-0176" title="DeWitteNA , CrunelleCL , SabbeB , MoggiF , DomG . Treatment for outpatients with comorbid schizophrenia and substance use disorders: a review. European Addiction Research2014;20(3):105‐14. ">De Witte 2014</a>; <a href="./references#CD001088-bbs2-0187" title="DonaldM , DownerJ , KavanaghD . Integrated versus non‐integrated management and care for clients with co‐occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials. Social Science and Medicine2005;60(6):1371‐83. ">Donald 2005</a>; <a href="./references#CD001088-bbs2-0193" title="DrakeRE , O'NealEL , WallachMA . A systematic review of psychosocial research on psychosocial interventions for people with co‐occurring severe mental and substance use disorders. Journal of Substance Abuse and Treatment2008;34(1):123‐38. ">Drake 2008</a>). </p> <p>This current review updates the 2013 Cochrane Review on <i>"Psychosocial treatment programmes for people with both severe mental illness and substance misuse</i>". The previous review (<a href="./references#CD001088-bbs2-0308" title="HuntGE , SiegfriedN , MorleyK , SitharthanT , ClearyM . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD001088.pub3] ">Hunt 2013</a>) included any programme of substance misuse treatment and located 32 randomised controlled trials (RCTs). The authors from three previous reviews found no evidence to support any one substance misuse programme as being superior to another (<a href="./references#CD001088-bbs2-0307" title="ClearyM , HuntGE , MathesonSL , SiegfriedN , WalterG . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD001088.pub2] ">Cleary 2008</a>; <a href="./references#CD001088-bbs2-0308" title="HuntGE , SiegfriedN , MorleyK , SitharthanT , ClearyM . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD001088.pub3] ">Hunt 2013</a>; <a href="./references#CD001088-bbs2-0309" title="LeyA , JefferyDP , McLarenS , SiegfriedN . Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2000, Issue 4. [DOI: 10.1002/14651858.CD001088] ">Ley 2000</a>). We felt an update of this review was warranted as there are several new studies that have been conducted in the last five years. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD001088-sec-0028" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD001088-sec-0028"></div> <p>To assess the effects of psychosocial interventions for reduction in substance use by people with a serious mental illness compared with standard care. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD001088-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD001088-sec-0029"></div> <section id="CD001088-sec-0030"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD001088-sec-0031"> <h4 class="title">Types of studies</h4> <p>We included all relevant, randomised controlled trials (RCTs) with or without blinding if they utilised a psychosocial intervention to reduce substance use in people with severe mental illness and substance misuse compared with standard care. We excluded quasi‐randomised trials, such as those where allocation was alternate or sequential. </p> </section> <section id="CD001088-sec-0032"> <h4 class="title">Types of participants</h4> <p>We included people diagnosed with a severe mental illness (for example, mixed patient populations with schizophrenia, bipolar disorder, major depression and other psychosis) and concurrent problem of substance misuse. We have defined people with 'severe' illness as those with a chronic mental illness like schizophrenia who present to adult services for long‐term care. Those with an organic disorder, non‐severe mental illness (for example, personality disorder, post‐traumatic stress disorder (PTSD), anxiety disorders, depressive symptoms based on scores from a scale) or those who solely abused tobacco were, if possible, excluded. Trials that included a mixture of patients with a severe mental illness diagnosis were included if a large proportion had a schizophrenia‐like illness or psychosis (see <a href="./references#CD001088-sec-0383" title="">Characteristics of included studies</a>). Studies were excluded if all of the participants had a diagnosis of bipolar disorder or major depressive disorder from 2013 on, so they do not overlap with affective disorder reviews. </p> </section> <section id="CD001088-sec-0033"> <h4 class="title">Types of interventions</h4> <p>We anticipated that studies included in the review would use a wide variety of psychosocial interventions for substance misuse, making direct comparisons difficult. In order to enhance the utility of the review, we developed a priori categories within which we made planned comparisons. These categories were developed from theoretical models of the types of behavioural and psychosocial interventions offered to clients and the context in which they are delivered. The types of interventions were grouped in two strata, based on duration and intensity of treatment. The first stratum describes long‐term interventions for dual diagnosis patients that offered an array of services with different levels of integration and assertive outreach (taking place over years rather than weeks or months), and the second describes stand‐alone psychosocial interventions that clients received over shorter periods. We did not include interventions for informal carers (partner or family members) as separate categories, though we did sometimes include them as part of the treatments mentioned below. </p> <section id="CD001088-sec-0034"> <h5 class="title">1. Provider‐oriented long‐term interventions: integrated and non‐integrated care by community mental health teams for dual diagnosis populations </h5> <section id="CD001088-sec-0035"> <h6 class="title">1.1 Integrated models of care with assertive community treatment (ACT)</h6> <p>Integrated treatment models for patients with a dual diagnosis unify services at the provider level rather than forcing clients to negotiate separate mental health and substance abuse treatment programmes (<a href="./references#CD001088-bbs2-0189" title="DrakeRE , BartelsSJ , TeagueGB , NoordsyDL , ClarkRE . Treatment of substance abuse in severely mentally ill patients. Journal of Nervous and Mental Disease1993;181(10):606‐11. ">Drake 1993</a>; <a href="./references#CD001088-bbs2-0193" title="DrakeRE , O'NealEL , WallachMA . A systematic review of psychosocial research on psychosocial interventions for people with co‐occurring severe mental and substance use disorders. Journal of Substance Abuse and Treatment2008;34(1):123‐38. ">Drake 2008</a>; <a href="./references#CD001088-bbs2-0263" title="MueserKT , DeaversF , PennDL , CassisiJE . Psychosocial treatments for schizophrenia. Annual Review of Clinical Psychology2013;9:465‐97. ">Mueser 2013</a>). The range of services provided varies according to client needs and should be able to handle patients at differing stages of readiness to change (<a href="./references#CD001088-bbs2-0292" title="TsuangJ , FongTW , LesserI . Psychosocial treatment of patients with schizophrenia and substance abuse disorders. Addictive Disorders and Their Treatment2006;5(2):53‐66. ">Tsuang 2006</a>). Substance abuse treatments are integrated into an array of direct services, such as frequent home visits, crisis intervention, housing skills training, vocational rehabilitation, medication monitoring, and family psycho‐education. Integrated treatment means that the same clinicians or teams of clinicians in the one setting provide long‐term treatments in a co‐ordinated fashion (<a href="./references#CD001088-bbs2-0150" title="BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: A descriptive review. Journal of Mental Health2006;15(6):619‐32. ">Barrowclough 2006a</a>; <a href="./references#CD001088-bbs2-0204" title="GreenAI , DrakeRE , BrunetteMF , NoordsyDL . Schizophrenia and co‐occurring substance use disorder. Americal Journal of Psychiatry2007;164(3):402‐8. ">Green 2007</a>). Teams consist of three to six clinicians and attempt to remain faithful to a specified model of care. To the client, the services should appear seamless with a consistent approach, philosophy and set of recommendations. Usually the caseloads of dual diagnosis teams are lower (approximately 10 to 15 clients shared within a team) than for standard case managers (approximately 20 to 30). Integrated treatment is a process that takes place over years rather than weeks or months. Studies included in this category must have clearly demonstrated the following: 1) assertive community outreach to engage and retain clients and to offer services to reluctant or uncooperative clients, 2) staged interventions to reduce substance use, and 3) adherence to the integrated team philosophy. The intervention could be community‐based or provided for special populations, such as homeless people or forensic patients. </p> </section> <section id="CD001088-sec-0036"> <h6 class="title">1.2 Non‐integrated models of care (ACTO) or intensive case management</h6> <p>Non‐integrated treatment entails similar interventions by community teams, as described above, except the same members do not deliver them in a co‐ordinated fashion and assertive community outreach is not included. Normally, case managers in this category are better trained and have higher clinical qualifications and better therapeutic skills than standard case managers. Intensive case management is defined as lower case load size (approximately 10 to 15 clients) than for standard case managers and tends to have a 'psychodynamic' flavour (see <a href="./references#CD001088-bbs2-0247" title="MarshallM , GrayA , LockwoodA , GreenR . Case management for people with severe mental disorders. Cochrane Database of Systematic Reviews1998, Issue 2. [DOI: 10.1002/14651858.CD000050] ">Marshall 1998</a>; <a href="./references#CD001088-bbs2-0263" title="MueserKT , DeaversF , PennDL , CassisiJE . Psychosocial treatments for schizophrenia. Annual Review of Clinical Psychology2013;9:465‐97. ">Mueser 2013</a>). To be included in this category, part of the intervention had to address the client's drug and alcohol misuse. </p> </section> </section> <section id="CD001088-sec-0037"> <h5 class="title">2. Patient or client focused short‐term interventions for substance misuse</h5> <p>These interventions can be broadly grouped into individual and group modalities. They are offered in addition to routine care (treatment as usual, standard case management) and are based on different theoretical models. Although they could be part of the provider‐oriented packages described above, studies included here were easier to evaluate since they described a simplified intervention that can be easily reproduced. As some studies used more than one intervention (for example, cognitive behavioural therapy combined with motivational interviewing), these were included in a separate category. </p> <section id="CD001088-sec-0038"> <h6 class="title">2.1 Individual approaches</h6> <section id="CD001088-sec-0039"> <p><b>2.1.1 Cognitive behavioural therapies</b></p> <p>Cognitive behavioural approaches include a variety of interventions (<a href="./references#CD001088-bbs2-0271" title="RectorNA , BeckAT . Cognitive behavioral therapy for schizophrenia: an empirical review. Journal of Nervous &amp; Mental Disease2012;200(10):832‐9. ">Rector 2012</a>; <a href="./references#CD001088-bbs2-0301" title="Work Group on Substance Use Disorders, KleberHD , WeissRD , AntonRF , RounsavilleBJ , GeorgeTP , StrainEC , et al. Treatment of patients with substance use disorders, second edition. American Psychiatric Association. Americal Journal of Psychiatry2007;164 Suppl:5‐123. ">Work Group 2007</a>). The defining features are: 1) emphasis on functional analysis of drug use, understanding the reasons for use and consequences; and 2) skills training for recognising the situations where a person is most vulnerable to drug use and avoiding these situations. A cognitive behavioural intervention seeks to establish links between drug misuse, irrational beliefs, and misperceptions at a personal level and endeavours to correct the thoughts, feelings and actions of the recipient with respect to and the promotion of alternative ways of coping (<a href="./references#CD001088-bbs2-0223" title="JonesC , CormacI , Silveira da Mota NetoJI , CampbellC . Cognitive behaviour therapy for schizophrenia. Cochrane Database of Systematic Reviews2004, Issue 2. [DOI: 10.1002/14651858.CD000524] ">Jones 2004</a>; <a href="./references#CD001088-bbs2-0224" title="JonesC , HackerD , CormacI , MeadenA , IrvingCB . Cognitive behavioural therapy versus other psychosocial treatments for schizophrenia. Cochrane Database of Systematic Reviews2012, Issue 4. [DOI: 10.1002/14651858.CD008712.pub2] ">Jones 2012</a>; <a href="./references#CD001088-bbs2-0288" title="ThomaN , PileckiB , McKayD . Contemporary cognitive behavior therapy: A review of theory, history, and evidence. Psychodynamic Psychiatry2015;43(3):423‐62. ">Thoma 2015</a>). The target symptom that is usually focused on is reducing problematic substance use or harm minimisation, such as reducing the risk of contracting HIV. </p> </section> <section id="CD001088-sec-0040"> <p><b>2.1.2 Motivational interviewing</b></p> <p>Motivational interviewing takes a non‐confrontational approach to treating substance misuse and is intended to enhance the individual's intrinsic motivation for change, in patients who often find it difficult to commit to change (<a href="./references#CD001088-bbs2-0292" title="TsuangJ , FongTW , LesserI . Psychosocial treatment of patients with schizophrenia and substance abuse disorders. Addictive Disorders and Their Treatment2006;5(2):53‐66. ">Tsuang 2006</a>). It matches the patient's level of problem recognition to change with specific strategies and goals and can be delivered in brief sessions or over a number of weeks. It is based on four key principles: 1) expressing empathy, 2) developing discrepancy, 3) supporting self‐efficacy, and 4) rolling with resistance (<a href="./references#CD001088-bbs2-0168" title="ChanutF , BrownTG , DongierM . Motivational interviewing and clinical psychiatry. Canadian Journal of Psychiatry2005;50(9):548‐54. ">Chanut 2005</a>); and is directed at five stages: 1) pre‐contemplation, 2) contemplation, 3) preparation, 4) action, and 5) maintenance (<a href="./references#CD001088-bbs2-0292" title="TsuangJ , FongTW , LesserI . Psychosocial treatment of patients with schizophrenia and substance abuse disorders. Addictive Disorders and Their Treatment2006;5(2):53‐66. ">Tsuang 2006</a>). A key hypothesis is that the patient's perspective on the importance of change is fundamental to the patient's readiness to address the problem. Developing the patient's confidence in their ability to achieve the desired change is also a key issue of motivational interviewing. This treatment is delivered individually or in small group settings. </p> </section> <section id="CD001088-sec-0041"> <p><b>2.1.3 Contingency management</b></p> <p>Based on principals of operant conditioning, contingency management (CM) offers incentives or rewards to reinforce specific goals (reduced substance use, risky behaviours etc). Typically, rewards are provided if a negative substance test is provided (urine test or breath test). Rewards can vary widely, ranging from encouraging statements ('keep up the good work') to large or small financial prize (vouchers for food, cash etc). This approach has shown consistent success with various drug use disorders: cannabis, opiate and cocaine dependence and polysubstance use disorders (<a href="./references#CD001088-bbs2-0196" title="DutraL , StathopoulouG , BasdenSL , LeyroTM , PowersMB , OttoMW . A meta‐analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry2008;165(2):179‐87. ">Dutra 2008</a>). Contingency management has also been added with other psychosocial interventions, for example, motivational interviewing plus cognitive behavioural therapies (<a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>). Thus, contingency management was added to the previous review due to the number of current and ongoing trials using this intervention. </p> </section> </section> <section id="CD001088-sec-0042"> <h6 class="title">2.2 Group approaches</h6> <section id="CD001088-sec-0043"> <p><b>2.2.1 Social skills training</b></p> <p>These groups are aimed at helping clients develop interpersonal skills for establishing and maintaining relationships with others, dealing with conflict, and handling social situations involving substance misuse (<a href="./references#CD001088-bbs2-0261" title="MueserKT . Clinical interventions for severe mental illness and co‐occurring substance use disorder. Acta Neuropsychiatrica2004;16(1):26‐35. ">Mueser 2004</a>; <a href="./references#CD001088-bbs2-0263" title="MueserKT , DeaversF , PennDL , CassisiJE . Psychosocial treatments for schizophrenia. Annual Review of Clinical Psychology2013;9:465‐97. ">Mueser 2013</a>). They are taught in a highly structured way by using role play, corrective feedback and homework. This usually occurs in a group format, although the methods can also be employed in individual work as a type of cognitive behavioural counselling. </p> </section> </section> </section> <section id="CD001088-sec-0044"> <h5 class="title">3. Standard care</h5> <p>For this review, standard care or 'treatment as usual' or 'routine' care was defined as the care that a person would normally receive had they not been included in the research trial. This could include standard case management (e.g. see <a href="./references#CD001088-bbs2-0183" title="DieterichM , IrvingCB , BergmanH , KhokharMA , ParkB , MarshallM . Intensive case management for severe mental illness. Cochrane Database of Systematic Reviews2017;1:CD007906. [DOI: 10.1002/14651858.CD007906.pub3] ">Dieterich 2017</a><a href="./references#CD001088-bbs2-0249" title="Mas‐ExpositoL , Amador‐CamposJA , Gomez‐BenitoJ , Mauri‐MasL , Lalucat‐JoL . Clinical case management for patients with schizophrenia with high care needs. Community Mental Health Journal2015;51(2):165‐70. ">Mas‐Esposito 2015</a>). Standard care varies between settings and can be supplemented by additional components, including psycho‐educational material, family therapy, or referral to self‐help groups (for example, Alcoholics Anonymous) or other agencies for substance abuse treatment. </p> </section> </section> <section id="CD001088-sec-0045"> <h4 class="title">Types of outcome measures</h4> <p>We intended to group data into short‐, medium‐ and long‐term outcomes. However, this would have resulted in much data loss as outcome periods varied and therefore, we reported for the following time periods: 3, 6, 9, 12, 18, 24 and 36 months (where applicable). </p> <p>We endeavoured to report binary outcomes, recording clear and clinically meaningful degrees of change (e.g. global impression of much improved, or more than 50% improvement on a rating scale ‐ as defined within the trials) before any others. Thereafter we listed other binary outcomes and then those that are continuous*. </p> <p>We only extracted data from valid scales (see <a href="#CD001088-sec-0069">Data collection and analysis</a>). </p> <p>For outcomes measured and scales used by included studies see (<a href="#CD001088-sec-0119">Included studies</a>). </p> <section id="CD001088-sec-0046"> <h5 class="title">Primary outcomes</h5> <section id="CD001088-sec-0047"> <h6 class="title">1. Leaving the study early</h6> <p>1.1 Lost to treatment: this is a measure of stability and engagement (number of participants who did not continue with the treatment following randomisation; however, some may have provided data for the study. This varies with study design as some treatments are ongoing for the study duration and some are short term. When studies reported exactly the same data for both lost to treatment and lost to evaluation (see below), and if there were no other studies with which to pool data, then we only reported the numbers lost to treatment (to reduce the number of comparison tables). We did not adjust numbers lost to treatment for death (see below). </p> </section> <section id="CD001088-sec-0048"> <h6 class="title">2. Substance use: changes in substance use (alcohol or drugs, or both) as defined by each of the studies </h6> <p>2.1 Clinically important change or any change in substance use<br/> 2.2 Average endpoint or change score on substance use scale </p> </section> <section id="CD001088-sec-0049"> <h6 class="title">3. Mental state (mental health symptoms)</h6> <p>3.1 Clinically important change or any change in mental state<br/> 3.2 Average endpoint or change score on mental state scale </p> </section> </section> <section id="CD001088-sec-0050"> <h5 class="title">Secondary outcomes</h5> <section id="CD001088-sec-0051"> <h6 class="title">1. Leaving the study early</h6> <p>1.1 Lost to evaluation (number of people lost to the study who did not provide data at particular time points).<br/> 1.1.1. For any reason<br/> 1.1.2 For specific reason </p> </section> <section id="CD001088-sec-0052"> <h6 class="title">2. Adverse events</h6> <p>2.1 Death (all causes)</p> <p>Some studies may not have reported on the number of participants dying over the treatment or evaluation period. If reported, we recorded death in a separate table, but these cases were retained in the lost to treatment and lost to evaluation figures as it is often unclear when the death occurred or the cause of death was not stated as unlikely to be linked to the intervention. </p> </section> <section id="CD001088-sec-0053"> <h6 class="title">3. Global state (a clinical measure of patient's psychological, social and occupational functioning in a single measure) </h6> <p>3.1 Clinically important change or any change in global state<br/> 3.2 Average endpoint or change score on global state scale </p> </section> <section id="CD001088-sec-0054"> <h6 class="title">4. Social functioning (social assessment measures and basic skills necessary for community living) </h6> <p>4.1 Clinically important change or any change in social functioning<br/> 4.2 Average endpoint or change score on quality of life/life satisfaction scale </p> </section> <section id="CD001088-sec-0055"> <h6 class="title">5. Quality of life/life satisfaction (objective and subjective quality of life satisfaction measures, measures of global patient satisfaction with daily living and services provided) </h6> <p>5.1 Clinically important change or any change in quality of life/life satisfaction<br/> 5.2 Average endpoint or change score on quality of life/life satisfaction scale </p> </section> <section id="CD001088-sec-0056"> <h6 class="title">6. Service use (including relapse)</h6> <p>Relapse is often used as an outcome measure. Relapse can be measured as a dichotomous event (re‐admitted to hospital), or continuous measure such as number of admissions over a specified period or time to admission (number of weeks, days). </p> <p>6.1 Re‐admission to hospital<br/> 6.2 Number of admissions<br/> 6.3 Number of days in community </p> </section> <section id="CD001088-sec-0057"> <h6 class="title">7. Homelessness: homelessness is common in this patient population. It is often used to measure a favourable outcome if a person finds stable living accomodation over a specified period </h6> <p>7.1 Number of days in stable living accomodation<br/> 7.2 Number of days on street </p> </section> <section id="CD001088-sec-0058"> <h6 class="title">8. Economic outcomes</h6> <p>8.1 Direct costs: e.g. costs to the patient for supplying a drug‐free urine sample<br/> 8.2 Indirect costs: e.g. savings based on number of days living in the community, versus costs of inpatient treatment or days in jail </p> </section> <section id="CD001088-sec-0059"> <h6 class="title">9. Compliance with treatment and medication (as defined by individual studies)</h6> </section> <section id="CD001088-sec-0060"> <h6 class="title">'Summary of findings' table</h6> <p>We used the GRADE approach to interpret findings (<a href="./references#CD001088-bbs2-0279" title="SchünemannHJ , OxmanAD , VistGE , HigginsJP , DeeksJJ , GlasziouP , et al. Chapter 12: Interpreting results and drawing conclusions. In Higgins JP, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Schünemann 2011</a>); and used <a href="http://community.cochrane.org/tools/review-production-tools/gradepro-gdt" target="_blank">GRADEpro GDT</a> to export data from our review to create 'Summary of findings' tables. These tables provide outcome‐specific information concerning the overall certainty of evidence from each included study in the comparison, the magnitude of effect of the interventions examined, and the sum of available data on all outcomes we rate as important to patient care and decision making. We selected the following main outcomes for inclusion in the 'Summary of findings' tables. </p> <p> <ol id="CD001088-list-0001"> <li> <p>Leaving the study early: numbers lost to treatment (medium term: 12 months; if these data were not available we used the short‐term data). </p> </li> <li> <p>Adverse event: death.</p> </li> <li> <p>Substance use: alcohol use (as measured in the trials). Described as a clinically important reduction in alcohol use. </p> </li> <li> <p>Substance use: drug use (as measured in the trials). Described as a clinically important reduction in illicit drug use. </p> </li> <li> <p>Mental state: (as measured in the trials, and if no specific scale assessment was done we reported on relapse or hospitalisation). </p> </li> <li> <p>Global state: (as measured in the trials) described as a clinically important change in functioning. </p> </li> <li> <p>Quality of life ‐ life satisfaction: (as measured in the trials) described as a clinically important change in satisfaction. </p> </li> </ol> </p> <p>If data were not available for these pre‐specified outcomes but were available for ones that were similar, we presented the closest outcome to the pre‐specified one in the table but took this into account when grading the finding*. </p> <p>* see <a href="#CD001088-sec-0380">Differences between protocol and review</a> Note 5. </p> </section> </section> </section> </section> <section id="CD001088-sec-0061"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD001088-sec-0062"> <h4 class="title">Electronic searches</h4> <section id="CD001088-sec-0063"> <h5 class="title">Cochrane Schizophrenia Group's Study‐Based Register of Trials</h5> <p>On 2 May 2018, the Information Specialist searched the register using the following search strategy: </p> <p>(*{PSY}* in Intervention) AND (*Substance Use* in Healthcare Condition) of STUDY</p> <p>In such a study‐based register, searching the major concept retrieves all the synonyms and relevant studies because all the studies have already been organised based on their interventions and linked to the relevant topics (<a href="./references#CD001088-bbs2-0282" title="ShokranehF , AdamsCE . Study‐based registers of randomized controlled trials: Starting a systematic review with data extraction or meta‐analysis. BioImpacts2017;7(4):209‐17. [DOI: 10.15171/bi.2017.25] ">Shokraneh 2017</a>). </p> <p>This register is compiled by systematic searches of major resources (AMED, BIOSIS, CENTRAL, CINAHL, ClinicalTrials.Gov, Embase, MEDLINE, PsycINFO, PubMed, WHO ICTRP) and their monthly updates, ProQuest Dissertations and Theses A&amp;I and its quarterly update, Chinese databases (CBM, CNKI, and Wanfang) and their annual updates, handsearches, grey literature, and conference proceedings (see <a href="http://schizophrenia.cochrane.org/register-trials" target="_blank">Group's website</a>). There is no language, date, document type, or publication status limitations for inclusion of records into the register. </p> <p>For previous searches, please see <a href="./appendices#CD001088-sec-0309">Appendix 1</a>. </p> </section> </section> <section id="CD001088-sec-0064"> <h4 class="title">Searching other resources</h4> <section id="CD001088-sec-0065"> <h5 class="title">1. Reference lists</h5> <p>We searched all references of articles selected for inclusion, major review articles (<a href="./references#CD001088-bbs2-0149" title="BakerAL , HilesSA , ThorntonLK , HidesL , LubmanDI . A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders. Acta Psychiatrica Scandinavica2012;126(4):243‐55. ">Baker 2012</a>; <a href="./references#CD001088-bbs2-0153" title="BennettME , BradshawKR , CatalanoLT . Treatment of substance use disorders in schizophrenia. American Journal of Drug &amp; Alcohol Abuse2017;43(4):377‐90. ">Bennett 2017</a>; <a href="./references#CD001088-bbs2-0176" title="DeWitteNA , CrunelleCL , SabbeB , MoggiF , DomG . Treatment for outpatients with comorbid schizophrenia and substance use disorders: a review. European Addiction Research2014;20(3):105‐14. ">De Witte 2014</a>; <a href="./references#CD001088-bbs2-0185" title="DixonLB , DickersonF , BellackAS , BennettM , DickinsonD , GoldbergRW , et al. The 2009 schizophrenia PORTpsychosocial treatment recommendations and summary statements. Schizophrenia Bulletin2010;36(1):48‐70. ">Dixon 2010</a>; <a href="./references#CD001088-bbs2-0193" title="DrakeRE , O'NealEL , WallachMA . A systematic review of psychosocial research on psychosocial interventions for people with co‐occurring severe mental and substance use disorders. Journal of Substance Abuse and Treatment2008;34(1):123‐38. ">Drake 2008</a>; <a href="./references#CD001088-bbs2-0196" title="DutraL , StathopoulouG , BasdenSL , LeyroTM , PowersMB , OttoMW . A meta‐analytic review of psychosocial interventions for substance use disorders. American Journal of Psychiatry2008;165(2):179‐87. ">Dutra 2008</a>; <a href="./references#CD001088-bbs2-0201" title="GalletlyC , CastleD , DarkF , HumberstoneV , JablenskyA , KillackeyE , et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders. Australian and New Zealand Journal of Psychiatry2016;50(5):410‐72. ">Galletly 2016</a>; <a href="./references#CD001088-bbs2-0217" title="HorsfallJ , ClearyM , HuntGE , WalterG . Psychosocial treatments for people with co‐occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence. Harvard Review of Psychiatry2009;17(1):24‐34. ">Horsfall 2009</a>; <a href="./references#CD001088-bbs2-0228" title="KellyTM , DaleyDC , DouaihyAB . Treatment of substance abusing patients with comorbid psychiatric disorders. Addictive Behaviors2012;37(1):11‐24. ">Kelly 2012</a>), as well as recent guidelines (<a href="./references#CD001088-bbs2-0265" title="NICE . Psychosis with coexisting substance misuse. Assessment and management in adults and young people. National Clinical Guideline 120. London: British Psychological Society and the Royal College of Psychiatrists, 2011:1‐322. [http://www.nice.org.uk/CG120] ">NICE 2011</a>; <a href="./references#CD001088-bbs2-0210" title="HasanA , FalkaiP , WobrockT , LiebermanJ , GlenthojB , GattazWF , et al. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation. World Journal of Biological Psychiatry2015;16(3):142‐70. ">Hasan 2015</a>) on this topic for further relevant trials. </p> </section> <section id="CD001088-sec-0066"> <h5 class="title">2. Journal databases</h5> <p>Further searches were completed (September 2018) by the principal review author (GEH) using the Cochrane Database of Systematic Reviews, MEDLINE (daily update, PREMEDLINE), and PsycINFO. A separate search for randomised trials using contingency management was completed as this was an additional intervention category for the previous update. We also searched MEDLINE for recent articles (2013 to 2018) by the first authors of all included studies in order to get a more complete list of recent publications. </p> <p>We also did 'forward' searches to identify trials that cited previously included RCTs using Web of Science and Scopus. Scopus was used to identify trials that cited the most recent versions of this review (<a href="./references#CD001088-bbs2-0307" title="ClearyM , HuntGE , MathesonSL , SiegfriedN , WalterG . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD001088.pub2] ">Cleary 2008</a>, <a href="./references#CD001088-bbs2-0308" title="HuntGE , SiegfriedN , MorleyK , SitharthanT , ClearyM . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD001088.pub3] ">Hunt 2013</a>) up to October 2018. </p> </section> <section id="CD001088-sec-0067"> <h5 class="title">3. Trials registries</h5> <p>In addition, web sites and journals that list ongoing trials in the USA, UK, Australia and various European countries were searched for RCTs through the Cochrane Schizophrenia Group Trials Register. The principal review author (GEH) searched <a href="http://www.clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a> for protocols of current and previously included studies for proposed outcome measures to assess selective reporting bias. </p> </section> <section id="CD001088-sec-0068"> <h5 class="title">4. Personal contact</h5> <p>We contacted the first author (or corresponding author) of newly included studies for this update regarding their knowledge of ongoing or unpublished trials. </p> </section> </section> </section> <section id="CD001088-sec-0069"> <h3 class="title" id="CD001088-sec-0069">Data collection and analysis</h3> <p>Methods for data collection and analysis methods employed for the 2018 search are below. For data collection and analysis methods in earlier versions see <a href="./appendices#CD001088-sec-0315">Appendix 2</a> and <a href="./appendices#CD001088-sec-0324">Appendix 4</a>. </p> <section id="CD001088-sec-0070"> <h4 class="title">Selection of studies</h4> <p>Review authors GEH and MC inspected all citations from the new electronic search and identified relevant abstracts, full‐text articles and trials against the inclusion criteria. To ensure reliability, KM inspected all full‐text articles for inclusion. Where there were uncertainties or disagreements, two additional review authors provided resolution (NS and CB‐S). Where disputes could not be resolved, these studies remained as awaiting assessment or ongoing studies and we contacted the authors for clarification. </p> </section> <section id="CD001088-sec-0071"> <h4 class="title">Data extraction and management</h4> <section id="CD001088-sec-0072"> <h5 class="title">1. Extraction</h5> <p>GEH and KM extracted data from the included studies. We resolved disputes by discussion and adjudication from the other review authors (NS and MC) when necessary. If it was not possible to extract data or if further information was needed, we attempted to contact the authors. We extracted data presented only in graphs and figures whenever possible, but the data were included only if two review authors independently had the same result. When further information was necessary, we contacted authors of studies in order to obtain missing data or for clarification of methods. </p> </section> <section id="CD001088-sec-0073"> <h5 class="title">2. Management</h5> <section id="CD001088-sec-0074"> <h6 class="title">2.1 Forms</h6> <p>We extracted data onto standard, simple forms.</p> </section> <section id="CD001088-sec-0075"> <h6 class="title">2.2 Scale‐derived data</h6> <p>We included continuous data from rating scales only if:<br/> <br/> a) the psychometric properties of the measuring instrument have been described in a peer‐reviewed journal (<a href="./references#CD001088-bbs2-0248" title="MarshallM , LockwoodA , BradleyC , AdamsC , JoyC , FentonM . Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry2000;176(March):249‐52. ">Marshall 2000</a>); and<br/> b) the measuring instrument has not been written or modified by one of the trialists for that particular trial;<br/> c) the instrument should be a global assessment of an area of functioning and not sub‐scores which are not, in themselves, validated or shown to be reliable. However there are exceptions, we included sub‐scores from mental state scales measuring positive and negative symptoms of schizophrenia. </p> <p>Ideally the measuring instrument should either be i. a self‐report or ii. completed by an independent rater or relative (not the therapist). We realise that this is not often reported clearly, we noted in <a href="#CD001088-sec-0117">Description of studies</a> if this was the case or not. </p> </section> <section id="CD001088-sec-0076"> <h6 class="title">2.3 Endpoint versus change data</h6> <p>There are advantages of both endpoint and change data. Change data can remove a component of between‐person variability from the analysis. On the other hand, calculation of change needs two assessments (baseline and endpoint) which can be difficult in unstable and difficult‐to‐measure conditions such as schizophrenia. We decided primarily to use endpoint data, and only use change data if the former were not available. We combined endpoint and change data in the analysis as we preferred to use mean differences (MD) rather than standardised mean differences (SMD) throughout (<a href="./references#CD001088-bbs2-0178" title="DeeksJJ , HigginsJPT , Altman DG(editors) . Chapter 9: Analysing data and undertaking meta‐analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Deeks 2011</a>). </p> </section> <section id="CD001088-sec-0077"> <h6 class="title">2.4 Skewed data</h6> <p>Continuous data on clinical and social outcomes are often not normally distributed. To avoid the pitfall of applying parametric tests to non‐parametric data, we applied the following standards to relevant data before inclusion. </p> <p>Please note, we entered data from studies of at least 200 participants in the analysis, because skewed data pose less of a problem in large studies. We also entered all relevant change data as when continuous data are presented on a scale that includes a possibility of negative values (such as change data), it is difficult to tell whether data are skewed or not. </p> <p>For endpoint data from studies &lt; 200 participants:</p> <p>(a) when a scale starts from zero, we subtracted the lowest possible value from the mean, and divided this by the standard deviation (SD). If this value was lower than 1, it strongly suggests a skew and we excluded these data. If this ratio was higher than one but below 2, there is suggestion of skew. We entered these data and tested whether its inclusion or exclusion change the results substantially. Finally, if the ratio was larger than 2 we included these data, because skew is less likely (<a href="./references#CD001088-bbs2-0143" title="AltmanDG , BlandJM . Detecting skewness from summary information. BMJ1996;313(7066):1200. [TP020600] ">Altman 1996</a>; <a href="./references#CD001088-bbs2-0212" title="HigginsJP , GreenS (editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). </p> <p>(b) if a scale starts from a positive value such as the Positive and Negative Syndrome Scale (PANSS, <a href="./references#CD001088-bbs2-0226" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi‐Health Systems, 1986. ">Kay 1986</a>), which can have values from 30 to 210, we modified the calculation described above to take the scale starting point into account. In these cases skew is present if 2 SD &gt; (S‐S min), where S is the mean score and 'S min' is the minimum score. </p> </section> <section id="CD001088-sec-0078"> <h6 class="title">2.5 Common measure</h6> <p>Where relevant, to facilitate comparison between trials, we converted variables that can be reported in different metrics, such as days in hospital (mean days per year, per week or per month) to a common metric (e.g. mean days per month). </p> </section> <section id="CD001088-sec-0079"> <h6 class="title">2.6 Conversion of continuous to binary</h6> <p>Where possible, we converted continuous outcome measures to dichotomous data. This can be done by identifying cut‐off points on rating scales and dividing participants accordingly into 'clinically improved' or 'not clinically improved'. It is generally assumed that if there is a 50% reduction in a scale‐derived score such as the Brief Psychiatric Rating Scale (BPRS, <a href="./references#CD001088-bbs2-0267" title="OverallJE , GorhamDR . The brief psychiatric rating scale. Psychological Reports1962;10(3):799‐812. ">Overall 1962</a>) or the Positive and Negative Syndrome Scale (PANSS, <a href="./references#CD001088-bbs2-0226" title="KaySR , OplerLA , FiszbeinA . Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, NY: Multi‐Health Systems, 1986. ">Kay 1986</a>), this can be considered as a clinically important response (<a href="./references#CD001088-bbs2-0242" title="LeuchtS , KaneJM , KisslingW , HamannJ , EtschelE , EngelRR . What does the PANSS mean?. Schizophrenia Research2005;79(2‐3):231‐8. [PUBMED: 15982856] ">Leucht 2005b</a>). If data based on these thresholds were not available, we used the primary cut‐off presented by the original authors. </p> </section> <section id="CD001088-sec-0080"> <h6 class="title">2.7 Direction of graphs</h6> <p>Where possible, we entered data in such a way that the area to the left of the line of no effect indicated a favourable outcome for the psychosocial intervention. Where keeping to this made it impossible to avoid outcome titles with clumsy double‐negatives (e.g. 'Not un‐improved'), we presented data where the left of the line indicates an unfavourable outcome and noted this in the relevant graphs. </p> </section> </section> </section> <section id="CD001088-sec-0081"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Review authors (GEH, NS, CB‐S) independently assessed risk of bias within the included studies by using criteria described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> to assess trial quality (<a href="./references#CD001088-bbs2-0213" title="HigginsJP , AltmanDG , Sterne JA(editors) . Chapter 8: Assessing risk of bias in included studies. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011a</a>). This set of criteria is based on evidence of associations between overestimate of effect and high risk of bias of the article such as sequence generation, allocation concealment, blinding, incomplete outcome data and selective reporting. </p> <p>If the raters disagreed, we made the final rating by consensus with all review authors. Where inadequate details of randomisation and other characteristics of trials were provided, we contacted authors of the studies contacted in order to obtain further information. If non‐concurrence occurred, we reported this. </p> <p>We noted the level of risk of bias in the text of the review and in <a href="#CD001088-fig-0001">Figure 1</a>; <a href="#CD001088-fig-0002">Figure 2</a> and 'Summary of findings' tables. </p> <div class="figure" id="CD001088-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001088-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD001088-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001088-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> </section> <section id="CD001088-sec-0082"> <h4 class="title">Measures of treatment effect</h4> <section id="CD001088-sec-0083"> <h5 class="title">1. Binary data</h5> <p>For binary outcomes we calculated a standard estimation of the risk ratio (RR) and its 95% confidence interval (CI). It has been shown that RR is more intuitive (<a href="./references#CD001088-bbs2-0157" title="BoisselJP , CucheratM , LiW , ChatellierG , GueyffierF , BuyseM , et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use. Therapie1999;54(4):405‐11. ">Boissel 1999</a>) than odds ratios as odds ratios tend to be interpreted as RR by clinicians (<a href="./references#CD001088-bbs2-0177" title="DeeksJ . Issues in the selection for meta‐analyses of binary data. Abstracts of 8th International Cochrane Colloquium; 2000 Oct 25‐28th; Cape Town, South Africa. 2000. ">Deeks 2000</a>). </p> </section> <section id="CD001088-sec-0084"> <h5 class="title">2. Continuous data</h5> <p>For continuous outcomes we estimated mean difference (MD) between groups. We preferred not to calculate effect size measures (standardised mean difference SMD). However, if scales of very considerable similarity were used, we presumed there was a small difference in measurement, and calculated effect size and transformed the effect back to the units of one or more of the specific instruments. </p> </section> </section> <section id="CD001088-sec-0085"> <h4 class="title">Unit of analysis issues</h4> <section id="CD001088-sec-0086"> <h5 class="title">1. Cluster trials</h5> <p>Studies increasingly employ 'cluster randomisation' (such as randomisation by clinician or practice), but analysis and pooling of clustered data poses problems. Authors often fail to account for intra‐class correlation in clustered studies, leading to a 'unit of analysis' error (<a href="./references#CD001088-bbs2-0184" title="DivineGW , BrownJT , FrazerLM . The unit analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine1992;7:623‐9. ">Divine 1992</a>) whereby P values are spuriously low, confidence intervals unduly narrow and statistical significance overestimated. This causes type I errors (<a href="./references#CD001088-bbs2-0155" title="BlandJM , KerrySM . Trials randomised in clusters. BMJ1997;315(7108):600. ">Bland 1997</a>; <a href="./references#CD001088-bbs2-0206" title="GullifordMC , UkoumunneOC , ChinnS . Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149(9):876‐83. ">Gulliford 1999</a>). </p> <p>None of the presently included trials used cluster randomisation. For the purposes of future updates of this review, where clustering is not accounted for in primary studies we planned to present data in a table with a (*) symbol to indicate the presence of a probable unit of analysis error. In subsequent versions of this review, should we include cluster‐RCTs, we will seek to contact first authors of studies to obtain intra‐class correlation coefficients (ICCs) for their clustered data and to adjust for this by using accepted methods (<a href="./references#CD001088-bbs2-0206" title="GullifordMC , UkoumunneOC , ChinnS . Components of variance and intraclass correlations for the design of community‐based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology1999;149(9):876‐83. ">Gulliford 1999</a>). Where clustering has been incorporated into the analysis of primary studies, we plan to present these data as if from a non‐cluster randomised study but adjust for the clustering effect. </p> <p>We have sought statistical advice and have been advised that the binary data as presented in a report should be divided by a 'design effect'. This is calculated using the mean number of participants per cluster (m) and the ICC (design effect = 1 + (m ‐ 1)*ICC) (<a href="./references#CD001088-bbs2-0188" title="DonnerA , KlarN . Issues in the meta‐analysis of cluster randomized trials. Statistics in Medicine2002;21:2971‐80. ">Donner 2002</a>). If the ICC is not reported we will assume it to be 0.1 (<a href="./references#CD001088-bbs2-0296" title="UkoumunneOC , GullifordMC , ChinnS , SterneJA , BurneyPG . Methods for evaluating area‐wide and organisation‐based interventions in health and health care: a systematic review. Health Technology Assessment1999;3(5):iii‐92. [MEDLINE: 10982317] ">Ukoumunne 1999</a>). </p> <p>If we had identified cluster trials, we would have analysed them taking into account ICCs and relevant data documented in the report. Synthesis with other studies would have been possible using the generic inverse variance technique. </p> </section> <section id="CD001088-sec-0087"> <h5 class="title">2. Cross‐over trials</h5> <p>None of the presently included studies employed a cross‐over trial design. For the purposes of future updates of the review, a major concern of cross‐over trials is the carry‐over effect. It occurs if an effect (for example, pharmacological, physiological or psychological) of the treatment in the first phase is carried over to the second phase. As a consequence, on entry to the second phase the participants can differ systematically from their initial state despite a wash‐out phase. For the same reason cross‐over trials are not appropriate if the condition of interest is unstable (<a href="./references#CD001088-bbs2-0198" title="ElbourneD , AltmanDG , HigginsJP , CurtinaF , WorthingtondHV , VaileA . Meta‐analyses involving cross‐over trials: methodological issues. International Journal of Epidemiology2002;31(1):140‐9. ">Elbourne 2002</a>). As both effects are very likely in severe mental illness, we proposed to only use the data of the first phase of cross‐over studies. </p> </section> <section id="CD001088-sec-0088"> <h5 class="title">3. Studies with multiple treatment groups</h5> <p>Where a study involves more than two treatment arms, if relevant, we presented the additional treatment arms in comparisons. If data were binary we simply added and combined within the two‐by‐two table. If data were continuous we combined data following the formula in Chapter 7 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD001088-bbs2-0212" title="HigginsJP , GreenS (editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>)<i>.</i> We did not use data where the additional treatment arms were not relevant. </p> </section> </section> <section id="CD001088-sec-0089"> <h4 class="title">Dealing with missing data</h4> <section id="CD001088-sec-0090"> <h5 class="title">1. Overall loss of credibility</h5> <p>At some degree of loss of follow‐up data must lose credibility (<a href="./references#CD001088-bbs2-0302" title="XiaJ , AdamsCE , BhagatN , BhagatV , BhoopathiP , El‐SayehH , et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin2009;33(7):254‐7. ">Xia 2009</a>). We chose that, for any particular outcome, should more than 50% of data be unaccounted for, we would not reproduce these data or use them within analyses. If, however, more than 50% of those in one arm of a study were lost, but the total loss was less than 50%, we addressed this within the 'Summary of findings' tables by down‐rating quality. We also planned to downgrade quality within the 'Summary of findings' tables should loss be 25% to 50% in total. </p> </section> <section id="CD001088-sec-0091"> <h5 class="title">2. Binary</h5> <p>In the case where attrition for a binary outcome is between 0% and 50% and where these data are not clearly described, we presented data on a 'once‐randomised‐always‐analyse' basis (an intention‐to‐treat (ITT) analysis). We assumed all those leaving the study early to have the same rates of negative outcome as those who completed ‐ except for the outcomes of death and adverse effects ‐ for these outcomes we used the rate of those who stayed in the study (in that particular arm of the trial) for those who did not. We undertook a sensitivity analysis to test how prone the primary outcomes were to change by comparing data only from people who completed the study to that point to the ITT analysis using the above assumptions. </p> </section> <section id="CD001088-sec-0092"> <h5 class="title">3. Continuous</h5> <section id="CD001088-sec-0093"> <h6 class="title">3.1 Attrition</h6> <p>We reported and used data where attrition for a continuous outcome was between 0% and 50%, and data only from people who completed the study to that point were reported. </p> </section> <section id="CD001088-sec-0094"> <h6 class="title">3.2 Standard deviations</h6> <p>If standard deviations (SDs) were not reported, we first tried to obtain the missing values from the authors. If not available, where there were missing measures of variance for continuous data, but an exact standard error (SE) and confidence intervals available for group means, and either 'P' value or 't' value available for differences in mean, we calculated them according to the rules described in the <i>Cochrane Handbook for Systemic reviews of Interventions</i> (<a href="./references#CD001088-bbs2-0212" title="HigginsJP , GreenS (editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>): When only the SE is reported, SDs are calculated by the formula SD = SE * square root (n). The <i>Cochrane Handbook for Systemic reviews of Interventions</i> (<a href="./references#CD001088-bbs2-0212" title="HigginsJP , GreenS (editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>) present detailed formulae for estimating SDs from P values, t or F values, confidence intervals, ranges or other statistics. If these formulae did not apply, we calculated the SDs according to a validated imputation method which is based on the SDs of the other included studies (<a href="./references#CD001088-bbs2-0200" title="FurukawaTA , BarbuiC , CiprianiA , BrambillaP , WatanabeN . Imputing missing standard deviations in meta‐analyses can provide accurate results. Journal of Clinical Epidemiology2006;59(7):7‐10. ">Furukawa 2006</a>). Although some of these imputation strategies can introduce error, the alternative would be to exclude a given study’s outcome and thus to lose information. We nevertheless examined the validity of the imputations in a sensitivity analysis excluding imputed values. </p> </section> <section id="CD001088-sec-0095"> <h6 class="title">3.3 Assumptions about participants who left the trials early or were lost to follow‐up</h6> <p>Various methods are available to account for participants who left the trials early or were lost to follow‐up. Some trials just present the results of study completers, others use the method of last observation carried forward (LOCF), while more recently methods such as multiple imputation or mixed‐effects models for repeated measurements have become more of a standard. While the latter methods seem to be somewhat better than LOCF (<a href="./references#CD001088-bbs2-0240" title="LeonAC , MallinckrodtCH , Chuang‐SteinC , ArchibaldDG , ArcherGE , ChartierK . Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biological Psychiatry2006;59(11):1001‐5. [PUBMED: 16905632] ">Leon 2006</a>), we feel that the high percentage of participants leaving the studies early and differences in the reasons for leaving the studies early between groups is often the core problem in randomised schizophrenia trials. We therefore did not exclude studies based on the statistical approach used. However, we preferred to use the more sophisticated approaches. (e.g. MMRM or multiple‐imputation) and only presented completer analyses if some kind of ITT data were not available at all. Moreover, we addressed this issue in the item "incomplete outcome data" of the 'Risk of bias' tool. </p> </section> </section> </section> <section id="CD001088-sec-0096"> <h4 class="title">Assessment of heterogeneity</h4> <section id="CD001088-sec-0097"> <h5 class="title">1. Clinical heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge clinical heterogeneity. We simply inspected all studies for clearly outlying people or situations which we had not predicted would arise. When such situations or participant groups arose, we fully discussed these. </p> </section> <section id="CD001088-sec-0098"> <h5 class="title">2. Methodological heterogeneity</h5> <p>We considered all included studies initially, without seeing comparison data, to judge methodological heterogeneity. We simply inspected all studies for clearly outlying methods which we had not predicted would arise. When such methodological outliers arose, we fully discussed these. </p> </section> <section id="CD001088-sec-0099"> <h5 class="title">3. Statistical heterogeneity</h5> <section id="CD001088-sec-0100"> <h6 class="title">3.1 Visual inspection</h6> <p>We visually inspected graphs to investigate the possibility of statistical heterogeneity.</p> </section> <section id="CD001088-sec-0101"> <h6 class="title">3.2 Employing the I<sup>2</sup> statistic </h6> <p>We investigated heterogeneity between studies by considering the I<sup>2</sup> statistic alongside the Chi<sup>2</sup> P value. The I<sup>2</sup> provides an estimate of the percentage of inconsistency thought to be due to chance (<a href="./references#CD001088-bbs2-0211" title="HigginsJP , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analyses. BMJ2003;327(7414):557‐60. ">Higgins 2003</a>). The importance of the observed value of I<sup>2</sup> depends on: i) magnitude and direction of effects, and ii) strength of evidence for heterogeneity (for example, P value from Chi<sup>2</sup> test, or a confidence interval for I<sup>2</sup>). An I<sup>2</sup> estimate greater than or equal to around 50% accompanied by a statistically significant Chi<sup>2</sup> statistic was interpreted as evidence of substantial levels of heterogeneity (<a href="./references#CD001088-bbs2-0212" title="HigginsJP , GreenS (editors) . Chapter 7: Selecting studies and collecting data. In: Higgins JP, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Higgins 2011</a>). When substantial levels of heterogeneity were found in the primary outcome, we explored reasons for the heterogeneity (<a href="#CD001088-sec-0106">Subgroup analysis and investigation of heterogeneity</a>). </p> </section> </section> </section> <section id="CD001088-sec-0102"> <h4 class="title">Assessment of reporting biases</h4> <p>Reporting biases arise when the dissemination of research findings is influenced by the nature and direction of results (<a href="./references#CD001088-bbs2-0197" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta‐analysis detected by a simple, graphical test. BMJ1997;315(7109):629‐34. ">Egger 1997</a>). These are described in Chapter 10. of the <i>Cochrane Handbook for Systemic reviews of Interventions</i> (<a href="./references#CD001088-bbs2-0287" title="SterneJA , EggerM , Moher D (editors) on behalf of the Cochrane Bias Methods Group. Chapter 10: Addressing reporting biases. In: Higgins JP, Green S (editors). Cochrane Handbook for Systematic Reviews of Intervention. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.handbook.cochrane.org. ">Sterne 2011</a>). </p> <section id="CD001088-sec-0103"> <h5 class="title">1. Protocol versus full study</h5> <p>We tried to locate protocols of included randomised trials. If the protocol was available, we compared outcomes in the protocol and in the published report. If the protocol was not available, we compared outcomes listed in the methods section of the trial report with actually reported results. </p> </section> <section id="CD001088-sec-0104"> <h5 class="title">2. Funnel plot</h5> <p>We are aware that funnel plots may be useful in investigating reporting biases but are of limited power to detect small‐study effects. We did not use funnel plots for outcomes where there were 10 or fewer studies, or where all studies are of similar size. In future versions of this review, if funnel plots are possible, we will seek statistical advice in their interpretation. </p> </section> </section> <section id="CD001088-sec-0105"> <h4 class="title">Data synthesis</h4> <p>We understand that there is no closed argument for preference for use of fixed‐effect or random‐effects models. The random‐effects method incorporates an assumption that the different studies are estimating different, yet related, intervention effects. This often seems to be true to us and the random‐effects model takes into account differences between studies, even if there is no statistically significant heterogeneity. There is, however, a disadvantage to the random‐effects model: it puts added weight onto small studies, which often are the most biased ones. Depending on the direction of effect, these studies can either inflate or deflate the effect size. We chose the random‐effects model for main analyses (see also <a href="#CD001088-sec-0110">Sensitivity analysis</a>) </p> </section> <section id="CD001088-sec-0106"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <section id="CD001088-sec-0107"> <h5 class="title">1. Subgroup analyses ‐ only primary outcomes</h5> <section id="CD001088-sec-0108"> <h6 class="title">1.1 Clinical state, stage or problem</h6> <p>We proposed to undertake this review and provide an overview of the effects of psychosocial interventions for people with schizophrenia and other psychoses, in general. In addition, however, we tried to report data on subgroups of people in the same clinical state, stage and with similar problems. </p> </section> </section> <section id="CD001088-sec-0109"> <h5 class="title">2. Investigation of heterogeneity</h5> <p>If inconsistency was high, we have reported this. First, we investigated whether data had been entered correctly. Second, if data were correct, we visually inspected the graph and successively removed outlying studies to see if homogeneity was restored. For this review we decided that should this occur, with data contributing to the summary finding of no more than around 10% of the total weighting, we would present the data. If not, then we did not pool the data and discussed the issues. We know of no supporting research for this 10% cut‐off, but we use prediction intervals as an alternative to this unsatisfactory state. </p> <p>When unanticipated clinical or methodological heterogeneity was obvious we simply stated hypotheses regarding these for future reviews or versions of this review. We do not anticipate undertaking analyses relating to these. </p> </section> </section> <section id="CD001088-sec-0110"> <h4 class="title">Sensitivity analysis</h4> <p>We conducted sensitivity analyses on outcomes of comparisons with four or more trials where studies with different quality were combined to ascertain if there were substantial differences in the results when lesser quality trials or those comprising participants with schizophrenia (or other psychoses) were compared to trials of higher quality or using mixed diagnostic groups. We applied all sensitivity analyses to the primary outcomes based on randomised sequence, allocation concealment and blinding of outcome measurement. We only conducted sensitivity analyses on comparisons with four or more studies as analyses with less than four trials would provide unclear decisions on whether there have been any possible biases in the estimate of effects. </p> <section id="CD001088-sec-0111"> <h5 class="title">1. Implication of randomisation</h5> <p>We aimed to include trials in a sensitivity analysis if they were described in some way so as to imply randomisation. For the primary outcomes, we included these studies and if there was no substantive difference when the implied randomised studies were added to those with a better description of randomisation then we entered all data from these studies. </p> </section> <section id="CD001088-sec-0112"> <h5 class="title">2. Assumptions for lost binary data</h5> <p>Where assumptions had to be made regarding people lost to follow‐up (see <a href="#CD001088-sec-0089">Dealing with missing data</a>), we compared the findings of the primary outcomes when we used our assumptions and when we used data only from people who completed the study to that point. If there was a substantial difference, we reported the results and discussed them but continued to employ our assumption. </p> <p>Where assumptions had to be made regarding missing sSD data (see <a href="#CD001088-sec-0089">Dealing with missing data</a>), we compared the findings of the primary outcomes when we used our assumptions and when we used data only from people who completed the study to that point. A sensitivity analysis was undertaken to test how prone results were to change when completer‐only data were compared to the imputed data using the above assumption. If there was a substantial difference, we reported results and discussed them but continued to employ our assumption. </p> </section> <section id="CD001088-sec-0113"> <h5 class="title">3. Risk of bias</h5> <p>We analysed the effects of excluding trials that were judged to be at high risk of bias across one or more of the domains of randomisation (see <a href="#CD001088-sec-0081">Assessment of risk of bias in included studies</a>) for the meta‐analysis of the primary outcomes. If the exclusion of trials at high risk of bias did not substantially alter the direction of effect or the precision of the effect estimates, then we included data from these trials in the analysis. </p> </section> <section id="CD001088-sec-0114"> <h5 class="title">4. Imputed values</h5> <p>A sensitivity analysis to assess the effects of including data from trials where we used imputed values for ICC in calculating the design effect in cluster‐randomised trials was not carried out as there are no cluster‐randomised trials included in the review. </p> </section> <section id="CD001088-sec-0115"> <h5 class="title">5. Fixed‐ and random‐effects</h5> <p>We synthesised data using a random‐effects model; however, we also synthesised data for the primary outcomes using fixed‐effect method to evaluate whether this altered the significance of the results. </p> <p>If we noted substantial differences in the direction or precision of effect estimates in any of the sensitivity analyses listed above, we did not pool data from the excluded trials with the other trials contributing to the outcome but presented them separately. </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD001088-sec-0116" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD001088-sec-0116"></div> <section id="CD001088-sec-0117"> <h3 class="title">Description of studies</h3> <section id="CD001088-sec-0118"> <h4 class="title">Results of the search</h4> <p>A total of 4866 citations were found using the search strategy devised for the original version of this review. The inclusion of the word 'drug' in the search strategy produced a vast number of irrelevant references. For the current update 113 additional relevant records were scrutinised which resulted in an additional nine studies considered for inclusion (<a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>; <a href="./references#CD001088-bbs2-0008" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12‐step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403‐11. [CSzG: 29165; NCT00583440] ">Bogenschutz 2014</a>; <a href="./references#CD001088-bbs2-0015" title="EackSM , HogartySS , BangaloreSS , KeshavanMS , CorneliusJR . Patterns of substance use during Cognitive Enhancement Therapy: an 18‐month randomized feasibility study. Journal of Dual Diagnosis2016;12:74‐82. [CSzG: 33634] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18‐month feasibility trial. Schizophrenia Research2015;161(2‐3):478‐83. [CSzG: 29308] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18‐month feasibility trial. Schizophrenia Bulletin2015;41:S310. [CSzG: 29436] WojtalikJA , EackSM . Fronto‐limbic neuroplasticity effects of Cognitive Enhancement Therapy during emotion regulation in schizophrenia patients who abuse cannabis. Schizophrenia Bulletin2015;41:S243. [CSzG: 29719] WojtalikJA , HogartySS , CorneliusJR , PhillipsML , KeshavanMS , NewhillCE , et al. Cognitive Enhancement Therapy improves frontolimbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study. Frontiers in Psychiatry2016;6:186. [CSzG: 33452] ">Eack 2015</a>; <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>; <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>; <a href="./references#CD001088-bbs2-0033" title="LoweJM , McDonellMG , LeicklyE , AngeloFA , VilardagaR , McPhersonS , et al. Determining ethyl glucuronide cutoffs when detecting self‐reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research2015;39(5):905‐10. McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , HirchakK , OluwoyeO , et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness. American Journal on Addictions2017;26(7):673‐5. [CSzG: 36340] McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , SrebnikD , AngeloF , et al. A randomized controlled trial of ethyl glucuronide‐ based contingency management for outpatients with co‐occurring alcohol use disorders and serious mental Illness. American Journal of Psychiatry2017;174(4):370‐7. [CSzG: 35589] McDonellMG , SkaliskyJ , LeicklyE , McPhersonS , BattalioS , NepomJR , et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence2015;157:184‐7. NCT01567943 . Contingency management of alcohol abuse in the severely mentally ill. http://ClinicalTrials.gov/show/NCT015679432012. [CSzG: 23792] OluwoyeO , LeicklyE , SkaliskyJ , McPhersonS , HirchakK , SrebnikD , et al. Serious mental illness in heavy drinkers is associated with poor treatment outcomes in outpatients with co‐occurring disorders. International Journal of Mental Health Addiction2018;16(3):672‐9. [CSzG: 37902] SkaliskyJ , LeicklyE , OluwoyeO , McPhersonSM , SrebnikD , RollJM , et al. Prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders. Cannabis and Cannabinoid Research2017;2(1):133‐8. [CSzG: 36516] ">McDonell 2017</a>; <a href="./references#CD001088-bbs2-0037" title="O'ConnellMJ , FlanaganEH , Delphin‐RittmonME , DavidsonL . Enhancing outcomes for persons with co‐occurring disorders through skills training and peer recovery support. Journal of Mental Health2018;in press:(online 10 March 2017). [CSzG: 35896; DOI: 10.1080/09638237.2017.1294733] ">O'Connell 2018</a>; <a href="./references#CD001088-bbs2-0038" title="NCT01478815 . Contingency management for persons with severe mental illness. http://ClinicalTrials.gov/show/NCT014788152011. [CSzG: 23332] PetryNM , AlessiSM , Rash CarlaJ . A randomized study of contingency management in cocaine‐dependent patients with severe and persistent mental health disorders. Drug and Alcohol Dependence2013;130:234‐7. [CSzG: 28275] ">Petry 2013</a>; <a href="./references#CD001088-bbs2-0039" title="RosenblumA , MatusowH , FongC , VogelH , UttaroT , MooreTL , et al. Efficacy of dual focus mutual aid for persons with mental illness and substance misuse. Drug and Alcohol Dependence2014;135:78‐87. [CSzG: 27823] ">Rosenblum 2014</a>). Together with the 32 studies from previous reviews, the current review included 41 studies. See also <a href="#CD001088-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD001088-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Study flow diagram for 2018 search" data-id="CD001088-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram for 2018 search</p> </div> </div> </div> </section> <section id="CD001088-sec-0119"> <h4 class="title">Included studies</h4> <p>In the previous review (<a href="./references#CD001088-bbs2-0308" title="HuntGE , SiegfriedN , MorleyK , SitharthanT , ClearyM . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD001088.pub3] ">Hunt 2013</a>), 32 randomised controlled trials (RCTs) were selected for inclusion. Three studies (<a href="./references#CD001088-bbs2-0018" title="GodleySH , Hoewing‐RobersonR , GodleyMD . Final MISA Report. Bloomington, IN: Lighthouse Institute, 1994. [CSzG: 970] ">Godley 1994</a>; <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>; <a href="./references#CD001088-bbs2-0034" title="CalsynRJ , YonkerRD , LemmingMR , MorseGA , KlinkenbergWD . Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behaviour and Mental Health2005;15(4):236‐48. [CSzG: 16813] FletcherTD , CunninghamJL , CalsynRJ , MorseGA , KlinkenbergWD . Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects. Administration and Policy in Mental Health2008;35(4):319‐36. [CSzG: 16624; MEDLINE: 18506618] MorseGA , CalsynRJ , KlinkenbergWD , CunninghamJ , LemmingMR . Integrated treatment for homeless clients with dual disorders: a quasi‐experimental evaluation. Journal of Dual Diagnosis2008;4(3):219‐37. [CSzG: 19618] MorseGA , CalsynRJ , KlinkenbergWD , HelminiakTW , WolffN , DrakeRE , et al. Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes. Community Mental Health Journal2006;42(4):377‐404. [CSzG: 13863] ">Morse 2006</a>) from the first update (<a href="./references#CD001088-bbs2-0307" title="ClearyM , HuntGE , MathesonSL , SiegfriedN , WalterG . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD001088.pub2] ">Cleary 2008</a>) contained only skewed data (shown as 'other data' within the <a href="./references#CD001088-sec-0307" title="">Data and analyses</a>). The remaining trials provided usable data (either dichotomous or continuous parametric data). For the current update, nine new trials were selected for inclusion thus in total, 41 RCTs were included in the current review. </p> <section id="CD001088-sec-0120"> <h5 class="title">1. Design</h5> <p>Three trials were set exclusively in hospital (<a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a>; <a href="./references#CD001088-bbs2-0006" title="BechdolfA , PohlmannB , GuttgemannsJ , GeyerC , LindnerK , FerberC , et al. State‐dependent motivational interviewing for people with schizophrenia and substance use : Results of a randomised controlled trial [Motivationsbehandlung für patienten mit der doppeldiagnose psychose und sucht]. Nervenarzt2011;83(7):888‐96. [MEDLINE: 21720841] ">Bechdolf 2011</a>; <a href="./references#CD001088-bbs2-0040" title="PantalonMV , SwansonAJ . Use of the University of Rhode Island Change Assessment to measure motivational readiness to change in psychiatric and dually diagnosed individuals. Psychology of Addictive Behaviors2003;17(2):91‐7. [CSzG: 9830] SwansonAJ , PantalonMV , CohenKR . Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease1999;187(10):630‐5. [CSzG: 9248] ">Swanson 1999</a>) and 26 in the community. Ten trials recruited patients or were conducted in both the community (outpatients) and in hospital (<a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>; <a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>; <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>; <a href="./references#CD001088-bbs2-0020" title="GraeberDA , MoyersTB , GriffithG , GuajardoE , ToniganS . A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal2003;39(3):189‐202. [CSzG: 9901] ">Graeber 2003</a>; <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>; <a href="./references#CD001088-bbs2-0022" title="HellersteinDJ , RosenthalRN , MinerCR . A prospective study of integrated outpatient treatment for substance‐abusing schizophrenic patients. American Journal on Addictions1995;4(1):33‐42. [CSzG: 5029] HellersteinDJ , RosenthalRN , MinerCR . Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly2001;72(4):291‐306. [CSzG: 8206] ">Hellerstein 1995</a>; <a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>; <a href="./references#CD001088-bbs2-0027" title="KavanaghDJ , YoungR , WhiteA , SaundersJB , WallisJ , ShockleyN , et al. A brief motivational intervention for substance misuse in recent‐onset psychosis. Drug and Alcohol Review2004;23(2):151‐5. [CSzG: 8309] ">Kavanagh 2004</a>; <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a>; <a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>), and two were set in the community and in jail (<a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a>; <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>). </p> <p>Most studies randomly allocated participants to one of two treatment conditions; the exceptions were <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>; <a href="./references#CD001088-bbs2-0012" title="BurnamMA , MortonSC , McGlynnEA , PetersonLP , StecherBM , HayesC , et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases1995;14(4):111‐34. [CSzG: 8751] McGlynnEA , BoyntonJ , MortonSC , StecherBM , HayesC , VaccaroJV , et al. Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles. Alcohol Treatment Quarterly1993;10(3‐4):171‐86. [CSzG: 4118] ">Burnam 1995</a>; <a href="./references#CD001088-bbs2-0025" title="JerrellJM . Cost‐effective treatment for persons with dual disorders. New Directions for Mental Health Services1996;70(Summer):79‐91. [CSzG: 16821] JerrellJM , HuTW , RidgelyMS . Cost‐effectiveness of substance disorder interventions for people with severe mental illness. Journal of Mental Health Administration1994;21(3):283‐97. [CSzG: 1166] JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] JerrellJM , RidgelyMS . Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services1999;50(1):109‐12. [CSzG: 16917] ">Jerrell 1995a</a>; <a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a>; <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>; <a href="./references#CD001088-bbs2-0034" title="CalsynRJ , YonkerRD , LemmingMR , MorseGA , KlinkenbergWD . Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behaviour and Mental Health2005;15(4):236‐48. [CSzG: 16813] FletcherTD , CunninghamJL , CalsynRJ , MorseGA , KlinkenbergWD . Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects. Administration and Policy in Mental Health2008;35(4):319‐36. [CSzG: 16624; MEDLINE: 18506618] MorseGA , CalsynRJ , KlinkenbergWD , CunninghamJ , LemmingMR . Integrated treatment for homeless clients with dual disorders: a quasi‐experimental evaluation. Journal of Dual Diagnosis2008;4(3):219‐37. [CSzG: 19618] MorseGA , CalsynRJ , KlinkenbergWD , HelminiakTW , WolffN , DrakeRE , et al. Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes. Community Mental Health Journal2006;42(4):377‐404. [CSzG: 13863] ">Morse 2006</a> and <a href="./references#CD001088-bbs2-0037" title="O'ConnellMJ , FlanaganEH , Delphin‐RittmonME , DavidsonL . Enhancing outcomes for persons with co‐occurring disorders through skills training and peer recovery support. Journal of Mental Health2018;in press:(online 10 March 2017). [CSzG: 35896; DOI: 10.1080/09638237.2017.1294733] ">O'Connell 2018</a>). These trials randomly allocated participants to one of three or four (<a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>) interventions. We have used only two of the intervention arms in <a href="./references#CD001088-bbs2-0012" title="BurnamMA , MortonSC , McGlynnEA , PetersonLP , StecherBM , HayesC , et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases1995;14(4):111‐34. [CSzG: 8751] McGlynnEA , BoyntonJ , MortonSC , StecherBM , HayesC , VaccaroJV , et al. Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles. Alcohol Treatment Quarterly1993;10(3‐4):171‐86. [CSzG: 4118] ">Burnam 1995</a> as the other did not fit into any a priori category described for inclusion in this review. Data are shown in additional tables. Study durations ranged from three months to three years and the length of the interventions ranged from less than one hour to three years. There were 25 trials from the USA, six from Australia, five from the UK, two from Germany and one each from Denmark, Ireland and Switzerland. </p> </section> <section id="CD001088-sec-0121"> <h5 class="title">2. Participants</h5> <p>A total of 4024 people participated in the trials after giving informed consent and were randomised into one of the treatment arms. All participants were adults (aged 18 to 65 years) who were 'severely mentally ill' with the majority having a diagnoses of schizophrenia, schizoaffective disorder or psychosis (affective and non‐affective). All had a current diagnosis of substance use disorder or had documented evidence of substance misuse. Some were homeless or had a history of unstable accommodation (<a href="./references#CD001088-bbs2-0012" title="BurnamMA , MortonSC , McGlynnEA , PetersonLP , StecherBM , HayesC , et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases1995;14(4):111‐34. [CSzG: 8751] McGlynnEA , BoyntonJ , MortonSC , StecherBM , HayesC , VaccaroJV , et al. Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles. Alcohol Treatment Quarterly1993;10(3‐4):171‐86. [CSzG: 4118] ">Burnam 1995</a>; <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>; <a href="./references#CD001088-bbs2-0034" title="CalsynRJ , YonkerRD , LemmingMR , MorseGA , KlinkenbergWD . Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behaviour and Mental Health2005;15(4):236‐48. [CSzG: 16813] FletcherTD , CunninghamJL , CalsynRJ , MorseGA , KlinkenbergWD . Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects. Administration and Policy in Mental Health2008;35(4):319‐36. [CSzG: 16624; MEDLINE: 18506618] MorseGA , CalsynRJ , KlinkenbergWD , CunninghamJ , LemmingMR . Integrated treatment for homeless clients with dual disorders: a quasi‐experimental evaluation. Journal of Dual Diagnosis2008;4(3):219‐37. [CSzG: 19618] MorseGA , CalsynRJ , KlinkenbergWD , HelminiakTW , WolffN , DrakeRE , et al. Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes. Community Mental Health Journal2006;42(4):377‐404. [CSzG: 13863] ">Morse 2006</a>; <a href="./references#CD001088-bbs2-0041" title="TracyK , BabuscioT , NichC , KilukB , CarrollKM , PetryNM , et al. Contingency management to reduce substance use in individuals who are homeless with co‐occurring psychiatric disorders. American Journal of Drug and Alcohol Abuse2007;33(2):253‐8. [CSzG: 14807; MEDLINE: 17497548] ">Tracy 2007</a>), and some were incarcerated at the time of the study (<a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a>; <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>). </p> </section> <section id="CD001088-sec-0122"> <h5 class="title">3. Interventions</h5> <p> <ol id="CD001088-list-0002"> <li> <p>Integrated models of care (four RCTs).</p> </li> <li> <p>Non‐integrated models of care (four RCTs).</p> </li> <li> <p>Combined cognitive behavioural therapy and motivational interviewing (nine RCTs).</p> </li> <li> <p>Cognitive behavioural therapy (two RCTs).</p> </li> <li> <p>Motivational interviewing (nine RCTs).</p> </li> <li> <p>Skills training (six RCTs).</p> </li> <li> <p>Contingency management (four RCTs).</p> </li> </ol> </p> </section> <section id="CD001088-sec-0123"> <h5 class="title">4. Outcomes</h5> <p>Where possible, we included dichotomous data relating to loss to treatment, loss to evaluation, death, abstinence or reduced substance use, relapse, attendance at aftercare, and arrests. </p> <p>All of the outcome scales and their abbreviations are listed in <a href="#CD001088-tbl-0010">Table 1</a>, together with the reference of the source of the scale. See below for descriptions of the continuous data scales that reported data used in the analyses. For a full list of the scales mentioned in each of the studies see <a href="./references#CD001088-sec-0383" title="">Characteristics of included studies</a>. </p> <div class="table" id="CD001088-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">List of scales and abbreviations used in included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name of tool</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Abbreviation</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Source of scale ‐ reference</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><i><b>Diagnostic tools</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnostic and Statistical Manual of Mental Disorders, 4th edition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0195" title="APA1994 . Diagnostic &amp; Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: APA, 1994. ">DSM‐IV</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <a href="./references#CD001088-bbs2-0195" title="APA1994 . Diagnostic &amp; Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: APA, 1994. ">DSM‐IV</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The classification of mental and behavioural disorders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0222" title="World Health Organization. The ICD‐10 Classification of Mental and Behavioural Disorders. Geneva: World Health Organization, 1992. ">ICD‐10</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0222" title="World Health Organization. The ICD‐10 Classification of Mental and Behavioural Disorders. Geneva: World Health Organization, 1992. ">ICD‐10</a>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Structured Clinical Interview for Diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SCID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0285" title="SpitzerRL , WilliamsJB , GibbonM , FirstMB . Structured Clinical Interview for DSM‐III‐R ‐ Patient Edition (SCID‐P). Washington, DC: American Psychiatric Press, 1990. ">Spitzer 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnostic Interview Schedule (DIS), computerised scoring for DSM‐III‐R criteria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C‐DIS‐R</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001088-bbs2-0194" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder (DSM III‐R). Diagnostic &amp; Statistical Manual of Mental Disorders (DSM III‐R). 3rd Edition. Washington D.C: American Psychiatric Association, 1987. ">DSM III‐R</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Substance use scales</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addiction Severity Index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0252" title="McLellanAT , LuborskyL , WoodyGE , O'BrienC . An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease1980;168(1):26‐33. ">McLellan 1980</a>; <a href="./references#CD001088-bbs2-0253" title="McLellanAT , KushnerH , MetzgerD , PetersR , SmithI , GrissomG , et al. The Fifth Edition of the Addiction Severity Index. Journal of Substance Abuse Treatment1992;9(3):199‐213. ">McLellan 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Alcohol Use Inventory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AUI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0216" title="HornJL , WanbergKW , FosterFM . The Alcohol Use Inventory. Minneapolis, MN: National Computer Systems, 1987. ">Horn 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Alcohol Use Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0260" title="MueserKT , DrakeRE , ClarkRE , McHugoGJ , Mercer‐McFaddenC , AckersonTH . Evaluating Substance Abuse in Persons with Severe Mental Illness. Cambridge, MA: Human Services Research Institute, 1995. ">Mueser 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Alcohol Use Disorders Identification Test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AUDIT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001088-bbs2-0276" title="SaundersJB , AaslandOG , Babor TF de la FuenteJR , GrantM . Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐‐II. Addiction1993;88(6):791‐804. ">Saunders 1993</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief Drinker Profile</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BDP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0255" title="MillerWR , MarlattAG . Brief Drinker Profile (BDP) Interview Booklet. Odessa, FL: Psychological Assessment Resources, Inc, 1987. ">Miller 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug and Alcohol Problem Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DAPS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>adapted non‐peer reviewed version of this scale used; see <a href="./references#CD001088-bbs2-0009" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991a</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug Use Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0260" title="MueserKT , DrakeRE , ClarkRE , McHugoGJ , Mercer‐McFaddenC , AckersonTH . Evaluating Substance Abuse in Persons with Severe Mental Illness. Cambridge, MA: Human Services Research Institute, 1995. ">Mueser 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opiate Treatment Index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0173" title="DarkeS , WardJ , HallW , HeatherN , WodakA . The Opiate Treatment Index (OTI) Researchers Manual. Technical report No. 11. Sydney: National Drug &amp; Alcohol Research Centre, 1991. ">Darke 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change Questionnaire‐Cannabis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RTCQ‐C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0273" title="RollnickS , HeatherN , GoldR , HallW . Development of a short 'readiness to change' questionnaire for use in brief opportunistic interventions among excessive drinkers. British Journal of Addiction1992;87(5):743‐54. ">Rollnick 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Substance Abuse Treatment Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SATS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0250" title="McHugoGJ , DrakeRE , BurtonHL , AckersonTH . A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. Journal of Nervous and Mental Disease1995;183(12):762‐7. ">McHugo 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Schedule for Clinical Assessment in Neuropsychiatry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SCAN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0299" title="WingJK , BaborT , BrughaT , et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry1990;47(6):589‐93. ">Wing 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Substance Use Severity Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0166" title="CareyKB , CoccoKM , SimonsJS . Concurrent validity of clinicians' rating of substance abuse among psychiatric outpatients. Psychiatric Services1996;47(8):842‐7. ">Carey 1996</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><i><b>Mental state scales</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addiction Severity Index (psychiatric subscale)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0252" title="McLellanAT , LuborskyL , WoodyGE , O'BrienC . An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease1980;168(1):26‐33. ">McLellan 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beck Depression Inventory ‐ Short Form</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BDI‐SF, BDI‐11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0151" title="BeckAT , BeckRW . Screening depressed patients in family practice. A rapid technique. Postgraduate Medicine1972;52(6):81‐5. ">Beck 1972</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief Psychiatric Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BPRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0246" title="LukoffD , NuechterleinKH , VenturaJ . Manual for expanded Brief Psychiatric Rating Scale (BPRS). Schizophrenia Bulletin1986;12(4):594‐602. ">Lukoff 1986</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief Scale for Anxiety</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0294" title="TyrerP , OwenRT , CicchettiDV . The brief scale for anxiety: a subdivision of the Comprehensive Psychopathological Rating Scale. Journal of Neurology, Neurosurgery and Psychiatry1984;47(9):970‐5. ">Tyrer 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief Symptom Inventory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BSI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0181" title="DerogatisLR , MelisaratosN . The brief symptom inventory: an introductory report. Psychological Medicine1983;13(3):595‐605. ">Derogatis 1983a</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calgary Depression Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CDS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0142" title="AddingtonD , AddingtonJ , Maticka‐TyndaleE , JoyceJ . Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research1992;6(3):201‐8. ">Addington 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comprehensive Psychopathological Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0147" title="AsbergM , MontgomerySA , PerrisC , et al. A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica Supplement1978;271:5‐27. ">Asberg 1978</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hamilton Rating Scale for Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HAM ‐ D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0208" title="HamiltonM . A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry1960;23(February):56‐62. ">Hamilton 1960</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital Anxiety and Depresion Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HADS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001088-bbs2-0306" title="ZigmondAS , SnaithRP . The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica1983;67(6):361‐70. ">Zigmond 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insight Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0175" title="DavidA , BuchananA , ReedA , AlmeidaO . The assessment of insight in psychosis. British Journal of Psychiatry1992;161(November):599‐602. ">David 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Montgomery Asberg Depression Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MADRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0258" title="MontgomerySA , AsbergM . A new depression scale designed to be sensitive to change. British Journal of Psychiatry1979;134(April):382‐9. ">Montgomery 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Positive &amp; Negative Syndrome Scale for schizophrenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PANNS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0227" title="KaySR , FiszbeinA , OplerLA . The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin1987;13(2):261‐76. ">Kay 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychiatric Epidemiologic Research Interview</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PERI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0186" title="DohrenwendBP , ShroutPE , EgriG , et al. Nonspecific psychological distress and other dimensions of psychopathology. Measures for use in the general population. Archives of General Psychiatry1980;37(11):1229‐36. ">Dohrenwend 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Scale for the Assessment of Negative Symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SANS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0145" title="AndreasenNC . Negative symptoms in schizophrenia. Archives of General Psychiatry1982;39:784‐8. ">Andreasen 1982</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Scale for the assessment of Positive Symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAPS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0266" title="NormanRM , MallaAK , CorteseL , DiazF . A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS. Schizophrenia Research1996;19(1):73‐85. ">Norman 1996</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom Checklist 90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SCL‐90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0179" title="DerogatisLR , LipmanRS , CoviL . SCL‐90: An outpatient psychiatric rating scale: Preliminary report. Psychopharmacology Bulletin1973;9(1):13‐27. ">Derogatis 1973</a>; <a href="./references#CD001088-bbs2-0180" title="DerogatisLR , YevzeroffH , WittelsbergerB . Social class, psychological disorder, and the nature of the psych0pathologic indicator. Journal of Consulting and Clinical Psychology1975;43(2):183‐91. ">Derogatis 1975</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom Checklist 90‐revised</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SCL‐90‐R</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0182" title="DerogatisLR . SCL‐90‐R: Administration, Scoring &amp; Procedures Manual‐II. Towson, MD: Clinical Psychometric Research, 1983. ">Derogatis 1983b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Schizophrenia Change Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SCR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0257" title="MontgomerySA , AsbergM , TaylorP , MontgomeryD . Development of a schizophrenia scale sensitive to change. Neuropharmacology1978;17(12):1061‐3. ">Montgomery 1978</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Young Mania Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>YMRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0303" title="YoungRC , BriggsJT , ZieglerVE , MeyerDA . A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry1978;133(November):429‐35. ">Young 1978</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><i><b>General function scales</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Global Assessment of Functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GAF</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0195" title="APA1994 . Diagnostic &amp; Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: APA, 1994. ">DSM‐IV</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health of the Nation Outcome Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HoNOS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0300" title="WingJK , CurtisR , BeevorA . The Health of the Nation Outcome Scales. London: Royal College of Psychiatrists, 1996. ">Wing 1996</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Role Functioning Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RFS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0203" title="GreenRS , GracelyEJ . Selecting a rating scale for evaluating services to the chronically mentally ill. Community Mental Health Journal1987;23(2):91‐102. ">Green 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Social Adjustment Scale for the Severely Mentally Ill</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAS‐SMI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0298" title="WieduwiltKM , JerrellJM . The reliability and validity of the SAS‐SMI. Journal of Psychiatric Research1999;33(2):105‐12. ">Wieduwilt 1999</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Social Functioning Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SFS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0154" title="BirchwoodM , SmithJ , CochraneR , WettonS , CopestakeS . The Social Functioning Scale: the development and validation of a scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry1990;157(December):853‐9. ">Birchwood 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The Social and Occupational Functioning Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SOFAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0202" title="GoldmanHH , SkodalAE , LaveTR . Revising Axis V for DSM‐IV: a review of measures of social functioning. Americal Journal of Psychiatry1992;149(9):1148‐56. ">Goldman 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><i><b>Quality of life scales</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief Quality of Life Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BQOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0239" title="LehmanAF . Evaluating Quality of Life for Persons with Severe Mental Ilness: Assessment Toolkit. Cambridge, Mass: The Evaluation Center at Health Services Research Institute, 1995. ">Lehman 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Life Satisfaction Checklist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LSC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0158" title="BondGR , MillerLD , KrumwiedRD , WardRS . Assertive case management in three CMHCs: a controlled study. Hospital and Community Psychiatry1988;39(4):411‐8. ">Bond 1988</a>; <a href="./references#CD001088-bbs2-0159" title="BondGR , WitheridgeTF , DincinJ , WasmerD , WebbJ , DeGraaf‐KaserR . Assertive community treatment for frequent users of psychiatric hospitals in a large city: a controlled study. American Journal of Community Psychology1990;18(6):865‐91. ">Bond 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Manchester Short Assessment of Quality of Life</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MANSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0270" title="PriebeS , HuxleyP , KnightS , EvansS . Application and results of the Manchester Short Assessment of Quality of Life (MANSA). International Journal of Social Psychiatry1999;45(1):7‐12. ">Priebe 1999</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of Life Interview</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>QOLI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0238" title="LehmanAF . A quality of life interview for the chronically mentally ill. Evaluation and Program Planning1988;11(1):51‐62. ">Lehman 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with Life Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SLS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0286" title="SteinLI , TestMA . Alternative to mental hospital treatment: 1 Conceptual model, treatment program, and clinical evaluation. Archives of General Psychiatry1980;37(4):392‐7. ">Stein 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>World Health Organization's Quality of Life assessment scale, short version</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>WHOQOL‐BREF</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0284" title="SkevingtonSM , LotfyM , O'ConnellKA . The World Health Organization's WHOQOL‐BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research2004;13(2):299‐310. ">Skevington 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><i><b>Other</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Client Satisfaction Questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSQ</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0236" title="LarsenDL , AttkissonCC , HargreavesWA , NguyenTD . Assessment of client/patient satisfaction: development of a general scale. Evaluation and Program Planning1979;2(2):197‐207. ">Larsen 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Medication Adherence Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MARS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001088-bbs2-0289" title="ThompsonK , KulkarniJ , SergejewAA . Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research2000;42(3):240‐7. ">Thompson 2000</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The Service Utilization Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SURS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0254" title="MihalopoulosC , McGorryPD , CarterRC . Is phase‐specific community ‐oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatrica Scandinavica1999;100(1):47‐55. ">Mihalopoulos 1999</a> </p> </td> </tr> </tbody> </table> </div> <section id="CD001088-sec-0124"> <h6 class="title">4.1 Substance use scales</h6> <section id="CD001088-sec-0125"> <p><b>a. Drug and alcohol scales from Addiction Severity Index (ASI)</b></p> <p>The ASI (<a href="./references#CD001088-bbs2-0252" title="McLellanAT , LuborskyL , WoodyGE , O'BrienC . An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease1980;168(1):26‐33. ">McLellan 1980</a>) provides two summary scores of problems of functioning in seven areas, including psychiatric problems, and those concerning drug and alcohol use. Severity ratings range from zero to nine and are assessments of lifetime and current problem severity derived by the interviewer. Composite scores are mathematically derived and are based on client responses to a set of items based on the last 30 days. Although difficulties have been reported concerning the use of the ASI with people who have severe mental illness (<a href="./references#CD001088-bbs2-0171" title="CorseSJ , HirschingerNB , ZanisD . The use of the Addiction Severity Index with people with severe mental illness. Psychiatric Rehabilitation Journal1995;19(1):9‐18. ">Corse 1995</a>), the psychometric properties of the subscales with this population have been reported by a number of authors (<a href="./references#CD001088-bbs2-0146" title="ApplebyL , DysonV , AltmanE , LuchinsDJ . Assessing substance use in multiproblem patients: reliability and validity of the Addiction Severity Index in a mental hospital population. Journal of Nervous &amp; Mental Disease1997;185(3):159‐65. ">Appleby 1997</a>; <a href="./references#CD001088-bbs2-0215" title="HodginsDC , el‐GuebalyN . More data on the Addiction Severity Index. Reliability and validity with the mentally ill substance abuser. Journal of Nervous &amp; Mental Disease1992;180(3):197‐201. ">Hodgins 1992</a>; <a href="./references#CD001088-bbs2-0304" title="ZanisDA , McLellanAT , CorseS . Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders?. Community Mental Health Journal1997;33(3):213‐27. ">Zanis 1997</a>). Given that the problems encountered by the scale are likely to be encountered by any other similar instrument based on self‐reports of those with severe and persistent mental illness, it was decided to include data obtained with the ASI (used in <a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0006" title="BechdolfA , PohlmannB , GuttgemannsJ , GeyerC , LindnerK , FerberC , et al. State‐dependent motivational interviewing for people with schizophrenia and substance use : Results of a randomised controlled trial [Motivationsbehandlung für patienten mit der doppeldiagnose psychose und sucht]. Nervenarzt2011;83(7):888‐96. [MEDLINE: 21720841] ">Bechdolf 2011</a>; <a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>; <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>; <a href="./references#CD001088-bbs2-0015" title="EackSM , HogartySS , BangaloreSS , KeshavanMS , CorneliusJR . Patterns of substance use during Cognitive Enhancement Therapy: an 18‐month randomized feasibility study. Journal of Dual Diagnosis2016;12:74‐82. [CSzG: 33634] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18‐month feasibility trial. Schizophrenia Research2015;161(2‐3):478‐83. [CSzG: 29308] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18‐month feasibility trial. Schizophrenia Bulletin2015;41:S310. [CSzG: 29436] WojtalikJA , EackSM . Fronto‐limbic neuroplasticity effects of Cognitive Enhancement Therapy during emotion regulation in schizophrenia patients who abuse cannabis. Schizophrenia Bulletin2015;41:S243. [CSzG: 29719] WojtalikJA , HogartySS , CorneliusJR , PhillipsML , KeshavanMS , NewhillCE , et al. Cognitive Enhancement Therapy improves frontolimbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study. Frontiers in Psychiatry2016;6:186. [CSzG: 33452] ">Eack 2015</a>; <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>; <a href="./references#CD001088-bbs2-0022" title="HellersteinDJ , RosenthalRN , MinerCR . A prospective study of integrated outpatient treatment for substance‐abusing schizophrenic patients. American Journal on Addictions1995;4(1):33‐42. [CSzG: 5029] HellersteinDJ , RosenthalRN , MinerCR . Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly2001;72(4):291‐306. [CSzG: 8206] ">Hellerstein 1995</a> and <a href="./references#CD001088-bbs2-0029" title="LehmanAF , HerronJD , SchwartzRP , MyersCP . Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial. Journal of Nervous and Mental Disease1993;181(2):86‐90. [CSzG: 1646] ">Lehman 1993</a>). </p> </section> <section id="CD001088-sec-0126"> <p><b>b. Alcohol Use Inventory (AUI)</b></p> <p>This inventory assesses alcohol use (<a href="./references#CD001088-bbs2-0216" title="HornJL , WanbergKW , FosterFM . The Alcohol Use Inventory. Minneapolis, MN: National Computer Systems, 1987. ">Horn 1987</a>) (used by <a href="./references#CD001088-bbs2-0023" title="HickmanME . The effects of personal feedback on alcohol intake in dually diagnosed clients: an empirical study of William R. Miller's motivational enhancement therapy. Unpublished thesis. University Graduate School, Dept. Counseling Psychology, Indiana University1997. [CSzG: 4153] ">Hickman 1997</a>). </p> </section> <section id="CD001088-sec-0127"> <p><b>c. Alcohol Use Scale (AUS)</b></p> <p>A five‐point scale based on clinicians' ratings of severity of disorder, ranging from one (abstinence) to five (severe dependence) (<a href="./references#CD001088-bbs2-0260" title="MueserKT , DrakeRE , ClarkRE , McHugoGJ , Mercer‐McFaddenC , AckersonTH . Evaluating Substance Abuse in Persons with Severe Mental Illness. Cambridge, MA: Human Services Research Institute, 1995. ">Mueser 1995</a>). This was used in <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a> and <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>. </p> </section> <section id="CD001088-sec-0128"> <p><b>d. Alcohol Use Disorders Identification Test (AUDIT)</b></p> <p>The AUDIT is a 10‐item questionnaire covering the domains of alcohol consumption, drinking behaviour and alcohol‐related problems (<a href="./references#CD001088-bbs2-0276" title="SaundersJB , AaslandOG , Babor TF de la FuenteJR , GrantM . Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐‐II. Addiction1993;88(6):791‐804. ">Saunders 1993</a>). Responses to each question are scored from zero to 4. A sum score of 8 or more indicates hazardous or harmful alcohol use. This was used in <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>. </p> </section> <section id="CD001088-sec-0129"> <p><b>e. Cannabis and Substance Use Assessment Schedule (CASUAS) (modified from the SCAN)</b></p> <p>This measures cannabis use and includes similar information to the ASI, such as percentage of days using cannabis in the past four weeks, frequency of cannabis use, and an index of severity (range zero to 4) with higher scores indicating greater severity (<a href="./references#CD001088-bbs2-0299" title="WingJK , BaborT , BrughaT , et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry1990;47(6):589‐93. ">Wing 1990</a>) (used by <a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>). </p> </section> <section id="CD001088-sec-0130"> <p><b>f. Drug Use Scale (DUS)</b></p> <p>A five‐point scale based on clinicians' ratings of severity of disorder, ranging from one (abstinence) to five (severe dependence) (<a href="./references#CD001088-bbs2-0260" title="MueserKT , DrakeRE , ClarkRE , McHugoGJ , Mercer‐McFaddenC , AckersonTH . Evaluating Substance Abuse in Persons with Severe Mental Illness. Cambridge, MA: Human Services Research Institute, 1995. ">Mueser 1995</a>) (used in <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a> and <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>). </p> </section> <section id="CD001088-sec-0131"> <p><b>g. Opiate Treatment Index (OTI)</b></p> <p>The OTI has six domains reflecting treatment outcomes of: drug use, HIV risk‐taking behaviour, social functioning, criminality, health status and psychological adjustment (<a href="./references#CD001088-bbs2-0173" title="DarkeS , WardJ , HallW , HeatherN , WodakA . The Opiate Treatment Index (OTI) Researchers Manual. Technical report No. 11. Sydney: National Drug &amp; Alcohol Research Centre, 1991. ">Darke 1991</a>; <a href="./references#CD001088-bbs2-0174" title="DarkeS , HallW , WodakA , HeatherN , WardJ . Development and validation of a multi‐dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. British Journal of Addiction1992;87(5):733‐42. ">Darke 1992</a>). The drug use domain consists of 11 items measuring drug use over the last three days (recent drug use) or previous month (28 days) for alcohol, cannabis, amphetamines, cocaine, opiates and other drugs. Clients are asked to estimate the number of drinks or usage of drugs on the two most recent use days in the previous month. The quantity over the two days (q1 + q2) is divided by day interval (t1 + t2). Thus, an OTI score of 1.0 indicates one drink, injection or joint per day; 0.14 to 0.99 more than once a week; 0.01 to 0.13 once a week or less, and 2.0 or more indicates use more than once a day. Higher scores indicate a greater degree of dysfunction or substance use. <a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a> and <a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a> used the OTI to measure substance use over the previous month. </p> </section> <section id="CD001088-sec-0132"> <p><b>h. Substance Abuse Treatment Scale (SATS)</b></p> <p>An eight‐point scale indicating progression toward recovery ranging from one (early stages of engagement) to eight (relapse prevention). Higher scores indicate greater progression (<a href="./references#CD001088-bbs2-0250" title="McHugoGJ , DrakeRE , BurtonHL , AckersonTH . A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. Journal of Nervous and Mental Disease1995;183(12):762‐7. ">McHugo 1995</a>). This was used by <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>, <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a> and <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>. </p> </section> <section id="CD001088-sec-0133"> <p><b>i. Alcohol and drug use disorders section of the Structured Clinical Interview for DSM‐III‐R (Patient Edition) (SCID)</b></p> <p>Items relate to substance use in the past month (<a href="./references#CD001088-bbs2-0285" title="SpitzerRL , WilliamsJB , GibbonM , FirstMB . Structured Clinical Interview for DSM‐III‐R ‐ Patient Edition (SCID‐P). Washington, DC: American Psychiatric Press, 1990. ">Spitzer 1990</a>). Higher scores indicate a greater degree of dysfunction (used by <a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a>). </p> </section> <section id="CD001088-sec-0134"> <p><b>j. Substance Use Severity Scale (USS)</b></p> <p>This is a five‐point scale, ranging from one (not using) to five (meets criteria for severe use) (<a href="./references#CD001088-bbs2-0166" title="CareyKB , CoccoKM , SimonsJS . Concurrent validity of clinicians' rating of substance abuse among psychiatric outpatients. Psychiatric Services1996;47(8):842‐7. ">Carey 1996</a>), used by <a href="./references#CD001088-bbs2-0034" title="CalsynRJ , YonkerRD , LemmingMR , MorseGA , KlinkenbergWD . Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behaviour and Mental Health2005;15(4):236‐48. [CSzG: 16813] FletcherTD , CunninghamJL , CalsynRJ , MorseGA , KlinkenbergWD . Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects. Administration and Policy in Mental Health2008;35(4):319‐36. [CSzG: 16624; MEDLINE: 18506618] MorseGA , CalsynRJ , KlinkenbergWD , CunninghamJ , LemmingMR . Integrated treatment for homeless clients with dual disorders: a quasi‐experimental evaluation. Journal of Dual Diagnosis2008;4(3):219‐37. [CSzG: 19618] MorseGA , CalsynRJ , KlinkenbergWD , HelminiakTW , WolffN , DrakeRE , et al. Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes. Community Mental Health Journal2006;42(4):377‐404. [CSzG: 13863] ">Morse 2006</a>. </p> </section> </section> <section id="CD001088-sec-0135"> <h6 class="title">4.2 Mental state assessment</h6> <section id="CD001088-sec-0136"> <p><b>a. Beck Depression Inventory (BDI)</b></p> <p>This contains 21 self‐report items which measure the severity of depression (<a href="./references#CD001088-bbs2-0151" title="BeckAT , BeckRW . Screening depressed patients in family practice. A rapid technique. Postgraduate Medicine1972;52(6):81‐5. ">Beck 1972</a>). Each item comprises four statements (rated from zer to 4) describing increasing severity on how they felt over the preceding week. Scores range from zero to 84, with higher scores indicating more severe symptoms (used in <a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>; <a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a> used the short form of this scale (BDI‐SF)). </p> </section> <section id="CD001088-sec-0137"> <p><b>b. Brief Psychiatric Rating Scale (BPRS)</b></p> <p>Used to assess the severity of a range of psychiatric symptoms, including psychotic symptoms (<a href="./references#CD001088-bbs2-0246" title="LukoffD , NuechterleinKH , VenturaJ . Manual for expanded Brief Psychiatric Rating Scale (BPRS). Schizophrenia Bulletin1986;12(4):594‐602. ">Lukoff 1986</a>), the scale has 24 items, of which 14 are based on the person's self‐report in the last two weeks and 10 on the person's behaviour during the interview. Each item can be defined on a seven‐point scale from one (not present) to seven (extremely severe). Total scoring ranges from 24 to 168 and there are five subscales with minimum scores ranging from three to four depending on the subscale (used in <a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>; <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>; <a href="./references#CD001088-bbs2-0015" title="EackSM , HogartySS , BangaloreSS , KeshavanMS , CorneliusJR . Patterns of substance use during Cognitive Enhancement Therapy: an 18‐month randomized feasibility study. Journal of Dual Diagnosis2016;12:74‐82. [CSzG: 33634] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18‐month feasibility trial. Schizophrenia Research2015;161(2‐3):478‐83. [CSzG: 29308] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18‐month feasibility trial. Schizophrenia Bulletin2015;41:S310. [CSzG: 29436] WojtalikJA , EackSM . Fronto‐limbic neuroplasticity effects of Cognitive Enhancement Therapy during emotion regulation in schizophrenia patients who abuse cannabis. Schizophrenia Bulletin2015;41:S243. [CSzG: 29719] WojtalikJA , HogartySS , CorneliusJR , PhillipsML , KeshavanMS , NewhillCE , et al. Cognitive Enhancement Therapy improves frontolimbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study. Frontiers in Psychiatry2016;6:186. [CSzG: 33452] ">Eack 2015</a>; <a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>; and <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>). </p> </section> <section id="CD001088-sec-0138"> <p><b>c. Brief Symptom Inventory (BSI)</b></p> <p>This measures psychiatric symptomatology (<a href="./references#CD001088-bbs2-0181" title="DerogatisLR , MelisaratosN . The brief symptom inventory: an introductory report. Psychological Medicine1983;13(3):595‐605. ">Derogatis 1983a</a>). A brief rating scale is used by an independent rater to assess severity of psychiatric symptoms. Scores range from zero to 4 with higher scores indicating more symptoms (used by <a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a>, <a href="./references#CD001088-bbs2-0008" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12‐step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403‐11. [CSzG: 29165; NCT00583440] ">Bogenschutz 2014</a>, <a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>, <a href="./references#CD001088-bbs2-0033" title="LoweJM , McDonellMG , LeicklyE , AngeloFA , VilardagaR , McPhersonS , et al. Determining ethyl glucuronide cutoffs when detecting self‐reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research2015;39(5):905‐10. McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , HirchakK , OluwoyeO , et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness. American Journal on Addictions2017;26(7):673‐5. [CSzG: 36340] McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , SrebnikD , AngeloF , et al. A randomized controlled trial of ethyl glucuronide‐ based contingency management for outpatients with co‐occurring alcohol use disorders and serious mental Illness. American Journal of Psychiatry2017;174(4):370‐7. [CSzG: 35589] McDonellMG , SkaliskyJ , LeicklyE , McPhersonS , BattalioS , NepomJR , et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence2015;157:184‐7. NCT01567943 . Contingency management of alcohol abuse in the severely mentally ill. http://ClinicalTrials.gov/show/NCT015679432012. [CSzG: 23792] OluwoyeO , LeicklyE , SkaliskyJ , McPhersonS , HirchakK , SrebnikD , et al. Serious mental illness in heavy drinkers is associated with poor treatment outcomes in outpatients with co‐occurring disorders. International Journal of Mental Health Addiction2018;16(3):672‐9. [CSzG: 37902] SkaliskyJ , LeicklyE , OluwoyeO , McPhersonSM , SrebnikD , RollJM , et al. Prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders. Cannabis and Cannabinoid Research2017;2(1):133‐8. [CSzG: 36516] ">McDonell 2017</a> and <a href="./references#CD001088-bbs2-0038" title="NCT01478815 . Contingency management for persons with severe mental illness. http://ClinicalTrials.gov/show/NCT014788152011. [CSzG: 23332] PetryNM , AlessiSM , Rash CarlaJ . A randomized study of contingency management in cocaine‐dependent patients with severe and persistent mental health disorders. Drug and Alcohol Dependence2013;130:234‐7. [CSzG: 28275] ">Petry 2013</a>). </p> </section> <section id="CD001088-sec-0139"> <p><b>d. Comprehensive Psychopathological Rating Scale (CPRS)</b></p> <p>This is an interview rating scale covering a wide range of psychiatric symptoms, and can be used in total or as subscales. The Montgomery Asperg Depression Rating Scale (MADRS), Brief Scale for Anxiety (BSA) and the Schizophrenia Change Scale (SCR) are all subscales of the CPRS. It comprises 65 items that cover the range of psychopathology over the preceding week (40 symptom items are rated by the participant) (<a href="./references#CD001088-bbs2-0147" title="AsbergM , MontgomerySA , PerrisC , et al. A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica Supplement1978;271:5‐27. ">Asberg 1978</a>). Each item is rated on a zero to 3 scale, varying from 'not present' to 'extremely severe', with high scores indicating more severe symptoms and a worse outcome (used by <a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>). </p> </section> </section> <section id="CD001088-sec-0140"> <h6 class="title">Global state: (a clinical measure of patient's psychological, social and occupational functioning in a single measure) </h6> <section id="CD001088-sec-0141"> <p><b>e. Global Assessment of Functioning (GAF)</b></p> <p>The Global Assessment of Functioning is a revised version of the Global Assessment Scale (GAS) (<a href="./references#CD001088-bbs2-0199" title="EndicottJ , SpitzerRL , FleissJL , CohenJ . The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. Archives of General Psychiatry1976;33(6):766‐71. ">Endicott 1976</a>). The (GAF) scale allows the clinical progress of the patient to be expressed in global terms using a single measure. The GAF allows the clinician to express the patient's psychological, social and occupational functioning on a continuum extending from superior mental health, with optimal social and occupational performance, to profound mental impairment when social and occupational functioning is precluded. Developed by <a href="./references#CD001088-bbs2-0195" title="APA1994 . Diagnostic &amp; Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: APA, 1994. ">DSM‐IV</a> to report global assessment of functioning on the Axis V (<a href="./references#CD001088-bbs2-0195" title="APA1994 . Diagnostic &amp; Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: APA, 1994. ">DSM‐IV</a>), it ranges from 1 to 100 (zero is used to acknowledge inadequate information). Higher scores indicate a better outcome; scores ranging from 1 to 20 indicate a person unable to function independently; 21 to 40 indicate major impairment, severely impaired by delusions; 41 to 60 moderately impaired, having serious symptoms and these patients usually need continuous treatment in a partial hospitalisation or outpatient setting; 61 to 80 indicate slight or mild impairment with transient symptoms; and 81 to 100, good or superior functioning. <a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>, <a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>, <a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>, <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>, <a href="./references#CD001088-bbs2-0006" title="BechdolfA , PohlmannB , GuttgemannsJ , GeyerC , LindnerK , FerberC , et al. State‐dependent motivational interviewing for people with schizophrenia and substance use : Results of a randomised controlled trial [Motivationsbehandlung für patienten mit der doppeldiagnose psychose und sucht]. Nervenarzt2011;83(7):888‐96. [MEDLINE: 21720841] ">Bechdolf 2011</a>, <a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>, <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>, <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a> and <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a> used this scale. </p> </section> <section id="CD001088-sec-0142"> <p><b>f. Hospital Anxiety and Depression Scale (HADS)</b></p> <p>The HADS is a 14‐item self‐assessment scale developed to detect states of depression and anxiety (<a href="./references#CD001088-bbs2-0306" title="ZigmondAS , SnaithRP . The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica1983;67(6):361‐70. ">Zigmond 1983</a>). Each of the items is rated on a four‐point Likert scale (zero to 3) with half of the items rated on a reverse scale (I feel cheerful, I can sit at ease and feel relaxed). Scale scores can be categorised into non‐cases (scores of zero to 7), doubtful cases (8 to 10) and definite cases (&gt;11) for depression (HADS‐D) and anxiety (HADS‐A) (used by <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>). </p> </section> <section id="CD001088-sec-0143"> <p><b>g. Health of the Outcome Nation Outcomes Scale (HoNOS)</b></p> <p>HoNOS is a 12‐item instrument on a scale of zero to 4 used to rate patients' symptoms and progress towards health (<a href="./references#CD001088-bbs2-0300" title="WingJK , CurtisR , BeevorA . The Health of the Nation Outcome Scales. London: Royal College of Psychiatrists, 1996. ">Wing 1996</a>). Item 3 can be used to rate drug and alcohol use (zero = no problem, 1 = some over‐indulgence but within social norm, 2 = loss of control, 3 = marked craving, 4 = incapacitated by alcohol or drug problem) and other items can be used to assess social functioning. Thus, ratings range from zero to 48 and higher scores indicate a poorer outcome (used by <a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>). </p> </section> <section id="CD001088-sec-0144"> <p><b>h. Insight Scale</b></p> <p>This is used to assess the patient's level of insight about their illness (<a href="./references#CD001088-bbs2-0175" title="DavidA , BuchananA , ReedA , AlmeidaO . The assessment of insight in psychosis. British Journal of Psychiatry1992;161(November):599‐602. ">David 1992</a>). Seven self‐report items are scored from zero = no insight to 2 = full insight. One additional self‐report item is scored zero to 4 (used by <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a> and <a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>). </p> </section> <section id="CD001088-sec-0145"> <p><b>i. The Positive and Negative Syndrome Scale (PANSS)</b></p> <p>The PANSS was developed from the BPRS and the Psychopathology Rating Scale (<a href="./references#CD001088-bbs2-0227" title="KaySR , FiszbeinA , OplerLA . The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin1987;13(2):261‐76. ">Kay 1987</a>). It is used as a method for evaluating positive, negative and other symptom dimensions in schizophrenia. The scale has 30 items and each item can be defined on a seven‐point scoring system, varying from one (absent) to seven (extreme), so total scores range from 30 to 210. This scale can be divided into three subscales for measuring the severity of general psychopathology (range 16 to 112), positive symptoms (PANSS‐P, range 7 to 49) and negative symptoms (PANSS‐N, range 7 to 49). A low score indicates low levels of symptoms. This was used by <a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>, <a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>, <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>, <a href="./references#CD001088-bbs2-0006" title="BechdolfA , PohlmannB , GuttgemannsJ , GeyerC , LindnerK , FerberC , et al. State‐dependent motivational interviewing for people with schizophrenia and substance use : Results of a randomised controlled trial [Motivationsbehandlung für patienten mit der doppeldiagnose psychose und sucht]. Nervenarzt2011;83(7):888‐96. [MEDLINE: 21720841] ">Bechdolf 2011</a>, <a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>, <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>, <a href="./references#CD001088-bbs2-0028" title="KempR , HarrisA , VurelE , SitharthanT . Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry2007;15(6):490‐3. [CSzG: 15549; MEDLINE: 17852064] ">Kemp 2007</a>, <a href="./references#CD001088-bbs2-0033" title="LoweJM , McDonellMG , LeicklyE , AngeloFA , VilardagaR , McPhersonS , et al. Determining ethyl glucuronide cutoffs when detecting self‐reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research2015;39(5):905‐10. McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , HirchakK , OluwoyeO , et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness. American Journal on Addictions2017;26(7):673‐5. [CSzG: 36340] McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , SrebnikD , AngeloF , et al. A randomized controlled trial of ethyl glucuronide‐ based contingency management for outpatients with co‐occurring alcohol use disorders and serious mental Illness. American Journal of Psychiatry2017;174(4):370‐7. [CSzG: 35589] McDonellMG , SkaliskyJ , LeicklyE , McPhersonS , BattalioS , NepomJR , et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence2015;157:184‐7. NCT01567943 . Contingency management of alcohol abuse in the severely mentally ill. http://ClinicalTrials.gov/show/NCT015679432012. [CSzG: 23792] OluwoyeO , LeicklyE , SkaliskyJ , McPhersonS , HirchakK , SrebnikD , et al. Serious mental illness in heavy drinkers is associated with poor treatment outcomes in outpatients with co‐occurring disorders. International Journal of Mental Health Addiction2018;16(3):672‐9. [CSzG: 37902] SkaliskyJ , LeicklyE , OluwoyeO , McPhersonSM , SrebnikD , RollJM , et al. Prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders. Cannabis and Cannabinoid Research2017;2(1):133‐8. [CSzG: 36516] ">McDonell 2017</a> and <a href="./references#CD001088-bbs2-0037" title="O'ConnellMJ , FlanaganEH , Delphin‐RittmonME , DavidsonL . Enhancing outcomes for persons with co‐occurring disorders through skills training and peer recovery support. Journal of Mental Health2018;in press:(online 10 March 2017). [CSzG: 35896; DOI: 10.1080/09638237.2017.1294733] ">O'Connell 2018</a>. </p> </section> <section id="CD001088-sec-0146"> <p><b>j. Psychiatric scale from Addiction Severity Index (ASI‐psychiatric)</b></p> <p>Psychiatric subscores (<a href="./references#CD001088-bbs2-0252" title="McLellanAT , LuborskyL , WoodyGE , O'BrienC . An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease1980;168(1):26‐33. ">McLellan 1980</a>) were reported in <a href="./references#CD001088-bbs2-0029" title="LehmanAF , HerronJD , SchwartzRP , MyersCP . Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial. Journal of Nervous and Mental Disease1993;181(2):86‐90. [CSzG: 1646] ">Lehman 1993</a> and <a href="./references#CD001088-bbs2-0022" title="HellersteinDJ , RosenthalRN , MinerCR . A prospective study of integrated outpatient treatment for substance‐abusing schizophrenic patients. American Journal on Addictions1995;4(1):33‐42. [CSzG: 5029] HellersteinDJ , RosenthalRN , MinerCR . Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly2001;72(4):291‐306. [CSzG: 8206] ">Hellerstein 1995</a>. See the ASI scoring above. </p> </section> <section id="CD001088-sec-0147"> <p><b>k. Scale for the Assessment of Negative Symptoms (SANS)</b></p> <p>The scale assesses negative symptoms for schizophrenia (<a href="./references#CD001088-bbs2-0145" title="AndreasenNC . Negative symptoms in schizophrenia. Archives of General Psychiatry1982;39:784‐8. ">Andreasen 1982</a>). This assesses five symptoms complexes to obtain the clinical rating of negative symptoms over the preceding week. They are affective blunting, alogia, apathy, anhedonia and disturbance of attention. Each item uses a six‐point scale ranging from zero (not at all) to 5 (indicating severe). High scores indicate a worse outcome (used by <a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>). </p> </section> <section id="CD001088-sec-0148"> <p><b>l. Symptom Checklist 90 (revised) (SCL‐90‐R)</b></p> <p>Used to measure psychiatric symptoms (<a href="./references#CD001088-bbs2-0182" title="DerogatisLR . SCL‐90‐R: Administration, Scoring &amp; Procedures Manual‐II. Towson, MD: Clinical Psychometric Research, 1983. ">Derogatis 1983b</a>), the scale has 90 self‐report items designed to measure nine symptom dimensions. Each item has a five‐point Likert scale ranging from zero (mild or not at all) to 4 (severe or extremely distressing), with higher scores indicating greater symptomatology (used by <a href="./references#CD001088-bbs2-0023" title="HickmanME . The effects of personal feedback on alcohol intake in dually diagnosed clients: an empirical study of William R. Miller's motivational enhancement therapy. Unpublished thesis. University Graduate School, Dept. Counseling Psychology, Indiana University1997. [CSzG: 4153] ">Hickman 1997</a>). </p> </section> </section> <section id="CD001088-sec-0149"> <h6 class="title">4.3 Quality of life and client satisfaction; quality of life scales measure objective and subjective quality of life satisfaction and global patient satisfaction with daily living and services provided (see Results, section 4.3). </h6> <section id="CD001088-sec-0150"> <p><b>a. The Quality of Life Interview (QOLI) and the Brief Quality of Life Scale (BQOL)</b></p> <p>The QOLI contains 153 items that measure global life satisfaction as well as objective and subjective quality of life (<a href="./references#CD001088-bbs2-0238" title="LehmanAF . A quality of life interview for the chronically mentally ill. Evaluation and Program Planning1988;11(1):51‐62. ">Lehman 1988</a>; <a href="./references#CD001088-bbs2-0239" title="LehmanAF . Evaluating Quality of Life for Persons with Severe Mental Ilness: Assessment Toolkit. Cambridge, Mass: The Evaluation Center at Health Services Research Institute, 1995. ">Lehman 1995</a>). It has eight domains (for example, living situations, daily activities and functioning, family relations, social relations). Rated on a seven‐point scale (1 = terrible, 2 = unhappy, 3 = mostly dissatisfied, 4 = equally satisfied and dissatisfied, 5 = mostly satisfied, 6 = pleased, and 7 = delighted), with higher scores indicating better quality of life. It was used by <a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>, <a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>, <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>, <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a> and <a href="./references#CD001088-bbs2-0029" title="LehmanAF , HerronJD , SchwartzRP , MyersCP . Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial. Journal of Nervous and Mental Disease1993;181(2):86‐90. [CSzG: 1646] ">Lehman 1993</a>. </p> </section> <section id="CD001088-sec-0151"> <p><b>b. World Health Organization's Quality of Life scale (WHOQOL‐BREF)</b></p> <p>The WHOQOL‐BREF is a 26‐item scale (<a href="./references#CD001088-bbs2-0284" title="SkevingtonSM , LotfyM , O'ConnellKA . The World Health Organization's WHOQOL‐BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research2004;13(2):299‐310. ">Skevington 2004</a>) assessing physical health, psychological well being, social relationships, and environmental factors (for example, home environment, recreation, access to health care, physical safety and financial resources). It also contains two general items and each item is rated on a five‐point scale (1 to 5, with higher scores = better quality) (used by <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a>). </p> </section> <section id="CD001088-sec-0152"> <p><b>c. Client Satisfaction Questionaire (CSQ)</b></p> <p>The CSF questionnaire (CSQ) (<a href="./references#CD001088-bbs2-0236" title="LarsenDL , AttkissonCC , HargreavesWA , NguyenTD . Assessment of client/patient satisfaction: development of a general scale. Evaluation and Program Planning1979;2(2):197‐207. ">Larsen 1979</a>) is a self‐report instrument that consists of eight items designed to measure global patient satisfaction of services provided and if they met their needs or approval. The items are rated on a four‐point scale (minimum of 1 = no definitely not to maximum 4 = very satisfied), with a minimum score of 8 and maximum of 32 and higher scores indicating greater satisfaction (used by <a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>). </p> </section> </section> <section id="CD001088-sec-0153"> <h6 class="title">4.4 Social functioning: social function scales measure degree of social assessment and basic skills necessary for community living (see Results, section 4.4, Social functioning). </h6> <section id="CD001088-sec-0154"> <p><b>a. Role Functioning Scale (RFS)</b></p> <p>This is a self‐report scale whereby the total of four subscales measures global role functioning (<a href="./references#CD001088-bbs2-0203" title="GreenRS , GracelyEJ . Selecting a rating scale for evaluating services to the chronically mentally ill. Community Mental Health Journal1987;23(2):91‐102. ">Green 1987</a>). Scores reported are summary scores derived from four independent raters. Higher scores indicate better functioning (used by <a href="./references#CD001088-bbs2-0025" title="JerrellJM . Cost‐effective treatment for persons with dual disorders. New Directions for Mental Health Services1996;70(Summer):79‐91. [CSzG: 16821] JerrellJM , HuTW , RidgelyMS . Cost‐effectiveness of substance disorder interventions for people with severe mental illness. Journal of Mental Health Administration1994;21(3):283‐97. [CSzG: 1166] JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] JerrellJM , RidgelyMS . Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services1999;50(1):109‐12. [CSzG: 16917] ">Jerrell 1995a</a> and <a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a>). </p> </section> <section id="CD001088-sec-0155"> <p><b>b. Social Adjustment Scale for the Severely Mentally Ill (SAS‐SMI)</b></p> <p>An abbreviated version of the Social Adjustment Scale II is used to assess social adjustment (<a href="./references#CD001088-bbs2-0298" title="WieduwiltKM , JerrellJM . The reliability and validity of the SAS‐SMI. Journal of Psychiatric Research1999;33(2):105‐12. ">Wieduwilt 1999</a>), with a self‐reported scale composed of 24 items covering seven areas including social, family and work functioning designed specifically for use with schizophrenic populations. Scores range from 1 to 7, with a high score indicating poor outcome (used by <a href="./references#CD001088-bbs2-0025" title="JerrellJM . Cost‐effective treatment for persons with dual disorders. New Directions for Mental Health Services1996;70(Summer):79‐91. [CSzG: 16821] JerrellJM , HuTW , RidgelyMS . Cost‐effectiveness of substance disorder interventions for people with severe mental illness. Journal of Mental Health Administration1994;21(3):283‐97. [CSzG: 1166] JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] JerrellJM , RidgelyMS . Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services1999;50(1):109‐12. [CSzG: 16917] ">Jerrell 1995a</a> and <a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a>). </p> </section> <section id="CD001088-sec-0156"> <p><b>c. Social Functioning Scale (SFS)</b></p> <p>A self‐report scale developed for people with schizophrenia which enumerates basic skills necessary for community living and performance (<a href="./references#CD001088-bbs2-0154" title="BirchwoodM , SmithJ , CochraneR , WettonS , CopestakeS . The Social Functioning Scale: the development and validation of a scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry1990;157(December):853‐9. ">Birchwood 1990</a>), the SFS is a 79‐item questionnaire that uses a four‐point rating scale (zero to 3) of frequency or ability. Items are grouped into seven domains. Raw scores for each subscale are converted to a standard score; overall functioning is based on the mean standard score (<a href="./references#CD001088-bbs2-0164" title="BurnsT , PatrickD . Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatrica Scandinavica2007;116(6):403‐18. ">Burns 2007</a>). Higher standardised scores indicate better functioning (range 55 to 135) (<a href="./references#CD001088-bbs2-0154" title="BirchwoodM , SmithJ , CochraneR , WettonS , CopestakeS . The Social Functioning Scale: the development and validation of a scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry1990;157(December):853‐9. ">Birchwood 1990</a>). This was used by <a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a> and <a href="./references#CD001088-bbs2-0037" title="O'ConnellMJ , FlanaganEH , Delphin‐RittmonME , DavidsonL . Enhancing outcomes for persons with co‐occurring disorders through skills training and peer recovery support. Journal of Mental Health2018;in press:(online 10 March 2017). [CSzG: 35896; DOI: 10.1080/09638237.2017.1294733] ">O'Connell 2018</a>. </p> </section> <section id="CD001088-sec-0157"> <p><b>d. The Social and Occupational Functioning Scale (SOFAS)</b></p> <p>SOFAS was derived from the GAF scale and is used to assess levels of physical and mental functioning in social and work settings (<a href="./references#CD001088-bbs2-0164" title="BurnsT , PatrickD . Social functioning as an outcome measure in schizophrenia studies. Acta Psychiatrica Scandinavica2007;116(6):403‐18. ">Burns 2007</a>; <a href="./references#CD001088-bbs2-0202" title="GoldmanHH , SkodalAE , LaveTR . Revising Axis V for DSM‐IV: a review of measures of social functioning. Americal Journal of Psychiatry1992;149(9):1148‐56. ">Goldman 1992</a>). Scored similarly to the GAF (see above) by an observer it ranges from zero to 100 with zero representing inadequate information. Higher scores indicate better outcomes (used by <a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a> and <a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>). </p> </section> <section id="CD001088-sec-0158"> <p><b>e. Service Utilisation Rating Scale (SURS)</b></p> <p>This measures inpatient and outpatient attendance and medication usage (<a href="./references#CD001088-bbs2-0254" title="MihalopoulosC , McGorryPD , CarterRC . Is phase‐specific community ‐oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatrica Scandinavica1999;100(1):47‐55. ">Mihalopoulos 1999</a>) (used by <a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>). </p> </section> </section> </section> </section> <section id="CD001088-sec-0159"> <h4 class="title">Excluded studies</h4> <p>In the current update (May 2018 search), we excluded (with reasons) 28 studies/reports or trials: six were not randomised, 15 did not include participants with a concurrent diagnosis of severe mental illness and substance misuse and five studies did not use a psychosocial intervention. One study identified from an on‐going trial list <a href="./references#CD001088-bbs2-0056" title="ACTRN12610000249055 . A randomised control trial of a group based intervention and relapse prevention package for substance misuse and psychosis. Australian New Zealand Clinical Trials Registry2010. CastleDJ , JamesW , KohG , KiselyN , PrestonN . An RCT A group‐based intervention for substance abuse in schizophrenia. Schizophrenia Research2003;60:276‐7. CastleDJ , JamesW , KohG , WightmanP , KiselyS , SpencerC , et al. Substance use in schizophrenia: why do people use, and what can be done about it?. Schizophrenia Research2002;53(3 Suppl 1):178. ">Castle 2002</a> (was abandoned due to lack of funds according to email from the primary author and excluded as there was no usable data) and another from the 'to be assessed' list (<a href="./references#CD001088-bbs2-0099" title="OdomAE . A randomized study of integrated outpatient treatment and assertive community treatment for patients with comorbid mental illness and substance use disorders: comparing treatment outcome for domiciled and homeless patients [PhD thesis]. New School University, 2005. ">Odom 2005</a>) was excluded as feedback from the author indicated there was no usable or published data. </p> <p>In the 2013 update, we excluded 46 studies or trials identified through the initial search (July 2012 search): five were not randomised, 30 did not include participants with a concurrent diagnosis of severe mental illness and substance misuse, 10 studies used a non‐psychosocial intervention or did not include a specific substance misuse treatment programme, and one trial had no usable data. Four further full text articles that were identified through subsequent searches (<a href="./references#CD001088-bbs2-0044" title="BagoienG , BjorngaardJ , OstensenC , RomundstadP , MorkenG . Motivational interviewing to patients with comorbid substance use admitted to an acute psychiatric department. Psychiatrische Praxis2011;38:S10. BagoienG , BjorngaardJH , OstensenC , ReitanSK , RomundstadP , MorkenG . The effects of motivational interviewing on patients with comorbid substance use admitted to a psychiatric emergency unit ‐ a randomised controlled trial with two year follow‐up. BMC Psychiatry2013;13:93. [PUBMED: 23517244] ">Bagoien 2013</a>; <a href="./references#CD001088-bbs2-0112" title="SigmonSC , SteingardS , BadgerGJ , AnthonySL , HigginsST . Contingent reinforcement of marijuana abstinence among individuals with serious mental illness: a feasibility study. Experimental &amp; Clinical Psychopharmacology2000;8(4):509‐17. ">Sigmon 2000</a>; <a href="./references#CD001088-bbs2-0114" title="NCT01167556 . Family motivational intervention in schizophrenia. http://ClinicalTrials.gov/show/NCT011675562006. SmeerdijkM , KeetR , DeHaanL , SchippersG , LinszenD . Family motivation intervention in early onset psychosis and cannabis abuse: a randomized clinical trial. Proceedings of the 12th International Congress on Schizophrenia Research; 2009 Mar 28‐Apr 1; San Diego, CA. Oxford Univ Press, 2009:371. SmeerdijkM , KeetR , DekkerN , VanRaaijB , KrikkeM , KoeterM , et al. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent onset schizophrenia. Early Intervention in Psychiatry2010;4 Suppl 1:6. SmeerdijkM , KeetR , DekkerN , vanRB , KrikkeM , KoeterM , et al. Motivational interviewing and interaction skills training for parents to change cannabis use in young adults with recent‐onset schizophrenia: a randomized controlled trial. Psychological Medicine2012;42(8):1627‐36. SmeerdijkM , KeetR , deHaanL , BarrowcloughC , LinszenD , SchippersG . Feasibility of teaching motivational interviewing to parents of young adults with recent‐onset schizophrenia and co‐occurring cannabis use. Journal of Substance Abuse Treatment2014;46(3):340‐5. SmeerdijkM , KeetR , vanRaaijB , KoeterM , LinszenD , deHaanL , et al. Motivational interviewing and interaction skills training for parents of young adults with recent‐onset schizophrenia and co‐occurring cannabis use: 15‐month follow‐up. Psychological Medicine2015;45(13):2839‐48. ">Smeerdijk 2012</a>; <a href="./references#CD001088-bbs2-0127" title='WeissRD , GriffinML , JaffeeWB , BenderRE , GraffFS , GallopRJ , et al. A "community‐friendly" version of integrated group therapy for patients with bipolar disorder and substance dependence: a randomized controlled trial. Drug &amp; Alcohol Dependence2009;104(3):212‐9. Weiss , R . Modifying group therapy for bipolar substance abusers. NCT00227838. http://www.clinicaltrials.gov2005. '>Weiss 2009</a>) were excluded. </p> <p>In the 2008 review, we excluded 68 studies (this did not include related studies, please see <a href="./references#CD001088-sec-0384" title="">Characteristics of excluded studies</a>). Twenty‐six were not randomised or used a quasi‐randomisation method, 18 did not have participants with a concurrent diagnosis of severe mental illness and substance misuse, and 14 used a non‐psychosocial intervention or did not include a specific substance misuse treatment programme. A further 10 RCTs were excluded either due to high attrition rates or unclear reporting (attempts were made to contact all authors for further information). One study previously listed in the 2008 review as ongoing (<a href="./references#CD001088-bbs2-0113" title="SitharthanT , SinghS , KranitisP , CurrieJ , FreemanP , MurugesanG , et al. Integrated drug and alcohol intervention: development of an opportunistic intervention program to reduce alcohol and other substance use among psychiatric patients. Australian and New Zealand Journal of Psychiatry1999;33(5):676‐83. [MEDLINE: PMID 10544991] ">Sitharthan 1999</a>) was excluded in the current review. Two studies previously included in the 2008 review (<a href="./references#CD001088-bbs2-0110" title="SchmitzJM , AverillP , SayreS , McClearyP , MoellerFG , SwannA . Cognitive‐behavioral treatment of bipolar disorder and substance abuse: A preliminary randomized study. Addictive Disorders and Their Treatment2002;1(1):17‐24. ">Schmitz 2002</a>; <a href="./references#CD001088-bbs2-0126" title="WeissRD , GriffinML , KolodziejME , GreenfieldSF , NajavitsLM , DaleyDC , et al. A randomized trial of integrated group therapy versus group drug counseling for patients with bipolar disorder and substance dependence. American Journal of Psychiatry2007;164(1):100‐7. ">Weiss 2007</a>) were excluded as all the participants had bipolar disorder so this criteria was applied retrospectively as well as prospectively. </p> <p>Two studies were listed as awaiting assessment (<a href="./references#CD001088-bbs2-0131" title="MeisterK , RietschelL , BurlonM , JannsenH , BockT , WegscheiderK , et al. A cluster‐randomized, parallel group, observer blind trial of a group based motivational‐behavioural therapy for young people with psychosis and substance use disorder. Early Intervention in Psychiatry2010;4 Suppl 1:163. Meister , K . Comorbid psychosis and addiction. Epidemiology, explanatory models and evaluation of motivational behavioural group therapy [Komorbidität psychose und sucht. Epidemiologie, erklärungsmodelle und evaluation einer motivational‐verhaltenstherapeutischen gruppentherapie]. Dissertation, University of Hamburg2010. ">Meister 2010</a>; <a href="./references#CD001088-bbs2-0099" title="OdomAE . A randomized study of integrated outpatient treatment and assertive community treatment for patients with comorbid mental illness and substance use disorders: comparing treatment outcome for domiciled and homeless patients [PhD thesis]. New School University, 2005. ">Odom 2005</a>). Both are dissertations: one requires translation from German to English. Further correspondence indicated no publication arose from latter dissertation so this was moved to the excluded category as there were no data available. </p> <p>We found 12 studies where we require more information from authors or text translated. WE have placed these in awaiting assessment until we have a response.There are currently five ongoing studies. </p> </section> </section> <section id="CD001088-sec-0160"> <h3 class="title">Risk of bias in included studies</h3> <p>For a summary of the overall risk of bias in the included trials please see <a href="#CD001088-fig-0001">Figure 1</a> and <a href="#CD001088-fig-0002">Figure 2</a>. </p> <section id="CD001088-sec-0161"> <h4 class="title">Allocation</h4> <section id="CD001088-sec-0162"> <h5 class="title">1. Random generation</h5> <p>All 41 studies were stated to be randomised. Some used blocking or stratification methods in the sequence to obtain evenly balanced groups or different proportions (2:1) for each intervention, site, or to control for various demographic variables (type or degree of substance use, gender or psychiatric diagnosis). Fourteen studies stated the sequence was computer‐generated (<a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>; <a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>; <a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a>; <a href="./references#CD001088-bbs2-0015" title="EackSM , HogartySS , BangaloreSS , KeshavanMS , CorneliusJR . Patterns of substance use during Cognitive Enhancement Therapy: an 18‐month randomized feasibility study. Journal of Dual Diagnosis2016;12:74‐82. [CSzG: 33634] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18‐month feasibility trial. Schizophrenia Research2015;161(2‐3):478‐83. [CSzG: 29308] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18‐month feasibility trial. Schizophrenia Bulletin2015;41:S310. [CSzG: 29436] WojtalikJA , EackSM . Fronto‐limbic neuroplasticity effects of Cognitive Enhancement Therapy during emotion regulation in schizophrenia patients who abuse cannabis. Schizophrenia Bulletin2015;41:S243. [CSzG: 29719] WojtalikJA , HogartySS , CorneliusJR , PhillipsML , KeshavanMS , NewhillCE , et al. Cognitive Enhancement Therapy improves frontolimbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study. Frontiers in Psychiatry2016;6:186. [CSzG: 33452] ">Eack 2015</a>; <a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>; <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>; <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>; <a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>; <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a>; <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>; <a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>; <a href="./references#CD001088-bbs2-0038" title="NCT01478815 . Contingency management for persons with severe mental illness. http://ClinicalTrials.gov/show/NCT014788152011. [CSzG: 23332] PetryNM , AlessiSM , Rash CarlaJ . A randomized study of contingency management in cocaine‐dependent patients with severe and persistent mental health disorders. Drug and Alcohol Dependence2013;130:234‐7. [CSzG: 28275] ">Petry 2013</a>), but often it was unclear how the sequence was generated (for example, random number table). Nine studies used urn randomisation or placed cards in envelopes that were shuffled to produce a random sequence (<a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>; <a href="./references#CD001088-bbs2-0008" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12‐step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403‐11. [CSzG: 29165; NCT00583440] ">Bogenschutz 2014</a>; <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>; <a href="./references#CD001088-bbs2-0025" title="JerrellJM . Cost‐effective treatment for persons with dual disorders. New Directions for Mental Health Services1996;70(Summer):79‐91. [CSzG: 16821] JerrellJM , HuTW , RidgelyMS . Cost‐effectiveness of substance disorder interventions for people with severe mental illness. Journal of Mental Health Administration1994;21(3):283‐97. [CSzG: 1166] JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] JerrellJM , RidgelyMS . Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services1999;50(1):109‐12. [CSzG: 16917] ">Jerrell 1995a</a>; <a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a>; <a href="./references#CD001088-bbs2-0028" title="KempR , HarrisA , VurelE , SitharthanT . Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry2007;15(6):490‐3. [CSzG: 15549; MEDLINE: 17852064] ">Kemp 2007</a>; <a href="./references#CD001088-bbs2-0029" title="LehmanAF , HerronJD , SchwartzRP , MyersCP . Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial. Journal of Nervous and Mental Disease1993;181(2):86‐90. [CSzG: 1646] ">Lehman 1993</a>; <a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>; <a href="./references#CD001088-bbs2-0033" title="LoweJM , McDonellMG , LeicklyE , AngeloFA , VilardagaR , McPhersonS , et al. Determining ethyl glucuronide cutoffs when detecting self‐reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research2015;39(5):905‐10. McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , HirchakK , OluwoyeO , et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness. American Journal on Addictions2017;26(7):673‐5. [CSzG: 36340] McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , SrebnikD , AngeloF , et al. A randomized controlled trial of ethyl glucuronide‐ based contingency management for outpatients with co‐occurring alcohol use disorders and serious mental Illness. American Journal of Psychiatry2017;174(4):370‐7. [CSzG: 35589] McDonellMG , SkaliskyJ , LeicklyE , McPhersonS , BattalioS , NepomJR , et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence2015;157:184‐7. NCT01567943 . Contingency management of alcohol abuse in the severely mentally ill. http://ClinicalTrials.gov/show/NCT015679432012. [CSzG: 23792] OluwoyeO , LeicklyE , SkaliskyJ , McPhersonS , HirchakK , SrebnikD , et al. Serious mental illness in heavy drinkers is associated with poor treatment outcomes in outpatients with co‐occurring disorders. International Journal of Mental Health Addiction2018;16(3):672‐9. [CSzG: 37902] SkaliskyJ , LeicklyE , OluwoyeO , McPhersonSM , SrebnikD , RollJM , et al. Prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders. Cannabis and Cannabinoid Research2017;2(1):133‐8. [CSzG: 36516] ">McDonell 2017</a>). Five other studies mentioned that a numbered table or random sequence was used to generate the sequence or that the sequence was stratified (<a href="./references#CD001088-bbs2-0027" title="KavanaghDJ , YoungR , WhiteA , SaundersJB , WallisJ , ShockleyN , et al. A brief motivational intervention for substance misuse in recent‐onset psychosis. Drug and Alcohol Review2004;23(2):151‐5. [CSzG: 8309] ">Kavanagh 2004</a>; <a href="./references#CD001088-bbs2-0036" title="NagelT , RobinsonG , CondonJ , TrauerT . Approach to treatment of mental illness and substance dependence in remote indigenous communities: results of a mixed methods study. Australian Journal of Rural Health2009;17(4):174‐82. [CSzG: 18782; MEDLINE: 19664081] ">Nagel 2009</a>; <a href="./references#CD001088-bbs2-0039" title="RosenblumA , MatusowH , FongC , VogelH , UttaroT , MooreTL , et al. Efficacy of dual focus mutual aid for persons with mental illness and substance misuse. Drug and Alcohol Dependence2014;135:78‐87. [CSzG: 27823] ">Rosenblum 2014</a>; <a href="./references#CD001088-bbs2-0040" title="PantalonMV , SwansonAJ . Use of the University of Rhode Island Change Assessment to measure motivational readiness to change in psychiatric and dually diagnosed individuals. Psychology of Addictive Behaviors2003;17(2):91‐7. [CSzG: 9830] SwansonAJ , PantalonMV , CohenKR . Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease1999;187(10):630‐5. [CSzG: 9248] ">Swanson 1999</a>; <a href="./references#CD001088-bbs2-0041" title="TracyK , BabuscioT , NichC , KilukB , CarrollKM , PetryNM , et al. Contingency management to reduce substance use in individuals who are homeless with co‐occurring psychiatric disorders. American Journal of Drug and Alcohol Abuse2007;33(2):253‐8. [CSzG: 14807; MEDLINE: 17497548] ">Tracy 2007</a>), but it was not clear if a computer was involved as no further details were provided. The 27 studies listed above (with the exception of <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>) were classified as low risk of selection bias as they provided some details of the allocation process or further particulars were provided by the researchers. Some participants in the <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a> study were not randomised due to procedural difficulties. The remaining studies did not provide enough details of how the allocation sequence was generated to make a judgement so were classified as of unclear quality with a moderate risk of selection bias and an overestimate of positive effect. </p> </section> <section id="CD001088-sec-0163"> <h5 class="title">2. Allocation concealment</h5> <p>Two studies provided a full description of the methods used to generate the random sequence and allocation concealment (<a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>). Ten studies provided some details or made explicit their method used for allocation concealment. Two studies used urn method randomisation (<a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>; <a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>), which has a low risk of bias if used properly, and some confirmed this via personal emails. Eight trials stated that allocation concealment was achieved by a third party or researcher who was independent of the treating team (<a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a>; <a href="./references#CD001088-bbs2-0015" title="EackSM , HogartySS , BangaloreSS , KeshavanMS , CorneliusJR . Patterns of substance use during Cognitive Enhancement Therapy: an 18‐month randomized feasibility study. Journal of Dual Diagnosis2016;12:74‐82. [CSzG: 33634] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18‐month feasibility trial. Schizophrenia Research2015;161(2‐3):478‐83. [CSzG: 29308] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18‐month feasibility trial. Schizophrenia Bulletin2015;41:S310. [CSzG: 29436] WojtalikJA , EackSM . Fronto‐limbic neuroplasticity effects of Cognitive Enhancement Therapy during emotion regulation in schizophrenia patients who abuse cannabis. Schizophrenia Bulletin2015;41:S243. [CSzG: 29719] WojtalikJA , HogartySS , CorneliusJR , PhillipsML , KeshavanMS , NewhillCE , et al. Cognitive Enhancement Therapy improves frontolimbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study. Frontiers in Psychiatry2016;6:186. [CSzG: 33452] ">Eack 2015</a>; <a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>; <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>; <a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>; <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a>; <a href="./references#CD001088-bbs2-0039" title="RosenblumA , MatusowH , FongC , VogelH , UttaroT , MooreTL , et al. Efficacy of dual focus mutual aid for persons with mental illness and substance misuse. Drug and Alcohol Dependence2014;135:78‐87. [CSzG: 27823] ">Rosenblum 2014</a>), but often no further details were provided. The studies listed above were judged as low risk as it was implied that the allocation concealment was adequate. Three trials (<a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>; <a href="./references#CD001088-bbs2-0023" title="HickmanME . The effects of personal feedback on alcohol intake in dually diagnosed clients: an empirical study of William R. Miller's motivational enhancement therapy. Unpublished thesis. University Graduate School, Dept. Counseling Psychology, Indiana University1997. [CSzG: 4153] ">Hickman 1997</a>; <a href="./references#CD001088-bbs2-0040" title="PantalonMV , SwansonAJ . Use of the University of Rhode Island Change Assessment to measure motivational readiness to change in psychiatric and dually diagnosed individuals. Psychology of Addictive Behaviors2003;17(2):91‐7. [CSzG: 9830] SwansonAJ , PantalonMV , CohenKR . Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease1999;187(10):630‐5. [CSzG: 9248] ">Swanson 1999</a> ) were judged high risk of bias as the researcher or therapist was involved with allocating patients or affected randomisation schedule. Six studies used sealed envelopes or patients selected a card (<a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>; <a href="./references#CD001088-bbs2-0008" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12‐step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403‐11. [CSzG: 29165; NCT00583440] ">Bogenschutz 2014</a>; <a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>; <a href="./references#CD001088-bbs2-0028" title="KempR , HarrisA , VurelE , SitharthanT . Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry2007;15(6):490‐3. [CSzG: 15549; MEDLINE: 17852064] ">Kemp 2007</a>; <a href="./references#CD001088-bbs2-0033" title="LoweJM , McDonellMG , LeicklyE , AngeloFA , VilardagaR , McPhersonS , et al. Determining ethyl glucuronide cutoffs when detecting self‐reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research2015;39(5):905‐10. McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , HirchakK , OluwoyeO , et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness. American Journal on Addictions2017;26(7):673‐5. [CSzG: 36340] McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , SrebnikD , AngeloF , et al. A randomized controlled trial of ethyl glucuronide‐ based contingency management for outpatients with co‐occurring alcohol use disorders and serious mental Illness. American Journal of Psychiatry2017;174(4):370‐7. [CSzG: 35589] McDonellMG , SkaliskyJ , LeicklyE , McPhersonS , BattalioS , NepomJR , et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence2015;157:184‐7. NCT01567943 . Contingency management of alcohol abuse in the severely mentally ill. http://ClinicalTrials.gov/show/NCT015679432012. [CSzG: 23792] OluwoyeO , LeicklyE , SkaliskyJ , McPhersonS , HirchakK , SrebnikD , et al. Serious mental illness in heavy drinkers is associated with poor treatment outcomes in outpatients with co‐occurring disorders. International Journal of Mental Health Addiction2018;16(3):672‐9. [CSzG: 37902] SkaliskyJ , LeicklyE , OluwoyeO , McPhersonSM , SrebnikD , RollJM , et al. Prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders. Cannabis and Cannabinoid Research2017;2(1):133‐8. [CSzG: 36516] ">McDonell 2017</a>; <a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>). However, it was not clear if the envelopes were opaque or if other measures were taken to ensure concealment, so these were judged as unclear risk. The remaining studies were classified as of unclear quality with a moderate risk of selection bias and overestimate of positive effect as no details were provided regarding allocation concealment, but this may be due to incomplete reporting and not how the study was conducted. </p> </section> </section> <section id="CD001088-sec-0164"> <h4 class="title">Blinding</h4> <section id="CD001088-sec-0165"> <h5 class="title">1. Performance bias</h5> <p>We classified blinding in respect to primary outcomes for performance and detection bias. Due to intervention characteristics, that is being a therapy or model of service, we assumed the participants and clinicians as being implicitly not blind to treatment assignment when considering performance bias. Therefore, we judged performance bias of all trials to be of high risk of bias since it is not possible to blind participants or personnel for a psychosocial intervention. </p> </section> <section id="CD001088-sec-0166"> <h5 class="title">2. Detection bias</h5> <p>Overall, 20 studies stated that independent raters were blinded to allocation when assessing clinical ratings of mental state or substance use, or the primary outcome involved urine or saliva samples. For 15 other studies it was unclear if the raters were blind to treatment as this was not stated. Six studies (<a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>; <a href="./references#CD001088-bbs2-0020" title="GraeberDA , MoyersTB , GriffithG , GuajardoE , ToniganS . A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal2003;39(3):189‐202. [CSzG: 9901] ">Graeber 2003</a>; <a href="./references#CD001088-bbs2-0028" title="KempR , HarrisA , VurelE , SitharthanT . Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry2007;15(6):490‐3. [CSzG: 15549; MEDLINE: 17852064] ">Kemp 2007</a>; <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>; <a href="./references#CD001088-bbs2-0036" title="NagelT , RobinsonG , CondonJ , TrauerT . Approach to treatment of mental illness and substance dependence in remote indigenous communities: results of a mixed methods study. Australian Journal of Rural Health2009;17(4):174‐82. [CSzG: 18782; MEDLINE: 19664081] ">Nagel 2009</a>; <a href="./references#CD001088-bbs2-0037" title="O'ConnellMJ , FlanaganEH , Delphin‐RittmonME , DavidsonL . Enhancing outcomes for persons with co‐occurring disorders through skills training and peer recovery support. Journal of Mental Health2018;in press:(online 10 March 2017). [CSzG: 35896; DOI: 10.1080/09638237.2017.1294733] ">O'Connell 2018</a>) were judged at high risk of bias because it was not clearly stated that the outcome assessors were blind to treatment allocation and it was therefore possible to assess the risk of bias in these studies with higher confidence for clinical‐based ratings. In three of these studies blinding status would not influence the primary outcome data as these were administrative measures (hospital readmissions, convictions, time to first outpatient appointment etc), however they were still judged high risk as less effort may have been made to follow‐up those in the control arm. </p> </section> </section> <section id="CD001088-sec-0167"> <h4 class="title">Incomplete outcome data</h4> <p>We only rated risk of incomplete outcome data in respect to the primary outcome. The number of participants lost to treatment or evaluation across studies ranged from 0% to 65%. The following trials were judged as adequately addressing incomplete outcome data and were rated as low risk of attrition bias because there were no missing outcome data (<a href="./references#CD001088-bbs2-0023" title="HickmanME . The effects of personal feedback on alcohol intake in dually diagnosed clients: an empirical study of William R. Miller's motivational enhancement therapy. Unpublished thesis. University Graduate School, Dept. Counseling Psychology, Indiana University1997. [CSzG: 4153] ">Hickman 1997</a>; <a href="./references#CD001088-bbs2-0029" title="LehmanAF , HerronJD , SchwartzRP , MyersCP . Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial. Journal of Nervous and Mental Disease1993;181(2):86‐90. [CSzG: 1646] ">Lehman 1993</a>; <a href="./references#CD001088-bbs2-0040" title="PantalonMV , SwansonAJ . Use of the University of Rhode Island Change Assessment to measure motivational readiness to change in psychiatric and dually diagnosed individuals. Psychology of Addictive Behaviors2003;17(2):91‐7. [CSzG: 9830] SwansonAJ , PantalonMV , CohenKR . Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease1999;187(10):630‐5. [CSzG: 9248] ">Swanson 1999</a>), or less than 25% attrition with no differences between treatment groups (<a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>; <a href="./references#CD001088-bbs2-0008" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12‐step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403‐11. [CSzG: 29165; NCT00583440] ">Bogenschutz 2014</a>; <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>; <a href="./references#CD001088-bbs2-0039" title="RosenblumA , MatusowH , FongC , VogelH , UttaroT , MooreTL , et al. Efficacy of dual focus mutual aid for persons with mental illness and substance misuse. Drug and Alcohol Dependence2014;135:78‐87. [CSzG: 27823] ">Rosenblum 2014</a>) and for one study (<a href="./references#CD001088-bbs2-0020" title="GraeberDA , MoyersTB , GriffithG , GuajardoE , ToniganS . A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal2003;39(3):189‐202. [CSzG: 9901] ">Graeber 2003</a>) there were no missing values for the primary outcome. </p> <p>The following trials were rated as high risk. <a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a> excluded 46 of 175 participants after they were randomised, a further 19 participants because they did not become engaged in treatment, and a further 27 were lost to follow‐up. Therefore, a high proportion of participants (92/175, 53%) were excluded from the analysis, which may have a clinically relevant bias in intervention effect estimates. The attrition rate was greater than 50% for <a href="./references#CD001088-bbs2-0022" title="HellersteinDJ , RosenthalRN , MinerCR . A prospective study of integrated outpatient treatment for substance‐abusing schizophrenic patients. American Journal on Addictions1995;4(1):33‐42. [CSzG: 5029] HellersteinDJ , RosenthalRN , MinerCR . Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly2001;72(4):291‐306. [CSzG: 8206] ">Hellerstein 1995</a> (at eight months), <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a> (at 12 months) and <a href="./references#CD001088-bbs2-0009" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991a</a>, <a href="./references#CD001088-bbs2-0018" title="GodleySH , Hoewing‐RobersonR , GodleyMD . Final MISA Report. Bloomington, IN: Lighthouse Institute, 1994. [CSzG: 970] ">Godley 1994</a> (at 18 months) and so data from these trials were excluded from the analysis as per protocol. In the <a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a> trial the attrition rate for the primary outcome measure was 37% (68/182); and for the controls no interviews were conducted to ascertain their whereabouts (moved from area, re incarcerated or died) and this may have led to severe bias. More than half the urine samples for the primary outcome were missing in <a href="./references#CD001088-bbs2-0038" title="NCT01478815 . Contingency management for persons with severe mental illness. http://ClinicalTrials.gov/show/NCT014788152011. [CSzG: 23332] PetryNM , AlessiSM , Rash CarlaJ . A randomized study of contingency management in cocaine‐dependent patients with severe and persistent mental health disorders. Drug and Alcohol Dependence2013;130:234‐7. [CSzG: 28275] ">Petry 2013</a>. Six further trials were rated as high risk as more than 40% of participants were lost to follow‐up; no reasons were given for them being missing or a full intention‐to‐treat (ITT) analysis was not reported (<a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a>; <a href="./references#CD001088-bbs2-0015" title="EackSM , HogartySS , BangaloreSS , KeshavanMS , CorneliusJR . Patterns of substance use during Cognitive Enhancement Therapy: an 18‐month randomized feasibility study. Journal of Dual Diagnosis2016;12:74‐82. [CSzG: 33634] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18‐month feasibility trial. Schizophrenia Research2015;161(2‐3):478‐83. [CSzG: 29308] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18‐month feasibility trial. Schizophrenia Bulletin2015;41:S310. [CSzG: 29436] WojtalikJA , EackSM . Fronto‐limbic neuroplasticity effects of Cognitive Enhancement Therapy during emotion regulation in schizophrenia patients who abuse cannabis. Schizophrenia Bulletin2015;41:S243. [CSzG: 29719] WojtalikJA , HogartySS , CorneliusJR , PhillipsML , KeshavanMS , NewhillCE , et al. Cognitive Enhancement Therapy improves frontolimbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study. Frontiers in Psychiatry2016;6:186. [CSzG: 33452] ">Eack 2015</a>; <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>; <a href="./references#CD001088-bbs2-0025" title="JerrellJM . Cost‐effective treatment for persons with dual disorders. New Directions for Mental Health Services1996;70(Summer):79‐91. [CSzG: 16821] JerrellJM , HuTW , RidgelyMS . Cost‐effectiveness of substance disorder interventions for people with severe mental illness. Journal of Mental Health Administration1994;21(3):283‐97. [CSzG: 1166] JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] JerrellJM , RidgelyMS . Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services1999;50(1):109‐12. [CSzG: 16917] ">Jerrell 1995a</a>; <a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a>; <a href="./references#CD001088-bbs2-0037" title="O'ConnellMJ , FlanaganEH , Delphin‐RittmonME , DavidsonL . Enhancing outcomes for persons with co‐occurring disorders through skills training and peer recovery support. Journal of Mental Health2018;in press:(online 10 March 2017). [CSzG: 35896; DOI: 10.1080/09638237.2017.1294733] ">O'Connell 2018</a>). </p> <p>Many, but not all, included studies provided reasons for attrition. Reasons given included: some of the participants died during the trial, some could not be contacted or moved elsewhere, and some withdrew. Eight studies reported their results based on a full ITT analysis with all missing data imputed for primary outcomes using appropriate methods (<a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>; <a href="./references#CD001088-bbs2-0006" title="BechdolfA , PohlmannB , GuttgemannsJ , GeyerC , LindnerK , FerberC , et al. State‐dependent motivational interviewing for people with schizophrenia and substance use : Results of a randomised controlled trial [Motivationsbehandlung für patienten mit der doppeldiagnose psychose und sucht]. Nervenarzt2011;83(7):888‐96. [MEDLINE: 21720841] ">Bechdolf 2011</a>; <a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>; <a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>; <a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>; <a href="./references#CD001088-bbs2-0033" title="LoweJM , McDonellMG , LeicklyE , AngeloFA , VilardagaR , McPhersonS , et al. Determining ethyl glucuronide cutoffs when detecting self‐reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research2015;39(5):905‐10. McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , HirchakK , OluwoyeO , et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness. American Journal on Addictions2017;26(7):673‐5. [CSzG: 36340] McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , SrebnikD , AngeloF , et al. A randomized controlled trial of ethyl glucuronide‐ based contingency management for outpatients with co‐occurring alcohol use disorders and serious mental Illness. American Journal of Psychiatry2017;174(4):370‐7. [CSzG: 35589] McDonellMG , SkaliskyJ , LeicklyE , McPhersonS , BattalioS , NepomJR , et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence2015;157:184‐7. NCT01567943 . Contingency management of alcohol abuse in the severely mentally ill. http://ClinicalTrials.gov/show/NCT015679432012. [CSzG: 23792] OluwoyeO , LeicklyE , SkaliskyJ , McPhersonS , HirchakK , SrebnikD , et al. Serious mental illness in heavy drinkers is associated with poor treatment outcomes in outpatients with co‐occurring disorders. International Journal of Mental Health Addiction2018;16(3):672‐9. [CSzG: 37902] SkaliskyJ , LeicklyE , OluwoyeO , McPhersonSM , SrebnikD , RollJM , et al. Prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders. Cannabis and Cannabinoid Research2017;2(1):133‐8. [CSzG: 36516] ">McDonell 2017</a>; <a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>; <a href="./references#CD001088-bbs2-0036" title="NagelT , RobinsonG , CondonJ , TrauerT . Approach to treatment of mental illness and substance dependence in remote indigenous communities: results of a mixed methods study. Australian Journal of Rural Health2009;17(4):174‐82. [CSzG: 18782; MEDLINE: 19664081] ">Nagel 2009</a>). These were rated as unclear as all imputation strategies can bias study results. The remaining trials were rated as 'unclear'. They either did not address this issue, presented insufficient information of attrition or exclusions to permit judgement (that is, no reasons for missing data provided or numbers lost to evaluation not stated for each group) or did not report a full ITT analysis with imputed missing values (<a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>; <a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0010" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991b</a>; <a href="./references#CD001088-bbs2-0012" title="BurnamMA , MortonSC , McGlynnEA , PetersonLP , StecherBM , HayesC , et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases1995;14(4):111‐34. [CSzG: 8751] McGlynnEA , BoyntonJ , MortonSC , StecherBM , HayesC , VaccaroJV , et al. Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles. Alcohol Treatment Quarterly1993;10(3‐4):171‐86. [CSzG: 4118] ">Burnam 1995</a>; <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>; <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>; <a href="./references#CD001088-bbs2-0027" title="KavanaghDJ , YoungR , WhiteA , SaundersJB , WallisJ , ShockleyN , et al. A brief motivational intervention for substance misuse in recent‐onset psychosis. Drug and Alcohol Review2004;23(2):151‐5. [CSzG: 8309] ">Kavanagh 2004</a>; <a href="./references#CD001088-bbs2-0028" title="KempR , HarrisA , VurelE , SitharthanT . Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry2007;15(6):490‐3. [CSzG: 15549; MEDLINE: 17852064] ">Kemp 2007</a>; <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a>; <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>; <a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>; <a href="./references#CD001088-bbs2-0034" title="CalsynRJ , YonkerRD , LemmingMR , MorseGA , KlinkenbergWD . Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behaviour and Mental Health2005;15(4):236‐48. [CSzG: 16813] FletcherTD , CunninghamJL , CalsynRJ , MorseGA , KlinkenbergWD . Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects. Administration and Policy in Mental Health2008;35(4):319‐36. [CSzG: 16624; MEDLINE: 18506618] MorseGA , CalsynRJ , KlinkenbergWD , CunninghamJ , LemmingMR . Integrated treatment for homeless clients with dual disorders: a quasi‐experimental evaluation. Journal of Dual Diagnosis2008;4(3):219‐37. [CSzG: 19618] MorseGA , CalsynRJ , KlinkenbergWD , HelminiakTW , WolffN , DrakeRE , et al. Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes. Community Mental Health Journal2006;42(4):377‐404. [CSzG: 13863] ">Morse 2006</a>; <a href="./references#CD001088-bbs2-0041" title="TracyK , BabuscioT , NichC , KilukB , CarrollKM , PetryNM , et al. Contingency management to reduce substance use in individuals who are homeless with co‐occurring psychiatric disorders. American Journal of Drug and Alcohol Abuse2007;33(2):253‐8. [CSzG: 14807; MEDLINE: 17497548] ">Tracy 2007</a>). </p> </section> <section id="CD001088-sec-0168"> <h4 class="title">Selective reporting</h4> <p>The following studies were rated as high quality in reporting outcomes with a low risk of reporting bias (<a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>;<a href="./references#CD001088-bbs2-0015" title="EackSM , HogartySS , BangaloreSS , KeshavanMS , CorneliusJR . Patterns of substance use during Cognitive Enhancement Therapy: an 18‐month randomized feasibility study. Journal of Dual Diagnosis2016;12:74‐82. [CSzG: 33634] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18‐month feasibility trial. Schizophrenia Research2015;161(2‐3):478‐83. [CSzG: 29308] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18‐month feasibility trial. Schizophrenia Bulletin2015;41:S310. [CSzG: 29436] WojtalikJA , EackSM . Fronto‐limbic neuroplasticity effects of Cognitive Enhancement Therapy during emotion regulation in schizophrenia patients who abuse cannabis. Schizophrenia Bulletin2015;41:S243. [CSzG: 29719] WojtalikJA , HogartySS , CorneliusJR , PhillipsML , KeshavanMS , NewhillCE , et al. Cognitive Enhancement Therapy improves frontolimbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study. Frontiers in Psychiatry2016;6:186. [CSzG: 33452] ">Eack 2015</a>; <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>; <a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>; <a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>; <a href="./references#CD001088-bbs2-0033" title="LoweJM , McDonellMG , LeicklyE , AngeloFA , VilardagaR , McPhersonS , et al. Determining ethyl glucuronide cutoffs when detecting self‐reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research2015;39(5):905‐10. McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , HirchakK , OluwoyeO , et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness. American Journal on Addictions2017;26(7):673‐5. [CSzG: 36340] McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , SrebnikD , AngeloF , et al. A randomized controlled trial of ethyl glucuronide‐ based contingency management for outpatients with co‐occurring alcohol use disorders and serious mental Illness. American Journal of Psychiatry2017;174(4):370‐7. [CSzG: 35589] McDonellMG , SkaliskyJ , LeicklyE , McPhersonS , BattalioS , NepomJR , et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence2015;157:184‐7. NCT01567943 . Contingency management of alcohol abuse in the severely mentally ill. http://ClinicalTrials.gov/show/NCT015679432012. [CSzG: 23792] OluwoyeO , LeicklyE , SkaliskyJ , McPhersonS , HirchakK , SrebnikD , et al. Serious mental illness in heavy drinkers is associated with poor treatment outcomes in outpatients with co‐occurring disorders. International Journal of Mental Health Addiction2018;16(3):672‐9. [CSzG: 37902] SkaliskyJ , LeicklyE , OluwoyeO , McPhersonSM , SrebnikD , RollJM , et al. Prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders. Cannabis and Cannabinoid Research2017;2(1):133‐8. [CSzG: 36516] ">McDonell 2017</a>; <a href="./references#CD001088-bbs2-0038" title="NCT01478815 . Contingency management for persons with severe mental illness. http://ClinicalTrials.gov/show/NCT014788152011. [CSzG: 23332] PetryNM , AlessiSM , Rash CarlaJ . A randomized study of contingency management in cocaine‐dependent patients with severe and persistent mental health disorders. Drug and Alcohol Dependence2013;130:234‐7. [CSzG: 28275] ">Petry 2013</a>; <a href="./references#CD001088-bbs2-0039" title="RosenblumA , MatusowH , FongC , VogelH , UttaroT , MooreTL , et al. Efficacy of dual focus mutual aid for persons with mental illness and substance misuse. Drug and Alcohol Dependence2014;135:78‐87. [CSzG: 27823] ">Rosenblum 2014</a>) as the pre‐specified outcomes listed in the trial protocol were fully reported (cases or means, SD and number (n) for each outcome at specific time points) in the study report. Conversely, five studies were rated as low quality with a high risk of reporting bias (<a href="./references#CD001088-bbs2-0018" title="GodleySH , Hoewing‐RobersonR , GodleyMD . Final MISA Report. Bloomington, IN: Lighthouse Institute, 1994. [CSzG: 970] ">Godley 1994</a>; <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>; <a href="./references#CD001088-bbs2-0034" title="CalsynRJ , YonkerRD , LemmingMR , MorseGA , KlinkenbergWD . Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behaviour and Mental Health2005;15(4):236‐48. [CSzG: 16813] FletcherTD , CunninghamJL , CalsynRJ , MorseGA , KlinkenbergWD . Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects. Administration and Policy in Mental Health2008;35(4):319‐36. [CSzG: 16624; MEDLINE: 18506618] MorseGA , CalsynRJ , KlinkenbergWD , CunninghamJ , LemmingMR . Integrated treatment for homeless clients with dual disorders: a quasi‐experimental evaluation. Journal of Dual Diagnosis2008;4(3):219‐37. [CSzG: 19618] MorseGA , CalsynRJ , KlinkenbergWD , HelminiakTW , WolffN , DrakeRE , et al. Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes. Community Mental Health Journal2006;42(4):377‐404. [CSzG: 13863] ">Morse 2006</a>; <a href="./references#CD001088-bbs2-0037" title="O'ConnellMJ , FlanaganEH , Delphin‐RittmonME , DavidsonL . Enhancing outcomes for persons with co‐occurring disorders through skills training and peer recovery support. Journal of Mental Health2018;in press:(online 10 March 2017). [CSzG: 35896; DOI: 10.1080/09638237.2017.1294733] ">O'Connell 2018</a>; <a href="./references#CD001088-bbs2-0041" title="TracyK , BabuscioT , NichC , KilukB , CarrollKM , PetryNM , et al. Contingency management to reduce substance use in individuals who are homeless with co‐occurring psychiatric disorders. American Journal of Drug and Alcohol Abuse2007;33(2):253‐8. [CSzG: 14807; MEDLINE: 17497548] ">Tracy 2007</a>) as they presented data in a way we could not consider as free of suggestion of selective outcome reporting. For these studies, there were no usable data or data were reported incompletely for each treatment arm or in a way (for example, as correction matrix, graphically or in a mixed‐methods model) that they could not be entered in a meta‐analysis. For the rest of the studies the risk of bias was assessed as unclear with a moderate risk of reporting bias due to insufficient information to permit judgement of yes or no; there was no protocol to assess the presence of selective reporting. </p> </section> <section id="CD001088-sec-0169"> <h4 class="title">Other potential sources of bias</h4> <p>Overall risk of other potential sources of bias was rated as low or unclear. Most were publicly funded trials. No declaration of interest was made by authors, and we are assuming there was none to be made. However, many study authors were active pioneers in developing and the implementation of the experimental intervention model across the scientific community and clinical world. This raises the issue of how researcher beliefs could affect the entire process of evaluating an intervention in an RCT. Although conscious of this issue, we decided not to make any attempt to rate it as it is very difficult to judge, and erroneous quantification could drive bias into our conclusions. </p> </section> </section> <section id="CD001088-sec-0170"> <h3 class="title" id="CD001088-sec-0170">Effects of interventions</h3> <p>See: <a href="./full#CD001088-tbl-0001"><b>Summary of findings for the main comparison</b> Integrated models of care compared to standard care for both severe mental illness and substance misuse</a>; <a href="./full#CD001088-tbl-0002"><b>Summary of findings 2</b> Non‐integrated models of care ‐ Assertive community treatment only/Intensive case management/Specialised case management services versus standard care for both severe mental illness and substance misuse</a>; <a href="./full#CD001088-tbl-0003"><b>Summary of findings 3</b> Cognitive behavioural therapy versus standard care for both severe mental illness and substance misuse</a>; <a href="./full#CD001088-tbl-0004"><b>Summary of findings 4</b> Contingency management versus standard care for both severe mental illness and substance misuse</a>; <a href="./full#CD001088-tbl-0005"><b>Summary of findings 5</b> Motivational interviewing versus standard care for both severe mental illness and substance misuse</a>; <a href="./full#CD001088-tbl-0006"><b>Summary of findings 6</b> Skills training versus standard care for both severe mental illness and substance misuse</a>; <a href="./full#CD001088-tbl-0007"><b>Summary of findings 7</b> Cognitive behavioural therapy + motivational interviewing versus standard care for both severe mental illness and substance misuse</a>; <a href="./full#CD001088-tbl-0008"><b>Summary of findings 8</b> Cognitive behavioural therapy + psychosocial rehabilitation versus standard care for both severe mental illness and substance misuse</a>; <a href="./full#CD001088-tbl-0009"><b>Summary of findings 9</b> Cognitive behavioural therapy + intensive case management versus standard care for both severe mental illness and substance misuse</a> </p> <section id="CD001088-sec-0171"> <h4 class="title">Comparison 1: Integrated models of care versus standard care</h4> <p>See <a href="./full#CD001088-tbl-0001">summary of findings Table for the main comparison</a>. Data for this comparison came from four trials (<a href="./references#CD001088-bbs2-0012" title="BurnamMA , MortonSC , McGlynnEA , PetersonLP , StecherBM , HayesC , et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases1995;14(4):111‐34. [CSzG: 8751] McGlynnEA , BoyntonJ , MortonSC , StecherBM , HayesC , VaccaroJV , et al. Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles. Alcohol Treatment Quarterly1993;10(3‐4):171‐86. [CSzG: 4118] ">Burnam 1995</a>; <a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a>; <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>; <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>). </p> <section id="CD001088-sec-0172"> <h5 class="title">1.1 Leaving the study early: 1. Lost to treatment ‐ by 36 months</h5> <p>By the end of treatment (36 months) we found no clear difference in the likelihood of participants being lost to treatment from the pooled results of <a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a>; <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a> and <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a> (treatment group 24% lost, control group 21% lost) (risk ratio (RR) 1.09, 95% confidence interval (CI) 0.82 to 1.45; participants = 603; studies = 3). Statistical heterogeneity was not present (Chi² = 1.95, df = 2 (P = 0.38); I² = 0%). (<a href="./references#CD001088-fig-0004" title="">Analysis 1.1</a>). </p> </section> <section id="CD001088-sec-0173"> <h5 class="title">1.2 Leaving the study early: 2. Lost to evaluation</h5> <p>The control group for <a href="./references#CD001088-bbs2-0012" title="BurnamMA , MortonSC , McGlynnEA , PetersonLP , StecherBM , HayesC , et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases1995;14(4):111‐34. [CSzG: 8751] McGlynnEA , BoyntonJ , MortonSC , StecherBM , HayesC , VaccaroJV , et al. Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles. Alcohol Treatment Quarterly1993;10(3‐4):171‐86. [CSzG: 4118] ">Burnam 1995</a> were 46% more likely to be lost to evaluation by three months (treatment group 15% lost, control group 28% lost), although this is not a clear difference between groups (RR 0.54, 95% CI 0.27 to 1.08; participants = 132; studies = 1). Six months data (<a href="./references#CD001088-bbs2-0012" title="BurnamMA , MortonSC , McGlynnEA , PetersonLP , StecherBM , HayesC , et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases1995;14(4):111‐34. [CSzG: 8751] McGlynnEA , BoyntonJ , MortonSC , StecherBM , HayesC , VaccaroJV , et al. Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles. Alcohol Treatment Quarterly1993;10(3‐4):171‐86. [CSzG: 4118] ">Burnam 1995</a>; <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>) also did not reveal any clear difference between groups (RR 0.69, 95% CI 0.27 to 1.73; participants = 330; studies = 2). Numbers lost to evaluation at nine months (RR 0.76, 95% CI 0.49 to 1.19; participants = 132; studies = 1), 12 months (RR 0.54, 95% CI 0.22 to 1.29; participants = 198; studies = 1), 24 months (RR 1.00, 95% CI 0.47 to 2.12; participants = 198; studies = 1), and 36 (RR 0.76, 95% CI 0.35 to 1.66; participants = 603; studies = 3) were also equivocal. For the 36‐month data, we combined the results from three studies (<a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a>; <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>; <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>) in a meta‐analysis . There was considerable statistical heterogeneity (Chi² = 7.70, df = 2 (P = 0.02); I² = 74%). Closer inspection of the forest plot indicated a higher retention rate in the treatment group in <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>, likely to account for this heterogeneity. (<a href="./references#CD001088-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD001088-sec-0174"> <h5 class="title">1.3 Adverse event: 1. Death ‐ by 36 months</h5> <p>We found no clear differences in the pooled results of <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a> and <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a> with regards to the likelihood of participants dying by the end of 36 months of treatment (treatment 3% died, control 3% died; (RR 1.18, 95% CI 0.39 to 3.57; participants = 421; studies = 2). Statistical heterogeneity was not present (Chi² = 0.68, df = 1, P = 0.41; I² = 0%). (<a href="./references#CD001088-fig-0006" title="">Analysis 1.3</a>). </p> </section> <section id="CD001088-sec-0175"> <h5 class="title">1.4 Substance use 1. Clinically important change (not in remission) ‐ by 36 months</h5> <p><a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a> reported data for remission from substance use (<a href="./references#CD001088-fig-0007" title="">Analysis 1.4</a>) The likelihood of participants not being in remission for alcohol use in the group was treatment 57% and 50% in the control group, which is not a clear difference between treatment groups (RR 1.15, 95% CI 0.84 to 1.56; participants = 143; studies = 1). The likelihood of participants not being in remission for drug use in the treatment group was 58% and 65% in the control group, which is also not a clear difference between treatment groups (RR 0.89, 95% CI 0.63 to 1.25; participants = 85; studies = 1). </p> </section> <section id="CD001088-sec-0176"> <h5 class="title">1.5 Substance use: 2. Average score for progress towards recovery (SATS, low = poor)</h5> <p><a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a> reported average SATS scores (<a href="./references#CD001088-fig-0008" title="">Analysis 1.5</a>). No clear difference in participants average SATS scores were found by six months (mean difference (MD) 0.07, 95% CI ‐0.28 to 0.42; participants = 203; studies = 1) or 36 months (MD 0.11, 95% CI ‐0.41 to 0.63; participants = 203; studies = 1). </p> </section> <section id="CD001088-sec-0177"> <h5 class="title">1.6 ‐ 1.11 Substance use: skewed data</h5> <p>Further outcome data related to substance use (<a href="./references#CD001088-fig-0009" title="">Analysis 1.6</a>; <a href="./references#CD001088-fig-0010" title="">Analysis 1.7</a>; <a href="./references#CD001088-fig-0011" title="">Analysis 1.8</a>; <a href="./references#CD001088-fig-0012" title="">Analysis 1.9</a>; <a href="./references#CD001088-fig-0013" title="">Analysis 1.10</a>) contained skewed data and are presented in 'Other data' tables. </p> </section> <section id="CD001088-sec-0178"> <h5 class="title">1.12 Mental state: 1. Average score (BPRS, high = poor) (skewed data)</h5> <p>We found that the BPRS scores reported by <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a> and <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a> contained wide confidence intervals (skewed data) and have presented these in 'Other data' tables (<a href="./references#CD001088-fig-0015" title="">Analysis 1.12</a>). </p> </section> <section id="CD001088-sec-0179"> <h5 class="title">1.13 Global state: 1. Average score (GAF, low = poor)</h5> <p>Only <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a> reported data for global state (<a href="./references#CD001088-fig-0016" title="">Analysis 1.13</a>). We found no clear differences for average global functioning scores (GAF) at six months (MD 1.10, 95% CI ‐1.58 to 3.78; participants = 162; studies = 1), 12 months (MD 0.70, 95% CI ‐2.07 to 3.47; participants = 171; studies = 1), 18 months (MD 1.00, 95% CI ‐1.58 to 3.58; participants = 176; studies = 1), 24 months (MD 1.70, 95% CI ‐1.18 to 4.58; participants = 166; studies = 1), 30 months (MD ‐0.60, 95% CI ‐3.56 to 2.36; participants = 164; studies = 1) or 36 months (MD 0.40, 95% CI ‐2.47 to 3.27; participants = 170; studies = 1). </p> </section> <section id="CD001088-sec-0180"> <h5 class="title">1.14 Global state: 2. Forensic measures (skewed data)</h5> <p>Data reported by <a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a> on arrests, convictions, felony, hospitalisation and jail were skewed and are presented in 'Other data' tables. (<a href="./references#CD001088-fig-0017" title="">Analysis 1.14</a>). </p> </section> <section id="CD001088-sec-0181"> <h5 class="title">1.15 Quality of life/ life satisfaction: Average general score (QOLI, range 1‐7, low = poor) </h5> <p>The pooled results of <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a> and <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a> revealed no clear difference between treatment groups in average general life satisfaction (QOLI) scores by 6 months (MD ‐0.11, 95% CI ‐0.41 to 0.20; participants = 361; studies = 2), 12 months (MD 0.02, 95% CI ‐0.28 to 0.32; participants = 372; studies = 2), 18 months (MD 0.09, 95% CI ‐0.27 to 0.44; participants = 377; studies = 2), 24 months (MD 0.02, 95% CI ‐0.29 to 0.33; participants = 370; studies = 2), 30 months (MD 0.02, 95% CI ‐0.27 to 0.32; participants = 366; studies = 2), and 36 months (MD 0.10, 95% CI ‐0.18 to 0.38; participants = 373; studies = 2). Statistical heterogeneity was not present at any of the six time points (for example, 24 months: Chi² = 1.09, df = 1, P = 0.30; I² = 8%). (<a href="./references#CD001088-fig-0018" title="">Analysis 1.15</a>). </p> </section> <section id="CD001088-sec-0182"> <h5 class="title">1.16 Service use: 1. Days in stable community residences (not in hospital)</h5> <p>We found that the pooled results of two studies (<a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>; <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>) for average number of days spent in stable community residences (not in hospital) by 12 months were equivocal (MD ‐10.00, 95% CI ‐38.61 to 18.60; participants = 378; studies = 2), and also at 24 months (MD 7.40, 95% CI ‐6.32 to 21.12; participants = 203; studies = 1), and 36 months (MD 5.17, 95% CI ‐9.20 to 19.55; participants = 364; studies = 2). Statistical heterogeneity was not present (Chi² = 0.31, df = 1, P = 0.58; I² = 0%). (<a href="./references#CD001088-fig-0019" title="">Analysis 1.16</a>). </p> </section> <section id="CD001088-sec-0183"> <h5 class="title">1.17 Service use: 2. Number hospitalised ‐ during the 36‐month study period</h5> <p>(<a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>) found no clear differences between treatment groups for the likelihood of hospitalisation by 36 months (treatment 42% hospitalised, control 48% hospitalised; RR 0.88, 95% CI 0.64 to 1.19; participants = 198; studies = 1) (<a href="./references#CD001088-fig-0020" title="">Analysis 1.17</a> ). </p> </section> <section id="CD001088-sec-0184"> <h5 class="title">1.18 Service use: 3. Relapse (hospitalisation days and crisis care) ‐ 36 months (skewed data) </h5> <p>Data for relapse (measured as average number of hospitalisation days and crisis care) were skewed and are presented in 'Other data' tables (<a href="./references#CD001088-fig-0021" title="">Analysis 1.18</a>). </p> </section> <section id="CD001088-sec-0185"> <h5 class="title">1.19 Service use: 4. Medication hours ‐ 36 months (skewed data)</h5> <p>Data reported by <a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a> for average number of hours requiring medication were skewed and are presented in 'Other data' tables (<a href="./references#CD001088-fig-0022" title="">Analysis 1.19</a>). </p> </section> <section id="CD001088-sec-0186"> <h5 class="title">1.20 Service use: 5. Various measures (skewed data)</h5> <p>These data were also skewed and presented in 'Other data' tables (<a href="./references#CD001088-fig-0023" title="">Analysis 1.20</a>). </p> </section> <section id="CD001088-sec-0187"> <h5 class="title">1.21 ‐ 1.24 Homelessness (skewed data)</h5> <p>Data regarding per cent of time on the street (<a href="./references#CD001088-fig-0024" title="">Analysis 1.21</a>) and time in independent housing (<a href="./references#CD001088-fig-0025" title="">Analysis 1.22</a>), average number of days in stable housing (<a href="./references#CD001088-fig-0026" title="">Analysis 1.23</a>) other various measures of homelessness (<a href="./references#CD001088-fig-0027" title="">Analysis 1.24</a>) were skewed and are presented in 'Other data' tables. </p> </section> </section> <section id="CD001088-sec-0188"> <h4 class="title">Comparison 2: Non‐integrated models of care Assertive community treatment/Intensive case management/Specialised management services versus standard care </h4> <p>See <a href="./full#CD001088-tbl-0002">summary of findings Table 2</a>. Four trials reported useable data for this comparison (<a href="./references#CD001088-bbs2-0009" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991a</a>; <a href="./references#CD001088-bbs2-0010" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991b</a>; <a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a>; <a href="./references#CD001088-bbs2-0029" title="LehmanAF , HerronJD , SchwartzRP , MyersCP . Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial. Journal of Nervous and Mental Disease1993;181(2):86‐90. [CSzG: 1646] ">Lehman 1993</a>). </p> <section id="CD001088-sec-0189"> <h5 class="title">2.1 Leaving the study early 1. Lost to treatment</h5> <p>Pooled results of <a href="./references#CD001088-bbs2-0009" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991a</a>; <a href="./references#CD001088-bbs2-0010" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991b</a> and <a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a> showed no clear difference between groups in numbers lost to treatment by six months (treatment 27% lost, control 22% lost; RR 1.23, 95% CI 0.73 to 2.06; participants = 134; studies = 3) Longer‐term evaluations at 12 months (treatment 28% lost, control 24% lost; RR 1.21, 95% CI 0.73 to 1.99; participants = 134; studies = 3), and 18 months (treatment 51% lost, control 37% lost; RR 1.35, 95% CI 0.83 to 2.19; participants = 134; studies = 3) also did not reveal any important difference between groups. Statistical heterogeneity was not present at six months, 12 months, 18 months, 24 months, 30 months or 36 months. (<a href="./references#CD001088-fig-0028" title="">Analysis 2.1</a>) </p> </section> <section id="CD001088-sec-0190"> <h5 class="title">2.2 Leaving the study early 2. Lost to evaluation</h5> <p>We found no meaningful difference in the pooled results (<a href="./references#CD001088-bbs2-0010" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991b</a>; <a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a>; <a href="./references#CD001088-bbs2-0029" title="LehmanAF , HerronJD , SchwartzRP , MyersCP . Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial. Journal of Nervous and Mental Disease1993;181(2):86‐90. [CSzG: 1646] ">Lehman 1993</a>) for lost to evaluation by six months (treatment 10% lost, control 10% lost;(RR 1.00, 95% CI 0.38 to 2.60; participants = 121; studies = 3) and by 12 months (treatment 12% lost, control 12% lost; RR 1.00, 95% CI 0.43 to 2.35; participants = 121; studies = 3) Pooled results (<a href="./references#CD001088-bbs2-0010" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991b</a>; <a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a>) at 18 months also revealed no major differences between treatment groups (treatment 43% lost, control 33% lost; RR 1.26, 95% CI 0.48 to 3.30; participants = 92; studies = 2). Statistical heterogeneity was not present at six, 12, or 18 months. (<a href="./references#CD001088-fig-0029" title="">Analysis 2.2</a>) </p> </section> <section id="CD001088-sec-0191"> <h5 class="title">2.3 ‐ 2.4 Substance use</h5> <p>Data for substance use <a href="./references#CD001088-fig-0030" title="">Analysis 2.3</a>, and <a href="./references#CD001088-fig-0031" title="">Analysis 2.4</a>, were skewed and are presented in 'Other data' tables. </p> </section> <section id="CD001088-sec-0192"> <h5 class="title">2.5 Mental state: Average scores on various scales (skewed data)</h5> <p>Mental state data from various scales were skewed and are presented in 'Other data' tables. (<a href="./references#CD001088-fig-0032" title="">Analysis 2.5</a>). </p> </section> <section id="CD001088-sec-0193"> <h5 class="title">2.6 ‐ 2.8 Global state: Foresnic measures (skewed data)</h5> <p>Data reported by <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a> on average number of arrests (<a href="./references#CD001088-fig-0033" title="">Analysis 2.6</a>), convictions (<a href="./references#CD001088-fig-0034" title="">Analysis 2.7</a>) and days in jail ( <a href="./references#CD001088-fig-0035" title="">Analysis 2.8</a>) were skewed and are presented in 'Other data' tables. </p> </section> <section id="CD001088-sec-0194"> <h5 class="title">2.9 Social functioning: 1. Average role functioning score (RFS, high = better functioning)</h5> <p>There was no clear difference between the psychosocial intervention and standard care group's average role functioning (RFS) scores (<a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a>) by six months (MD ‐0.78, 95% CI ‐2.91 to 1.35; participants = 50; studies = 1) or 12 months (MD 0.70, 95% CI ‐1.56 to 2.96; participants = 50; studies = 1), although by 18 months there was a clear difference, favouring the standard care group (MD ‐2.67, 95% CI ‐5.28 to ‐0.06; participants = 29; studies = 1). The average baseline means (SD) on the RFS were similar between groups so do not explain this difference: baseline treatment 9.46 (4.11) to 10.77 (2.36) at 18 months; and baseline control 10.03 (3.87) to 13.44 (4.78) at 18 months. Note that higher scores indicate better functioning. (<a href="./references#CD001088-fig-0036" title="">Analysis 2.9</a>). </p> </section> <section id="CD001088-sec-0195"> <h5 class="title">2.10 Social functioning: 2. Average social adjustment score (RFS, high = better functioning)</h5> <p>There was no clear between treatment groups for average social adjustment scores (SAS) (<a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a>) by 6 months (MD ‐0.93, 95% CI ‐6.34 to 4.48; participants = 50; studies = 1), 12 months (MD 3.09, 95% CI ‐2.71 to 8.89; participants = 50; studies = 1) or 18 months (MD ‐3.75, 95% CI ‐10.12 to 2.62; participants = 29; studies = 1). (<a href="./references#CD001088-fig-0037" title="">Analysis 2.10</a>). </p> </section> <section id="CD001088-sec-0196"> <h5 class="title">2.11 Quality of life/lfe satisfaction: Average score (QOLI, high = good) ‐ 12 months (skewed data) </h5> <p>Data for average life satisfaction (QOLI) were skewed so are presented in 'Other data' tables. (<a href="./references#CD001088-fig-0038" title="">Analysis 2.11</a>). </p> </section> <section id="CD001088-sec-0197"> <h5 class="title">2.12 Service use: Relapse (skewed data)</h5> <p><a href="./references#CD001088-bbs2-0010" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991b</a> reported % days in hospital but data were skewed and are presented in 'Other data' tables. (<a href="./references#CD001088-fig-0039" title="">Analysis 2.12</a>). </p> </section> <section id="CD001088-sec-0198"> <h5 class="title">2.13 Service use: 1. Various measures ‐ 24 months (skewed data)</h5> <p>Data, reported by <a href="./references#CD001088-bbs2-0034" title="CalsynRJ , YonkerRD , LemmingMR , MorseGA , KlinkenbergWD . Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behaviour and Mental Health2005;15(4):236‐48. [CSzG: 16813] FletcherTD , CunninghamJL , CalsynRJ , MorseGA , KlinkenbergWD . Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects. Administration and Policy in Mental Health2008;35(4):319‐36. [CSzG: 16624; MEDLINE: 18506618] MorseGA , CalsynRJ , KlinkenbergWD , CunninghamJ , LemmingMR . Integrated treatment for homeless clients with dual disorders: a quasi‐experimental evaluation. Journal of Dual Diagnosis2008;4(3):219‐37. [CSzG: 19618] MorseGA , CalsynRJ , KlinkenbergWD , HelminiakTW , WolffN , DrakeRE , et al. Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes. Community Mental Health Journal2006;42(4):377‐404. [CSzG: 13863] ">Morse 2006</a> relating to admissions and length of stay were all skewed data and are presented in 'Other data' tables. (<a href="./references#CD001088-fig-0040" title="">Analysis 2.13</a>). We found no pattern overall of one package of care favoured over another. </p> </section> <section id="CD001088-sec-0199"> <h5 class="title">2.14 Homlessness: Average number of days in stable housing (skewed data)</h5> <p><a href="./references#CD001088-bbs2-0034" title="CalsynRJ , YonkerRD , LemmingMR , MorseGA , KlinkenbergWD . Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behaviour and Mental Health2005;15(4):236‐48. [CSzG: 16813] FletcherTD , CunninghamJL , CalsynRJ , MorseGA , KlinkenbergWD . Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects. Administration and Policy in Mental Health2008;35(4):319‐36. [CSzG: 16624; MEDLINE: 18506618] MorseGA , CalsynRJ , KlinkenbergWD , CunninghamJ , LemmingMR . Integrated treatment for homeless clients with dual disorders: a quasi‐experimental evaluation. Journal of Dual Diagnosis2008;4(3):219‐37. [CSzG: 19618] MorseGA , CalsynRJ , KlinkenbergWD , HelminiakTW , WolffN , DrakeRE , et al. Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes. Community Mental Health Journal2006;42(4):377‐404. [CSzG: 13863] ">Morse 2006</a> reported average number of days in stable housing but data were skewed are presented in 'Other data' tables (<a href="./references#CD001088-fig-0041" title="">Analysis 2.14</a>). </p> </section> </section> <section id="CD001088-sec-0200"> <h4 class="title">Comparison 3: Cognitive behavioural therapy versus standard care</h4> <p>See <a href="./full#CD001088-tbl-0003">summary of findings Table 3</a>. Data for this comparison came from two trials (<a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>; <a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>). </p> <section id="CD001088-sec-0201"> <h5 class="title">3.1 Leaving the study early 1. Lost to treatment</h5> <p>We found that loss from treatment data (<a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>; <a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>) by three months were not clearly different (treatment 18%, control 23% lost; (RR 1.12, 95% CI 0.44 to 2.86; participants = 152; studies = 2). Statistical heterogeneity was not present (Chi² = 0.00, df = 1, P = 0.95; I² = 0%). (<a href="./references#CD001088-fig-0042" title="">Analysis 3.1</a>). </p> </section> <section id="CD001088-sec-0202"> <h5 class="title">3.2 Leaving the study early: 2. Lost to evaluation</h5> <p>The number of participants lost to evaluation (<a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>) after nine months were similar in each group (treatment 30%, control 29%; (RR 1.04, 95% CI 0.43 to 2.51; participants = 47; studies = 1). (<a href="./references#CD001088-fig-0043" title="">Analysis 3.2</a>). </p> </section> <section id="CD001088-sec-0203"> <h5 class="title">3.3 Substance use: 1. Percentage of participants who used cannabis ‐ in last four weeks </h5> <p><a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a> reported % of participants using cannabis in the previous four weeks. No clear differences between treatment groups were found at three months assessment (treatment 57%, control 54%; RR 1.04, 95% CI 0.62 to 1.74; participants = 47; studies = 1) or at six months (RR 1.30, 95% CI 0.79 to 2.15; participants = 47; studies = 1). (<a href="./references#CD001088-fig-0044" title="">Analysis 3.3</a>). </p> </section> <section id="CD001088-sec-0204"> <h5 class="title">3.4 Substance use: 2. Average score (various scales) (skewed data)</h5> <p>Various measures of substance use reporting skewed data are shown in 'Other data' tables. (<a href="./references#CD001088-fig-0045" title="">Analysis 3.4</a>). </p> </section> <section id="CD001088-sec-0205"> <h5 class="title">3.5 Mental state: 1. Average insight score (Insight scale, low = poor) ‐ by three months </h5> <p>There was no clear difference between treatment groups on insight scores (Insight Scale) by three months (<a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>) (MD 0.52, 95% CI ‐0.78 to 1.82; participants = 105; studies = 1). (<a href="./references#CD001088-fig-0046" title="">Analysis 3.5</a>). </p> </section> <section id="CD001088-sec-0206"> <h5 class="title">3.6 Mental state: 2. Average score (various scales) (skewed data)</h5> <p>Various measures of mental state reporting skewed data are shown in 'Other data' tables. (<a href="./references#CD001088-fig-0047" title="">Analysis 3.6</a>). </p> </section> <section id="CD001088-sec-0207"> <h5 class="title">3.7 Social Functioning: 1. Average score (SOFAS, low = poor)</h5> <p>There was no clear difference between treatment groups in average social and occupational functioning scores (<a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>) (SOFAS) by three months (MD ‐0.80, 95% CI ‐9.95 to 8.35; participants = 47; studies = 1) or by six months (MD ‐4.70, 95% CI ‐14.52 to 5.12; participants = 47; studies = 1). (<a href="./references#CD001088-fig-0048" title="">Analysis 3.7</a>). </p> </section> <section id="CD001088-sec-0208"> <h5 class="title">3.8 Social Functioning: 2. Average score (HONOS) (skewed data)</h5> <p>Average HONOS scores were skewed and are presented in 'Other data' tables. (<a href="./references#CD001088-fig-0049" title="">Analysis 3.8</a>). </p> </section> <section id="CD001088-sec-0209"> <h5 class="title">3.9 Service use: 1. Outpatient medication (SURS) (skewed data)</h5> <p>Outpatient medication data are shown in 'Other data' tables due to skewed data. (<a href="./references#CD001088-fig-0050" title="">Analysis 3.9</a>). </p> </section> </section> <section id="CD001088-sec-0210"> <h4 class="title">Comparison 4: Contingency management versus standard care</h4> <p>See <a href="./full#CD001088-tbl-0004">summary of findings Table 4</a>. Four trials assessed this comparison (<a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>; <a href="./references#CD001088-bbs2-0033" title="LoweJM , McDonellMG , LeicklyE , AngeloFA , VilardagaR , McPhersonS , et al. Determining ethyl glucuronide cutoffs when detecting self‐reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research2015;39(5):905‐10. McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , HirchakK , OluwoyeO , et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness. American Journal on Addictions2017;26(7):673‐5. [CSzG: 36340] McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , SrebnikD , AngeloF , et al. A randomized controlled trial of ethyl glucuronide‐ based contingency management for outpatients with co‐occurring alcohol use disorders and serious mental Illness. American Journal of Psychiatry2017;174(4):370‐7. [CSzG: 35589] McDonellMG , SkaliskyJ , LeicklyE , McPhersonS , BattalioS , NepomJR , et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence2015;157:184‐7. NCT01567943 . Contingency management of alcohol abuse in the severely mentally ill. http://ClinicalTrials.gov/show/NCT015679432012. [CSzG: 23792] OluwoyeO , LeicklyE , SkaliskyJ , McPhersonS , HirchakK , SrebnikD , et al. Serious mental illness in heavy drinkers is associated with poor treatment outcomes in outpatients with co‐occurring disorders. International Journal of Mental Health Addiction2018;16(3):672‐9. [CSzG: 37902] SkaliskyJ , LeicklyE , OluwoyeO , McPhersonSM , SrebnikD , RollJM , et al. Prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders. Cannabis and Cannabinoid Research2017;2(1):133‐8. [CSzG: 36516] ">McDonell 2017</a>; <a href="./references#CD001088-bbs2-0038" title="NCT01478815 . Contingency management for persons with severe mental illness. http://ClinicalTrials.gov/show/NCT014788152011. [CSzG: 23332] PetryNM , AlessiSM , Rash CarlaJ . A randomized study of contingency management in cocaine‐dependent patients with severe and persistent mental health disorders. Drug and Alcohol Dependence2013;130:234‐7. [CSzG: 28275] ">Petry 2013</a>; <a href="./references#CD001088-bbs2-0041" title="TracyK , BabuscioT , NichC , KilukB , CarrollKM , PetryNM , et al. Contingency management to reduce substance use in individuals who are homeless with co‐occurring psychiatric disorders. American Journal of Drug and Alcohol Abuse2007;33(2):253‐8. [CSzG: 14807; MEDLINE: 17497548] ">Tracy 2007</a>). </p> <section id="CD001088-sec-0211"> <h5 class="title">4.1 Leaving the study early: 1. Lost to treatment</h5> <p>No clear differences were found for lost to treatment by four to eight weeks (<a href="./references#CD001088-bbs2-0038" title="NCT01478815 . Contingency management for persons with severe mental illness. http://ClinicalTrials.gov/show/NCT014788152011. [CSzG: 23332] PetryNM , AlessiSM , Rash CarlaJ . A randomized study of contingency management in cocaine‐dependent patients with severe and persistent mental health disorders. Drug and Alcohol Dependence2013;130:234‐7. [CSzG: 28275] ">Petry 2013</a>; <a href="./references#CD001088-bbs2-0041" title="TracyK , BabuscioT , NichC , KilukB , CarrollKM , PetryNM , et al. Contingency management to reduce substance use in individuals who are homeless with co‐occurring psychiatric disorders. American Journal of Drug and Alcohol Abuse2007;33(2):253‐8. [CSzG: 14807; MEDLINE: 17497548] ">Tracy 2007</a>) (treatment 4%, control 21%; (RR 0.34, 95% CI 0.04 to 2.81; participants = 49; studies = 2). However, pooled results (<a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>; <a href="./references#CD001088-bbs2-0033" title="LoweJM , McDonellMG , LeicklyE , AngeloFA , VilardagaR , McPhersonS , et al. Determining ethyl glucuronide cutoffs when detecting self‐reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research2015;39(5):905‐10. McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , HirchakK , OluwoyeO , et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness. American Journal on Addictions2017;26(7):673‐5. [CSzG: 36340] McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , SrebnikD , AngeloF , et al. A randomized controlled trial of ethyl glucuronide‐ based contingency management for outpatients with co‐occurring alcohol use disorders and serious mental Illness. American Journal of Psychiatry2017;174(4):370‐7. [CSzG: 35589] McDonellMG , SkaliskyJ , LeicklyE , McPhersonS , BattalioS , NepomJR , et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence2015;157:184‐7. NCT01567943 . Contingency management of alcohol abuse in the severely mentally ill. http://ClinicalTrials.gov/show/NCT015679432012. [CSzG: 23792] OluwoyeO , LeicklyE , SkaliskyJ , McPhersonS , HirchakK , SrebnikD , et al. Serious mental illness in heavy drinkers is associated with poor treatment outcomes in outpatients with co‐occurring disorders. International Journal of Mental Health Addiction2018;16(3):672‐9. [CSzG: 37902] SkaliskyJ , LeicklyE , OluwoyeO , McPhersonSM , SrebnikD , RollJM , et al. Prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders. Cannabis and Cannabinoid Research2017;2(1):133‐8. [CSzG: 36516] ">McDonell 2017</a>) reported that those assigned to the contingency management group were more likely not to complete the treatment period (leaving the study early) than participants in the standard care group at three months (treatment 48%, control 31% lost; (RR 1.55, 95% CI 1.13 to 2.11; participants = 255; studies = 2, Z = 2.76, P = 0.0057). (<a href="./references#CD001088-fig-0051" title="">Analysis 4.1</a>). </p> </section> <section id="CD001088-sec-0212"> <h5 class="title">4.2 Leaving the study early: 2. Lost to evaluation</h5> <p>No clear differences were found for lost to evaluation by six months (<a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>; <a href="./references#CD001088-bbs2-0033" title="LoweJM , McDonellMG , LeicklyE , AngeloFA , VilardagaR , McPhersonS , et al. Determining ethyl glucuronide cutoffs when detecting self‐reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research2015;39(5):905‐10. McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , HirchakK , OluwoyeO , et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness. American Journal on Addictions2017;26(7):673‐5. [CSzG: 36340] McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , SrebnikD , AngeloF , et al. A randomized controlled trial of ethyl glucuronide‐ based contingency management for outpatients with co‐occurring alcohol use disorders and serious mental Illness. American Journal of Psychiatry2017;174(4):370‐7. [CSzG: 35589] McDonellMG , SkaliskyJ , LeicklyE , McPhersonS , BattalioS , NepomJR , et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence2015;157:184‐7. NCT01567943 . Contingency management of alcohol abuse in the severely mentally ill. http://ClinicalTrials.gov/show/NCT015679432012. [CSzG: 23792] OluwoyeO , LeicklyE , SkaliskyJ , McPhersonS , HirchakK , SrebnikD , et al. Serious mental illness in heavy drinkers is associated with poor treatment outcomes in outpatients with co‐occurring disorders. International Journal of Mental Health Addiction2018;16(3):672‐9. [CSzG: 37902] SkaliskyJ , LeicklyE , OluwoyeO , McPhersonSM , SrebnikD , RollJM , et al. Prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders. Cannabis and Cannabinoid Research2017;2(1):133‐8. [CSzG: 36516] ">McDonell 2017</a>) (treatment 33%, control 24%; (RR 1.36, 95% CI 0.91 to 2.02; participants = 255; studies = 2, P = 0.13). (<a href="./references#CD001088-fig-0052" title="">Analysis 4.2</a>). </p> </section> <section id="CD001088-sec-0213"> <h5 class="title">4.3 Substance use: 1. Stimulant‐positive urine test (higher = poor outcome)</h5> <p>Clearly more participants in the standard care group had stimulant‐positive urine tests compared to participants in the psychosocial group by 12 weeks (<a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>) (treatment 10%, controls 25%; n = 176, (RR 0.34, 95% CI 0.17 to 0.68; participants = 176; studies = 1), Z = 3.04, P = 0.0024) but there was no difference at six months (treatment 54%, control 65%; n = 176, (RR 0.83, 95% CI 0.65 to 1.06; participants = 176; studies = 1), Z = 1.46, P = 0.14. (<a href="./references#CD001088-fig-0053" title="">Analysis 4.3</a>). </p> </section> <section id="CD001088-sec-0214"> <h5 class="title">4.4 Substance use: 2 Average number of continuous days alcohol negative urine test (skewed data) </h5> <p>These data were skewed and are presented in 'Other data' tables. (<a href="./references#CD001088-fig-0054" title="">Analysis 4.4</a>). </p> </section> <section id="CD001088-sec-0215"> <h5 class="title">4.5 Substance use: 3. Injection use</h5> <p>Injection use during treatment was clearly lower in the psychosocial arm compared to the standard care arm at three months (<a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>) (treatment 37%, control 66%; (RR 0.57, 95% CI 0.42 to 0.77; participants = 176; studies = 1), Z = 3.62, P &lt; 0.001), but was not clearly different at the six‐month follow‐up (treatment 44%, control 56%; n = 107, (RR 0.78, 95% CI 0.53 to 1.15; participants = 107; studies = 1), Z = 1.24, P = 0.22). (<a href="./references#CD001088-fig-0055" title="">Analysis 4.5</a>). </p> </section> <section id="CD001088-sec-0216"> <h5 class="title">4.6 Substance use: 4. Average scores on various measures (skewed data)</h5> <p>Average scores on various substance use measures were skewed and reported in 'Other data' tables. (<a href="./references#CD001088-fig-0056" title="">Analysis 4.6</a>). </p> </section> <section id="CD001088-sec-0217"> <h5 class="title">4.7 Mental state: 1. Average scores (various scales) (skewed data)</h5> <p>Average scores on various mental state scales were skewed and reported in 'Other data' tables. (<a href="./references#CD001088-fig-0057" title="">Analysis 4.7</a>). </p> </section> <section id="CD001088-sec-0218"> <h5 class="title">4.8 Service use: 1. Relapse (hospitalised ‐ six months post‐randomisation)</h5> <p>Relapse rates (hospitalised within 6 months after randomisation) were clearly lower in the psychosocial group compared to the standard care group (<a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a>) (treatment 2%, control 11%;(RR 0.21, 95% CI 0.05 to 0.93; participants = 176; studies = 1). (<a href="./references#CD001088-fig-0058" title="">Analysis 4.8</a>). </p> </section> </section> <section id="CD001088-sec-0219"> <h4 class="title">Comparison 5: Motivational interviewing versus standard care</h4> <p>See <a href="./full#CD001088-tbl-0005">summary of findings Table 5</a>. Data for this comparison came from nine trials (<a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a>; <a href="./references#CD001088-bbs2-0006" title="BechdolfA , PohlmannB , GuttgemannsJ , GeyerC , LindnerK , FerberC , et al. State‐dependent motivational interviewing for people with schizophrenia and substance use : Results of a randomised controlled trial [Motivationsbehandlung für patienten mit der doppeldiagnose psychose und sucht]. Nervenarzt2011;83(7):888‐96. [MEDLINE: 21720841] ">Bechdolf 2011</a>; <a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>; <a href="./references#CD001088-bbs2-0020" title="GraeberDA , MoyersTB , GriffithG , GuajardoE , ToniganS . A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal2003;39(3):189‐202. [CSzG: 9901] ">Graeber 2003</a>; <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>; <a href="./references#CD001088-bbs2-0023" title="HickmanME . The effects of personal feedback on alcohol intake in dually diagnosed clients: an empirical study of William R. Miller's motivational enhancement therapy. Unpublished thesis. University Graduate School, Dept. Counseling Psychology, Indiana University1997. [CSzG: 4153] ">Hickman 1997</a>; <a href="./references#CD001088-bbs2-0027" title="KavanaghDJ , YoungR , WhiteA , SaundersJB , WallisJ , ShockleyN , et al. A brief motivational intervention for substance misuse in recent‐onset psychosis. Drug and Alcohol Review2004;23(2):151‐5. [CSzG: 8309] ">Kavanagh 2004</a>; <a href="./references#CD001088-bbs2-0036" title="NagelT , RobinsonG , CondonJ , TrauerT . Approach to treatment of mental illness and substance dependence in remote indigenous communities: results of a mixed methods study. Australian Journal of Rural Health2009;17(4):174‐82. [CSzG: 18782; MEDLINE: 19664081] ">Nagel 2009</a>; <a href="./references#CD001088-bbs2-0040" title="PantalonMV , SwansonAJ . Use of the University of Rhode Island Change Assessment to measure motivational readiness to change in psychiatric and dually diagnosed individuals. Psychology of Addictive Behaviors2003;17(2):91‐7. [CSzG: 9830] SwansonAJ , PantalonMV , CohenKR . Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease1999;187(10):630‐5. [CSzG: 9248] ">Swanson 1999</a>). </p> <section id="CD001088-sec-0220"> <h5 class="title">5.1 Leaving the study early: 1. Lost to treatment</h5> <p><a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a> had an unusually long treatment period using motivational interviewing (six months). There were no differences in numbers of participants lost to treatment at three months (RR 0.89, 95% CI 0.30 to 2.61; participants = 62; studies = 1) or six months (RR 1.71, 95% CI 0.63 to 4.64; participants = 62; studies = 1). <a href="./references#CD001088-fig-0059" title="">Analysis 5.1</a>). </p> </section> <section id="CD001088-sec-0221"> <h5 class="title">5.2 Leaving the study early: 2. Lost to evaluation</h5> <p>Pooled results from seven studies (<a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a>; <a href="./references#CD001088-bbs2-0006" title="BechdolfA , PohlmannB , GuttgemannsJ , GeyerC , LindnerK , FerberC , et al. State‐dependent motivational interviewing for people with schizophrenia and substance use : Results of a randomised controlled trial [Motivationsbehandlung für patienten mit der doppeldiagnose psychose und sucht]. Nervenarzt2011;83(7):888‐96. [MEDLINE: 21720841] ">Bechdolf 2011</a>; <a href="./references#CD001088-bbs2-0020" title="GraeberDA , MoyersTB , GriffithG , GuajardoE , ToniganS . A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal2003;39(3):189‐202. [CSzG: 9901] ">Graeber 2003</a>; <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>; <a href="./references#CD001088-bbs2-0023" title="HickmanME . The effects of personal feedback on alcohol intake in dually diagnosed clients: an empirical study of William R. Miller's motivational enhancement therapy. Unpublished thesis. University Graduate School, Dept. Counseling Psychology, Indiana University1997. [CSzG: 4153] ">Hickman 1997</a>; <a href="./references#CD001088-bbs2-0027" title="KavanaghDJ , YoungR , WhiteA , SaundersJB , WallisJ , ShockleyN , et al. A brief motivational intervention for substance misuse in recent‐onset psychosis. Drug and Alcohol Review2004;23(2):151‐5. [CSzG: 8309] ">Kavanagh 2004</a>; <a href="./references#CD001088-bbs2-0040" title="PantalonMV , SwansonAJ . Use of the University of Rhode Island Change Assessment to measure motivational readiness to change in psychiatric and dually diagnosed individuals. Psychology of Addictive Behaviors2003;17(2):91‐7. [CSzG: 9830] SwansonAJ , PantalonMV , CohenKR . Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease1999;187(10):630‐5. [CSzG: 9248] ">Swanson 1999</a>) revealed no difference in those lost to evaluation by three months (treatment 15% lost, control 15% lost; (RR 1.08, 95% CI 0.69 to 1.70; participants = 457; studies = 7). Similarly, six‐month data (<a href="./references#CD001088-bbs2-0006" title="BechdolfA , PohlmannB , GuttgemannsJ , GeyerC , LindnerK , FerberC , et al. State‐dependent motivational interviewing for people with schizophrenia and substance use : Results of a randomised controlled trial [Motivationsbehandlung für patienten mit der doppeldiagnose psychose und sucht]. Nervenarzt2011;83(7):888‐96. [MEDLINE: 21720841] ">Bechdolf 2011</a>; <a href="./references#CD001088-bbs2-0020" title="GraeberDA , MoyersTB , GriffithG , GuajardoE , ToniganS . A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal2003;39(3):189‐202. [CSzG: 9901] ">Graeber 2003</a>; <a href="./references#CD001088-bbs2-0027" title="KavanaghDJ , YoungR , WhiteA , SaundersJB , WallisJ , ShockleyN , et al. A brief motivational intervention for substance misuse in recent‐onset psychosis. Drug and Alcohol Review2004;23(2):151‐5. [CSzG: 8309] ">Kavanagh 2004</a>; <a href="./references#CD001088-bbs2-0036" title="NagelT , RobinsonG , CondonJ , TrauerT . Approach to treatment of mental illness and substance dependence in remote indigenous communities: results of a mixed methods study. Australian Journal of Rural Health2009;17(4):174‐82. [CSzG: 18782; MEDLINE: 19664081] ">Nagel 2009</a>) (RR 0.85, 95% CI 0.29 to 2.53; participants = 164; studies = 4) and 12‐month data were not clearly different (RR 0.92, 95% CI 0.44 to 1.92; participants = 247; studies = 3) between motivational interviewing and the standard care group. Statistical heterogeneity was not present at three, six or 12 months. (<a href="./references#CD001088-fig-0060" title="">Analysis 5.2</a>). </p> </section> <section id="CD001088-sec-0222"> <h5 class="title">5.3 Adverse event: 1. Death</h5> <p>We found no clear differences between the treatment groups in the likelihood of death due to all causes by 18 months (<a href="./references#CD001088-bbs2-0036" title="NagelT , RobinsonG , CondonJ , TrauerT . Approach to treatment of mental illness and substance dependence in remote indigenous communities: results of a mixed methods study. Australian Journal of Rural Health2009;17(4):174‐82. [CSzG: 18782; MEDLINE: 19664081] ">Nagel 2009</a>) (treatment 4%, control 4%; RR 1.04, 95% CI 0.07 to 15.73; participants = 49; studies = 1). (<a href="./references#CD001088-fig-0061" title="">Analysis 5.3</a>). </p> </section> <section id="CD001088-sec-0223"> <h5 class="title">5.4 Substance use: 1. Using substances ‐ by class of drug ‐ by about12 months</h5> <p>We found that alcohol dependence and abuse were not clearly different between treatment groups (<a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a>) (treatment 39%, control 29%; (RR 1.35, 95% CI 0.62 to 2.92; participants = 52; studies = 1). Also, we found no clear differences in the likelihood of participants using amphetamine (treatment 9%, control 38%; (RR 0.24, 95% CI 0.03 to 1.92; participants = 19; studies = 1) or cannabis (treatment 50%, control 65%; (RR 0.77, 95% CI 0.49 to 1.21; participants = 62; studies = 1). (<a href="./references#CD001088-fig-0062" title="">Analysis 5.4</a>). </p> </section> <section id="CD001088-sec-0224"> <h5 class="title">5.5 Substance use: 2. Polydrug consumption levels ‐ by 12 months (OTI, high = poor)</h5> <p>Polydrug use was not found to be clearly different for three‐month (MD ‐0.41, 95% CI ‐0.91 to 0.09; participants = 89; studies = 1) and 12‐month (MD ‐0.07, 95% CI ‐0.56 to 0.42; participants = 89; studies = 1) evaluation data (OTI, high = poor) (<a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a>). ( <a href="./references#CD001088-fig-0063" title="">Analysis 5.5</a>). </p> </section> <section id="CD001088-sec-0225"> <h5 class="title">5.6 Substance use: 3. Any change ‐ not abstinent or not improved on all substances ‐ by 12 months </h5> <p>We found no clear difference (<a href="./references#CD001088-bbs2-0027" title="KavanaghDJ , YoungR , WhiteA , SaundersJB , WallisJ , ShockleyN , et al. A brief motivational intervention for substance misuse in recent‐onset psychosis. Drug and Alcohol Review2004;23(2):151‐5. [CSzG: 8309] ">Kavanagh 2004</a>) between treatment groups in the number of participants not abstaining or not improved on all substances by 12 months (treatment 38%, control 75%; n = 25, (RR 0.51, 95% CI 0.24 to 1.10; participants = 25; studies = 1). (<a href="./references#CD001088-fig-0064" title="">Analysis 5.6</a>). </p> </section> <section id="CD001088-sec-0226"> <h5 class="title">5.7 Substance use: 4. Any change ‐ not abstaining from alcohol</h5> <p>Three‐month data reported by (<a href="./references#CD001088-bbs2-0020" title="GraeberDA , MoyersTB , GriffithG , GuajardoE , ToniganS . A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal2003;39(3):189‐202. [CSzG: 9901] ">Graeber 2003</a>) did not reveal any clear difference between treatment groups for numbers of participants not abstaining from alcohol (treatment 40%, control 77%; n = 28, (RR 0.52, 95% CI 0.26 to 1.03; participants = 28; studies = 1). However, by six months we found data from this small study (<a href="./references#CD001088-bbs2-0020" title="GraeberDA , MoyersTB , GriffithG , GuajardoE , ToniganS . A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal2003;39(3):189‐202. [CSzG: 9901] ">Graeber 2003</a>) showed clearly more participants in the standard care group were not abstaining from alcohol (treatment 42%, control 92%; (RR 0.36, 95% CI 0.17 to 0.75; participants = 28; studies = 1). (<a href="./references#CD001088-fig-0065" title="">Analysis 5.7</a>). </p> </section> <section id="CD001088-sec-0227"> <h5 class="title">5.8 Substance use: 5. Change in cannabis use from baseline (T0, lower scores indicate better outcome) </h5> <p>Change in cannabis use from baseline was lower in at three months (<a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>) (n = 62, MD ‐12.81 CI ‐23.05 to ‐2.57, P = 0.014), six months (n = 62, MD ‐9.64 CI ‐18.05 to ‐1.23, P = 0.025), but not at 12 months (n = 62, MD ‐5.82 CI ‐14.77 to 3.13). (<a href="./references#CD001088-fig-0066" title="">Analysis 5.8</a>). </p> </section> <section id="CD001088-sec-0228"> <h5 class="title">5.9 Substance use: 6. Cannabis consumption past 30 days ‐ average score (ASI, high = poor) (skewed data) </h5> <p>Average ASI scores for cannabis consumption were skewed and are presented in 'Other data' tables. (<a href="./references#CD001088-fig-0067" title="">Analysis 5.9</a>), </p> </section> <section id="CD001088-sec-0229"> <h5 class="title">5.10 Substance use: 7. Engagement with substance misuse treatment at three months (SATS, low = poor) </h5> <p>Data reported by (<a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>) showed engagement with substance misuse scores (SATS) at three months were not clearly different between groups (MD 0.30, 95% CI ‐0.47 to 1.07; participants = 59; studies = 1). (<a href="./references#CD001088-fig-0068" title="">Analysis 5.10</a>). </p> </section> <section id="CD001088-sec-0230"> <h5 class="title">5.11 Substance use: 8. Average scores (OTI, high = poor) (skewed data)</h5> <p>Average substance use scores on the Opiate Treatment Index (OTI) (<a href="./references#CD001088-fig-0069" title="">Analysis 5.11</a>) are reported in 'Other data' tables due to skewed data. </p> </section> <section id="CD001088-sec-0231"> <h5 class="title">6.12 Substance use: 9. Other measures of alcohol use (various scales, skewed data)</h5> <p>Other measures of alcohol use reported by (<a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>; <a href="./references#CD001088-bbs2-0020" title="GraeberDA , MoyersTB , GriffithG , GuajardoE , ToniganS . A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal2003;39(3):189‐202. [CSzG: 9901] ">Graeber 2003</a>; <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a>; <a href="./references#CD001088-bbs2-0023" title="HickmanME . The effects of personal feedback on alcohol intake in dually diagnosed clients: an empirical study of William R. Miller's motivational enhancement therapy. Unpublished thesis. University Graduate School, Dept. Counseling Psychology, Indiana University1997. [CSzG: 4153] ">Hickman 1997</a>) were skewed and are presented as 'Other data tables'. (<a href="./references#CD001088-fig-0070" title="">Analysis 5.12</a>). </p> </section> <section id="CD001088-sec-0232"> <h5 class="title">5.13 Mental state: 1. Average score (SCL‐90‐R, high = poor) ‐ by three months</h5> <p>We found that three‐month data by <a href="./references#CD001088-bbs2-0023" title="HickmanME . The effects of personal feedback on alcohol intake in dually diagnosed clients: an empirical study of William R. Miller's motivational enhancement therapy. Unpublished thesis. University Graduate School, Dept. Counseling Psychology, Indiana University1997. [CSzG: 4153] ">Hickman 1997</a> revealed no clear differences between treatment groups in average general severity scores (MD ‐0.19, 95% CI ‐0.59 to 0.21; participants = 30; studies = 1), average positive distress symptoms scores (MD ‐0.19, 95% CI ‐0.66 to 0.28; participants = 30; studies = 1), or average total positive symptoms scores (MD ‐4.20, 95% CI ‐18.72 to 10.32; participants = 30; studies = 1) as measured by the SCL‐90. (<a href="./references#CD001088-fig-0071" title="">Analysis 5.13</a>). </p> </section> <section id="CD001088-sec-0233"> <h5 class="title">5.14 Mental state: 2. Average score (PANSS negative symptoms, high = poor)</h5> <p>Average PANSS negative symptom scores reported by (<a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>) were not clearly different between treatment groups at three months (MD ‐0.10, 95% CI ‐2.06 to 1.86; participants = 62; studies = 1) or six months (MD 0.00, 95% CI ‐1.80 to 1.80; participants = 62; studies = 1). (<a href="./references#CD001088-fig-0072" title="">Analysis 5.14</a>). </p> </section> <section id="CD001088-sec-0234"> <h5 class="title">5.15 Mental state: 3. Average score (PANSS positive symptoms, high = poor)</h5> <p>Average PANSS positive symptom scores reported by (<a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>) were not clearly different between treatment groups at three months (MD ‐0.30, 95% CI ‐2.55 to 1.95; participants = 62; studies = 1) or six months (MD ‐0.10, 95% CI ‐2.58 to 2.38; participants = 62; studies = 1). ( <a href="./references#CD001088-fig-0073" title="">Analysis 5.15</a>). </p> </section> <section id="CD001088-sec-0235"> <h5 class="title">5.16 Mental state: 4. Average score (HADS and BSI, high = poor) (skewed data)</h5> <p>Mental state data reported by <a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a>; <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a> were skewed and are presented in 'Other data' tables, <a href="./references#CD001088-fig-0074" title="">Analysis 5.16</a>. </p> </section> <section id="CD001088-sec-0236"> <h5 class="title">5.17 Global state: Average score (GAF, low = poor)</h5> <p>Average GAF scores reported by (<a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>) were not clearly different between treatment groups at three months (MD ‐0.40, 95% CI ‐3.53 to 2.73; participants = 51; studies = 1), six months (MD ‐1.00, 95% CI ‐4.81 to 2.81; participants = 49; studies = 1) or 12 months (MD 2.30, 95% CI ‐1.30 to 5.90; participants = 54; studies = 1). (<a href="./references#CD001088-fig-0075" title="">Analysis 5.17</a>). </p> </section> <section id="CD001088-sec-0237"> <h5 class="title">5.18 Global state: Forensic measures ‐ average number of crimes (skewed data)</h5> <p>Average number of crimes reported at six and 12 months were skewed and are presented in 'Other data' tables (<a href="./references#CD001088-fig-0076" title="">Analysis 5.18</a>). </p> </section> <section id="CD001088-sec-0238"> <h5 class="title">5.19 Social functioning: 1. Average score (OTI, high = poor)</h5> <p>Average OTI social functioning scores reported by (<a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a>) did not reveal any clear differences between treatment groups by six months (MD ‐0.71, 95% CI ‐2.76 to 1.34; participants = 102; studies = 1), or by 12 months (MD ‐1.42, 95% CI ‐3.35 to 0.51; participants = 102; studies = 1). (<a href="./references#CD001088-fig-0077" title="">Analysis 5.19</a>). </p> </section> <section id="CD001088-sec-0239"> <h5 class="title">5.20 Social functioning: 2. Average score (SOFAS, high = poor)</h5> <p>Social occupational functioning (SOFAS) scores reported by (<a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>) were not clearly different between treatment groups at three months (MD 0.10, 95% CI ‐3.02 to 3.22; participants = 62; studies = 1), six months (MD ‐0.10, 95% CI ‐3.51 to 3.31; participants = 62; studies = 1) or 12 months (MD 2.70, 95% CI ‐1.08 to 6.48; participants = 62; studies = 1). (<a href="./references#CD001088-fig-0078" title="">Analysis 5.20</a>). </p> </section> <section id="CD001088-sec-0240"> <h5 class="title">5.21 Service use: 1. Relapse (hospital readmission by 12 months)</h5> <p>We found no clear differences in hospital readmissions by 12 months (<a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a>) (treatment 30%, control 34%) (RR 0.87, 95% CI 0.42 to 1.80; participants = 62; studies = 1). (<a href="./references#CD001088-fig-0079" title="">Analysis 5.21</a>). </p> </section> <section id="CD001088-sec-0241"> <h5 class="title">6.22 Service use: 2. Lost to first aftercare appointment</h5> <p>We found participants in Motivational interviewing group were more likely to attend their first aftercare appointment (<a href="./references#CD001088-bbs2-0040" title="PantalonMV , SwansonAJ . Use of the University of Rhode Island Change Assessment to measure motivational readiness to change in psychiatric and dually diagnosed individuals. Psychology of Addictive Behaviors2003;17(2):91‐7. [CSzG: 9830] SwansonAJ , PantalonMV , CohenKR . Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease1999;187(10):630‐5. [CSzG: 9248] ">Swanson 1999</a>) (treatment 58%, control 84%; n = 93, (RR 0.69, 95% CI 0.53 to 0.90; participants = 93; studies = 1), compared with those receiving standard care. (<a href="./references#CD001088-fig-0080" title="">Analysis 5.22</a>). </p> </section> </section> <section id="CD001088-sec-0242"> <h4 class="title">Comparison 6: Skills training versus standard care</h4> <p>See <a href="./full#CD001088-tbl-0006">summary of findings Table 6</a>. Data for this comparison came from five trials (<a href="./references#CD001088-bbs2-0008" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12‐step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403‐11. [CSzG: 29165; NCT00583440] ">Bogenschutz 2014</a>; <a href="./references#CD001088-bbs2-0015" title="EackSM , HogartySS , BangaloreSS , KeshavanMS , CorneliusJR . Patterns of substance use during Cognitive Enhancement Therapy: an 18‐month randomized feasibility study. Journal of Dual Diagnosis2016;12:74‐82. [CSzG: 33634] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18‐month feasibility trial. Schizophrenia Research2015;161(2‐3):478‐83. [CSzG: 29308] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18‐month feasibility trial. Schizophrenia Bulletin2015;41:S310. [CSzG: 29436] WojtalikJA , EackSM . Fronto‐limbic neuroplasticity effects of Cognitive Enhancement Therapy during emotion regulation in schizophrenia patients who abuse cannabis. Schizophrenia Bulletin2015;41:S243. [CSzG: 29719] WojtalikJA , HogartySS , CorneliusJR , PhillipsML , KeshavanMS , NewhillCE , et al. Cognitive Enhancement Therapy improves frontolimbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study. Frontiers in Psychiatry2016;6:186. [CSzG: 33452] ">Eack 2015</a>; <a href="./references#CD001088-bbs2-0022" title="HellersteinDJ , RosenthalRN , MinerCR . A prospective study of integrated outpatient treatment for substance‐abusing schizophrenic patients. American Journal on Addictions1995;4(1):33‐42. [CSzG: 5029] HellersteinDJ , RosenthalRN , MinerCR . Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly2001;72(4):291‐306. [CSzG: 8206] ">Hellerstein 1995</a>; <a href="./references#CD001088-bbs2-0025" title="JerrellJM . Cost‐effective treatment for persons with dual disorders. New Directions for Mental Health Services1996;70(Summer):79‐91. [CSzG: 16821] JerrellJM , HuTW , RidgelyMS . Cost‐effectiveness of substance disorder interventions for people with severe mental illness. Journal of Mental Health Administration1994;21(3):283‐97. [CSzG: 1166] JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] JerrellJM , RidgelyMS . Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services1999;50(1):109‐12. [CSzG: 16917] ">Jerrell 1995a</a>; <a href="./references#CD001088-bbs2-0039" title="RosenblumA , MatusowH , FongC , VogelH , UttaroT , MooreTL , et al. Efficacy of dual focus mutual aid for persons with mental illness and substance misuse. Drug and Alcohol Dependence2014;135:78‐87. [CSzG: 27823] ">Rosenblum 2014</a>). </p> <section id="CD001088-sec-0243"> <h5 class="title">6.1 Leaving the study early: 1. Lost to treatment</h5> <p>Our analyses found that the pooled results of <a href="./references#CD001088-bbs2-0008" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12‐step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403‐11. [CSzG: 29165; NCT00583440] ">Bogenschutz 2014</a> and <a href="./references#CD001088-bbs2-0039" title="RosenblumA , MatusowH , FongC , VogelH , UttaroT , MooreTL , et al. Efficacy of dual focus mutual aid for persons with mental illness and substance misuse. Drug and Alcohol Dependence2014;135:78‐87. [CSzG: 27823] ">Rosenblum 2014</a> showed no clear difference in lost to treatment between skills training and standard care groups at three months (treatment 16%, control 19%, (RR 0.97, 95% CI 0.68 to 1.36; participants = 461; studies = 3). Data reported by <a href="./references#CD001088-bbs2-0022" title="HellersteinDJ , RosenthalRN , MinerCR . A prospective study of integrated outpatient treatment for substance‐abusing schizophrenic patients. American Journal on Addictions1995;4(1):33‐42. [CSzG: 5029] HellersteinDJ , RosenthalRN , MinerCR . Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly2001;72(4):291‐306. [CSzG: 8206] ">Hellerstein 1995</a> and <a href="./references#CD001088-bbs2-0025" title="JerrellJM . Cost‐effective treatment for persons with dual disorders. New Directions for Mental Health Services1996;70(Summer):79‐91. [CSzG: 16821] JerrellJM , HuTW , RidgelyMS . Cost‐effectiveness of substance disorder interventions for people with severe mental illness. Journal of Mental Health Administration1994;21(3):283‐97. [CSzG: 1166] JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] JerrellJM , RidgelyMS . Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services1999;50(1):109‐12. [CSzG: 16917] ">Jerrell 1995a</a> showed a 51% greater likelihood that participants would be lost to treatment from the standard care group by six months which was clearly more than the skills training group (treatment 16%, control 31%; (RR 0.49, 95% CI 0.24 to 0.97; participants = 94; studies = 2), although this clear difference was not present at 12 months (treatment 33%, control 33%; (RR 1.42, 95% CI 0.20 to 10.10; participants = 122; studies = 3). By contrast, at 18 months we found a clear difference between the treatment groups where participants given skills training were twice as likely to be lost to treatment (treatment 59%, control 24%; (RR 2.60, 95% CI 1.36 to 4.97; participants = 75; studies = 2) (<a href="./references#CD001088-fig-0081" title="">Analysis 6.1</a>). </p> </section> <section id="CD001088-sec-0244"> <h5 class="title">6.2 Lost to evaluation</h5> <p>Data reported by (<a href="./references#CD001088-bbs2-0008" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12‐step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403‐11. [CSzG: 29165; NCT00583440] ">Bogenschutz 2014</a>) showed no clear differences in lost to evaluation between groups at six months (RR 0.92, 95% CI 0.40 to 2.08; participants = 121; studies = 1), nine months (RR 1.05, 95% CI 0.47 to 2.33; participants = 121; studies = 1) and 12 months (RR 1.14, 95% CI 0.55 to 2.36; participants = 121; studies = 1). <a href="./references#CD001088-fig-0082" title="">Analysis 6.2</a>. </p> </section> <section id="CD001088-sec-0245"> <h5 class="title">6.3 Adverse event: 1. Death</h5> <p>We found <a href="./references#CD001088-bbs2-0008" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12‐step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403‐11. [CSzG: 29165; NCT00583440] ">Bogenschutz 2014</a> showed no clear difference between skills training and standard care with regards to the likelihood of participants dying by 12 months of treatment (treatment 1.2% died, control 8% died) (RR 0.15, 95% CI 0.02 to 1.42; participants = 121; studies = 1). <a href="./references#CD001088-fig-0083" title="">Analysis 6.3</a>. </p> </section> <section id="CD001088-sec-0246"> <h5 class="title">6.4 Substance use: 1. Alcohol use: proportion days abstinent from alcohol (TLFB method)</h5> <p>Proportion of days abstinent from alcohol was clearly higher in the skills training group compared to standard care group at three months (MD 0.02, 95% CI 0.00 to 0.04; participants = 107; studies = 1), but was clearly lower at six months (MD ‐0.05, 95% CI ‐0.07 to ‐0.03; participants = 100; studies = 1), and there was no difference between treatment groups at nine months (MD 0.01, 95% CI ‐0.01 to 0.03; participants = 98; studies = 1) or 12 months (MD 0.03, 95% CI 0.00 to 0.06; participants = 93; studies = 1). (<a href="./references#CD001088-fig-0084" title="">Analysis 6.4</a>). </p> </section> <section id="CD001088-sec-0247"> <h5 class="title">6.5 ‐ 6.6 Substance use: (skewed data)</h5> <p>Average scores of various substance use scales (<a href="./references#CD001088-fig-0085" title="">Analysis 6.5</a>) or average days used (<a href="./references#CD001088-fig-0086" title="">Analysis 6.6</a>) were skewed and reported in 'Other data' tables. </p> </section> <section id="CD001088-sec-0248"> <h5 class="title">6.7 Social Functioning: 1. Average score (RFS, high = better functioning)</h5> <p>Average role functioning scores reported in (<a href="./references#CD001088-bbs2-0025" title="JerrellJM . Cost‐effective treatment for persons with dual disorders. New Directions for Mental Health Services1996;70(Summer):79‐91. [CSzG: 16821] JerrellJM , HuTW , RidgelyMS . Cost‐effectiveness of substance disorder interventions for people with severe mental illness. Journal of Mental Health Administration1994;21(3):283‐97. [CSzG: 1166] JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] JerrellJM , RidgelyMS . Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services1999;50(1):109‐12. [CSzG: 16917] ">Jerrell 1995a</a>) showed no clear differences between treatment groups by six months (MD 0.61, 95% CI ‐1.63 to 2.85; participants = 47; studies = 1), 12 months (MD 1.07, 95% CI ‐1.15 to 3.29; participants = 47; studies = 1) or 18 months (MD ‐2.55, 95% CI ‐6.24 to 1.14; participants = 25; studies = 1). (<a href="./references#CD001088-fig-0087" title="">Analysis 6.7</a>). </p> </section> <section id="CD001088-sec-0249"> <h5 class="title">6.8 Social Functioning: 2. Average score (SAS, high = better functioning)</h5> <p>No clear differences between treatment groups were observed in social adjustment, measured as average SAS score by (<a href="./references#CD001088-bbs2-0025" title="JerrellJM . Cost‐effective treatment for persons with dual disorders. New Directions for Mental Health Services1996;70(Summer):79‐91. [CSzG: 16821] JerrellJM , HuTW , RidgelyMS . Cost‐effectiveness of substance disorder interventions for people with severe mental illness. Journal of Mental Health Administration1994;21(3):283‐97. [CSzG: 1166] JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] JerrellJM , RidgelyMS . Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services1999;50(1):109‐12. [CSzG: 16917] ">Jerrell 1995a</a>) at six months (MD ‐0.92, 95% CI ‐6.58 to 4.74; participants = 47; studies = 1), 12 months (MD 2.58, 95% CI ‐3.39 to 8.55; participants = 47; studies = 1) or 18 months (MD ‐4.66, 95% CI ‐15.29 to 5.97; participants = 25; studies = 1). (<a href="./references#CD001088-fig-0088" title="">Analysis 6.8</a>). </p> </section> <section id="CD001088-sec-0250"> <h5 class="title">6.9 Service use: 1. Average days in hospital (skewed data)</h5> <p>Data from <a href="./references#CD001088-bbs2-0022" title="HellersteinDJ , RosenthalRN , MinerCR . A prospective study of integrated outpatient treatment for substance‐abusing schizophrenic patients. American Journal on Addictions1995;4(1):33‐42. [CSzG: 5029] HellersteinDJ , RosenthalRN , MinerCR . Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly2001;72(4):291‐306. [CSzG: 8206] ">Hellerstein 1995</a> for days in hospital were skewed and are presented in 'Other data' tables. (<a href="./references#CD001088-fig-0089" title="">Analysis 6.9</a>). </p> </section> </section> <section id="CD001088-sec-0251"> <h4 class="title">Comparison 7: Cognitive behavioural therapy + motivational interviewing versus standard care </h4> <p>See <a href="./full#CD001088-tbl-0007">summary of findings Table 7</a>. Data for this comparIson came from nine trials (<a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>; <a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>; <a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>; <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>; <a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>; <a href="./references#CD001088-bbs2-0028" title="KempR , HarrisA , VurelE , SitharthanT . Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry2007;15(6):490‐3. [CSzG: 15549; MEDLINE: 17852064] ">Kemp 2007</a>; <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a>). </p> <section id="CD001088-sec-0252"> <h5 class="title">7.1 Leaving the study early: 1. Lost to treatment</h5> <p>We found that the results from <a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a> indicated that clearly more participants assigned to CBT+ MI group were lost to treatment by three months (treatment 12%, control 0%; n = 130, RR 17.00 95% CI 1.00 to 288.56; participants = 130; studies = 1). In contrast, <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a> reported no group difference in lost to treatment by three months (treatment 29%, control 24%; n = 88, RR 1.19 95% CI 0.56 to 2.55; participants = 88; studies = 1), as did <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a> (treatment 30%, control 44%, n = 100, RR 0.68 95% CI 0.40 to 1.15; participants = 100; studies = 1). Combined, participants in the CBT + MI groups were no more likely to be lost to treatment by three months than participants in the standard care groups (treatment 23%, control 20%; RR 1.20, 95% CI 0.44 to 3.30; participants = 318; studies = 3), but there was considerable statistical heterogeneity (Chi² = 6.71, df = 2, P = 0.03; I² = 70%). Six month‐data reported in (<a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>; <a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>; <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>; <a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>) revealed no difference between CBT + MI group and standard care for loss to treatment (treatment 29%, control 28%; RR 0.90, 95% CI 0.66 to 1.22; participants = 815; studies = 5, P = 0.48). Similarly, we found nine‐ to 10‐month data (<a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>; <a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>) were not clearly different (treatment 25%, control 32%; (RR 0.80, 95% CI 0.52 to 1.22; participants = 211; studies = 3), nor were 12‐month data (<a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>) (treatment 17.7%, control 17.8%; RR 0.99, 95% CI 0.62 to 1.59; participants = 327; studies = 1). Statistical heterogeneity was not present at six or nine to 10 months). (<a href="./references#CD001088-fig-0090" title="">Analysis 7.1</a>). </p> </section> <section id="CD001088-sec-0253"> <h5 class="title">7.2 Leaving the study early: 2. Lost to evaluation</h5> <p>We found all lost to evaluation data to be equivocal between CBT + MI and standard care by three months (<a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>; <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>) (treatment 17% lost, control 23% lost; RR 0.75, 95% CI 0.46 to 1.21; participants = 230; studies = 2), by six months (<a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>; <a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>; <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>; <a href="./references#CD001088-bbs2-0028" title="KempR , HarrisA , VurelE , SitharthanT . Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry2007;15(6):490‐3. [CSzG: 15549; MEDLINE: 17852064] ">Kemp 2007</a>) (treatment 21% lost, control 26% lost; RR 0.80, 95% CI 0.57 to 1.12; participants = 469; studies = 5), at nine months (<a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>) (treatment 24%, control 26%; RR 0.82, 95% CI 0.46 to 1.47; participants = 146; studies = 2), 12‐14 months (<a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>; <a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>; <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>; <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a>) (treatment 34%, control 34%; RR 0.99, 95% CI 0.73 to 1.34; participants = 464; studies = 5), 18 months (<a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>); (treatment 20%, control 22%; RR 0.92, 95% CI 0.61 to 1.38; participants = 363; studies = 2), and 24 months (<a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>) (treatment 21%, control 28%; (RR 0.76, 95% CI 0.52 to 1.11; participants = 327; studies = 1). Statistical heterogeneity was not present for any of the above subgroup analyses. (<a href="./references#CD001088-fig-0091" title="">Analysis 7.2</a>). </p> </section> <section id="CD001088-sec-0254"> <h5 class="title">7.3 Adverse event: 1. Death ‐ by about one year</h5> <p>Pooled results from (<a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>; <a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>) found no clear difference in numbers of participants dying in either the CBT + MI groups or standard care groups by about one year (treatment 1.9%, control 3.2%; n = 603, RR 0.60, 95% CI 0.20 to 1.76; participants = 603; studies = 4). Statistical heterogeneity was not present (Chi² = 2.94, df = 3, P = 0.40; I² = 0%). (<a href="./references#CD001088-fig-0092" title="">Analysis 7.3</a>). </p> </section> <section id="CD001088-sec-0255"> <h5 class="title">7.4 Adverse event: 2. Death or hospitalisation by 24 months</h5> <p>Similarly, there was no clear difference for the likelihood of participants hospitalised or dying versus alive and not admitted to hospital by 24 months (<a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>) (treatment 23%, control 20%; n = 326, RR 1.15, 95% CI 0.76 to 1.74; participants = 326; studies = 1). (<a href="./references#CD001088-fig-0093" title="">Analysis 7.4</a>). </p> </section> <section id="CD001088-sec-0256"> <h5 class="title">7.5 Substance use: 1. Average number of different drugs used during past month</h5> <p>Polydrug usage was not clearly different between CBT + MI and standard care groups by three months (<a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>) (MD 0.37, 95% CI ‐0.01 to 0.75; participants = 119; studies = 1), or by six months (MD 0.19, 95% CI ‐0.22 to 0.60; participants = 119; studies = 1). (<a href="./references#CD001088-fig-0094" title="">Analysis 7.5</a>). </p> </section> <section id="CD001088-sec-0257"> <h5 class="title">7.6 Substance use: 2. Cannabis use last 30 days</h5> <p>Moreover, cannabis use in the last 30 days was not clearly different between the two treatment groups at three months the end of treatment (MD ‐0.20, 95% CI ‐2.54 to 2.14; participants = 54; studies = 1), or at 12 months (MD ‐0.30, 95% CI ‐2.84 to 2.24; participants = 42; studies = 1). (<a href="./references#CD001088-fig-0095" title="">Analysis 7.6</a>). </p> </section> <section id="CD001088-sec-0258"> <h5 class="title">7.7 Substance use: 3. Clinically important change ‐ change in main substance use, abstinent or large decrease </h5> <p><a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a> reported data that showed no clear difference between CBT + MI and standard care groups for numbers of participants with a large decrease in main substance use or were abstinent (baseline to three months) (RR (Non‐event) 0.67, 95% CI 0.43 to 1.04; participants = 100; studies = 1). (<a href="./references#CD001088-fig-0096" title="">Analysis 7.7</a>). </p> </section> <section id="CD001088-sec-0259"> <h5 class="title">7.8 ‐ 7.9 Substance use: skewed data</h5> <p>Average scores of various substance use measures that reported skewed data are shown in 'Other data' tables (<a href="./references#CD001088-fig-0097" title="">Analysis 7.8</a>; <a href="./references#CD001088-fig-0098" title="">Analysis 7.9</a>). </p> </section> <section id="CD001088-sec-0260"> <h5 class="title">7.10 Mental state: 1. Average score (PANSS total, high = poor)</h5> <p>No clear differences were found between CBI + MI and standard care groups for average total PANSS scores by six months (<a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>; <a href="./references#CD001088-bbs2-0028" title="KempR , HarrisA , VurelE , SitharthanT . Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry2007;15(6):490‐3. [CSzG: 15549; MEDLINE: 17852064] ">Kemp 2007</a>) (n = 78, MD 0.99 CI ‐5.91 to 7.89), nine to 10 months (<a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>) (n = 92, MD ‐5.01 CI ‐11.25 to 1.22), 12 months (<a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>) (n = 274, MD 2.52 CI ‐0.68 to 5.72) and by 24 months (<a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>) (n = 247, MD 2.71 CI ‐0.58 to 6.00,). (<a href="./references#CD001088-fig-0099" title="">Analysis 7.10</a>). </p> </section> <section id="CD001088-sec-0261"> <h5 class="title">7.11 Mental state: 2. Average score (PANSS positive, high = poor)</h5> <p>No clear differences were found between CBI+MI and standard care groups for average PANSS positive subscale scores at 12 months (MD 0.03, 95% CI ‐1.18 to 1.24; participants = 274; studies = 1) or 24 months (MD 0.52, 95% CI ‐0.80 to 1.84; participants = 247; studies = 1). (<a href="./references#CD001088-fig-0100" title="">Analysis 7.11</a>). </p> </section> <section id="CD001088-sec-0262"> <h5 class="title">7.12 Mental state: 3. Average score (PANSS negative, high = poor)</h5> <p>No clear differences were found between CBI + MI and standard care groups for average PANSS negative subscale scores at 12 (MD 0.39, 95% CI ‐0.65 to 1.43; participants = 274; studies = 1) or 24 months (MD 0.16, 95% CI ‐0.84 to 1.16; participants = 247; studies = 1). (<a href="./references#CD001088-fig-0101" title="">Analysis 7.12</a>). </p> </section> <section id="CD001088-sec-0263"> <h5 class="title">7.13 Mental state: 4. Average score (various scales, high = poor) (skewed data)</h5> <p>Average scores for other measures of mental state that reported skewed data are presented in 'Other data' tables. (<a href="./references#CD001088-fig-0102" title="">Analysis 7.13</a>). </p> </section> <section id="CD001088-sec-0264"> <h5 class="title">7.14 Global state: 1. Average score (GAF, low = poor)</h5> <p>Average global assessment scores for functioning (GAF) were not clearly different by three months (<a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>; <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a>; <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a>) (MD ‐0.17, 95% CI ‐2.79 to 2.46; participants = 277; studies = 3), six months (MD 1.65, 95% CI ‐2.46 to 5.76; participants = 219; studies = 2), 12 months (<a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a>; <a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>; <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a>) (MD 1.24, 95% CI ‐1.86 to 4.34; participants = 445; studies = 4), 18 months (MD 4.57, 95% CI ‐3.07 to 12.21; participants = 72; studies = 2) or 24 months (MD ‐0.21, 95% CI ‐2.93 to 2.51; participants = 234; studies = 1). Lower scores indicate poorer functioning. Statistical heterogeneity was not present at any time period. (<a href="./references#CD001088-fig-0103" title="">Analysis 7.14</a>). </p> </section> <section id="CD001088-sec-0265"> <h5 class="title">7.15 Global state: 2. Forensic measures ‐ arrests reported ‐ by six months</h5> <p>The number of reported arrests (<a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>) were not clearly different between the CBT + MI and standard care group by six months (treatment 13%, control 27%; (RR 0.49, 95% CI 0.22 to 1.10; participants = 110; studies = 1). (<a href="./references#CD001088-fig-0104" title="">Analysis 7.15</a>). </p> </section> <section id="CD001088-sec-0266"> <h5 class="title">7.16 Social functioning: 1. Average score (SFS, low = poor)</h5> <p><a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a> reported on social functioning using average SFS scores. There was no clear difference between CBT+ MI and standard care group scores by nine months (end of treatment) (MD 5.01, 95% CI ‐0.55 to 10.57; participants = 32; studies = 1). However, by 12 months (three months following end of treatment) results favoured the CBT+ MI group (high scores = better) (MD 7.27, 95% CI 0.86 to 13.68; participants = 32; studies = 1). (<a href="./references#CD001088-fig-0105" title="">Analysis 7.16</a>). </p> </section> <section id="CD001088-sec-0267"> <h5 class="title">7.17 Quality of life/ life satisfaction: 1. Average score (BQOL, general life satisfaction, low = poor) ‐ by six months </h5> <p>Average general life satisfaction scores (BQOL) were higher for the CBT + MI group (<a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>) by six months (MD 0.58, 95% CI 0.00 to 1.16; participants = 110; studies = 1, P = 0.049), although confidence intervals crossed the line of no effect. Differences in baseline means (SD) did not account for this finding (treatment 4.25 (1.65) to 4.79 (1.66) at 6 months, and control 3.96 (1.58) to 4.21 (1.43) at 6 months). Lower scores indicate less life satisfaction. (<a href="./references#CD001088-fig-0106" title="">Analysis 7.17</a>). </p> </section> <section id="CD001088-sec-0268"> <h5 class="title">7.18 Quality of life/ life satisfaction: 2. Average score (BQOL, overall quality of life, low = poor) ‐ by six months </h5> <p>No clear differences between treatment groups were found in overall quality of life scores (BQOL) by six months (<a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a>) (MD ‐0.02, 95% CI ‐0.61 to 0.57; participants = 110; studies = 1). (<a href="./references#CD001088-fig-0107" title="">Analysis 7.18</a>). </p> </section> <section id="CD001088-sec-0269"> <h5 class="title">7.19 Quality of life/ life satisfaction: 3. Average score (WHOQOL, BREF, higher scores = better QoL) ‐ by six months </h5> <p>No clear differences between treatment groups were found in WHOQOL Bref scores by six months (<a href="./references#CD001088-bbs2-0028" title="KempR , HarrisA , VurelE , SitharthanT . Stop using stuff: trial of a drug and alcohol intervention for young people with comorbid mental illness and drug and alcohol problems. Australasian Psychiatry2007;15(6):490‐3. [CSzG: 15549; MEDLINE: 17852064] ">Kemp 2007</a>) (MD ‐15.70, 95% CI ‐36.19 to 4.79; participants = 16; studies = 1). (<a href="./references#CD001088-fig-0108" title="">Analysis 7.19</a>). </p> </section> <section id="CD001088-sec-0270"> <h5 class="title">7.20 Quality of life/ life satisfaction: 4. Average score (MANSA, higher scores = better QoL) </h5> <p>No clear differences between treatment groups were found in quality of life scores using the MANSA by six months (<a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>) (MD ‐2.70, 95% CI ‐7.01 to 1.61; participants = 64; studies = 1) or by 10 months (MD 0.90, 95% CI ‐3.73 to 5.53; participants = 61; studies = 1). (<a href="./references#CD001088-fig-0109" title="">Analysis 7.20</a>). </p> </section> <section id="CD001088-sec-0271"> <h5 class="title">7.21 Quality of life/ life satisfaction: 5. Average score (CSQ, client satisfaction, higher = good) </h5> <p>One study (<a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a>) reported client satisfaction using average CSQ score, there was a clear difference in scores, favouring the CBT + MI group by 10 months (MD 6.40, 95% CI 3.87 to 8.93; participants = 62; studies = 1, P &lt; 0.001). (<a href="./references#CD001088-fig-0110" title="">Analysis 7.21</a>). </p> </section> <section id="CD001088-sec-0272"> <h5 class="title">7.22 Service use: 1. Relapse (hospitalised)</h5> <p>We were only able to include limited data for relapse and found no major difference in the likelihood of relapse (measured by number of hospitalisations) between groups (<a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>) by end of nine‐month treatment phase (treatment 17% relapsed, control 28% relapsed; RR 0.58, 95% CI 0.29 to 1.16; participants = 107; studies = 2), or by 12 months (three months after treatment finished (<a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>) (treatment 33%, control 67%; (RR 0.50, 95% CI 0.24 to 1.04; participants = 36; studies = 1), or 18 months (nine months after treatment finished) (<a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a>; <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a>) (treatment 20%, control 33%; (RR 0.61, 95% CI 0.34 to 1.10; participants = 105; studies = 2). (<a href="./references#CD001088-fig-0111" title="">Analysis 7.22</a>). </p> </section> <section id="CD001088-sec-0273"> <h5 class="title">7.23 Economic outcomes: 1. Diret cost in US$ (BQOL, money subscale) (skewed data)</h5> <p>The average direct cost subscale of the BQOL at six months reported by <a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a> was skewed and is presented in 'Other data' tables (<a href="./references#CD001088-fig-0112" title="">Analysis 7.23</a>). </p> </section> </section> <section id="CD001088-sec-0274"> <h4 class="title">Comparison 8: Cognitive behavioural therapy + psychological rehabilitation versus standard care </h4> <section id="CD001088-sec-0275"> <h5 class="title">8.1 ‐ 8.3 Global state: Forensic measures</h5> <p>See also <a href="./full#CD001088-tbl-0008">summary of findings Table 8</a>. </p> <p>All outcome data regarding forensic measures were skewed data and are reported in 'Other data' tables (<a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>). There was no real indication that the number of arrests was less in the cognitive behavioural therapy + psychosocial rehabilitation group over all the time periods (<a href="./references#CD001088-fig-0113" title="">Analysis 8.1</a>), and this also applied to the number of convictions (<a href="./references#CD001088-fig-0114" title="">Analysis 8.2</a>). The number of days in jail for each group was also not really noticeably different (<a href="./references#CD001088-fig-0115" title="">Analysis 8.3</a>). It should be stressed that all data were skewed and not re‐analysed, and are merely reported again in this review. </p> </section> </section> <section id="CD001088-sec-0276"> <h4 class="title">Comparison 9: Combined cognitive behavioural therapy + intensive case management versus standard care </h4> <section id="CD001088-sec-0277"> <h5 class="title">9.1 ‐ 9.3 Global state: Forensic measures</h5> <p>See <a href="./full#CD001088-tbl-0009">summary of findings Table 9</a>. </p> <p>All outcome data regarding forensic measures were skewed data and are reported in 'Other data' tables (<a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>). There is some indication that the number of arrests was less in the cognitive behavioural therapy + intensive case management group over all the time periods (<a href="./references#CD001088-fig-0116" title="">Analysis 9.1</a>), and this also applied to the number of convictions (<a href="./references#CD001088-fig-0117" title="">Analysis 9.2</a>). However, the number of days in jail for each group was not noticeably different (<a href="./references#CD001088-fig-0118" title="">Analysis 9.3</a>). It should be stressed that all data were skewed and not re‐analysed, merely reported again in this review. </p> </section> </section> <section id="CD001088-sec-0278"> <h4 class="title">Comparison 10: Sensitivity analyses</h4> <p>All of the included studies were described as randomised and random sequence generation was judged as at low or unclear risk of bias for all included trials. Therefore, we did not undertake the anticipated sensitivity analysis. There were only two comparisons (<a href="./references#CD001088-fig-0103" title="">Analysis 7.14</a>; <a href="./references#CD001088-fig-0060" title="">Analysis 5.2</a>) where four or more studies were reported for a comparison and sensitivity analyses were undertaken for these. </p> <p><a href="./references#CD001088-fig-0120" title="">Analysis 10.2</a> grouped studies investigating motivational interviewing plus cognitive behavioural therapy according to risk of bias for allocation concealment and <a href="./references#CD001088-fig-0119" title="">Analysis 10.1</a> grouped studies investigating motivational interviewing according to diagnostic entry criteria (mixed diagnoses versus schizophrenia only trials) for the short to medium term (three to six months). Neither of these analyses altered the overall result. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD001088-sec-0279" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD001088-sec-0279"></div> <section id="CD001088-sec-0280"> <h3 class="title" id="CD001088-sec-0280">Summary of main results</h3> <section id="CD001088-sec-0281"> <h4 class="title">Comparison 1: Integrated models of care versus standard care</h4> <p>Please see <a href="./full#CD001088-tbl-0001">summary of findings Table for the main comparison</a>. Overall, there was low‐quality evidence of no difference between integrated models of care and standard care in terms of numbers lost to treatment or deaths by 36 months, although individually some studies (<a href="./references#CD001088-bbs2-0012" title="BurnamMA , MortonSC , McGlynnEA , PetersonLP , StecherBM , HayesC , et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases1995;14(4):111‐34. [CSzG: 8751] McGlynnEA , BoyntonJ , MortonSC , StecherBM , HayesC , VaccaroJV , et al. Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles. Alcohol Treatment Quarterly1993;10(3‐4):171‐86. [CSzG: 4118] ">Burnam 1995</a>; <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>) showed some effect for retaining participants in evaluation during the early stages of each study. At the end of each treatment period differences were no longer apparent. All four studies had sample sizes greater than 100 participants, drawn from homeless (<a href="./references#CD001088-bbs2-0012" title="BurnamMA , MortonSC , McGlynnEA , PetersonLP , StecherBM , HayesC , et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases1995;14(4):111‐34. [CSzG: 8751] McGlynnEA , BoyntonJ , MortonSC , StecherBM , HayesC , VaccaroJV , et al. Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles. Alcohol Treatment Quarterly1993;10(3‐4):171‐86. [CSzG: 4118] ">Burnam 1995</a>), forensic (<a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a>) and community populations (<a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>; <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a>). Modified scales were used by <a href="./references#CD001088-bbs2-0012" title="BurnamMA , MortonSC , McGlynnEA , PetersonLP , StecherBM , HayesC , et al. An experimental evaluation of residential and nonresidential treatment for dually diagnosed homeless adults. Journal of Addictive Diseases1995;14(4):111‐34. [CSzG: 8751] McGlynnEA , BoyntonJ , MortonSC , StecherBM , HayesC , VaccaroJV , et al. Treatment for the dually diagnosed homeless: program models and implementation experience: Los Angeles. Alcohol Treatment Quarterly1993;10(3‐4):171‐86. [CSzG: 4118] ">Burnam 1995</a>, precluding inclusion. </p> <p>There was low‐quality evidence of no difference in alcohol or substance use between integrated models of care and standard care in terms of, or not, of remission by 36 months. </p> <p>Moreover, there was low‐quality evidence of no difference between integrated models of care and standard care in terms of average general global functioning scores and moderate‐quality evidence of no difference for quality of life scores. </p> <p>Outcome measures of jail and hospital days, arrests and hours of medication service were all skewed in <a href="./references#CD001088-bbs2-0013" title='ChandlerD , SpicerG . Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders. Community Mental Health Journal2006;42(4):405‐25. [CSzG: 16816] DrakeRE , MorrisseyJP , MueserKT . The challenge of treating forensic dual diagnosis clients: comment on "Integrated treatment for jail recidivists with co‐occurring psychiatric and substance use disorders". Community Mental Health Journal2006;42(4):427‐32. [CSzG: 16818] '>Chandler 2006</a>. This resulted in attrition being the only clear outcome measure which could be analysed. We were able to include data from <a href="./references#CD001088-bbs2-0017" title="EssockSM , MueserKT , DrakeRE , CovellNH , McHugoGJ , FrismanLK , et al. Comparison of ACT and and standard case management for delivering integrated treatment for co‐occurring disorders. Psychiatric Services2006;57(2):185‐96. [CSzG: 12680] KanterJ . Clinical case management, case management and ACT. Psychiatric Services2006; Vol. 57, issue 4:578. ManuelJI . A longitudinal analysis of psychiatric medication adherence and provider continuity among individuals with co‐occurring disorders. Dissertation Abstracts International Section A: Humanities and Social Sciences2009;69(10A):4126. ManuelJI , CovellNH , JacksonCT , EssockSM . Does assertive community treatment increase medication adherence for people with co‐occurring psychotic and substance use disorders?. Journal of the American Psychiatric Nurses Association2011;17(1):51‐6. [CSzG: 22855] ">Essock 2006</a> and <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>. They provided both treatment and controls groups with a certain level of integrated care, the difference being that the assertive community treatment (ACT) teams provided most outpatient services themselves, while standard care (standard case management) brokered services to other clinicians. The null results found in this review suggest that providing services by the same team may not be crucial to successful integration of services, although readers are advised that the quality of evidence is low overall. </p> <p><a href="./references#CD001088-bbs2-0034" title="CalsynRJ , YonkerRD , LemmingMR , MorseGA , KlinkenbergWD . Impact of assertive community treatment and client characteristics on criminal justice outcomes in dual disorder homeless individuals. Criminal Behaviour and Mental Health2005;15(4):236‐48. [CSzG: 16813] FletcherTD , CunninghamJL , CalsynRJ , MorseGA , KlinkenbergWD . Evaluation of treatment programs for dual disorder individuals: modeling longitudinal and mediation effects. Administration and Policy in Mental Health2008;35(4):319‐36. [CSzG: 16624; MEDLINE: 18506618] MorseGA , CalsynRJ , KlinkenbergWD , CunninghamJ , LemmingMR . Integrated treatment for homeless clients with dual disorders: a quasi‐experimental evaluation. Journal of Dual Diagnosis2008;4(3):219‐37. [CSzG: 19618] MorseGA , CalsynRJ , KlinkenbergWD , HelminiakTW , WolffN , DrakeRE , et al. Treating homeless clients with severe mental illness and substance use disorders: costs and outcomes. Community Mental Health Journal2006;42(4):377‐404. [CSzG: 13863] ">Morse 2006</a> was a three‐arm study with about 50 people in each arm. Interesting data were presented for important outcomes but all were continuous and skewed. None gave the impression of a real difference occurring between the psychosocial interventions and the standard care. Again, considering the huge effort that must have gone into the integrated assertive community treatment and ACT, this might indicate how difficult this group of people are to treat, or how standard care has as good an effect as anything in terms of substance misuse and general housing outcomes. </p> </section> <section id="CD001088-sec-0282"> <h4 class="title">Comparison 2: Non‐integrated models of care ‐ assertive community treatment only (ACTO) or intensive case management or specialised case management services versus standard care </h4> <p>Please see <a href="./full#CD001088-tbl-0002">summary of findings Table 2</a>. There was very low‐quality evidence of no difference between assertive community treatment or intensive case management and standard care in terms of being lost to treatment by 12 months. Death was not measured in any of the trials. Alcohol or drug use as data were skewed or not reported. </p> <p>Moreover, there was very low‐quality evidence of no difference between treatment groups in terms of mental state, average general global functioning or general life satisfaction. </p> <p>The results showed no support for retaining participants at any time period. We were only able to include little data as attrition rates were high (<a href="./references#CD001088-bbs2-0009" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991a</a>), adapted scales were used, and the data were skewed or reporting was unclear (<a href="./references#CD001088-bbs2-0010" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991b</a>; <a href="./references#CD001088-bbs2-0029" title="LehmanAF , HerronJD , SchwartzRP , MyersCP . Rehabilitation for adults with severe mental illness and substance use disorders: a clinical trial. Journal of Nervous and Mental Disease1993;181(2):86‐90. [CSzG: 1646] ">Lehman 1993</a>; <a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a>). The role functioning (RFS) data provided by <a href="./references#CD001088-bbs2-0026" title="JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] ">Jerrell 1995b</a> by the end of the study (18 months) favoured the Twelve‐Step recovery control group, with a small but significant difference. The social adjustment scores were similar between groups. </p> <p>One small study (<a href="./references#CD001088-bbs2-0018" title="GodleySH , Hoewing‐RobersonR , GodleyMD . Final MISA Report. Bloomington, IN: Lighthouse Institute, 1994. [CSzG: 970] ">Godley 1994</a>) presents data by site and, clearly, practice by site does differ considerably. There is not really a clear pattern in the data suggesting an effect, and where there is some suggestion of a difference between groups the data are based on very few people. </p> </section> <section id="CD001088-sec-0283"> <h4 class="title">Comparison 3: Cognitive behavioural therapy (CBT) versus standard care</h4> <p>Please see <a href="./full#CD001088-tbl-0003">summary of findings Table 3</a>. There was low‐quality evidence of no difference between CBT and standard care in terms of numbers lost to treatment by three months. Death was not measured in any of the trials. Neither trial reported alcohol use separately, so this effect could not be estimated and evidence for substance use by six months was very low quality. </p> <p>There was low‐quality evidence of no difference between CBT and standard care for mental state (BPRS) at six months, and evidence was very low for global functioning at six months. No study reported life satisfaction. </p> <p>Support for retention in CBT was from the pooled results of <a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a> and <a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>. One study (<a href="./references#CD001088-bbs2-0016" title="EdwardsJ , ElkinsK , HintonM , HarriganSM , DonovanK , AthanasopoulosO , et al. Randomized controlled trial of a cannabis‐focused intervention for young people with first‐episode psychosis. Acta Psychiatrica Scandinavica2006;114(2):109‐17. [CSzG: 13211] ">Edwards 2006</a>) found a 30% increased likelihood of cannabis use by those in the treatment group after 10 weekly sessions of CBT. No other differences were observed on measures of substance use or mental state and functioning, but again much of the data were unusable. </p> </section> <section id="CD001088-sec-0284"> <h4 class="title">Comparison 4: Contingency management versus standard care</h4> <p>Please see <a href="./full#CD001088-tbl-0004">summary of findings Table 4</a>. There was moderate‐quality evidence between contingency management and standard care in terms of numbers lost to treatment by three months. Death was not measured in any of the trials. There was also no useable data available for alcohol use (data skewed) and no clear difference between treatment groups for substance use (stimulant‐positive urine tests) by six months. </p> <p>Moreover, there was low‐quality evidence of no difference between contingency management and standard care for mental state (number hospitalised) at six months. Neither trial reported on global assessment of functioning and general life satisfaction. </p> <p><a href="./references#CD001088-bbs2-0032" title="AngeloFN , McDonellMG , LewinMR , SrebnikD , LoweJ , RollJ , et al. Predictors of stimulant abuse treatment outcomes in severely mentally ill outpatients. Drug and Alcohol Dependence2013;131(1‐2):162‐5. McDonellMG , SrebnikD , AngeloF , McPhersonS , LoweJM , SugarA , et al. Randomized controlled trial of contingency management for stimulant use in community mental health patients with serious mental illness. American Journal of Psychiatry2013;170(1):94‐101. [CSzG: 24857] MurphySM , McDonellMG , McPhersonS , SrebnikD , AngeloF , RollJM , et al. An economic evaluation of a contingency‐management intervention for stimulant use among community mental health patients with serious mental illness. Drug and Alcohol Dependence2015;153:293‐9. [CSzG: 29903] NCT00809770 . Contingency management of psychostimulant abuse in the severely mentally ill. ClinicalTrials.gov2008. [CSzG: 17380] WeissRD . Contingency management for patients with serious mental illness and stimulant dependence. American Journal of Psychiatry2013;170(1):6‐8. ">McDonell 2013</a> reported fewer participants with a stimulant‐positive urine at the end of treatment (three months) for the contingency management arm compared to standard care. However, by six months (three months post‐treatment) this was no longer significant. Moreover, they also reported less injection use at the end of treatment (three months) for the active arm compared to standard care, and again this was no longer significant at six months. Over the six‐month trial, fewer participants in the contingency managed arm were hospitalised compared to standard care. <a href="./references#CD001088-bbs2-0038" title="NCT01478815 . Contingency management for persons with severe mental illness. http://ClinicalTrials.gov/show/NCT014788152011. [CSzG: 23332] PetryNM , AlessiSM , Rash CarlaJ . A randomized study of contingency management in cocaine‐dependent patients with severe and persistent mental health disorders. Drug and Alcohol Dependence2013;130:234‐7. [CSzG: 28275] ">Petry 2013</a> reported longer consecutive weeks of cocaine abstinence in 10 participants receiving contingency management compared to treatment as usual (TAU) (n = 9). However, less than half the expected samples were remitted and when missing samples were not included, no between‐group differences were apparent. <a href="./references#CD001088-bbs2-0033" title="LoweJM , McDonellMG , LeicklyE , AngeloFA , VilardagaR , McPhersonS , et al. Determining ethyl glucuronide cutoffs when detecting self‐reported alcohol use in addiction treatment patients. Alcoholism: Clinical and Experimental Research2015;39(5):905‐10. McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , HirchakK , OluwoyeO , et al. Pretreatment ethyl glucuronide levels predict response to a contingency management intervention for alcohol use disorders among adults with serious mental illness. American Journal on Addictions2017;26(7):673‐5. [CSzG: 36340] McDonellMG , LeicklyE , McPhersonS , SkaliskyJ , SrebnikD , AngeloF , et al. A randomized controlled trial of ethyl glucuronide‐ based contingency management for outpatients with co‐occurring alcohol use disorders and serious mental Illness. American Journal of Psychiatry2017;174(4):370‐7. [CSzG: 35589] McDonellMG , SkaliskyJ , LeicklyE , McPhersonS , BattalioS , NepomJR , et al. Using ethyl glucuronide in urine to detect light and heavy drinking in alcohol dependent outpatients. Drug and Alcohol Dependence2015;157:184‐7. NCT01567943 . Contingency management of alcohol abuse in the severely mentally ill. http://ClinicalTrials.gov/show/NCT015679432012. [CSzG: 23792] OluwoyeO , LeicklyE , SkaliskyJ , McPhersonS , HirchakK , SrebnikD , et al. Serious mental illness in heavy drinkers is associated with poor treatment outcomes in outpatients with co‐occurring disorders. International Journal of Mental Health Addiction2018;16(3):672‐9. [CSzG: 37902] SkaliskyJ , LeicklyE , OluwoyeO , McPhersonSM , SrebnikD , RollJM , et al. Prevalence and correlates of cannabis use in outpatients with serious mental illness receiving treatment for alcohol use disorders. Cannabis and Cannabinoid Research2017;2(1):133‐8. [CSzG: 36516] ">McDonell 2017</a> reported longer durations of continuous alcohol abstinence in the contingent intervention group at three months, however, these differences were not statistically different at the three‐month post‐treatment follow‐up. </p> </section> <section id="CD001088-sec-0285"> <h4 class="title">Comparison 5: Motivational interviewing (MI) versus standard care</h4> <p>Please see <a href="./full#CD001088-tbl-0005">summary of findings Table 5</a>. There was very low‐quality evidence of no difference between motivational interviewing and standard care in terms of numbers lost to treatment (six months), lost to evaluation (12 months) or deaths (18 months). There was very low‐quality evidence of not abstaining from alcohol (six months) or polydrug use (12 months). </p> <p>There was very low‐quality evidence of no difference between motivational interviewing and standard care in terms of mental state (Symptom Checklist 90 (SCL‐90), three months) and average global functioning at 12 months. None of the trials measured general life satisfaction. </p> <p>Some support was found for the effectiveness of motivational interviewing in reducing substance use, even though studies were generally small, interventions brief, and follow‐up times shorter than for other comparisons. <a href="./references#CD001088-bbs2-0020" title="GraeberDA , MoyersTB , GriffithG , GuajardoE , ToniganS . A pilot study comparing motivational interviewing and an educational intervention in patients with schizophrenia and alcohol use disorders. Community Mental Health Journal2003;39(3):189‐202. [CSzG: 9901] ">Graeber 2003</a> found that there was more likelihood that participants in the treatment group would abstain from alcohol after only three sessions of motivational interviewing; by three months and six months this increased. <a href="./references#CD001088-bbs2-0011" title="BonsackC . Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23471] BonsackC , ManettiSG , FavrodJ , MontagrinY , BessonJ , BovetP , et al. Motivational intervention to reduce cannabis use in young people with psychosis: A randomized controlled trial. Psychotherapy and Psychosomatics2011;80(5):287‐97. [CSzG: 23093] ">Bonsack 2011</a> reported that individual sessions of motivational interviewing for up to six months reduced the number of joints consumed at three and six months, but not at 12 months follow‐up. Similarly, participants in the treatment group of <a href="./references#CD001088-bbs2-0027" title="KavanaghDJ , YoungR , WhiteA , SaundersJB , WallisJ , ShockleyN , et al. A brief motivational intervention for substance misuse in recent‐onset psychosis. Drug and Alcohol Review2004;23(2):151‐5. [CSzG: 8309] ">Kavanagh 2004</a> showed they were more likely to be abstaining or had improved on all substances by 12 months after three hours of motivational interviewing over six to nine sessions. More participants in the treatment group of <a href="./references#CD001088-bbs2-0040" title="PantalonMV , SwansonAJ . Use of the University of Rhode Island Change Assessment to measure motivational readiness to change in psychiatric and dually diagnosed individuals. Psychology of Addictive Behaviors2003;17(2):91‐7. [CSzG: 9830] SwansonAJ , PantalonMV , CohenKR . Motivational interviewing and treatment adherence among psychiatric and dually diagnosed patients. Journal of Nervous and Mental Disease1999;187(10):630‐5. [CSzG: 9248] ">Swanson 1999</a> attended their first aftercare appointment after one 15‐minute and one one‐hour session. <a href="./references#CD001088-bbs2-0021" title="GrahamHL , BirchwoodM , GriffithE , FreemantleN , McCroneP , StefanidouCA , et al. A pilot study to assess the feasibility and impact of a brief motivational intervention on problem drug and alcohol use in adult mental health inpatient units: study protocol for a randomized controlled trial. Trials2014;15(1):308. [CSzG: 29050] GrahamHL , CopelloA , GriffithE , FreemantleN , McCroneP , ClarkeL , et al. Pilot randomised trial of a brief intervention for comorbid substance misuse in psychiatric in‐patient settings. Acta Psychiatrica Scandinavica2016;133(4):298‐309. [CSzG: 33324] ISRCTN43548483 . A pilot study to assess the feasibility and impact of a motivational intervention (MI) on problem drug and alcohol use in adult mental health inpatient units. http://isrctn.org/ISRCTN435484832014. [CSzG: 28909] ">Graham 2016</a> reported marginal improvements in engagement in treatment at three months after a brief (two‐week) inpatient intervention. <a href="./references#CD001088-bbs2-0006" title="BechdolfA , PohlmannB , GuttgemannsJ , GeyerC , LindnerK , FerberC , et al. State‐dependent motivational interviewing for people with schizophrenia and substance use : Results of a randomised controlled trial [Motivationsbehandlung für patienten mit der doppeldiagnose psychose und sucht]. Nervenarzt2011;83(7):888‐96. [MEDLINE: 21720841] ">Bechdolf 2011</a> also reported higher chances of attending outpatients over a period of six months. In contrast, <a href="./references#CD001088-bbs2-0001" title="BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Evaluation of a motivational interview for substance use within psychiatric inpatient services. Addiction2002;97(10):1329‐38. [CSzG: 8308] BakerA , LewinT , ReichlerH , ClancyR , CarrV , GarrettR , et al. Motivational interviewing among psychiatric inpatients with substance use disorders. Acta Psychiatrica Scandinavica2002;106(3):233‐40. [CSzG: 16812] ">Baker 2002</a> reported little differences between groups after one 45‐minute session, which was more apparent at 12 months than at three months when the treatment showed some benefit. <a href="./references#CD001088-bbs2-0023" title="HickmanME . The effects of personal feedback on alcohol intake in dually diagnosed clients: an empirical study of William R. Miller's motivational enhancement therapy. Unpublished thesis. University Graduate School, Dept. Counseling Psychology, Indiana University1997. [CSzG: 4153] ">Hickman 1997</a> showed little difference in mental state scores after one brief session. The results indicate that multiple sessions of motivational interviewing may lead to short‐term reductions in substance use and increased attendance at outpatient appointments. </p> </section> <section id="CD001088-sec-0286"> <h4 class="title">Comparison 6: Skills training versus standard care</h4> <p>Please see <a href="./full#CD001088-tbl-0006">summary of findings Table 6</a>. There was very low‐quality evidence of no difference between skills training and standard care in terms of numbers lost to treatment by 12 months and low‐quality evidence of no difference for death. There were no useable data for substance use by 12 months as the data were skewed. No clear differences were reported in days abstinent from alcohol. </p> <p>Moreover, there was very low‐quality evidence of no difference between skills training and standard care for relapse (in mental state symptoms) at eight months and no differences for global state at 12 months. No trial reported on general life satisfaction. </p> <p>Pooled results from <a href="./references#CD001088-bbs2-0008" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12‐step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403‐11. [CSzG: 29165; NCT00583440] ">Bogenschutz 2014</a> and <a href="./references#CD001088-bbs2-0039" title="RosenblumA , MatusowH , FongC , VogelH , UttaroT , MooreTL , et al. Efficacy of dual focus mutual aid for persons with mental illness and substance misuse. Drug and Alcohol Dependence2014;135:78‐87. [CSzG: 27823] ">Rosenblum 2014</a> reported no differences in lost to treatment at three months. Pooled results of <a href="./references#CD001088-bbs2-0022" title="HellersteinDJ , RosenthalRN , MinerCR . A prospective study of integrated outpatient treatment for substance‐abusing schizophrenic patients. American Journal on Addictions1995;4(1):33‐42. [CSzG: 5029] HellersteinDJ , RosenthalRN , MinerCR . Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly2001;72(4):291‐306. [CSzG: 8206] ">Hellerstein 1995</a> and <a href="./references#CD001088-bbs2-0025" title="JerrellJM . Cost‐effective treatment for persons with dual disorders. New Directions for Mental Health Services1996;70(Summer):79‐91. [CSzG: 16821] JerrellJM , HuTW , RidgelyMS . Cost‐effectiveness of substance disorder interventions for people with severe mental illness. Journal of Mental Health Administration1994;21(3):283‐97. [CSzG: 1166] JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] JerrellJM , RidgelyMS . Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services1999;50(1):109‐12. [CSzG: 16917] ">Jerrell 1995a</a> showed that control group participants were more likely to be lost from the study at six to nine months. However, by 18 months <a href="./references#CD001088-bbs2-0025" title="JerrellJM . Cost‐effective treatment for persons with dual disorders. New Directions for Mental Health Services1996;70(Summer):79‐91. [CSzG: 16821] JerrellJM , HuTW , RidgelyMS . Cost‐effectiveness of substance disorder interventions for people with severe mental illness. Journal of Mental Health Administration1994;21(3):283‐97. [CSzG: 1166] JerrellJM , RidgelyMS . Comparative effectiveness of three approaches to serving people with severe mental illness and substance abuse disorders. Journal of Nervous and Mental Disease1995;183(9):566‐76. [CSzG: 3727] JerrellJM , RidgelyMS . Impact of robustness of program implementation on outcomes of clients in dual diagnosis programs. Psychiatric Services1999;50(1):109‐12. [CSzG: 16917] ">Jerrell 1995a</a> and <a href="./references#CD001088-bbs2-0015" title="EackSM , HogartySS , BangaloreSS , KeshavanMS , CorneliusJR . Patterns of substance use during Cognitive Enhancement Therapy: an 18‐month randomized feasibility study. Journal of Dual Diagnosis2016;12:74‐82. [CSzG: 33634] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18‐month feasibility trial. Schizophrenia Research2015;161(2‐3):478‐83. [CSzG: 29308] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18‐month feasibility trial. Schizophrenia Bulletin2015;41:S310. [CSzG: 29436] WojtalikJA , EackSM . Fronto‐limbic neuroplasticity effects of Cognitive Enhancement Therapy during emotion regulation in schizophrenia patients who abuse cannabis. Schizophrenia Bulletin2015;41:S243. [CSzG: 29719] WojtalikJA , HogartySS , CorneliusJR , PhillipsML , KeshavanMS , NewhillCE , et al. Cognitive Enhancement Therapy improves frontolimbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study. Frontiers in Psychiatry2016;6:186. [CSzG: 33452] ">Eack 2015</a> reported that participants in their treatment programme were more likely to be lost. <a href="./references#CD001088-bbs2-0022" title="HellersteinDJ , RosenthalRN , MinerCR . A prospective study of integrated outpatient treatment for substance‐abusing schizophrenic patients. American Journal on Addictions1995;4(1):33‐42. [CSzG: 5029] HellersteinDJ , RosenthalRN , MinerCR . Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly2001;72(4):291‐306. [CSzG: 8206] ">Hellerstein 1995</a> offered their treatment group a same site co‐ordinated treatment approach and their control group were offered the same treatment, which was not case co‐ordinated. In the largest study to date, <a href="./references#CD001088-bbs2-0039" title="RosenblumA , MatusowH , FongC , VogelH , UttaroT , MooreTL , et al. Efficacy of dual focus mutual aid for persons with mental illness and substance misuse. Drug and Alcohol Dependence2014;135:78‐87. [CSzG: 27823] ">Rosenblum 2014</a> found those in the double‐trouble in recovery group self‐reported fewer days using alcohol or drugs over 30 days compared to waiting list controls. However, the data were skewed and effects were not apparent at both study sites. <a href="./references#CD001088-bbs2-0015" title="EackSM , HogartySS , BangaloreSS , KeshavanMS , CorneliusJR . Patterns of substance use during Cognitive Enhancement Therapy: an 18‐month randomized feasibility study. Journal of Dual Diagnosis2016;12:74‐82. [CSzG: 33634] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: Results of an 18‐month feasibility trial. Schizophrenia Research2015;161(2‐3):478‐83. [CSzG: 29308] EackSM , HogartySS , GreenwaldDP , LitschgeMY , McKnightSA , BangaloreSS , et al. Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18‐month feasibility trial. Schizophrenia Bulletin2015;41:S310. [CSzG: 29436] WojtalikJA , EackSM . Fronto‐limbic neuroplasticity effects of Cognitive Enhancement Therapy during emotion regulation in schizophrenia patients who abuse cannabis. Schizophrenia Bulletin2015;41:S243. [CSzG: 29719] WojtalikJA , HogartySS , CorneliusJR , PhillipsML , KeshavanMS , NewhillCE , et al. Cognitive Enhancement Therapy improves frontolimbic regulation of emotion in alcohol and/or cannabis misusing schizophrenia: a preliminary study. Frontiers in Psychiatry2016;6:186. [CSzG: 33452] ">Eack 2015</a> also reported reductions in alcohol use in the last 30 days (but not cannabis use) during cognitive enhancement therapy in a small pilot study. In contrast, <a href="./references#CD001088-bbs2-0008" title="BogenschutzMP , RiceSL , ToniganJS , VogelHS , NowinskiJ , HumeD , et al. 12‐step facilitation for the dually diagnosed: a randomized clinical trial. Journal of Substance Abuse Treatment2014;46(4):403‐11. [CSzG: 29165; NCT00583440] ">Bogenschutz 2014</a> reported no differences in abstinence from alcohol or drugs in individuals following a 12 weeks of a 12‐step facilitation therapy. </p> </section> <section id="CD001088-sec-0287"> <h4 class="title">Comparison 7: Cognitive behavioural therapy + motivational interviewing (CBT + MI) versus standard care </h4> <p>Please see <a href="./full#CD001088-tbl-0007">summary of findings Table 7</a>. There was low‐quality evidence of no difference between cognitive behavioural therapy + motivational interviewing and standard care in terms of numbers lost to treatment or deaths by 12 months. All the data for alcohol use were skewed and evidence of no differences for drug use by six months was low quality. </p> <p>There was very low‐quality evidence of no difference between cognitive behavioural therapy + motivational interviewing and standard care in terms of mental state (relapse) and average global state (GAF scores) at 12 months. Moreover, there was low‐quality evidence for no difference in quality of life scores at six months between treatment arms. </p> <p>We found some support for the effectiveness of cognitive behavioural therapy + motivational interviewing over standard care, yet, findings were inconsistent and, again, much data were unable to be used from all seven eligible studies. The <a href="./references#CD001088-bbs2-0003" title="BarrowcloughC , HaddockG , TarrierN , LewisSW , MoringJ , O'BrienR , et al. Randomized controlled trial of motivational interviewing, cognitive behavior therapy and family intervention for patients with comorbid schizophrenia and substance use disorders. American Journal of Psychiatry2001;158(10):1706‐13. [CSzG: 7863] HaddockG . Dual diagnosis project: evaluation of family support and cognitive behaviour therapy for recent onset schizophrenia sufferers with substance misuse problems. National Research Register2001; Vol. 1. [CSzG: 5489; N0244032344] HaddockG , BarrowcloughC , TarrierN , MoringJ , O'BrienR , SchofieldN , et al. Cognitive‐behavioural therapy and motivational intervention for schizophrenia and substance misuse: 18‐month outcomes of a randomised controlled trial. British Journal of Psychiatry2003;183(November):418‐26. [CSzG: 11201] ">Barrowclough 2001</a> was a small study but showed an increased likelihood of relapse in the control group up until 18 months. Global functioning was slightly lower in the control group by nine months, although this difference was not sustained at later time periods (up to 18 months). <a href="./references#CD001088-bbs2-0019" title="Gouzoulis‐MayfrankE , KonigS , KoebkeS , SchnessT , Schmitz‐BuhlM , DaumannJ . Trans‐sector integrated treatment in psychosis and addiction. Deutsches Arzteblatt International2015;112(41):683‐91. [CSzG: 33168] U1111‐1119‐5851 . Evaluation of an integrative therapy approach for the comorbidity of psychosis and addiction. http://www.drks.de/DRKS000006712011. [CSzG: 22748] ">Gouzoulis‐Mayfrank 2015</a> reported transient large decreases in substance use at three months in treated participants compared to standard care, but the sample size was small and attrition was high (&gt; 50% by 12 months). <a href="./references#CD001088-bbs2-0007" title="BellackAS , BennettME , GearonJS , BrownCH , YangY . A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental iIlness. Archives of General Psychiatry2006;63(4):426‐32. [CSzG: 12628] BennettM , BellackA , DixonL , BrownC . The effects of a group based behavioral approach to substance misuse and schizophrenia. Schizophrenia Bulletin2011;1:296. [CSzG: 22833] BrownCH , BennettME , LiL , BellackAS . Predictors of initiation and engagement in substance abuse treatment among individuals with co‐occurring serious mental illness and substance use disorders. Addictive Behaviors2011;36(5):439‐47. [CSzG: 22844] NCT00295139 . Behavioral treatment of drug abuse in SPMI patients. http://www.clinicaltrials.gov2006. [CSzG: 14598] ">Bellack 2006</a> showed slightly decreased general life satisfaction scores and a 51% increased likelihood of being arrested in their reasonably sized control group by six months. By contrast, <a href="./references#CD001088-bbs2-0002" title="BakerA , BucciS , Kay‐LambkinF . Intervention for alcohol, cannabis and amphetamine use among people with a psychotic illness. NDARC Technical Report No. 193. Sydney: National Drug and Alcohol Research Centre, 2004:1‐100. [CSzG: 16861; ISBN:1 887027 84 7] BakerA , BucciS , LewinTJ , Kay‐LambkinF , ConstablePM , CarrVJ . Cognitive‐behavioural therapy for substance use disorders in people with psychotic disorders ‐ Randomised controlled trial. British Journal of Psychiatry2006;188(5):439‐48. [CSzG: 13856] BakerA , BucciS , LewinTJ , RichmondR , CarrVJ . Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies. Psychiatry Research2005;134(3):241‐50. [CSzG: 16810] ">Baker 2006</a> showed that participants were more likely to leave the treatment group by three months. The treatment group also seemed to have a slightly higher mean number of drugs used by three months; this difference was not apparent by six months, and <a href="./references#CD001088-bbs2-0030" title="MadiganK , BrennanD , LawlorE , TurnerN , KinsellaA , O'ConnorJJ , et al. A multi‐center, randomized controlled trial of a group psychological intervention for psychosis with comorbid cannabis dependence over the early course of illness. Schizophrenia Research2013;143(1):138‐42. [CSzG: 25073] ">Madigan 2013</a> showed no difference in cannabis use at three or six months. Moreover, the phase‐specific study by <a href="./references#CD001088-bbs2-0005" title="BarrowcloughC , LobbanlF , WarburtonJ , ChoudhryI , GreggL , WoodH , et al. Helper recap: Rethinking choices after psychosis ‐ a phase specific psychological therapy for people with problematic cannabis use following a first episode of psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:161. [CSzG: 23469] BarrowcloughC , MarshallM , GreggL , FitzsimmonsM , TomensonB , WarburtonJ , et al. A phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis: a randomized controlled trial. Psychological Medicine2014;44(13):2749‐61. [CSzG: 29048] BerryK , GreggL , LobbanF , BarrowcloughC . Therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Comprehensive Psychiatry2016;67:73‐80. [CSzG: 33604] BerryK , PalmerT , GreggL , BarrowcloughC , LobbanF . Attachment and therapeutic alliance in psychological therapy for people with recent onset psychosis who use cannabis. Clinical Psychology &amp; Psychotherapy2018;25(3):440‐5. [CSzG: 37966] WorrellL . Helper programme (substance misuse)‐ a phase‐specific psychological therapy for people with problematic cannabis use following a first episode of psychosis (recap). http://public.ukcrn.org.uk2011. [CSzG: 23027] ">Barrowclough 2014</a> found no evidence that brief or long‐term cognitive behavioural therapy + motivational interviewing therapy conferred benefit over standard care in reducing frequency or amount of cannabis use at nine months or 18 months following a first episode of psychosis. The largest study to date (<a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>) reported no differences between interventions and death or hospitalised versus not admitted to hospital and alive by 24 months. Nor did this study report any differences in substance use, mental state (Positive and Negative Syndrome Scale (PANSS)), or other outcomes. <a href="./references#CD001088-bbs2-0024" title="FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:159. [CSzG: 23478] FohlmannAH , HjorthoejC , LarsenA , NordentoftM . CapOpus. randomized clinical trial: Specialized addiction treatment (MI &amp; CBT) versus treatment as usual for young patients with cannabis abuse and psychosis. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23478] HjorthajCR . Validity of self‐reported cannabis use as measured by the timeline follow‐back instrument in a trial randomizing people with comorbid cannabis use disorder and schizophrenia spectrum disorder. Early Intervention in Psychiatry2010;4 Suppl 1:160. [CSzG: 23483] HjorthojC , FohlmannA , LarsenAM , MadsenMT , VesteragerL , GluudC , et al. Design paper: the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Trials2008;9:42. [CSzG: 16594] HjorthojCR , FohlmannA , LarsenA‐M , MadsenMTR , VesteragerL , GluudC , et al. Interim analysis of the CapOpus trial: a randomized, parallel‐group, observer‐blinded clinical trial of specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. Schizophrenia Research2010;117(2‐3):190. [CSzG: 20563] HjorthojCR , FohlmannA , LarsenAM , ArendtM , NordentoftM . Correlations and agreement between delta‐9‐tetrahydrocannabinol (THC) in blood plasma and timeline follow‐back (TLFB)‐assisted self‐reported use of cannabis of patients with cannabis use disorder and psychotic illness attending the CapOpus randomized clinical trial. Addiction2011;107(6):1123‐31. [CSzG: 23547; MEDLINE: 22151583] HjorthojCR , OrlovskaS , FohlmannA , NordentoftM . Psychiatric treatment following participation in the CapOpus randomized trial for patients with comorbid cannabis use disorder and psychosis. Schizophrenia Research2013;151(1‐3):191‐6. [CSzG: 28381] HjorthojCR , VesteragerL , NordentoftM . Test‐retest reliability of the Danish adult reading test in patients with comorbid psychosis and cannabis‐use disorder. Nordic Journal of Psychiatry2013;67(3):159‐63. [CSzG: 28766; MEDLINE: 22624828] HjorthøjCR , FohlmannA , LarsenAM , GluudC , ArendtM , NordentoftM . Specialized psychosocial treatment plus treatment as usual (TAU) versus TAU for patients with cannabis use disorder and psychosis: the CapOpus randomized trial. Psychological Medicine2013;43(7):1499‐510. [CSzG: 28754; PUBMED: 23040144] NCT00484302 . Cannabis and psychosis randomized clinical trial: specialized addiction treatment versus treatment as usual for young patients with cannabis abuse and psychosis. http://www.clinicaltrials.gov2007. [CSzG: 15056] NordentoftM , HjorthojC , FohlmannA . Capopus trial: An observer‐blinded RCT of specialized addiction treatment versus standard treatment for young patients with cannabis. Proceedings of the 17th European Psychiatric Association, EPA Congress; 2009 Jan 24‐28; Lisbon Portugal2009;24:S1178. [CSzG: 20894] ToftdahlNG , NordentoftM , HjorthojC . The effect of changes in cannabis exposure on psychotic symptoms in patients with comorbid cannabis use disorder. Journal of Dual Diagnosis2016;12(2):129‐36. [CSzG: 33821] ">Hjorthoj 2013</a> reported higher satisfaction scores by 10 months, but no differences were reported in quality of life scores or other outcomes. </p> <p>Further research is required to determine whether long‐term cognitive behavioural therapy combined with motivational interviewing is useful and cost‐effective. </p> </section> <section id="CD001088-sec-0288"> <h4 class="title">Comparison 8: Cognitive behavioural therapy + psychological rehabilitation versus standard care </h4> <p>Please see <a href="./full#CD001088-tbl-0008">summary of findings Table 8</a>. All of the outcomes for this comparison were very‐low quality or the outcome was not measured. It is problematic to interpret the skewed data and all data were from one study (<a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a>) allocating less than 100 people to this comparison. It is feasible that a subtle difference between treatment groups could not be highlighted because of the limited power of the trial but, from what data we have, there is no indication that the number of arrests is less in the cognitive behavioural therapy plus psychosocial rehabilitation group over all the time periods. This also applies to the number of convictions and the number of days in jail. </p> </section> <section id="CD001088-sec-0289"> <h4 class="title">Comparison 9: Cognitive behavioural therapy + intensive case management versus standard care </h4> <p>Please see <a href="./full#CD001088-tbl-0009">summary of findings Table 9</a>. All of the outcomes for this comparison were very‐low quality or the outcome was not measured. Again <a href="./references#CD001088-bbs2-0031" title="MaloneyMP . Reducing criminal recidivism in jail‐incarcerated mothers with co‐occurring disorders. Manuscript kindly provided by Dr Maloney ‐ no further details given. ">Maloney 2006</a> reports useful outcomes relating to functioning in society but again the data are skewed and difficult to interpret. Unlike the preceding comparison, however, there is a suggestion that there may be some positive effect for people allocated to the cognitive behavioural therapy + intensive case management group. The number of arrests is less in the cognitive behavioural therapy + intensive case management group over all time periods, and this also applies to the number of convictions at 12 and 30 months. However, the number of days in jail for each group is not noticeably different. This may give some hope that the very intensive approach does have some benefit in terms of these important outcomes but, again, these findings from such a small study should be replicated before making any change in policy. Economic analyses would also be of interest for this package of care that is likely to be expensive. </p> </section> <section id="CD001088-sec-0290"> <h4 class="title">Sensitivity analysis</h4> <p>Sensitivity analyses were conducted to ascertain if there were substantial differences in the results when lesser quality trials were excluded. There were relatively few trials to conduct the sensitivity analysis due to the small numbers of trials in each intervention and the large number of outcome measures at variable time points. There was no indication that trials of lesser quality or those recruiting patients with severe mental illness other than schizophrenia influenced the overall outcomes in this review. </p> </section> </section> <section id="CD001088-sec-0291"> <h3 class="title" id="CD001088-sec-0291">Overall completeness and applicability of evidence</h3> <p>Many of the included studies were described as pilot studies which included small samples sizes. Eighteen trials involved more than 100 participants and three of these involved more than 200 participants after randomisation (<a href="./references#CD001088-bbs2-0004" title="BarrowcloughC . A pilot study to assess the impact of motivational intervention on schizophrenia patients with associated substance misuse. National Research Register2004; Vol. 3:1‐4. [CSzG: 12949] BarrowcloughC . A randomized controlled trial of integrated motivational interviewing and cognitive behavior therapy (mi‐cbt) for people with a schizophrenia diagnosis and substance misuse ‐ the MIDAS trial. Schizophrenia Bulletin2011;37 Suppl 1:295. [CSzG: 22830] BarrowcloughC . An evaluation of motivational (MI) plus cognitive therapy (CBT) for schizophrenia and substance misuse. http://www.controlled‐trials.com2003. [CSzG: 14484] BarrowcloughC . An evaluation of motivational interventions (MI) plus cognitive behaviour therapy (CBT) for schizophrenia and substance misuse ‐ MIDAS. National Research Register2004; Vol. 1. [CSzG: 12947] BarrowcloughC , EisnerE , BucciS , EmsleyR , WykesT . The impact of alcohol on clinical outcomes in established psychosis: a longitudinal study. Addiction2014;109(8):1297‐305. BarrowcloughC , EmsleyR , EisnerE , BeardmoreR , WykesT . Does change in cannabis use in established psychosis affect clinical outcome?. Schizophrenia Bulletin2013;39(2):339‐48. BarrowcloughC , HaddockG , BeardmoreR , ConrodP , CraigT , DaviesL , et al. Evaluating integrated MI and CBT for people with psychosis and substance misuse: recruitment, retention and sample characteristics of the MIDAS trial. Addictive Behaviors2009;34(10):859‐66. [CSzG: 18777] BarrowcloughC , HaddockG , FitzsimmonsM , JohnsonR . Treatment development for psychosis and co‐occurring substance misuse: a descriptive review. Journal of Mental Health2006;15(6):619‐32. [CSzG: 16834] BarrowcloughC , HaddockG , WykesT , BeardmoreR , ConrodP , CraigT , et al. Integrated motivational interviewing and cognitive behavioural therapy for people with psychosis and comorbid substance misuse: randomised controlled trial. BMJ2010;341(7784):6325. [CSzG: 21934; MEDLINE: 21106618] BarrowcloughC , MeierP , BeardmoreR , EmsleyR . Predicting therapeutic alliance in clients with psychosis and substance misuse. Journal of Nervous and Mental Disease2010;198(5):373‐7. [CSzG: 20696] BerryK , GreggL , HartwellR , HaddockG , FitzsimmonsM , BarrowcloughC . Therapist‐client relationships in a psychological therapy trial for psychosis and substance misuse. Drug and Alcohol Dependence2015;152:170‐6. [CSzG: 29829] HaddockG , BeardmoreR , EarnshawP , FitzsimmonsM , NothardS , ButlerR , et al. Assessing fidelity to integrated motivational interviewing and CBT therapy for psychosis and substance use: the MI‐CBT fidelity scale (MI‐CTS). Journal of Mental Health 2012;21(1):38‐482012;21(1):38‐48. HartleyS , HaddockG , BarrowcloughC . Anxiety and depression and their links with delusions and hallucinations in people with a dual diagnosis of psychosis and substance misuse: A study using data from a randomised controlled trial. Behaviour Research and Therapy2012;50(1):65‐71. [CSzG: 23617] JohnsonR . MIDAS ‐ mental health clinical trials ‐ information for service users and carers. http://www.controlled‐trials.com/2005. [CSzG: 12916] ShabaruddinFH , DaviesLM . Cost of delivering psychiatric inpatient care to mental health patients with psychosis and co‐occuring substance use: A UK based study. Value in Health2011;14:A291. [CSzG: 23430] ">Barrowclough 2010</a>; <a href="./references#CD001088-bbs2-0014" title="ClarkRE , TeagueGB , RickettsSK , BushPW , XieH , McGuireTG , et al. Cost‐effectiveness of assertive community treatment versus standard case management for persons with co‐occurring severe mental illness and substance use disorders. Health Services Research1998;33(5):1285‐8. [CSzG: 5636] ClarkeRE . Family support and substance use outcomes for persons with mental illness and substance use. Schizophrenia Bulletin2001;27(1):93‐101. [CSzG: 5884] DrakeRE . Ten year follow up of dual diagnosis treatment. CRISP database accessed 10/05/022002. DrakeRE , McHugoGJ , ClarkRE , TeagueGB , XieH , MilesK . Assertive community treatment for patients with co‐occurring severe mental illness and substance use disorder: a clinical trial. American Journal of Orthopsychiatry1998;68(2):201‐15. [CSzG: 4974] McHugoGJ , DrakeRE , TeagueGB , XieH . Fidelity to assertive community treatment and client outcomes in the New Hampshire dual disorders study. Psychiatric Services1999;50(6):818‐24. [CSzG: 5155] XieH , DrakeR , McHugoG . Are there distinctive trajectory groups in substance abuse remission over 10 years? An application of the group‐based modeling approach. Administration and Policy in Mental health and Mental Health Services2006;33(4):423‐32. [CSzG: 17219] XieH , McHugoGJ , FoxMB , DrakeRE . Substance abuse relapse in a ten‐year prospective follow‐up of clients with mental health and substance use disorders. Psychiatric Services2005;56(10):1282‐7. [CSzG: 16831] ">Drake 1998a</a>; <a href="./references#CD001088-bbs2-0039" title="RosenblumA , MatusowH , FongC , VogelH , UttaroT , MooreTL , et al. Efficacy of dual focus mutual aid for persons with mental illness and substance misuse. Drug and Alcohol Dependence2014;135:78‐87. [CSzG: 27823] ">Rosenblum 2014</a>). However, the overall power for a particular common outcome and comparison was low due to the variety of interventions and outcomes measured. </p> <p>Examination of the summary of findings indicates that several critical or important outcomes were not measured by any of the studies, and therefore no power exists. Future research could examine these comparisons in order to bring to light any potential benefits in the management of patients with a dual diagnosis. </p> <p>The majority of studies presented medium‐term data; with six months to one year follow‐up. This is a reasonable length of time to assess differences in the intervention effects. Longer‐term studies (one to three years) employed integrated and assertive community care interventions. These types of studies are important to engage patients in treatment programmes that help recovery from serious mental illness. </p> <p>All study participants had a diagnosis of severe mental illness and substance misuse. Participants were from a wide range of settings, so the results of this review will be applicable to similar patients, particularly those in the USA (25 trials). Some generalisation can be assumed for the UK (five trials) and Australia (six trials) for cognitive behavioural therapy and motivational interviewing as the studies from these areas examined these interventions. Integrated, non‐integrated, and skills‐training intervention findings may apply elsewhere only if the intervention is delivered in a similar manner. However, as there are differences between the USA (<a href="./references#CD001088-bbs2-0161" title="BondGR , DrakeRE . New directions for psychiatric rehabilitation in the USA. Epidemiology &amp; Psychiatric Science2017;26(3):223‐7. ">Bond 2017</a>) and other countries' services, including education and training of health service staff, generalisation to other areas must be interpreted with caution (<a href="./references#CD001088-bbs2-0187" title="DonaldM , DownerJ , KavanaghD . Integrated versus non‐integrated management and care for clients with co‐occurring mental health and substance use disorders: a qualitative systematic review of randomised controlled trials. Social Science and Medicine2005;60(6):1371‐83. ">Donald 2005</a>; <a href="./references#CD001088-bbs2-0244" title="LoweAL , Abou‐SalehMT . The British experience of dual diagnosis in the national health service. Acta Neuropsychiatrica2004;16(1):41‐6. ">Lowe 2004</a>; <a href="./references#CD001088-bbs2-0295" title="TyrerP , WeaverT . Desperately seeking solutions: the search for appropriate treatment for comorbid substance misuse and psychosis. Psychiatric Bulletin2004;28(1):1‐2. ">Tyrer 2004</a>). This is also true for resource‐constrained settings. We did not identify any trials from low‐ or middle‐income countries. </p> </section> <section id="CD001088-sec-0292"> <h3 class="title" id="CD001088-sec-0292">Quality of the evidence</h3> <p>Primary outcome measures selected for this review were: remaining in treatment, substance use, and mental state. Pooled results demonstrated no consistent evidence to support any one treatment intervention over standard care. Some support for motivational interviewing was found from individual studies for substance use reduction. When motivational interviewing was offered in conjunction with cognitive behavioural therapy there was little support for improved mental state. These findings suggest that motivational interviewing is a crucial component to the effectiveness of treatment with cognitive behavioural therapy. However, it was challenging to identify the key aspects of each intervention given that these are mostly complex, multi‐faceted interventions. Little attention was paid to reporting the fidelity of the delivery of each intervention so quality was difficult to gauge. </p> <section id="CD001088-sec-0293"> <h4 class="title">Missing outcomes or too few data</h4> <p>Out of the primary outcome measures, studies only reported numbers lost to treatment clearly enough to allow pooling of results in each of the comparisons. Often the other primary outcome measures (substance use, mental state) were reported as continuous rather than binary data and much of these data were problematic. With this particular population, skewed data may be unavoidable and, as such, is problematic to present and manage in a meta‐analysis. However, opportunities were missed to report simple and useful binary outcomes. </p> </section> </section> <section id="CD001088-sec-0294"> <h3 class="title" id="CD001088-sec-0294">Potential biases in the review process</h3> <p>It is possible that we failed to identify small negative trials, and we would be most interested if readers know of these. We endeavoured to reduce this potential bias by conducting a wide search, duplicate extraction, multiple checking, and handsearching key references and journals. We also contacted many of the authors of these trials over the years, and for this review we asked if they knew of any recently completed or ongoing trials. The introduction of web sites and journals to register trials hopefully will reduce the 'file drawer' phenomenon, as negative trials are less likely to be published. </p> <p>A limitation of this review is that there was substantial variation between studies as to what constituted standard care, in addition to some differences between the interventions themselves. For example, fidelity, duration, and intensity of treatment conditions varied, furthermore the outcome reporting periods also differed. This resulted in difficulties in grouping and interpreting data. There was a high volume of problematic data due to skew, use of non‐validated scales, or unclear reporting. Further high‐quality randomised trials are required which employ large samples, use validated and clinically relevant measures, and present data in a way that can be incorporated into a meta‐analysis. </p> <p>It is possible that our consideration of these data have been biased by our foreknowledge of the past work (<a href="./references#CD001088-bbs2-0307" title="ClearyM , HuntGE , MathesonSL , SiegfriedN , WalterG . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2008, Issue 1. [DOI: 10.1002/14651858.CD001088.pub2] ">Cleary 2008</a>; <a href="./references#CD001088-bbs2-0308" title="HuntGE , SiegfriedN , MorleyK , SitharthanT , ClearyM . Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2013, Issue 10. [DOI: 10.1002/14651858.CD001088.pub3] ">Hunt 2013</a>; <a href="./references#CD001088-bbs2-0309" title="LeyA , JefferyDP , McLarenS , SiegfriedN . Treatment programmes for people with both severe mental illness and substance misuse. Cochrane Database of Systematic Reviews2000, Issue 4. [DOI: 10.1002/14651858.CD001088] ">Ley 2000</a>). It is difficult to know what to do about this except to state that we do make every effort to be open to any new information or interpretation. </p> </section> <section id="CD001088-sec-0295"> <h3 class="title" id="CD001088-sec-0295">Agreements and disagreements with other studies or reviews</h3> <p>The findings of this review agree with other narrative syntheses of the literature, which have come to the same conclusions. There is little evidence from trials to support any one psychosocial treatment over another to reduce substance use or improve mental state for people with a serious mental illness (<a href="./references#CD001088-bbs2-0149" title="BakerAL , HilesSA , ThorntonLK , HidesL , LubmanDI . A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders. Acta Psychiatrica Scandinavica2012;126(4):243‐55. ">Baker 2012</a>; <a href="./references#CD001088-bbs2-0169" title="ClearyM , HuntGE , MathesonS , WalterG . Psychosocial treatments for people with co‐occurring severe mental illness and substance misuse: systematic review. Journal of Advanced Nursing2009;65(2):238‐58. ">Cleary 2009a</a>; <a href="./references#CD001088-bbs2-0172" title="CrockfordD , AddingtonD . Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders. Canadian Journal of Psychiatry2017;62(9):624‐34. ">Crockford 2017</a>; <a href="./references#CD001088-bbs2-0185" title="DixonLB , DickersonF , BellackAS , BennettM , DickinsonD , GoldbergRW , et al. The 2009 schizophrenia PORTpsychosocial treatment recommendations and summary statements. Schizophrenia Bulletin2010;36(1):48‐70. ">Dixon 2010</a>; <a href="./references#CD001088-bbs2-0191" title="DrakeRE , Mercer‐McFaddenC , MueserKT , McHugoGJ , BondGR . A review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin1998;24(4):589‐608. ">Drake 1998b</a>; <a href="./references#CD001088-bbs2-0214" title="HjorthojC , FohlmannA , NordentoftM . Treatment of cannabis use disorders in people with schizophrenia spectrum disorders ‐ a systematic review. Addictive Behaviors2009;34(6‐7):520‐5. ">Hjorthoj 2009</a>; <a href="./references#CD001088-bbs2-0217" title="HorsfallJ , ClearyM , HuntGE , WalterG . Psychosocial treatments for people with co‐occurring severe mental illnesses and substance use disorders (dual diagnosis): a review of empirical evidence. Harvard Review of Psychiatry2009;17(1):24‐34. ">Horsfall 2009</a>; <a href="./references#CD001088-bbs2-0265" title="NICE . Psychosis with coexisting substance misuse. Assessment and management in adults and young people. National Clinical Guideline 120. London: British Psychological Society and the Royal College of Psychiatrists, 2011:1‐322. [http://www.nice.org.uk/CG120] ">NICE 2011</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD001088-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD001088-fig-0001" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD001088-fig-0002" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram for 2018 search" data-id="CD001088-fig-0003" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Study flow diagram for 2018 search</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated models of care versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment ‐ by 36 months." data-id="CD001088-fig-0004" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment ‐ by 36 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated models of care versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation." data-id="CD001088-fig-0005" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated models of care versus standard care, Outcome 3 Adverse event: 1. Death ‐ by 36 months." data-id="CD001088-fig-0006" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 3 Adverse event: 1. Death ‐ by 36 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated models of care versus standard care, Outcome 4 Substance use: 1. Clinically important change (not in remission) ‐ by 36 months." data-id="CD001088-fig-0007" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 4 Substance use: 1. Clinically important change (not in remission) ‐ by 36 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated models of care versus standard care, Outcome 5 Substance use: 2. Average score for progress towards recovery (SATS, low = poor)." data-id="CD001088-fig-0008" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 5 Substance use: 2. Average score for progress towards recovery (SATS, low = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0009"> <p> <div class="table" id="CD001088-tblf-0001"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>36 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 6 Substance use: 3a. Alcohol use: average score (AUS) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0009">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0010"> <p> <div class="table" id="CD001088-tblf-0002"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 month</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 month</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 month</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 month</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 month</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>36 month</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 7 Substance use: 3b. Alcohol use: average number of days using in last 6 months (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0010">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0011"> <p> <div class="table" id="CD001088-tblf-0003"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>62</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>36 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 8 Substance use: 4a. Drug use: average score (DUS) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0011">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0012"> <p> <div class="table" id="CD001088-tblf-0004"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>57.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>64</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>69</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>36 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>51.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 9 Substance use: 4b. Drug use: average number of days using in last 6 months (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0012">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0013"> <p> <div class="table" id="CD001088-tblf-0005"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>93</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>87</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>88</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>80</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>36 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 10 Substance use: 5. Avearage score (SATS, low = poor) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0013">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0014"> <p> <div class="table" id="CD001088-tblf-0006"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment (IACT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment (IACT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment (IACT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment (IACT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 11 Substance use: 6. Average score ( USS, high = poor) 1=client not abstinent, 5 client mets criteria for severe use) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0014">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0015"> <p> <div class="table" id="CD001088-tblf-0007"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>78</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>75</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>82</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>89</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>84</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>83</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>36 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 12 Mental state: 1. Average score (BPRS, high = poor) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0015">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-001-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-001-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated models of care versus standard care, Outcome 13 Global state: 1. Average score (GAF, low = poor)." data-id="CD001088-fig-0016" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 13 Global state: 1. Average score (GAF, low = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0017"> <p> <div class="table" id="CD001088-tblf-0008"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Arrests ‐ 36 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Convictions ‐ 36 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Felony ‐ 36 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Hospital or jail ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>118</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>221</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>210</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Jail days ‐ 36 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60.71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>73.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>66.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 14 Global state: 2. Forensic measures (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0017">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-001-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-001-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated models of care versus standard care, Outcome 15 Quality of life/ life satisfaction: 1. Average general score (QOLI, range 1‐7, low = poor)." data-id="CD001088-fig-0018" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 15 Quality of life/ life satisfaction: 1. Average general score (QOLI, range 1‐7, low = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-001-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-001-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated models of care versus standard care, Outcome 16 Service use: 1. Days in stable community residences (not in hospital)." data-id="CD001088-fig-0019" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 16 Service use: 1. Days in stable community residences (not in hospital). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-001-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-001-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Integrated models of care versus standard care, Outcome 17 Service use: 2. Number hospitalised ‐ during the 36 month study period." data-id="CD001088-fig-0020" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 17 Service use: 2. Number hospitalised ‐ during the 36 month study period. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-001-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0021"> <p> <div class="table" id="CD001088-tblf-0009"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>79</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>105</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Drake 1998a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>98</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 18 Service use: 3. Relapse (hospitalisation days and crisis care) ‐ 36 months (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0021">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0022"> <p> <div class="table" id="CD001088-tblf-0010"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Chandler 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 19 Service use: 4. Medication hours ‐ 36 months (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0022">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0023"> <p> <div class="table" id="CD001088-tblf-0011"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Days institutionalised (hospital or incarcerated) ‐ 36 months (site 2)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Integrated models of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>262</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P = 0.02<br/> using Mann Whitney U test (non‐parametric test). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TAU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>158</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Days in hospital ‐ 36 months (site 2)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Integrated models of care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>P = 0.002<br/> using Mann Whitney U test (non‐parametric test). </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TAU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 20 Service use: 5. Various measures (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0023">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0024"> <p> <div class="table" id="CD001088-tblf-0012"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>112</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>112</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>9 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 21 Homelessness: 1. Proportion of time on the street ‐ past 60 days. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0024">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0025"> <p> <div class="table" id="CD001088-tblf-0013"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>112</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41.64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>112</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>9 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>109</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 22 Homelessness: 2. Proportion of time in independent housing ‐ past 60 days. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0025">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0026"> <p> <div class="table" id="CD001088-tblf-0014"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 23 Homelessness: 3. Average number of days in stable housing (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0026">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0027"> <p> <div class="table" id="CD001088-tblf-0015"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Time on streets (%) ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Time on streets (%) ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Time on streets (%) ‐ 9 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39.45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Days in stable community residence ‐ 24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>264.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>130.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Essock 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>245.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>143.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Time in independent housing in past 60 days ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Time in independent housing in past 60 days ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Time in independent housing in past 60 days ‐ 9 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Burnam 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1 Integrated models of care versus standard care, Outcome 24 Homelessness: 4. Various measures (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0027">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment." data-id="CD001088-fig-0028" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation." data-id="CD001088-fig-0029" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0030"> <p> <div class="table" id="CD001088-tblf-0016"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol ‐ 6 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol ‐ 12 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol ‐ 18 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Drugs ‐ 6 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Drugs ‐ 12 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Drugs ‐ 18 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>General ‐ 12 months (ASI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lehman 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>89.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lehman 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>81.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 3 Substance use: 1. Average scores on various scales (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0030">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0031"> <p> <div class="table" id="CD001088-tblf-0017"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment (ACT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment (ACT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control (Standard care)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment (ACT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control (Standard care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment (ACT)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control (Standard care)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 4 Substance use: 2. Average score (USS, high = poor (1=client not abstinent, 5 client mets criteria for severe use) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0031">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0032"> <p> <div class="table" id="CD001088-tblf-0018"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Depression symptoms ‐ 6 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Depression symptoms ‐ 12 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Depression symptoms ‐ 18 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>General ‐ average score ‐ 12 months (ASI)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lehman 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lehman 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Manic symptoms ‐ 6 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Manic symptoms ‐ 12 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Manic symptoms ‐ 18 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Schizophrenia symptoms ‐ 6 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Schizophrenia symptoms ‐ 12 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Schizophrenia symptoms ‐ 18 months (C‐DIS‐R)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 5 Mental state: 1. Average scores on various scales (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0032">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0033"> <p> <div class="table" id="CD001088-tblf-0019"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 6 Global state: 1. Forensic measures ‐ number of arrests (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0033">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0034"> <p> <div class="table" id="CD001088-tblf-0020"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 7 Global state: 2. Forensic measures ‐ number of convictions (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0034">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0035"> <p> <div class="table" id="CD001088-tblf-0021"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 8 Global state: 3. Forensic measures ‐ days in jail (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0035">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-002-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-002-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 9 Social functioning: 1. Average role functioning score (RFS, high = better functioning)." data-id="CD001088-fig-0036" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-002-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 9 Social functioning: 1. Average role functioning score (RFS, high = better functioning). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-002-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-002-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-002-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 10 Social functioning: 2. Average social adjustment score (SAS, high = better functioning)." data-id="CD001088-fig-0037" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-002-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 10 Social functioning: 2. Average social adjustment score (SAS, high = better functioning). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-002-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0038"> <p> <div class="table" id="CD001088-tblf-0022"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lehman 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>QOLI min score=1</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lehman 1993</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 11 Quality of life/ life satisfaction: 1. Average score (QOLI, skewed data) ‐ 12 months. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0038">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0039"> <p> <div class="table" id="CD001088-tblf-0023"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>% days in hospital</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bond 1991b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bond 1991b</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>59.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 12 Service use: 1. Relapse (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0039">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0040"> <p> <div class="table" id="CD001088-tblf-0024"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>State Operated admissions (site 1, Robert Young)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>State Operated admissions (site 2, Pilsen‐Little)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.82</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>State operated days admitted (site 1)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>State Operated days admitted (site 2)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>76.91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>110.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Private Hospital length of stay (site 1, days)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Private Hospital length of stay (site 2, days)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Godley 1994</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 13 Service use: 2. Various measures ‐ 24 months (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0040">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0041"> <p> <div class="table" id="CD001088-tblf-0025"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>54</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Morse 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2 Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care, Outcome 14 Homelessness: 1. Average number of days in stable housing (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0041">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment." data-id="CD001088-fig-0042" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation." data-id="CD001088-fig-0043" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 3 Substance use: 1. Percentage of participants who used cannabis ‐ in last 4 weeks." data-id="CD001088-fig-0044" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 3 Substance use: 1. Percentage of participants who used cannabis ‐ in last 4 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0045"> <p> <div class="table" id="CD001088-tblf-0026"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>CASUAS</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>HONOS ‐ item 3</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 4 Substance use: 2. Average score (various scales) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0045">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 5 Mental state: 1. Average insight score (Insight Scale, low = poor) ‐ by 3 months." data-id="CD001088-fig-0046" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 5 Mental state: 1. Average insight score (Insight Scale, low = poor) ‐ by 3 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0047"> <p> <div class="table" id="CD001088-tblf-0027"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Anxiety symptoms ‐ 3 months (BAS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Depressive symptoms ‐ 3 months (BDI‐SF)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Depressive symptoms ‐ 3 months (MADRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Depressive symptoms ‐ 6 months (BDI‐SF)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>General symptoms total score ‐ 3 months (BPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>General ‐ 3 months (CPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>General ‐ 3 months (SCR)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>General symptoms total score ‐ 6 months (BPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>45.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Negative symptoms ‐ 3 months (SANS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Negative symptoms ‐ 6 months (SANS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 6 Mental state: 2. Average score (various scales) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0047">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 7 Social functioning: 1. Average score (SOFAS, low = poor)." data-id="CD001088-fig-0048" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 7 Social functioning: 1. Average score (SOFAS, low = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0049"> <p> <div class="table" id="CD001088-tblf-0028"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>67</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Naeem 2005</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 8 Social functioning: 2. Average score (HONOS) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0049">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0050"> <p> <div class="table" id="CD001088-tblf-0029"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Edwards 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3 Cognitive behavioural therapy versus standard care, Outcome 9 Service use: 1. Outpatient medication (SURS) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0050">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Contingency management versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment." data-id="CD001088-fig-0051" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Contingency management versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Contingency management versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation ‐ 6 months." data-id="CD001088-fig-0052" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Contingency management versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation ‐ 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Contingency management versus standard care, Outcome 3 Substance use: 1. Stimulant‐positive urine test (higher = poor outcome)." data-id="CD001088-fig-0053" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Contingency management versus standard care, Outcome 3 Substance use: 1. Stimulant‐positive urine test (higher = poor outcome). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0054"> <p> <div class="table" id="CD001088-tblf-0030"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Contingency management versus standard care, Outcome 4 Substance use: 2. Number of continuous days alcohol negative urine tests, 3 months (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0054">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-004-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-004-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Contingency management versus standard care, Outcome 5 Substance use: 3. Injection use." data-id="CD001088-fig-0055" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-004-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4 Contingency management versus standard care, Outcome 5 Substance use: 3. Injection use. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-004-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0056"> <p> <div class="table" id="CD001088-tblf-0031"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Stimulant use days ‐ 3 months (skewed data)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.91</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Stimulant use days ‐ 6 months (skewed data)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Days of alcohol ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Days of alcohol ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2017</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>5. Longest consecutive weeks of cocaine abstinence</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Petry 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Petry 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4 Contingency management versus standard care, Outcome 6 Substance use: 4. Average scores on various measures (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0056">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0057"> <p> <div class="table" id="CD001088-tblf-0032"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Brief Symptom Inventory ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Brief Symptom Inventroy ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>PANSS, excitement scale ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>85</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>PANSS, excitement scale ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>McDonell 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4 Contingency management versus standard care, Outcome 7 Mental state: 1. Average scores (various scales) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0057">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-004-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-004-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Contingency management versus standard care, Outcome 8 Service use: 1. Relapse (hospitalised ‐ 6 months post‐randomisation." data-id="CD001088-fig-0058" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-004-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.8</div> <div class="figure-caption"> <p>Comparison 4 Contingency management versus standard care, Outcome 8 Service use: 1. Relapse (hospitalised ‐ 6 months post‐randomisation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-004-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment." data-id="CD001088-fig-0059" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 2 Leaving the study early: 2.Lost to evaluation." data-id="CD001088-fig-0060" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 2 Leaving the study early: 2.Lost to evaluation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 3 Adverse event: 1. Death, due to all causes, by 18 months." data-id="CD001088-fig-0061" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 3 Adverse event: 1. Death, due to all causes, by 18 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 4 Substance use: 1. Using substances ‐ by class of drug ‐ by about 12 months." data-id="CD001088-fig-0062" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 4 Substance use: 1. Using substances ‐ by class of drug ‐ by about 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 5 Substance use: 2. Polydrug consumption levels ‐ by 12 months (OTI, high = poor)." data-id="CD001088-fig-0063" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.5</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 5 Substance use: 2. Polydrug consumption levels ‐ by 12 months (OTI, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 6 Substance use: 3. Any change ‐ not abstinent or not improved on all substances ‐ by 12 months." data-id="CD001088-fig-0064" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.6</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 6 Substance use: 3. Any change ‐ not abstinent or not improved on all substances ‐ by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 7 Substance use: 4. Any change ‐ not abstaining from alcohol." data-id="CD001088-fig-0065" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.7</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 7 Substance use: 4. Any change ‐ not abstaining from alcohol. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 8 Substance use: 5. Change in cannabis use from baseline (T0) (lower scores indicate better outcome)." data-id="CD001088-fig-0066" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.8</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 8 Substance use: 5. Change in cannabis use from baseline (T0) (lower scores indicate better outcome). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0067"> <p> <div class="table" id="CD001088-tblf-0033"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>By 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bonsack 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bonsack 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>By 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bonsack 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bonsack 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.9</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 9 Substance use: 6. Cannabis consumption past 30 days (ASI, high = poor) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0067">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 10 Substance use: 7. Engagement with substance misuse treatment at 3 months (SATS, low = poor))." data-id="CD001088-fig-0068" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.10</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 10 Substance use: 7. Engagement with substance misuse treatment at 3 months (SATS, low = poor)). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0069"> <p> <div class="table" id="CD001088-tblf-0034"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Alcohol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Amphetamine</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Cannabis</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Polydrug use</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>46</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.11</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 11 Substance use: 8. Average scores (OTI, high = poor) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0069">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0070"> <p> <div class="table" id="CD001088-tblf-0035"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol volume (AUI subscale)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hickman 1997</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Drinking days ‐ by 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graeber 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graeber 2003</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol consumption, last 30 days (ASI) ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bonsack 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bonsack 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol consumption, last 30 days (ASI) ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bonsack 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bonsack 2011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol use (AUDIT) ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol use (CAUS) ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Drug use (CDUS) ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Drug use (SDS) ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.12</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 12 Substance use: 9. Other measures of alcohol use (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0070">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-13" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-13.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 13 Mental state: 1. Average scores (SCL‐90‐R, high = poor) ‐ by 3 months." data-id="CD001088-fig-0071" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-13.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.13</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 13 Mental state: 1. Average scores (SCL‐90‐R, high = poor) ‐ by 3 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-13.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 14 Mental state: 2. Average scores (PANSS negative symptoms, high = poor)." data-id="CD001088-fig-0072" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.14</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 14 Mental state: 2. Average scores (PANSS negative symptoms, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 15 Mental state: 3. Average scores (PANSS positive symptoms, high = poor)." data-id="CD001088-fig-0073" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.15</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 15 Mental state: 3. Average scores (PANSS positive symptoms, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0074"> <p> <div class="table" id="CD001088-tblf-0036"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>HADS‐A, Anxiety</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>HADS‐D, Depression</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Graham 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>BSI</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.16</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 16 Mental state: 4. Average score (HADS, BSI, high = poor) (skewed data) ‐ by 3 months. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0074">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 17 Global state: 1. Average score (GAF, low = poor)." data-id="CD001088-fig-0075" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.17</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 17 Global state: 1. Average score (GAF, low = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0076"> <p> <div class="table" id="CD001088-tblf-0037"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2002</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.18</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 18 Global state: 2. Forensic measures ‐ average number of crimes (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0076">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 19 Social functioning: 1. Average score (OTI, high = poor)." data-id="CD001088-fig-0077" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.19</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 19 Social functioning: 1. Average score (OTI, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 20 Social functioning: 2. Average score (SOFAS, low = poor)." data-id="CD001088-fig-0078" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.20</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 20 Social functioning: 2. Average score (SOFAS, low = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 21 Service use: Hospital admission to 12 months." data-id="CD001088-fig-0079" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.21</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 21 Service use: Hospital admission to 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-005-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-005-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Motivational interviewing versus standard care, Outcome 22 Service use: Lost to first aftercare appointment." data-id="CD001088-fig-0080" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.22</div> <div class="figure-caption"> <p>Comparison 5 Motivational interviewing versus standard care, Outcome 22 Service use: Lost to first aftercare appointment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-005-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Skills training versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment." data-id="CD001088-fig-0081" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Skills training versus standard care, Outcome 1 Leaving the study early: 1. Lost to treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Skills training versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation." data-id="CD001088-fig-0082" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Skills training versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Skills training versus standard care, Outcome 3 Adverse event: 1. Death ‐ by 12 months." data-id="CD001088-fig-0083" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Skills training versus standard care, Outcome 3 Adverse event: 1. Death ‐ by 12 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Skills training versus standard care, Outcome 4 Substance use: 1. Alcohol use: proportion days abstinent from alcohol (TLFB method)." data-id="CD001088-fig-0084" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Skills training versus standard care, Outcome 4 Substance use: 1. Alcohol use: proportion days abstinent from alcohol (TLFB method). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0085"> <p> <div class="table" id="CD001088-tblf-0038"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Time period</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Alcohol</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.95</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Countrol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>Drugs</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.70</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Jerrell 1995a</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.5</div> <div class="figure-caption"> <p>Comparison 6 Skills training versus standard care, Outcome 5 Substance use: 2. Average scores (C‐DIS‐R) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0085">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0086"> <p> <div class="table" id="CD001088-tblf-0039"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Any alcohol in last 30 days, at follow‐up (6 months)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rosenblum 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rosenblum 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Any illicit drug in last 30 days, at follow‐up (6 months)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rosenblum 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>91</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Rosenblum 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.6</div> <div class="figure-caption"> <p>Comparison 6 Skills training versus standard care, Outcome 6 Sustance use: 3. Average days used (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0086">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-006-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-006-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Skills training versus standard care, Outcome 7 Social functioning: 1. Average score (RFS, high = better functioning)." data-id="CD001088-fig-0087" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.7</div> <div class="figure-caption"> <p>Comparison 6 Skills training versus standard care, Outcome 7 Social functioning: 1. Average score (RFS, high = better functioning). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-006-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-006-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Skills training versus standard care, Outcome 8 Social functioning: 2. Average score (SAS, high = better functioning)." data-id="CD001088-fig-0088" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.8</div> <div class="figure-caption"> <p>Comparison 6 Skills training versus standard care, Outcome 8 Social functioning: 2. Average score (SAS, high = better functioning). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-006-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0089"> <p> <div class="table" id="CD001088-tblf-0040"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hellerstein 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hellerstein 1995</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.9</div> <div class="figure-caption"> <p>Comparison 6 Skills training versus standard care, Outcome 9 Service use: 1. Days in hospital (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0089">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 1 Leaving the study early 1. Lost to treatment." data-id="CD001088-fig-0090" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 1 Leaving the study early 1. Lost to treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation." data-id="CD001088-fig-0091" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 2 Leaving the study early: 2. Lost to evaluation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 3 Adverse event: 1. Death ‐ by about 1 year." data-id="CD001088-fig-0092" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 3 Adverse event: 1. Death ‐ by about 1 year. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 4 Adverse event: 2. Death or hospitalisation by 24 months." data-id="CD001088-fig-0093" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.4</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 4 Adverse event: 2. Death or hospitalisation by 24 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 5 Substance use: 1. Average number of different drugs used during the past month (OTI, high = poor)." data-id="CD001088-fig-0094" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.5</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 5 Substance use: 1. Average number of different drugs used during the past month (OTI, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 6 Substance use: 2. Cannabis use last 30 days." data-id="CD001088-fig-0095" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.6</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 6 Substance use: 2. Cannabis use last 30 days. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 7 Substance use 3. Clinically important change ‐change in main substance use, abstinent or large decease." data-id="CD001088-fig-0096" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.7</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 7 Substance use 3. Clinically important change ‐change in main substance use, abstinent or large decease. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0097"> <p> <div class="table" id="CD001088-tblf-0041"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol ‐ estimated daily consumption ‐ past month ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol ‐ estimated daily consumption ‐ past month ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol ‐ estimated daily consumption ‐ past month ‐ 12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol ‐ frequency per month by 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol quantity per session ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Alcohol Assessment ‐ AUDIT ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>General ‐ ASI score ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bellack 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bellack 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>74.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>155</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Drug abuse screening test ‐ DAST‐10 by 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Amphetamine‐ estimated daily consumption ‐ past month ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Amphetamine‐ estimated daily consumption ‐ past month ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Amphetamine‐ estimated daily consumption ‐ past month ‐ 12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Cannabis‐ estimated daily consumption ‐ past month ‐ 3 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Cannabis‐ estimated daily consumption ‐ past month ‐ 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Cannabis‐ estimated daily consumption ‐ past month ‐ 12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>cannabis ‐ days of use last month by 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Cannabis ‐ days of use last month by 10‐12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Cannabis ‐ joints last 30 days by 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>47.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>113.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Kemp 2007</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Cannabis ‐ joints last 30 days by 10 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Proportion of days abstinence from all substances last 90 days by 6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>147</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.06</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>148</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Proportion of days abstinence from all substances last 90 days by 12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>137</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>136</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Proportion of days abstinence from all substances last 90 days by 18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>129</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>127</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Proportion of days abstinence from all substances last 90 days by 24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>130</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2010</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>37.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>36.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>117</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.8</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 8 Substance use: 4. Averages of various measures (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0097">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0098"> <p> <div class="table" id="CD001088-tblf-0042"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Treatment Group</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Median</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>range</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>CBT + MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐25.6 to 83.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>U = 86.5<br/> <br/> P &lt; 0.03<br/> Non‐parametric analysis.<br/> <br/> Data summed over 4 time periods (to 12 months) and subtracted from baseline. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>TAU</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐6.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>‐67.9‐53.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.9</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 9 Substance use: 5. Average change in % days abstinent during &amp; after treatment. </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0098">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-10" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-10.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 10 Mental state: 1. Average score (PANSS, total, high = poor)." data-id="CD001088-fig-0099" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-10.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.10</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 10 Mental state: 1. Average score (PANSS, total, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-10.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-11" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-11.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 11 Mental state: 2. Average score (PANSS positive symptoms, high = poor)." data-id="CD001088-fig-0100" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-11.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.11</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 11 Mental state: 2. Average score (PANSS positive symptoms, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-11.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-12" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-12.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 12 Mental state: 3. Average score (PANSS negative symptoms, high = poor)." data-id="CD001088-fig-0101" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-12.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.12</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 12 Mental state: 3. Average score (PANSS negative symptoms, high = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-12.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0102"> <p> <div class="table" id="CD001088-tblf-0043"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Depressive symptoms ‐ 3 months (BDI‐11)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Depressive symptoms ‐ 6 months (BDI‐11)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Depressive symptoms ‐ 12 months (BDI‐11)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Depressive symptoms ‐ 3 months Calgary Depression Scale</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Depressive symptoms ‐ 12 months Calgary Depression Scale</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>General symptoms total score ‐ 6 months (BPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>General symptoms total score ‐ 12 months (BPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>General symptoms total score ‐ 3 months (BPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>General symptoms ‐ 18 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment (long)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Total score ‐ 3 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gouzoulis‐Mayfrank 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>65.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gouzoulis‐Mayfrank 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Total score ‐ 6 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gouzoulis‐Mayfrank 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26.823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Gouzoulis‐Mayfrank 2015</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>77.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>33.254</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Total score ‐ 12 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>63.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.96</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Total score ‐ 18 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>11.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Manic symptoms ‐ 3 months (BPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Manic symptoms ‐ 6 months (BPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Manic symptoms ‐ 12 months (BPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Negative symptoms ‐ 3 months (BPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Negative symptoms ‐ 6 months (BPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.08</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Negative symptoms ‐ 12 months (BPRS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.86</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>44</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Baker 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Negative symptoms ‐ 6 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Negative symptoms ‐ 9‐10 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Negative symptoms ‐ 12 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.97</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.02</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Negative symptoms ‐ 18 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>10.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.71</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>23</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6.5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Negative symptoms ‐ 3 months (SANS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>40</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Negative symptoms ‐ 12 months (SANS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Positive symptoms ‐ 6 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.09</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>28</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Positive symptoms ‐ 9‐10 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.69</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hjorthoj 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.99</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>26</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Positive symptoms ‐ 12 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.35</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Positive symptoms ‐ 18 months (PANSS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2001</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment (Long)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Barrowclough 2014</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>21</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Positive symptoms ‐ 3 months (SAPS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3.7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>42</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>Positive symptoms ‐ 12 months (SAPS)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>32</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Madigan 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5.1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.13</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 13 Mental state: 4. Average score (various scales, high = poor)) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0102">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-14" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-14.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 14 Global state: 1. Average score (GAF, low = poor)." data-id="CD001088-fig-0103" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-14.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.14</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 14 Global state: 1. Average score (GAF, low = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-14.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-15" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-15.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 15 Global state: 2. Forensic measures ‐ arrests reported ‐ by 6 months." data-id="CD001088-fig-0104" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-15.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.15</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 15 Global state: 2. Forensic measures ‐ arrests reported ‐ by 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-15.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-16" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-16.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 16 Social functioning: 1. Average score (SFS, low = poor)." data-id="CD001088-fig-0105" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-16.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.16</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 16 Social functioning: 1. Average score (SFS, low = poor). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-16.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-17" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-17.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 17 Quality of life/ life satisfaction: 1. Average score (BQOL (general life satisfaction, low = poor) ‐ by 6 months." data-id="CD001088-fig-0106" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-17.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.17</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 17 Quality of life/ life satisfaction: 1. Average score (BQOL (general life satisfaction, low = poor) ‐ by 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-17.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-18" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-18.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 18 Quality of life/ life satisfaction: 2. Average score (BQOL (overall quality of life, low = poor) ‐ by 6 months." data-id="CD001088-fig-0107" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-18.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.18</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 18 Quality of life/ life satisfaction: 2. Average score (BQOL (overall quality of life, low = poor) ‐ by 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-18.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-19" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-19.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 19 Quality of life/ life satisfaction: 3. Average score (WHOQOL, Bref, higher scores = better QoL) ‐ by 6 months." data-id="CD001088-fig-0108" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-19.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.19</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 19 Quality of life/ life satisfaction: 3. Average score (WHOQOL, Bref, higher scores = better QoL) ‐ by 6 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-19.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-20" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-20.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 20 Quality of life/ life satisfaction: 4. Average score (MANSA, higher scores = better QoL)." data-id="CD001088-fig-0109" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-20.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.20</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 20 Quality of life/ life satisfaction: 4. Average score (MANSA, higher scores = better QoL). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-20.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-21" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-21.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 21 Quality of life/ life satisfaction: 5. Average score (CSQ ‐ client satisfaction, high = good) ‐ by 10 months." data-id="CD001088-fig-0110" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-21.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.21</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 21 Quality of life/ life satisfaction: 5. Average score (CSQ ‐ client satisfaction, high = good) ‐ by 10 months. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-21.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-007-22" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-007-22.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 22 Service use: 1. Relapse (hospitalised)." data-id="CD001088-fig-0111" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-22.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.22</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 22 Service use: 1. Relapse (hospitalised). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-007-22.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0112"> <p> <div class="table" id="CD001088-tblf-0044"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>6 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bellack 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>329</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>649</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>61</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bellack 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>49</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.23</div> <div class="figure-caption"> <p>Comparison 7 Cognitive behavioural therapy + motivational interviewing versus standard care, Outcome 23 Economic outcomes: 1. Direct cost in US$ (BQOL, money subscale) (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0112">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0113"> <p> <div class="table" id="CD001088-tblf-0045"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>.84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Cognitive behavioural therapy + psychosocial rehabilitation versus standard care, Outcome 1 Global state: 1. Forensic measures ‐ number of arrests (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0113">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0114"> <p> <div class="table" id="CD001088-tblf-0046"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.2</div> <div class="figure-caption"> <p>Comparison 8 Cognitive behavioural therapy + psychosocial rehabilitation versus standard care, Outcome 2 Global state: 2. Forensic measures ‐ number of convictions (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0114">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0115"> <p> <div class="table" id="CD001088-tblf-0047"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8.78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>4.67</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>19.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>34.49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.3</div> <div class="figure-caption"> <p>Comparison 8 Cognitive behavioural therapy + psychosocial rehabilitation versus standard care, Outcome 3 Global state: 3. Forensic measures ‐ days in jail (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0115">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0116"> <p> <div class="table" id="CD001088-tblf-0048"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.31</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.34</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.81</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Cognitive behavioural therapy + intensive case management versus standard care, Outcome 1 Global state: 1. Forensic measures‐ number of arrests (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0116">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0117"> <p> <div class="table" id="CD001088-tblf-0049"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.23</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.22</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.63</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.53</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Cognitive behavioural therapy + intensive case management versus standard care, Outcome 2 Global state: 2. Forensic measures ‐ number of convictions (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0117">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0118"> <p> <div class="table" id="CD001088-tblf-0050"> <table> <div class="table-heading"><span class="table-title"></span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Intervention</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Mean</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>SD</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>N</b> </p> </td> </tr> </thead> <tbody> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>12 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>17.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>12.90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>30.12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>18 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>15.15</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>24 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13.46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>31.76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.07</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> <tr> <td align="center" bgcolor="#ffffff" colspan="5" rowspan="1" valign=""> <p><b>30 months</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>14.08</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Maloney 2006</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24.59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>38.27</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>43</p> </td> </tr> </tbody> </table> </div> </p> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Cognitive behavioural therapy + intensive case management versus standard care, Outcome 3 Global state: 3. Forensic measures ‐ days in jail (skewed data). </p> </div> </div> <div class="tools"><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0118">Navigate to figure in review</a></div> </div> <div class="figure" id="CD001088-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Sensitivity analysis, Outcome 1 Motivational interviewing versus standard care: Leaving the study early: 1. Lost to evaluation short term (3‐6 months): Diagnostic criteria." data-id="CD001088-fig-0119" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Sensitivity analysis, Outcome 1 Motivational interviewing versus standard care: Leaving the study early: 1. Lost to evaluation short term (3‐6 months): Diagnostic criteria. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD001088-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/urn:x-wiley:14651858:media:CD001088:CD001088-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_t/tCD001088-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Sensitivity analysis, Outcome 2 Cognitive behavioural therapy + motivational interviewing versus standard care: Global state: 1. Average score (GAF, low = poor) at 12 months: Allocation concealment." data-id="CD001088-fig-0120" src="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Sensitivity analysis, Outcome 2 Cognitive behavioural therapy + motivational interviewing versus standard care: Global state: 1. Average score (GAF, low = poor) at 12 months: Allocation concealment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/media/CDSR/CD001088/image_n/nCD001088-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table data-id="CD001088-tbl-0011"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Suggested design for trial</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Methods</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Allocation: centralised sequence generation with table of random numbers or computer‐generated code, stratified by severity of substance use. Sequence concealed until interventions assigned.<br/> Blinding: those recruiting and assigning participants, those assessing outcomes will be blind to treatment allocation.<br/> Duration: minimum of 1 year. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Participants</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnosis: severe mental illness based on a diagnosis of schizophrenia, schizoaffective disorder, and other psychotic disorders.<br/> N = 440* recruited to obtain a minimum sample of 280 at 12 months given the high drop‐out rate for some of the outcome measures.<br/> Age: adults 18‐55 years.<br/> Sex: men and women.<br/> Setting: hospital and community. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Interventions</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1. Standard care plus 3‐5 sessions of motivational interviewing + 3 months of weekly CBT.<br/> 2. Standard care plus one motivational interview. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Outcomes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Lost to treatment.<br/> Death.<br/> Substance use: number of patients using substances, OTI.<br/> Mental state: BPRS, PANSS.<br/> Relapse: number of patients readmitted to hospital over a specified follow‐up period.<br/> Quality of life: BQOL.<br/> Functioning: GAF.<br/> Arrests, number homeless. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Notes</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>* size of study to detect a 10% difference in improvement with 80% certainty.<br/> If scales are used to measure outcome then there should be binary cut‐off points, defined before study start, of clinically important improvement. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>BPRS: Brief Psychiatric Rating Scale<br/> BQOL: Brief Quality of Life Scale<br/> CBT: Cognitive behavioural therapy<br/> GAF: Global Assessment of Functioning<br/> OTI: Opiate Treatment Index<br/> PANSS: Positive &amp; Negative Syndrome Scale for schizophrenia </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Suggested design for trial</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001088-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Integrated models of care compared to standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>INTEGRATED MODELS OF CARE compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> outpatient<br/> <b>Intervention:</b> INTEGRATED MODELS OF CARE<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>INTEGRATED MODELS OF CARE</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b><br/> Follow‐up: mean 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>212 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>231 per 1000</b><br/> (174 to 308) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.09</b> <br/> (0.82 to 1.45) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>603<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were available for 36 months only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b><br/> Follow‐up: mean 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>28 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>33 per 1000</b><br/> (11 to 101) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.18</b> <br/> (0.39 to 3.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>421<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were available for 36 months only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: any change ‐ Alcohol use (not in remission)</b> <br/> Follow‐up: mean 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>575 per 1000</b><br/> (420 to 780) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.15</b> <br/> (0.84 to 1.56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>143<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were available for 36 months only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: any change ‐ Drug use (not in remission)</b> <br/> Follow‐up: mean 36 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>650 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>578 per 1000</b><br/> (409 to 812) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.89</b> <br/> (0.63 to 1.25) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were available for 36 months only</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were available for this important outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state: average score</b> <br/> <b>(</b>GAF scale of 1 ‐ 100)Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean global assessment</p> <p>of functioning in the intervention groups was <b>0.70 higher</b> (‐2.07 lower to 3.47 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>171<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NOTE: The GAF measures functioning on a scale of 1 to 100 and the difference detected in this single trial is not of clinical importance. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction: avearge score (General life satisfaction)</b><br/> Quality of Life Interview section, scale of 1 to 7<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean general life satisfaction in the intervention groups was<br/> <b>0.02 higher</b><br/> (‐0.28 lower to 0.32 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>372<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The scale is from 1 to 7 and the very small difference was not statistically significant and is not of clinical importance. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as SERIOUS: Blinding of participants and personnel in all three trials was not possible and performance bias was rated as unclear risk of bias. Similarly, all trials were at an unclear risk of detection bias.<br/> <sup>2</sup> Imprecision: Rated as SERIOUS: The number of events is less than 300 and the overall sample size is small.<br/> <sup>3</sup> Risk of bias: Rated as SERIOUS: Blinding of participants and personnel in both trials was not possible and performance bias was rated as unclear risk of bias. Similarly all trials were at an unclear risk of detection bias as outcomes ratings were not blinded.<br/> <sup>4</sup> Imprecision: Rated as SERIOUS: The event rate is very low and the 95% confidence interval is wide.<br/> <sup>5</sup> Risk of bias: Rated as SERIOUS: Blinding of participants and personnel was not possible and performance bias was rated as unclear risk of bias. Similarly there was an unclear risk of detection bias as outcomes ratings were not blinded.<br/> <sup>6</sup> Imprecision: Rated as SERIOUS: The confidence interval is very wide and the sample size small. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Integrated models of care compared to standard care for both severe mental illness and substance misuse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001088-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Non‐integrated models of care ‐ Assertive community treatment only/Intensive case management/Specialised case management services versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>ASSERTIVE COMMUNITY TREATMENT INTENSIVE CASE MANAGEMENT compared to STANDARD CARE for people with both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> outpatient<br/> <b>Intervention:</b> ASSERTIVE COMMUNITY TREATMENT<b>/</b> INTENSIVE CASE MANAGEMENT<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>NON‐INTEGRATED MODELS OF CARE OR INTENSIVE CASE MANAGEMENT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b><br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>239 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>289 per 1000</b><br/> (174 to 475) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.21</b> <br/> (0.73 to 1.99) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>134<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death was not measured in any of the trials.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol ‐ average score</b> <br/> (C‐DIS‐R computer program for Diagnostic Interview Schedule: average score)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed from one trial and there was no analysis of the difference between randomised arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug ‐ average score</b> <br/> C‐DIS‐R computer program for Diagnostic Interview Schedule: average score<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed from one trial and there was no analysis of the difference between randomised arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: Average score</b><br/> Schizophrenia symptoms on C‐DIS‐R computer program for Diagnostic Interview Schedule: average score<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed from one trial and there was no analysis of the difference between randomised arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global State: Average score</b><br/> (Role Functioning Scale, high = better functioning)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean global assessment of functioning in the intervention groups was<br/> <b>0.70 higher</b><br/> (1.56 lower to 2.96 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NOTE: the scale is 1 to 7 and the difference observed is not of clinical importance and is not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction:</b> (Quality of Life Interview section, scale of 1 to 7)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed from one trial and there was no analysis of the difference between randomised arms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as VERY SERIOUS: Random generation and allocation concealment was not adequately reported and the risk of bias is unclear. Both performance and detection bias was unclear as blinding was not performed or was unclearly reported. Attrition was unclear or very high (57% in Bond‐Anderson 91) so overall the risk of bias was rated as very serious.<br/> <sup>2</sup> Imprecision: Rated as SERIOUS: The confidence interval is wide and the sample size is very small.<br/> <sup>3</sup> Risk of bias: Rated as SERIOUS: Blinding of participants and personnel was not possible and performance bias was rated as unclear risk of bias. Similarly there was an unclear risk of detection bias as outcomes ratings were participant/clinician mediated.<br/> <br/> <sup>4</sup>Imprecision: Rated as VERY SERIOUS: The sample size is small and the confidence interval is very wide. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Non‐integrated models of care ‐ Assertive community treatment only/Intensive case management/Specialised case management services versus standard care for both severe mental illness and substance misuse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001088-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Cognitive behavioural therapy versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>COGNITIVE BEHAVIOUR THERAPY compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> outpatient<br/> <b>Intervention:</b> COGNITIVE BEHAVIOUR THERAPY<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>COGNITIVE BEHAVIOUR THERAPY</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b><br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>97 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>108 per 1000</b><br/> (43 to 277) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.12</b> <br/> (0.44 to 2.86) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>152<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Death was not measured in any of the trials.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a> measured alcohol together with drug use in the Health of the Nation Outcome (HoNOS) scale. Edwards did not report on alcohol. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (Cannabis)</b><br/> Percentage of participants who used cannabis in last 4 weeks<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>500 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>650 per 1000</b><br/> (395 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.30</b> <br/> (0.79 to 2.15) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data for other drugs were skewed and were not compared between intervention and control.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state: average score</b> (Insight scale)<br/> Follow‐up: by 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean mental state in the intervention groups was<br/> <b>0.52 higher</b><br/> (0.78 lower to 1.82 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>105<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference noted is unlikely to be clinically important</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Social functioning: Average score*</b><br/> The Social and Occupational Functioning Scale (SOFAS): scale of 1 to 100<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean global assessment of functioning in the intervention groups was<br/> <b>4.70 lower</b><br/> (14.52 lower to 5.12 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Global state data were not reported by the trials</p> <p>The other trial in this comparison (<a href="./references#CD001088-bbs2-0035" title="NaeemF , KingdonD , TurkingtonD . Cognitive behaviour therapy for schizophrenia in patients with mild to moderate substance misuse problems. Cognitive Behaviour Therapy2005;34(4):207‐15. [CSzG: 12597] TurkingtonD , KingdonD , TurnerT . Effectiveness of a brief cognitive‐behavioural therapy intervention in the treatment of schizophrenia. British Journal of Psychiatry2002;180:523‐7. [CSzG: 8740] ">Naeem 2005</a>) measured Functioning with the HoNOS scale. Data were skewed and meta‐analysis was not possible </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/ life satisfaction</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No study measured Quality of life</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as SERIOUS: The participants and personnel were not blinded and performance bias may be present. Missing data were addressed by Last Observation Carried Forward in Edward 2006 but attrition bias may be present as loss to follow‐up was 30% at 9 months.<br/> <sup>2</sup> Imprecision: Rated as SERIOUS: The event rate is low and the confidence interval is wide.<br/> <sup>3</sup> Imprecision: Rated as VERY SERIOUS: The event rate is low, the sample size small and the confidence interval is wide.<br/> <sup>4</sup> Imprecision: Rated as VERY SERIOUS: The confidence interval is very wide and the sample size small. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span> <span class="table-title">Cognitive behavioural therapy versus standard care for both severe mental illness and substance misuse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001088-tbl-0004"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Contingency management versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CONTINGENCY MANAGEMENT compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> community<br/> <b>Intervention:</b> Contingency Management<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>CONTINGENCY MANAGEMENT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b><br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>315 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>487 per 1000</b><br/> (355 to 664) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.55</b> <br/> (1.13 to 2.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>255<br/> (2 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None of the trials measured death as an outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="3" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed and no between‐arm comparison were reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (non‐alcohol)</b> <br/> Number with stimulant‐positive urine test<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>647 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>537 per 1000</b><br/> (421 to 686) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b> <br/> (0.65 to 1.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>176<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,3</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Service use*:</b><br/> Number hospitalised<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>106 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>22 per 1000</b><br/> (5 to 98) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.21</b> <br/> (0.05 to 0.93) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>176<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Predefinded outcome of <b>Mental state</b> data were skewed and unuseable. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neither trial measured <b>Global state</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neither trial measured <b>Quality of life</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as SERIOUS: Blinding was not possible so performance bias was rated as an unclear risk of bias. Primary outcome in both trials was urinalysis so detection bias was unlikely, Attrition bias was an unclear risk and greater than 20% across groups in both trials.<br/> <sup>2</sup> Imprecision: We did not downgrade. The confidence interval is wide although it does not cross 1 indicating appreciable harm. </p> <p><sup>3</sup> Impresion: Rated as SERIOUS: The event rate is low (less than 300 according to GRADE) and the confidence interval includes 1 and appreciable benefit.<br/> <sup>4</sup> Imprecision: Rated as SERIOUS: The event rate is very low and the confidence interval is wide. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 4.</span> <span class="table-title">Contingency management versus standard care for both severe mental illness and substance misuse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001088-tbl-0005"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Motivational interviewing versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>MOTIVATIONAL INTERVIEWING compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> hospital and community<br/> <b>Intervention:</b> MOTIVATIONAL INTERVIEWING<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>MOTIVATIONAL INTERVIEWING</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Lost to treatment</b><br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>156 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>266 per 1000</b><br/> (94 to 560) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.71</b> <br/> (0.63 to 4.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Death</b><br/> Follow‐up: mean 18 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>40 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>42 per 1000</b><br/> (3 to 629) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.04</b> <br/> (0.07 to 15.73) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>49<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>3,4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Alcohol use</b><br/> Not abstaining from alcohol<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>923 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>332 per 1000</b><br/> (157 to 692) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.36</b> <br/> (0.17 to 0.75) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>5,6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Drug (non‐alcohol) use</b><br/> Polydrug consumption levels measured by Opiate Treatment Index (OT)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean drug (non‐alcohol) use in the intervention groups was<br/> <b>0.07 lower</b><br/> (0.56 lower to 0.42 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>7,8</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state</b><br/> Symptom Checklist 90‐revised ‐ General Severity Index: Scale 0 to 4: Average score<br/> Follow‐up: mean 3 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean mental state in the intervention groups was<br/> <b>0.19 lower</b><br/> (0.59 lower to 0.21 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This is unlikely to be of clinical significance.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global Assessment of Functioning</b> <br/> GAF scale of 1‐ 100<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean global assessment of functioning in the intervention groups was<br/> <b>2.30 higher</b><br/> (1.30 lower to 5.90 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>54<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,9</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The difference is unlikely to be of clinical significance given the scale is from 1 to 100. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>None of the eight trials contributing data to this comparison measured general life satisfaction. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as SERIOUS: This single trial has unclear risk of allocation concealment and an unclear risk for performance bias.<br/> <sup>2</sup> Imprecision: Rated as VERY SERIOUS: The sample size is very small (N = 62), the event rate very low and the confidence interval very wide.<br/> <sup>3</sup> Risk of bias: Rated as SERIOUS: Allocation concealment was unclear and blinding was not possible so performance bias is unclear. Assessors were not blinded so there is a high risk of detection bias. Attrition was 29% at 18 months.<br/> <sup>4</sup> Imprecision: Rated as VERY SERIOUS: The event rate is very small and the confidence interval is very wide.<br/> <sup>5</sup> Risk of bias: Rated as SERIOUS: Random generation, allocation concealment and performance bias (lack of blinding) posed an unclear risk of bias. Detection bias was likely as assessors were not blinded. <br/> <sup>6</sup> Imprecision: Rated as VERY SERIOUS: The sample size was extremely small (N = 30), and the event rate very low. <br/> <sup>7</sup> Risk of bias: Rated as SERIOUS: Selection bias was unclear and performance bias may be present as personnel and participants were not blinded. Assessors were blinded. Attrition bias is a high risk as 44% were lost to follow‐up by 12 months. <br/> <sup>8</sup> Imprecision: Rated as VERY SERIOUS: The single trial has a very small sample size (N = 30) and imprecision is very likely.<br/> <sup>9</sup> Imprecision: Rated as VERY SERIOUS: The single trial sample size is very small (N = 54) and the confidence interval is very wide.<br/> <sup>10</sup> Risk of bias: Rated as VERY SERIOUS: Selection bias was a high risk as allocation concealment was modified to allow for participant refusal and to minimise disruption to the treatment programme. Performance and detection bias were unclear as blinding was not possible for personnel and participants and assessor blinding was not reported. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 5.</span> <span class="table-title">Motivational interviewing versus standard care for both severe mental illness and substance misuse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001088-tbl-0006"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Skills training versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>SKILLS TRAINING compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> community and outpatient<br/> <b>Intervention:</b> SKILLS TRAINING<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>SKILLS TRAINING</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b> <br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>138 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>196 per 1000</b><br/> (28 to 1000) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.42</b> <br/> (0.20 to 10.1) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>122<br/> (3 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>79 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>12 per 1000</p> <p>(2 to 112)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.15</b> </p> <p>(0.02 to 1.42</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>121</p> <p>(1 study)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>3,4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol</b><br/> (C‐DIS‐R average score)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed and no estimate of effect was calculated between randomised arms.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (non‐alcohol)</b> <br/> (C‐DIS‐R average score)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed and no estimate of effect was calculated between randomised arms.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data were available for analyses.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Social functioning*:</b><br/> Role Functioning Scale: scale 1 to 7<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean assessment of functioning in the intervention groups was<br/> <b>1.07 higher</b><br/> (1.15 lower to 3.29 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>47<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Global state data were not reported.</p> <p>NOTE: the scale is 1 to 7 and the difference observed is not of clinical importance and is not statistically significant. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Neither trial measured general life satisfaction.</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of Bias: Rated as VERY SERIOUS: Blinding was not possible and performance bias may be present. It was unclear whether assessors were blinded and detection bias may be present. Attrition bias was a high risk in <a href="./references#CD001088-bbs2-0022" title="HellersteinDJ , RosenthalRN , MinerCR . A prospective study of integrated outpatient treatment for substance‐abusing schizophrenic patients. American Journal on Addictions1995;4(1):33‐42. [CSzG: 5029] HellersteinDJ , RosenthalRN , MinerCR . Integrating services for schizophrenia and substance abuse. Psychiatric Quarterly2001;72(4):291‐306. [CSzG: 8206] ">Hellerstein 1995</a> with 47% loss to follow‐up at 4 months and 64% at 8 months with no reasons for drop‐outs provided and not addressed in analysis.<br/> <sup>2</sup> Imprecision: Rated as SERIOUS: The event rate was low (zero events in one trial) with a wide confidence interval.<br/> <sup>3</sup> Risk of Bias: Rated as SERIOUS: The trial outcomes were self‐reported abstinence and there is no report of whether raters were blind to treatment allocation when assessing the participant's self‐report. </p> <p><sup>4</sup> Inconsistency: this is not possible to evaluate as there is only a single study. </p> <p><sup>5</sup> Imprecision: The single trial has a small sample size of 121 with very low event rates. The confidence interval crosses the line of no effect and appreciable harm.<br/> <sup>6</sup> Risk of Bias: Rated as SERIOUS: Blinding was not possible and performance bias may be present. It was unclear whether<br/> <sup>7</sup> Imprecision: Rated as VERY SERIOUS: The single trial has a very small sample size (N =47) and the confidence interval is wide. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 6.</span> <span class="table-title">Skills training versus standard care for both severe mental illness and substance misuse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001088-tbl-0007"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Cognitive behavioural therapy + motivational interviewing versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>COGNITIVE BEHAVIOURAL THERAPY + MOTIVATIONAL INTERVIEWING compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> outpatient<br/> <b>Intervention:</b> COGNITIVE BEHAVIOUR THERAPY + MOTIVATIONAL INTERVIEWING<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Assumed risk</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>COGNITIVE BEHAVIOUR THERAPY + MOTIVATIONAL INTERVIEWING</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Lost to treatment</b><br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>178 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>176 per 1000</b> </p> <p>(110 to 283)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.99</b> <br/> (0.62 to 1.59) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>327<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Adverse event: Death</b> <br/> Follow‐up: mean 12 months </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>32 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>19 per 1000</b> </p> <p>(6 to 56)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>RR 0.60</b> <br/> (0.20 to 1.76) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>603<br/> (4 studies) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>2,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol</b> (<br/> Estimated daily consumption in previous month)<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Moderate</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were skewed from one trial and there was no analysis of the difference between randomised arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (non‐alcohol) use</b><br/> (Average number of different drugs used during the past month measured by the Opiate Treatment Index)<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>32 per 1000</b> </p> <p>The average number of different drugs used in past month in the intervention group was <b>0.19 higher</b> (0.22 lower to 0.60 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>19 per 1000</b><br/> (6 to 56) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>119<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>4,5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Relapse:*</b><br/> Relapse at 3 months after 9 months of treatment<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>667 per 1000</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>333 per 1000</b><br/> (160 to 693) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.50</b> <br/> (0.24 to 1.04) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>36<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>6,7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>* Clinically important change in mental state not reported.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global State:</b><br/> GAF scale of 1‐ 100<br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean Global Assessment of Functioning in the intervention groups was <b>1.24 higher</b> (1.86 lower to 4.34 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>445<br/> (4 studies) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>8,9,10</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NOTE: The GAF measures functioning on a scale of 1 to 100 and the difference detected in this single trial is not of clinical importance. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life / life satisfaction:</b><br/> Brief Quality of Life Scale<br/> Follow‐up: mean 6 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"></td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean general life satisfaction in the intervention groups was<br/> <b>0.58 higher</b><br/> (0.00 to 1.16 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>110<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low</b><sup>11,12</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as SERIOUS: The single trial which reported on 12 month loss to treatment had adequate random generation and allocation concealment. However, we down‐graded it for possible performance bias as participants and clinicians were not blinded. Detection bias was a low risk as outcome assessors were blinded.<br/> <sup>2</sup> Imprecision: Rated as SERIOUS: The event rate is low and the confidence interval is wide and includes the line of no effect and appreciable harm.<br/> <sup>3</sup> Risk of bias: Rated as SERIOUS: The four trials included in this meta‐analysis were well‐conducted. A lack of blinding is unlikely to affect measurement of death. However, attrition was &gt; 20% in all four trials and although missing data were balanced across groups, there is an unclear risk of bias due to attrition bias.<br/> <sup>4</sup> Risk of bias: Rated as SERIOUS: Random generation and allocation concealment were unclear and blinding was not possible for participants or clinicians. Attrition was high at 20% at 12 months, but missing outcome data were balanced between groups.<br/> <sup>5</sup> Imprecision: Rated as SERIOUS: The sample size is small and the confidence interval is wide.<br/> <sup>6</sup> Risk of bias: Rated as SERIOUS: The risk of attrition bias is unclear (22% across both groups at 18 months) despite missing outcome balanced between groups. A lack of blinding of participants and clinicians may result in performance bias.<br/> <sup>7</sup> Imprecision: Rated as VERY SERIOUS: The event rate is extremely low in this very small single trial (N = 36) and the confidence interval is wide.<br/> <sup>8</sup> Risk of bias: Rated as SERIOUS: Attrition was &gt; 20% in all four trials and although missing data were balanced across groups, there is an unclear risk of bias due to attrition bias.<br/> <sup>9</sup> Inconsistency: Rated as SERIOUS: Heterogeneity was present (ChiÂ² = 5.20, df = 3 (P = 0.16); IÂ² = 42%). One trial (Barrowclough) showed significant improvement in the treatment group compared with the others, but we were unable to explain the reason for this.<br/> <sup>10</sup> Imprecision: Rated as SERIOUS: Four trials provided data for this meta‐analysis. The confidence interval is wide.<br/> <sup>11</sup> Risk of bias: Rated as SERIOUS: Blinding of participants and clinicians was not possible and performance bias may be a risk. Attrition was 25% at 6 months and missing data were not balanced across interventions. Missing outcomes are enough to induce clinically relevant bias in observed effect size.<br/> <sup>12</sup> Imprecision: Rated as SERIOUS: The sample size of the single trial is small and the confidence interval is wide. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 7.</span> <span class="table-title">Cognitive behavioural therapy + motivational interviewing versus standard care for both severe mental illness and substance misuse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001088-tbl-0008"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Cognitive behavioural therapy + psychosocial rehabilitation versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>COGNITIVE BEHAVIOUR THERAPY and PSYCHOSOCIAL REHABILITATION compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> jail and community<br/> <b>Intervention:</b> COGNITIVE BEHAVIOUR THERAPY and PSYCHOSOCIAL REHABILITATION<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>COGNITIVE BEHAVIOUR THERAPY and PSYCHOSOCIAL REHABILITATION</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leavint the study early: Loss to Treatment</b><br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>61<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Data were only reported per trial and not per randomised arm.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial did not measure death as an outcome.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Alcohol</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (non‐alcohol)</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. The data were skewed and was not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. The data were skewed and was not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global State</b>‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. The data were skewed and was not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. The data were skewed and was not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as VERY SERIOUS: Although the random generation is reported as computer‐generated the numbers in the arms vary and no report is made as to whether randomisation was done in a ratio fashion. Blinding was not done and performance bias may be unclear and detection bias is high risk as the assessors were not blinded. There is a high risk of selective reporting bias as few outcomes are reported per arm and mainly by site.<br/> <sup>2</sup> Imprecision: Rated as VERY SERIOUS: The sample size is small and any estimate of effect (had it been reported per arm) is highly likely to be imprecise. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 8.</span> <span class="table-title">Cognitive behavioural therapy + psychosocial rehabilitation versus standard care for both severe mental illness and substance misuse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD001088-tbl-0009"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Cognitive behavioural therapy + intensive case management versus standard care for both severe mental illness and substance misuse</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>COMBINED COGNITIVE BEHAVIOUR THERAPY and INTENSIVE CASE MANAGEMENT compared to STANDARD CARE for both severe mental illness and substance misuse</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population:</b> people with both severe mental illness and substance misuse<br/> <b>Settings:</b> jail and community<br/> <b>Intervention:</b> COMBINED COGNITIVE BEHAVIOUR THERAPY and INTENSIVE CASE MANAGEMENT<br/> <b>Comparison:</b> STANDARD CARE </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of Participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>STANDARD CARE</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>COMBINED COGNITIVE BEHAVIOUR THERAPY and INTENSIVE CASE MANAGEMENT</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Leaving the study early: Loss to Treatment</b><br/> Follow‐up: mean 12 months </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59<br/> (1 study) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low</b><sup>1,2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unable to use data ‐ (no breakdown by treatment arms)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse event: Death</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The trial did not measure death.</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: alcohol</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Substance use: Drug (non‐alcohol)</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Mental state</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Global State</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Quality of life/life satisfaction</b> ‐ not measured </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>This trial focused on criminal outcomes of jail and offences. Data were skewed and not compared between arms. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio; </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> we are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Risk of bias: Rated as VERY SERIOUS: Although the random generation is reported as computer‐generated the numbers in the arms vary and no report is made as to whether randomisation was done in a ratio fashion. Blinding was not done and performance bias may be unclear and detection bias is high risk as the assessors were not blinded. There is a high risk of selective reporting bias as few outcomes are reported per arm and mainly by site.<br/> <sup>2</sup> Risk of bias: Rated as VERY SERIOUS: Although the random generation is reported as computer‐generated the numbers in the arms vary and no report is made as to whether randomisation was done in a ratio fashion. Blinding was not done and performance bias may be unclear and detection bias is high risk as the assessors were not blinded. There is a high risk of selective reporting bias as few outcomes are reported per arm and mainly by site. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 9.</span> <span class="table-title">Cognitive behavioural therapy + intensive case management versus standard care for both severe mental illness and substance misuse</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD001088-tbl-0010"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">List of scales and abbreviations used in included studies</span></div> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Name of tool</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Abbreviation</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Source of scale ‐ reference</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><i><b>Diagnostic tools</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnostic and Statistical Manual of Mental Disorders, 4th edition</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0195" title="APA1994 . Diagnostic &amp; Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: APA, 1994. ">DSM‐IV</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> <a href="./references#CD001088-bbs2-0195" title="APA1994 . Diagnostic &amp; Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: APA, 1994. ">DSM‐IV</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The classification of mental and behavioural disorders</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0222" title="World Health Organization. The ICD‐10 Classification of Mental and Behavioural Disorders. Geneva: World Health Organization, 1992. ">ICD‐10</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0222" title="World Health Organization. The ICD‐10 Classification of Mental and Behavioural Disorders. Geneva: World Health Organization, 1992. ">ICD‐10</a>  </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Structured Clinical Interview for Diagnosis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SCID</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0285" title="SpitzerRL , WilliamsJB , GibbonM , FirstMB . Structured Clinical Interview for DSM‐III‐R ‐ Patient Edition (SCID‐P). Washington, DC: American Psychiatric Press, 1990. ">Spitzer 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diagnostic Interview Schedule (DIS), computerised scoring for DSM‐III‐R criteria</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>C‐DIS‐R</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001088-bbs2-0194" title="American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder (DSM III‐R). Diagnostic &amp; Statistical Manual of Mental Disorders (DSM III‐R). 3rd Edition. Washington D.C: American Psychiatric Association, 1987. ">DSM III‐R</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><i><b>Substance use scales</b> </i> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addiction Severity Index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0252" title="McLellanAT , LuborskyL , WoodyGE , O'BrienC . An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease1980;168(1):26‐33. ">McLellan 1980</a>; <a href="./references#CD001088-bbs2-0253" title="McLellanAT , KushnerH , MetzgerD , PetersR , SmithI , GrissomG , et al. The Fifth Edition of the Addiction Severity Index. Journal of Substance Abuse Treatment1992;9(3):199‐213. ">McLellan 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Alcohol Use Inventory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AUI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0216" title="HornJL , WanbergKW , FosterFM . The Alcohol Use Inventory. Minneapolis, MN: National Computer Systems, 1987. ">Horn 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Alcohol Use Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>AUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0260" title="MueserKT , DrakeRE , ClarkRE , McHugoGJ , Mercer‐McFaddenC , AckersonTH . Evaluating Substance Abuse in Persons with Severe Mental Illness. Cambridge, MA: Human Services Research Institute, 1995. ">Mueser 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Alcohol Use Disorders Identification Test</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>AUDIT</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001088-bbs2-0276" title="SaundersJB , AaslandOG , Babor TF de la FuenteJR , GrantM . Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption‐‐II. Addiction1993;88(6):791‐804. ">Saunders 1993</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief Drinker Profile</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BDP</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0255" title="MillerWR , MarlattAG . Brief Drinker Profile (BDP) Interview Booklet. Odessa, FL: Psychological Assessment Resources, Inc, 1987. ">Miller 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug and Alcohol Problem Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DAPS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>adapted non‐peer reviewed version of this scale used; see <a href="./references#CD001088-bbs2-0009" title="BondGR , McDonelEC , MillerLD , PensecM . Assertive community treatment and reference groups: an evaluation of their effectiveness for young adults with serious mental illness and substance abuse problems. Psychosocial Rehabilitation Journal1991;15(2):31‐43. [CSzG: 16926] ">Bond 1991a</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Drug Use Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>DUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0260" title="MueserKT , DrakeRE , ClarkRE , McHugoGJ , Mercer‐McFaddenC , AckersonTH . Evaluating Substance Abuse in Persons with Severe Mental Illness. Cambridge, MA: Human Services Research Institute, 1995. ">Mueser 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Opiate Treatment Index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>OTI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0173" title="DarkeS , WardJ , HallW , HeatherN , WodakA . The Opiate Treatment Index (OTI) Researchers Manual. Technical report No. 11. Sydney: National Drug &amp; Alcohol Research Centre, 1991. ">Darke 1991</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Change Questionnaire‐Cannabis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RTCQ‐C</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0273" title="RollnickS , HeatherN , GoldR , HallW . Development of a short 'readiness to change' questionnaire for use in brief opportunistic interventions among excessive drinkers. British Journal of Addiction1992;87(5):743‐54. ">Rollnick 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Substance Abuse Treatment Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SATS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0250" title="McHugoGJ , DrakeRE , BurtonHL , AckersonTH . A scale for assessing the stage of substance abuse treatment in persons with severe mental illness. Journal of Nervous and Mental Disease1995;183(12):762‐7. ">McHugo 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Schedule for Clinical Assessment in Neuropsychiatry</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SCAN</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0299" title="WingJK , BaborT , BrughaT , et al. SCAN. Schedules for Clinical Assessment in Neuropsychiatry. Archives of General Psychiatry1990;47(6):589‐93. ">Wing 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Substance Use Severity Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>USS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0166" title="CareyKB , CoccoKM , SimonsJS . Concurrent validity of clinicians' rating of substance abuse among psychiatric outpatients. Psychiatric Services1996;47(8):842‐7. ">Carey 1996</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><i><b>Mental state scales</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Addiction Severity Index (psychiatric subscale)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>ASI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0252" title="McLellanAT , LuborskyL , WoodyGE , O'BrienC . An improved evaluation instrument for substance abuse patients: The Addiction Severity Index. Journal of Nervous and Mental Disease1980;168(1):26‐33. ">McLellan 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Beck Depression Inventory ‐ Short Form</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BDI‐SF, BDI‐11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0151" title="BeckAT , BeckRW . Screening depressed patients in family practice. A rapid technique. Postgraduate Medicine1972;52(6):81‐5. ">Beck 1972</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief Psychiatric Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BPRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0246" title="LukoffD , NuechterleinKH , VenturaJ . Manual for expanded Brief Psychiatric Rating Scale (BPRS). Schizophrenia Bulletin1986;12(4):594‐602. ">Lukoff 1986</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief Scale for Anxiety</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0294" title="TyrerP , OwenRT , CicchettiDV . The brief scale for anxiety: a subdivision of the Comprehensive Psychopathological Rating Scale. Journal of Neurology, Neurosurgery and Psychiatry1984;47(9):970‐5. ">Tyrer 1984</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief Symptom Inventory</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BSI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0181" title="DerogatisLR , MelisaratosN . The brief symptom inventory: an introductory report. Psychological Medicine1983;13(3):595‐605. ">Derogatis 1983a</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Calgary Depression Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CDS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0142" title="AddingtonD , AddingtonJ , Maticka‐TyndaleE , JoyceJ . Reliability and validity of a depression rating scale for schizophrenics. Schizophrenia Research1992;6(3):201‐8. ">Addington 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comprehensive Psychopathological Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CPRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0147" title="AsbergM , MontgomerySA , PerrisC , et al. A comprehensive psychopathological rating scale. Acta Psychiatrica Scandinavica Supplement1978;271:5‐27. ">Asberg 1978</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hamilton Rating Scale for Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HAM ‐ D</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0208" title="HamiltonM . A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry1960;23(February):56‐62. ">Hamilton 1960</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Hospital Anxiety and Depresion Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>HADS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001088-bbs2-0306" title="ZigmondAS , SnaithRP . The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica1983;67(6):361‐70. ">Zigmond 1983</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Insight Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0175" title="DavidA , BuchananA , ReedA , AlmeidaO . The assessment of insight in psychosis. British Journal of Psychiatry1992;161(November):599‐602. ">David 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Montgomery Asberg Depression Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MADRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0258" title="MontgomerySA , AsbergM . A new depression scale designed to be sensitive to change. British Journal of Psychiatry1979;134(April):382‐9. ">Montgomery 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Positive &amp; Negative Syndrome Scale for schizophrenia</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PANNS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0227" title="KaySR , FiszbeinA , OplerLA . The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin1987;13(2):261‐76. ">Kay 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Psychiatric Epidemiologic Research Interview</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>PERI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0186" title="DohrenwendBP , ShroutPE , EgriG , et al. Nonspecific psychological distress and other dimensions of psychopathology. Measures for use in the general population. Archives of General Psychiatry1980;37(11):1229‐36. ">Dohrenwend 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Scale for the Assessment of Negative Symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SANS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0145" title="AndreasenNC . Negative symptoms in schizophrenia. Archives of General Psychiatry1982;39:784‐8. ">Andreasen 1982</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Scale for the assessment of Positive Symptoms</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAPS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0266" title="NormanRM , MallaAK , CorteseL , DiazF . A study of the interrelationship between and comparative interrater reliability of the SAPS, SANS and PANSS. Schizophrenia Research1996;19(1):73‐85. ">Norman 1996</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom Checklist 90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SCL‐90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0179" title="DerogatisLR , LipmanRS , CoviL . SCL‐90: An outpatient psychiatric rating scale: Preliminary report. Psychopharmacology Bulletin1973;9(1):13‐27. ">Derogatis 1973</a>; <a href="./references#CD001088-bbs2-0180" title="DerogatisLR , YevzeroffH , WittelsbergerB . Social class, psychological disorder, and the nature of the psych0pathologic indicator. Journal of Consulting and Clinical Psychology1975;43(2):183‐91. ">Derogatis 1975</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Symptom Checklist 90‐revised</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SCL‐90‐R</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0182" title="DerogatisLR . SCL‐90‐R: Administration, Scoring &amp; Procedures Manual‐II. Towson, MD: Clinical Psychometric Research, 1983. ">Derogatis 1983b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Schizophrenia Change Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SCR</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0257" title="MontgomerySA , AsbergM , TaylorP , MontgomeryD . Development of a schizophrenia scale sensitive to change. Neuropharmacology1978;17(12):1061‐3. ">Montgomery 1978</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Young Mania Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>YMRS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0303" title="YoungRC , BriggsJT , ZieglerVE , MeyerDA . A rating scale for mania: reliability, validity and sensitivity. British Journal of Psychiatry1978;133(November):429‐35. ">Young 1978</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><i><b>General function scales</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Global Assessment of Functioning</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>GAF</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0195" title="APA1994 . Diagnostic &amp; Statistical Manual of Mental Disorders. 4th Edition. Washington, DC: APA, 1994. ">DSM‐IV</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Health of the Nation Outcome Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>HoNOS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0300" title="WingJK , CurtisR , BeevorA . The Health of the Nation Outcome Scales. London: Royal College of Psychiatrists, 1996. ">Wing 1996</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Role Functioning Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>RFS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0203" title="GreenRS , GracelyEJ . Selecting a rating scale for evaluating services to the chronically mentally ill. Community Mental Health Journal1987;23(2):91‐102. ">Green 1987</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Social Adjustment Scale for the Severely Mentally Ill</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SAS‐SMI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0298" title="WieduwiltKM , JerrellJM . The reliability and validity of the SAS‐SMI. Journal of Psychiatric Research1999;33(2):105‐12. ">Wieduwilt 1999</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Social Functioning Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SFS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0154" title="BirchwoodM , SmithJ , CochraneR , WettonS , CopestakeS . The Social Functioning Scale: the development and validation of a scale of social adjustment for use in family intervention programmes with schizophrenic patients. British Journal of Psychiatry1990;157(December):853‐9. ">Birchwood 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The Social and Occupational Functioning Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SOFAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0202" title="GoldmanHH , SkodalAE , LaveTR . Revising Axis V for DSM‐IV: a review of measures of social functioning. Americal Journal of Psychiatry1992;149(9):1148‐56. ">Goldman 1992</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><i><b>Quality of life scales</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Brief Quality of Life Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>BQOL</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0239" title="LehmanAF . Evaluating Quality of Life for Persons with Severe Mental Ilness: Assessment Toolkit. Cambridge, Mass: The Evaluation Center at Health Services Research Institute, 1995. ">Lehman 1995</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Life Satisfaction Checklist</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>LSC</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0158" title="BondGR , MillerLD , KrumwiedRD , WardRS . Assertive case management in three CMHCs: a controlled study. Hospital and Community Psychiatry1988;39(4):411‐8. ">Bond 1988</a>; <a href="./references#CD001088-bbs2-0159" title="BondGR , WitheridgeTF , DincinJ , WasmerD , WebbJ , DeGraaf‐KaserR . Assertive community treatment for frequent users of psychiatric hospitals in a large city: a controlled study. American Journal of Community Psychology1990;18(6):865‐91. ">Bond 1990</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Manchester Short Assessment of Quality of Life</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MANSA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0270" title="PriebeS , HuxleyP , KnightS , EvansS . Application and results of the Manchester Short Assessment of Quality of Life (MANSA). International Journal of Social Psychiatry1999;45(1):7‐12. ">Priebe 1999</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Quality of Life Interview</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>QOLI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0238" title="LehmanAF . A quality of life interview for the chronically mentally ill. Evaluation and Program Planning1988;11(1):51‐62. ">Lehman 1988</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Satisfaction with Life Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SLS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0286" title="SteinLI , TestMA . Alternative to mental hospital treatment: 1 Conceptual model, treatment program, and clinical evaluation. Archives of General Psychiatry1980;37(4):392‐7. ">Stein 1980</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>World Health Organization's Quality of Life assessment scale, short version</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>WHOQOL‐BREF</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0284" title="SkevingtonSM , LotfyM , O'ConnellKA . The World Health Organization's WHOQOL‐BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Quality of Life Research2004;13(2):299‐310. ">Skevington 2004</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><i><b>Other</b> </i> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Client Satisfaction Questionnaire</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>CSQ</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0236" title="LarsenDL , AttkissonCC , HargreavesWA , NguyenTD . Assessment of client/patient satisfaction: development of a general scale. Evaluation and Program Planning1979;2(2):197‐207. ">Larsen 1979</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Medication Adherence Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>MARS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD001088-bbs2-0289" title="ThompsonK , KulkarniJ , SergejewAA . Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research2000;42(3):240‐7. ">Thompson 2000</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The Service Utilization Rating Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>SURS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD001088-bbs2-0254" title="MihalopoulosC , McGorryPD , CarterRC . Is phase‐specific community ‐oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatrica Scandinavica1999;100(1):47‐55. ">Mihalopoulos 1999</a> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">List of scales and abbreviations used in included studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/full#CD001088-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001088-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Integrated models of care versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Leaving the study early: 1. Lost to treatment ‐ by 36 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>603</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.09 [0.82, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Leaving the study early: 2. Lost to evaluation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.27, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>330</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.27, 1.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 By 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>132</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.49, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.22, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 By 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.47, 2.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 By 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>603</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.35, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse event: 1. Death ‐ by 36 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.39, 3.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Substance use: 1. Clinically important change (not in remission) ‐ by 36 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Alcohol use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.84, 1.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Drug use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.63, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Substance use: 2. Average score for progress towards recovery (SATS, low = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.07 [‐0.28, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 By 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.11 [‐0.41, 0.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Substance use: 3a. Alcohol use: average score (AUS) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Substance use: 3b. Alcohol use: average number of days using in last 6 months (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.7 6 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.8 12 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.9 18 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.10 24 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.11 30 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.12 36 month</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Substance use: 4a. Drug use: average score (DUS) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.6 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Substance use: 4b. Drug use: average number of days using in last 6 months (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.7 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.8 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.9 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.10 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.11 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.12 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Substance use: 5. Avearage score (SATS, low = poor) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.5 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.6 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Substance use: 6. Average score ( USS, high = poor) 1=client not abstinent, 5 client mets criteria for severe use) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Mental state: 1. Average score (BPRS, high = poor) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.5 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.6 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Global state: 1. Average score (GAF, low = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>162</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [‐1.58, 3.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐2.07, 3.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 By 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [‐1.58, 3.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.4 By 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>166</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.70 [‐1.18, 4.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.5 By 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐3.56, 2.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.6 By 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>170</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [‐2.47, 3.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Global state: 2. Forensic measures (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 Arrests ‐ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 Convictions ‐ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 Felony ‐ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.4 Hospital or jail ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.5 Jail days ‐ 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Quality of life/ life satisfaction: 1. Average general score (QOLI, range 1‐7, low = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>361</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.11 [‐0.41, 0.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>372</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.28, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.3 By 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>377</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [‐0.27, 0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.4 By 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>370</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.29, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.5 By 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>366</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [‐0.27, 0.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.6 By 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>373</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.18, 0.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Service use: 1. Days in stable community residences (not in hospital) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>378</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐10.00 [‐38.61, 18.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 By 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>203</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.40 [‐6.32, 21.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3 By 36 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.17 [‐9.20, 19.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Service use: 2. Number hospitalised ‐ during the 36 month study period <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.64, 1.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Service use: 3. Relapse (hospitalisation days and crisis care) ‐ 36 months (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Service use: 4. Medication hours ‐ 36 months (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Service use: 5. Various measures (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 Days institutionalised (hospital or incarcerated) ‐ 36 months (site 2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 Days in hospital ‐ 36 months (site 2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Homelessness: 1. Proportion of time on the street ‐ past 60 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>21.3 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Homelessness: 2. Proportion of time in independent housing ‐ past 60 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.3 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Homelessness: 3. Average number of days in stable housing (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.3 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.4 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">24 Homelessness: 4. Various measures (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.3 Time on streets (%) ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.4 Time on streets (%) ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.5 Time on streets (%) ‐ 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.6 Days in stable community residence ‐ 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.7 Time in independent housing in past 60 days ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.8 Time in independent housing in past 60 days ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>24.9 Time in independent housing in past 60 days ‐ 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Integrated models of care versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001088-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Leaving the study early: 1. Lost to treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.23 [0.73, 2.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.21 [0.73, 1.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 By 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>134</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.83, 2.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Leaving the study early: 2. Lost to evaluation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.38, 2.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.43, 2.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 By 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.48, 3.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Substance use: 1. Average scores on various scales (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Alcohol ‐ 6 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Alcohol ‐ 12 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Alcohol ‐ 18 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 Drugs ‐ 6 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5 Drugs ‐ 12 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6 Drugs ‐ 18 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7 General ‐ 12 months (ASI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Substance use: 2. Average score (USS, high = poor (1=client not abstinent, 5 client mets criteria for severe use) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 1. Average scores on various scales (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Depression symptoms ‐ 6 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Depression symptoms ‐ 12 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3 Depression symptoms ‐ 18 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4 General ‐ average score ‐ 12 months (ASI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.5 Manic symptoms ‐ 6 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.6 Manic symptoms ‐ 12 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.7 Manic symptoms ‐ 18 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.8 Schizophrenia symptoms ‐ 6 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.9 Schizophrenia symptoms ‐ 12 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.10 Schizophrenia symptoms ‐ 18 months (C‐DIS‐R)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Global state: 1. Forensic measures ‐ number of arrests (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Global state: 2. Forensic measures ‐ number of convictions (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Global state: 3. Forensic measures ‐ days in jail (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.30 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Social functioning: 1. Average role functioning score (RFS, high = better functioning) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.78 [‐2.91, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐1.56, 2.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.3 By 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.67 [‐5.28, ‐0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Social functioning: 2. Average social adjustment score (SAS, high = better functioning) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.93 [‐6.34, 4.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.09 [‐2.71, 8.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 By 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>29</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.75 [‐10.12, 2.62]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Quality of life/ life satisfaction: 1. Average score (QOLI, skewed data) ‐ 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Service use: 1. Relapse (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.5 % days in hospital</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Service use: 2. Various measures ‐ 24 months (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 State Operated admissions (site 1, Robert Young)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 State Operated admissions (site 2, Pilsen‐Little)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 State operated days admitted (site 1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.4 State Operated days admitted (site 2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.5 Private Hospital length of stay (site 1, days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.6 Private Hospital length of stay (site 2, days)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Homelessness: 1. Average number of days in stable housing (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.4 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Non‐integrated models of care (Assertive Community Treatment / Intensive Case Management / Specialised case management sercives) versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001088-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Cognitive behavioural therapy versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Leaving the study early: 1. Lost to treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>152</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.44, 2.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Leaving the study early: 2. Lost to evaluation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 By 9 months after start of treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.43, 2.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Substance use: 1. Percentage of participants who used cannabis ‐ in last 4 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.62, 1.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.30 [0.79, 2.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Substance use: 2. Average score (various scales) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 CASUAS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 HONOS ‐ item 3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Mental state: 1. Average insight score (Insight Scale, low = poor) ‐ by 3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [‐0.78, 1.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Mental state: 2. Average score (various scales) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Anxiety symptoms ‐ 3 months (BAS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Depressive symptoms ‐ 3 months (BDI‐SF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Depressive symptoms ‐ 3 months (MADRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 Depressive symptoms ‐ 6 months (BDI‐SF)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.6 General symptoms total score ‐ 3 months (BPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.7 General ‐ 3 months (CPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.8 General ‐ 3 months (SCR)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.9 General symptoms total score ‐ 6 months (BPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.11 Negative symptoms ‐ 3 months (SANS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.12 Negative symptoms ‐ 6 months (SANS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Social functioning: 1. Average score (SOFAS, low = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.80 [‐9.95, 8.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.70 [‐14.52, 5.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Social functioning: 2. Average score (HONOS) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Service use: 1. Outpatient medication (SURS) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Cognitive behavioural therapy versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001088-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Contingency management versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Leaving the study early: 1. Lost to treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Week 4 ‐ 8 (1 ‐ 2 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.04, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Lost to treatment ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.55 [1.13, 2.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Leaving the study early: 2. Lost to evaluation ‐ 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>255</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [0.91, 2.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Substance use: 1. Stimulant‐positive urine test (higher = poor outcome) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Stimulant‐positive urine test ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.17, 0.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Stimulant‐positive urine test ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.65, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Substance use: 2. Number of continuous days alcohol negative urine tests, 3 months (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Substance use: 3. Injection use <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 During treatment ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.42, 0.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 During follow‐up ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.53, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Substance use: 4. Average scores on various measures (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Stimulant use days ‐ 3 months (skewed data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Stimulant use days ‐ 6 months (skewed data)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.3 Days of alcohol ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.4 Days of alcohol ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.5 5. Longest consecutive weeks of cocaine abstinence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Mental state: 1. Average scores (various scales) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 Brief Symptom Inventory ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 Brief Symptom Inventroy ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 PANSS, excitement scale ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.4 PANSS, excitement scale ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Service use: 1. Relapse (hospitalised ‐ 6 months post‐randomisation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.21 [0.05, 0.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Contingency management versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001088-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Motivational interviewing versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Leaving the study early: 1. Lost to treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.30, 2.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.71 [0.63, 4.64]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Leaving the study early: 2.Lost to evaluation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>457</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.69, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>164</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.29, 2.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.44, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse event: 1. Death, due to all causes, by 18 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.07, 15.73]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Substance use: 1. Using substances ‐ by class of drug ‐ by about 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Alcohol abuse/dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.62, 2.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 Amphetamine abuse/dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.03, 1.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 Cannabis abuse/dependence</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.49, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Substance use: 2. Polydrug consumption levels ‐ by 12 months (OTI, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.41 [‐0.91, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.07 [‐0.56, 0.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Substance use: 3. Any change ‐ not abstinent or not improved on all substances ‐ by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.24, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Substance use: 4. Any change ‐ not abstaining from alcohol <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.26, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.36 [0.17, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Substance use: 5. Change in cannabis use from baseline (T0) (lower scores indicate better outcome) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐12.81 [‐23.05, ‐2.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.64 [‐18.05, ‐1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.82 [‐14.77, 3.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Substance use: 6. Cannabis consumption past 30 days (ASI, high = poor) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>9.2 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Substance use: 7. Engagement with substance misuse treatment at 3 months (SATS, low = poor)) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.47, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Substance use: 8. Average scores (OTI, high = poor) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 Alcohol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 Amphetamine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.3 Cannabis</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.4 Polydrug use</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Substance use: 9. Other measures of alcohol use (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 Alcohol volume (AUI subscale)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 Drinking days ‐ by 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.3 Alcohol consumption, last 30 days (ASI) ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.4 Alcohol consumption, last 30 days (ASI) ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.5 Alcohol use (AUDIT) ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.6 Alcohol use (CAUS) ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.7 Drug use (CDUS) ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.8 Drug use (SDS) ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Mental state: 1. Average scores (SCL‐90‐R, high = poor) ‐ by 3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 General severity index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.59, 0.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Positive symptom distress index</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.66, 0.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 Positive symptom scores</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.20 [‐18.72, 10.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Mental state: 2. Average scores (PANSS negative symptoms, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐2.06, 1.86]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [‐1.80, 1.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Mental state: 3. Average scores (PANSS positive symptoms, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐2.55, 1.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>15.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐2.58, 2.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Mental state: 4. Average score (HADS, BSI, high = poor) (skewed data) ‐ by 3 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 HADS‐A, Anxiety</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 HADS‐D, Depression</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.3 BSI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Global state: 1. Average score (GAF, low = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.40 [‐3.53, 2.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.0 [‐4.81, 2.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>17.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.30 [‐1.30, 5.90]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Global state: 2. Forensic measures ‐ average number of crimes (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>18.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Social functioning: 1. Average score (OTI, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.71 [‐2.76, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>19.2 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.42 [‐3.35, 0.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Social functioning: 2. Average score (SOFAS, low = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐3.02, 3.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐3.51, 3.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.70 [‐1.08, 6.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Service use: Hospital admission to 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.42, 1.80]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Service use: Lost to first aftercare appointment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.69 [0.53, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Motivational interviewing versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001088-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Skills training versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Leaving the study early: 1. Lost to treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>461</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.68, 1.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 By 6‐9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>94</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.24, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.20, 10.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 By 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.60 [1.36, 4.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Leaving the study early: 2. Lost to evaluation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.66, 1.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 1. By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.40, 2.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 2. By 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.47, 2.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 3. By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.55, 2.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse event: 1. Death ‐ by 12 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>121</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.15 [0.02, 1.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Substance use: 1. Alcohol use: proportion days abstinent from alcohol (TLFB method) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>398</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 1. 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [0.00, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 2. 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.05 [‐0.07, ‐0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.3 3. 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.01, 0.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.4 4. 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>93</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [0.00, 0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Substance use: 2. Average scores (C‐DIS‐R) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Alcohol</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 Drugs</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Sustance use: 3. Average days used (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Any alcohol in last 30 days, at follow‐up (6 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 Any illicit drug in last 30 days, at follow‐up (6 months)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Social functioning: 1. Average score (RFS, high = better functioning) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [‐1.63, 2.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.2 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [‐1.15, 3.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.3 By 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.55 [‐6.24, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Social functioning: 2. Average score (SAS, high = better functioning) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.92 [‐6.58, 4.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.58 [‐3.39, 8.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 By 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.66 [‐15.29, 5.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Service use: 1. Days in hospital (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Skills training versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001088-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Cognitive behavioural therapy + motivational interviewing versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Leaving the study early 1. Lost to treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>318</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.44, 3.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>815</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.66, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 By 9‐10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>211</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.52, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.62, 1.59]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Leaving the study early: 2. Lost to evaluation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>230</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.46, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.57, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 By 9 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>146</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.46, 1.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4 By 12‐14 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>464</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.73, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5 By 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>363</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.61, 1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6 By 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.52, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Adverse event: 1. Death ‐ by about 1 year <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>603</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.20, 1.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Adverse event: 2. Death or hospitalisation by 24 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.15 [0.76, 1.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Substance use: 1. Average number of different drugs used during the past month (OTI, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 By 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [‐0.01, 0.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>119</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.19 [‐0.22, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Substance use: 2. Cannabis use last 30 days <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 3 months (end of treatment)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.20 [‐2.54, 2.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.2 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.30 [‐2.84, 2.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Substance use 3. Clinically important change ‐change in main substance use, abstinent or large decease <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.43, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1 From baseline to 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.43, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Substance use: 4. Averages of various measures (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1 Alcohol ‐ estimated daily consumption ‐ past month ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.2 Alcohol ‐ estimated daily consumption ‐ past month ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.3 Alcohol ‐ estimated daily consumption ‐ past month ‐ 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.4 Alcohol ‐ frequency per month by 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.5 Alcohol quantity per session ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.6 Alcohol Assessment ‐ AUDIT ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.7 General ‐ ASI score ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.8 Drug abuse screening test ‐ DAST‐10 by 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.9 Amphetamine‐ estimated daily consumption ‐ past month ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.10 Amphetamine‐ estimated daily consumption ‐ past month ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.11 Amphetamine‐ estimated daily consumption ‐ past month ‐ 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.12 Cannabis‐ estimated daily consumption ‐ past month ‐ 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.13 Cannabis‐ estimated daily consumption ‐ past month ‐ 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.14 Cannabis‐ estimated daily consumption ‐ past month ‐ 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.16 cannabis ‐ days of use last month by 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.17 Cannabis ‐ days of use last month by 10‐12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.18 Cannabis ‐ joints last 30 days by 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.19 Cannabis ‐ joints last 30 days by 10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.20 Proportion of days abstinence from all substances last 90 days by 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.21 Proportion of days abstinence from all substances last 90 days by 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.22 Proportion of days abstinence from all substances last 90 days by 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.23 Proportion of days abstinence from all substances last 90 days by 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Substance use: 5. Average change in % days abstinent during &amp; after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10 Mental state: 1. Average score (PANSS, total, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>78</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [‐5.91, 7.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.2 By 9‐10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐5.01 [‐11.25, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.3 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.52 [‐0.68, 5.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>10.4 By 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.71 [‐0.58, 6.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11 Mental state: 2. Average score (PANSS positive symptoms, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1 By 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.03 [‐1.18, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.2 By 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [‐0.80, 1.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12 Mental state: 3. Average score (PANSS negative symptoms, high = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1 by 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>274</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.39 [‐0.65, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.2 by 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.16 [‐0.84, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13 Mental state: 4. Average score (various scales, high = poor)) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1 Depressive symptoms ‐ 3 months (BDI‐11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.2 Depressive symptoms ‐ 6 months (BDI‐11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.3 Depressive symptoms ‐ 12 months (BDI‐11)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.4 Depressive symptoms ‐ 3 months Calgary Depression Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.5 Depressive symptoms ‐ 12 months Calgary Depression Scale</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.6 General symptoms total score ‐ 6 months (BPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.7 General symptoms total score ‐ 12 months (BPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.8 General symptoms total score ‐ 3 months (BPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.9 General symptoms ‐ 18 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.10 Total score ‐ 3 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.11 Total score ‐ 6 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.12 Total score ‐ 12 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.13 Total score ‐ 18 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.14 Manic symptoms ‐ 3 months (BPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.15 Manic symptoms ‐ 6 months (BPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.16 Manic symptoms ‐ 12 months (BPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.17 Negative symptoms ‐ 3 months (BPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.18 Negative symptoms ‐ 6 months (BPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.19 Negative symptoms ‐ 12 months (BPRS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.20 Negative symptoms ‐ 6 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.21 Negative symptoms ‐ 9‐10 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.22 Negative symptoms ‐ 12 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.23 Negative symptoms ‐ 18 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.24 Negative symptoms ‐ 3 months (SANS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.25 Negative symptoms ‐ 12 months (SANS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.26 Positive symptoms ‐ 6 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.27 Positive symptoms ‐ 9‐10 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.28 Positive symptoms ‐ 12 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.29 Positive symptoms ‐ 18 months (PANSS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.30 Positive symptoms ‐ 3 months (SAPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.31 Positive symptoms ‐ 12 months (SAPS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14 Global state: 1. Average score (GAF, low = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>277</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.17 [‐2.79, 2.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.2 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [‐2.46, 5.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.3 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>445</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [‐1.86, 4.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.4 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.57 [‐3.07, 12.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.5 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>234</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.21 [‐2.93, 2.51]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">15 Global state: 2. Forensic measures ‐ arrests reported ‐ by 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.49 [0.22, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">16 Social functioning: 1. Average score (SFS, low = poor) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.1 By end of 9 month treatment</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.01 [‐0.55, 10.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>16.2 By 12 months (3 months following treatment end)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.27 [0.86, 13.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">17 Quality of life/ life satisfaction: 1. Average score (BQOL (general life satisfaction, low = poor) ‐ by 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.00, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">18 Quality of life/ life satisfaction: 2. Average score (BQOL (overall quality of life, low = poor) ‐ by 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.02 [‐0.61, 0.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">19 Quality of life/ life satisfaction: 3. Average score (WHOQOL, Bref, higher scores = better QoL) ‐ by 6 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐15.70 [‐36.19, 4.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">20 Quality of life/ life satisfaction: 4. Average score (MANSA, higher scores = better QoL) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.1 By 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.70 [‐7.01, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>20.2 By 10 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [‐3.73, 5.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">21 Quality of life/ life satisfaction: 5. Average score (CSQ ‐ client satisfaction, high = good) ‐ by 10 months <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.40 [3.87, 8.93]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">22 Service use: 1. Relapse (hospitalised) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.1 By end of 9 month treatment phase</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>107</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.29, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.2 By 3 months after treatment finished ‐ 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [0.24, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>22.3 By 9 months after treatment finished ‐ 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>105</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.34, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">23 Economic outcomes: 1. Direct cost in US$ (BQOL, money subscale) (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>23.1 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Cognitive behavioural therapy + motivational interviewing versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001088-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Cognitive behavioural therapy + psychosocial rehabilitation versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Forensic measures ‐ number of arrests (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 2. Forensic measures ‐ number of convictions (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Global state: 3. Forensic measures ‐ days in jail (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.30 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Cognitive behavioural therapy + psychosocial rehabilitation versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001088-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Cognitive behavioural therapy + intensive case management versus standard care</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Global state: 1. Forensic measures‐ number of arrests (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Global state: 2. Forensic measures ‐ number of convictions (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Global state: 3. Forensic measures ‐ days in jail (skewed data) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 12 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 18 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.4 30 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Other data</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>No numeric data</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Cognitive behavioural therapy + intensive case management versus standard care</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD001088-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Sensitivity analysis</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Motivational interviewing versus standard care: Leaving the study early: 1. Lost to evaluation short term (3‐6 months): Diagnostic criteria <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>506</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.69, 1.54]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Mixed diagnoses (Schizophrenia, bipolar, &amp; depressed patients )</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.61, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Schizophrenia &amp; other psychoses only</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>208</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.18, 4.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Cognitive behavioural therapy + motivational interviewing versus standard care: Global state: 1. Average score (GAF, low = poor) at 12 months: Allocation concealment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Unclear risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>144</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.63 [‐1.89, 5.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 Low risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.67 [‐6.79, 14.14]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Sensitivity analysis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD001088.pub4/references#CD001088-tbl-0021">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD001088.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD001088-note-0005">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD001088-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD001088-note-0007">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD001088-note-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD001088-note-0003">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD001088-note-0002">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD001088-note-0008">Polski</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD001088-note-0001">繁體中文</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD001088-note-0023">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001088\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001088\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001088\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD001088\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD001088\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=Ko3zGe0H&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001088.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD001088.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD001088.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD001088.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD001088.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726056399"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001088.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726056403"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD001088.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e8a50ad9e9379',t:'MTc0MDcyNjA1Ni4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 